ethambutol has been researched along with rifampin in 2311 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 903 (39.07) | 18.7374 |
1990's | 304 (13.15) | 18.2507 |
2000's | 388 (16.79) | 29.6817 |
2010's | 580 (25.10) | 24.3611 |
2020's | 136 (5.88) | 2.80 |
Authors | Studies |
---|---|
Kitaura, K; Mineura, K; Murayama, Y; Nakamizo, A; Nakamizo, Y; Niino, H; Okachi, R; Ono, T | 1 |
Johansson, CB; Topcu, G; Ulubelen, A | 1 |
Bansal, NP; Dick, JD; Houston, TA; Jones, PB; Parrish, NM; Stapon, A; Townsend, CA | 1 |
Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Pavana, RK; Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
Agarwal, KC; Chaturvedi, V; Gaikwad, A; Manju, YK; Pandey, J; Sinha, S; Srivastva, AK; Tripathi, RP; Verma, SS | 1 |
Hashizume, H; Kawasaki, M; Komatsu, M; Matsumoto, M; Sasaki, H; Shimokawa, Y; Tomishige, T; Tsubouchi, H | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Ballell, L; Chung, GA; Field, RA; Young, RJ | 1 |
Banerjee, D; Dhakla, P; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
Abe, C; Chiba, T; Morikawa, H; Nishimura, K; Onozaki, K; Takii, T; Yamamoto, Y | 1 |
Aarnoutse, RE; Alisjahbana, B; Nijland, HM; Parwati, I; Ruslami, R; van Crevel, R | 1 |
Duarte-Fajardo, ZV; Estrada-Soto, S; González-Salazar, F; Hernández-Núñez, E; Molina-Salinas, GM; Navarrete-Vázquez, G; Said-Fernández, S; Vargas-Villarreal, J | 1 |
Alves, LL; Araújo, DP; de Almeida, MV; de Souza, MA; Ferreira, AP; Hyaric, ML; Lourenço, MC; Reis, EF; Taveira, AF; Vicente, FR | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Akhalaia, M; Gegia, M; Han, J; Khechinashvili, G; Li, H; Mdivani, N; Mendes, RE; Tang, YW | 1 |
Alland, D; Hazbón, MH; Safi, H; Sayers, B | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Aarnoutse, RE; Boeree, MJ; Kibiki, GS; Kisanga, ER; van den Boogaard, J | 1 |
Karthikeyan, SV; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cartabuke, RH; Nguyen, HT; Nguyen, L; Ogwang, S; Singh, A; Wolff, KA | 1 |
Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Govender, K; Govender, P; Govender, T; Kruger, HG; Maguire, GE; Muthusamy, K; Onajole, OK; Pillay, M; van Helden, PD; Wiid, I | 1 |
Alves, M; Del Olmo, E; Escarcena, R; Feliciano, AS; Hernandez-Pando, R; López-Pérez, JL; Molina-Salinas, GM; Said-Fernández, S | 1 |
Rieder, RJ; Zavizion, B; Zhao, Z | 1 |
Banerjee, D; Indumathi, S; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
Alland, D; Fleischmann, RD; Jarrahi, B; Jones, MB; Peterson, SN; Safi, H | 1 |
Abe, C; Chiba, T; Horita, Y; Inagaki, E; Kuroishi, R; Kurono, Y; Maeda, Y; Mori, M; Nishimura, K; Onozaki, K; Takii, T; Yamamoto, Y | 1 |
Kumar, RS; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P | 1 |
Bala, BD; Karthikeyan, SV; Perumal, S; Raja, VP; Sriram, D; Yogeeswari, P | 1 |
Banerjee, D; Bhat, P; Dinakaran, M; Gadhwal, S; Sriram, D; Yogeeswari, P | 1 |
Aarnoutse, RE; Adhiarta, IG; Alisjahbana, B; Kariadi, SH; Nijland, HM; Ruslami, R; van Crevel, R | 1 |
Angulo-Barturen, I; Beltrán, M; Cáceres, N; Cardona, PJ; García, JI; García-Bustos, JF; Rullas, J | 1 |
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
Balamurugan, K; Perumal, S; Prasanna, P; Sriram, D; Yogeeswari, P | 1 |
Balamurugan, K; Maheswari, SU; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
Briguglio, I; Carta, A; Corona, P; Guglierame, P; Jabes, D; Molicotti, P; Palomba, M; Piras, S; Zanetti, S | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Degani, MS; Devarajan, P; Kakwani, MD; Majee, S; Rajan, MG; Ray, M; Samad, A; Suryavanshi, P | 1 |
Kumar, RS; Libertsen, LA; Perumal, S; Rajesh, SM; Sriram, D; Yogeeswari, P | 1 |
Menéndez, JC; Perumal, S; Ranjith Kumar, R; Sriram, D; Yogeeswari, P | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Mugunthan, G; Ramakrishna, K; Ravindranathan Kartha, KP; Sriram, D; Yogeeswari, P | 1 |
Kantevari, S; Sridhar, B; Sriram, D; Surineni, G; Yempala, T; Yogeeswari, P | 1 |
Gunasekaran, P; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
Chitra, S; Manisankar, P; Muthusubramanian, S; Paul, N; Sriram, D; Yogeeswari, P | 2 |
Joseph-Nathan, P; Lankin, DC; Molina-Salinas, GM; Muñoz, MA; Pauli, GF; Rivas-Galindo, VM; Said-Fernández, S; Waksman, N | 1 |
Murugavel, M; Muthusubramanian, S; Paul, N; Sriram, D | 1 |
Constant, P; Daffé, M; Massimba Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Senadeera, SP; Sureram, S | 1 |
Bucar, F; Gröblacher, B; Kunert, O | 1 |
Chikhalia, KH; Kumari, P; Patel, PK; Patel, RV; Rajani, DP | 1 |
Almansour, AI; Arumugam, N; Sriram, D; Suresh Kumar, R | 1 |
Alexandrova, L; Andreevskaya, S; Chernousova, L; Chizhov, A; Karpenko, I; Khandazhinskaya, A; Kochetkov, S; Matyugina, E; Smirnova, T | 1 |
Ali, MA; Choon, TS; Ismail, R; Kumar, RS; Wei, AC; Yoon, YK | 1 |
Gonnade, RG; Mujahid, M; Muthukrishnan, M; Sriram, D; Yogeeswari, P | 1 |
Alexandrova, LA; Andreevskaya, SN; Chernousova, LN; Chizhov, AO; Efremenkova, OV; Karpenko, IL; Kochetkov, SN; Shmalenyuk, ER; Smirnova, TG | 1 |
Barry, CE; Dartois, V | 1 |
Close, W; Cook, JM; Deschamps, JR; Kabir, MS; Lane, M; Medina-Bielski, S; Monte, A; Polanowski, RL; Rott, M; Schwan, WR; Sherman, D; Tiruveedhula, VV; Verma, R; Witzigmann, CM | 1 |
Danac, R; Mangalagiu, II | 1 |
Kantevari, S; Sridevi, JP; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
Asís, SE; Buldain, GY; Muscia, GC | 1 |
Balkan, A; Dharmarajan, S; Ozadali, K; Tan, OU; Yogeeswari, P | 1 |
Chikhalia, KH; Kumari, P; Patel, AB | 1 |
Ambady, A; Guptha, S; Hegde, N; Hosagrahara, VP; Humnabadkar, V; Kaur, P; Mahadevaswamy, J; Nagalapur, K; Narayan, A; Panda, M; Raichurkar, A; Ramachandran, S; Ramachandran, V; Rudrapatna, SS; Sambandamurthy, VK; Sharma, S; Shirude, PS | 1 |
Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
Basireddy, VS; Dharmarajan, S; Guttala, RS; Jagarlamudi, PS; Mukkara, LD; Pagadala, LR; Perumal, Y; Ravirala, N; Singh, A; Singireddi, S; Thummaluru, VR; Ummanni, R; Upadhyayula, SM | 1 |
Devi, PB; Jeankumar, VU; Pedgaonkar, GS; Renuka, J; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 2 |
Babu, KS; Chuppala, A; Jeankumar, VU; Reddy, KI; Renuka, J; Sree, KS; Sridevi, JP; Srihari, K; Sriram, D; Yogeeswari, P | 1 |
Aree, T; Ganihigama, DU; Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Sangher, S; Sureram, S | 1 |
Boido, V; Cannas, S; Loddo, R; Molicotti, P; Novelli, F; Parapini, S; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Zanetti, S | 1 |
Devi, PB; Samala, G; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
Chaturvedi, V; Dasgupta, A; Gupta, AD; Jaiswal, S; Kashyap, VK; Khan, SR; Krishnan, MY; Lal, J; Roy, KK; Saxena, AK; Sharma, A; Sharma, SK; Singh, S; Sinha, S; Srivastava, R | 1 |
Bowornwiriyapan, K; Daengrot, C; Phongpaichit, S; Rukachaisirikul, V; Sakayaroj, J; Tansakul, C; Thongpanchang, T | 1 |
Renuka, J; Samala, G; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
Bera, S; Chaturvedi, V; Jana, AK; Kumar M, SL; Manna, SK; Mishra, P; Mondal, S; Panda, G; Parai, MK; Saha, T; Singh, P; Singh, S; Sinha, S; Trivedi, P | 1 |
Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR | 1 |
Daletos, G; de Voogd, NJ; Hartmann, R; Kalscheuer, R; Koliwer-Brandl, H; Lin, W; Proksch, P; Wray, V | 1 |
Askri, M; Boudriga, S; Golz, C; Knorr, M; Mhiri, C; Nana, F; Sriram, D; Strohmann, C; Yogeeswari, P | 1 |
Chen, M; Gao, N; Jiang, JD; Jiang, W; Li, D; Li, Y; Lin, Y; Lu, Y; Si, S; Wan, K; You, X; Zhu, N | 1 |
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS | 1 |
Bhatt, JD; Chudasama, CJ; Patel, KD | 1 |
Caneschi, W; Couri, MRC; da Silveira, LS; de Almeida, MV; de Oliveira, PF; de Souza Fernandes, F; Diniz, CG; Fernandes, TS; Le Hyaric, M; Lourenço, MCS; Martins, SPL; Pereira, DE; Tavares, DC | 1 |
Dusthackeer, AVN; Jaswanth S, B; Malathi, J; Narender, M; Raghuram R, A; Raghuram Reddy, A; Umadevi, KR; Umasankar, K; Venkat Rao, K | 1 |
Devi, PB; Meda, N; Samala, G; Saxena, S; Sriram, D; Yogeeswari, P | 1 |
Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Pancholia, S; Shah, P; Sridevi, JP; Sriram, D; Yogeshwari, P | 1 |
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Kumar, D; Sridevi, JP; Sriram, D; Vaja, MD; Yogeeswari, P | 1 |
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kumar, D; Lherbet, C; More, UA; Tigadi, N; Yang, KS | 1 |
Bowornwiriyapan, K; Duangjai, A; Muanprasat, C; Phainuphong, P; Phongpaichit, S; Rukachaisirikul, V; Saithong, S; Sakayaroj, J; Srimaroeng, C | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bantu, R; Jilla, L; Nagarapu, L; Sajja, Y; Sriram, D; Vanguru, S; Vulupala, HR; Yogeswari, P | 1 |
Bobesh, KA; Gunda, S; Jeankumar, VU; Reshma, RS; Saxena, S; Sriram, D; Yogeeswari, P | 1 |
Beuerman, RW; Cao, D; Corkran, HM; Dick, T; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Mukherjee, D; Stocker, BL; Tan, DTH; Tan, DZ; Tan, JK; Timmer, MSM; Zou, H | 1 |
Brindha Devi, P; Gunda, S; Samala, G; Saxena, S; Sriram, D; Yogeeswari, P | 1 |
Bacqué, E; Bauer, A; Cogo, E; Couturier, C; Kaneko, T; Lagrange, S; Lair, C; Menegotto, J; Pellet, A; Perron, C; Scheiper, B; Upton, A | 1 |
Chakraborti, AK; Kumar, A; Sriram, D; Tanwar, B; Yogeeswari, P | 1 |
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kulkarni, VH; Lherbet, C; Nadagouda, MN | 1 |
Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
Abbadi, BL; Back, DF; Basso, LA; Campos, MM; Giacobbo, BC; Grams, ES; Machado, P; Pissinate, K; Rodrigues-Junior, V; Santos, DS; Sperotto, N; Subtil, FT; Trindade, RV; Villela, AD | 1 |
Avalos-Alanís, FG; Carranza-Rosales, P; Guzmán-Delgado, NE; Hernández-Fernández, E; Hernández-Fernández, J; López-Cortina, S; Morales-Vargas, A; Ordóñez, M; Santiago-Mauricio, MG; Velázquez-Moreno, VM | 1 |
Adhikari, C; Krishna, VS; Reshma, RS; Sharada, DS; Sriram, D; Vidyacharan, S | 1 |
Feng, LS; Gao, C; Hu, YQ; Lv, ZS; Wu, X; Xu, Z; Zhang, S; Zhao, F | 1 |
Chang, L; Feng, LS; Gao, C; Lv, ZS; Ren, QC; Xu, Z; Zhang, S | 1 |
Feng, LS; Gao, C; Lv, ZS; Ren, QC; Song, XF; Xu, Z | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Sychra, P; Valášková, L; Vávrová, K; Vlčková, H | 1 |
Bantu, R; Nagarapu, L; Sajja, Y; Sriram, D; Vanguru, S; Vulupala, HR; Yogeswari, P | 1 |
Abay, E; Axtman, M; Ballell, L; Barry, CE; Boesche, M; Boshoff, HIM; Brunschwig, C; Chibale, K; Drewes, G; Gessner, RK; Ghidelli-Disse, S; Ghorpade, SR; Gordon, R; Harris, CJ; Lafuente-Monasterio, MJ; Lawrence, N; Lelièvre, J; Mizrahi, V; Moosa, A; Mueller, R; Nchinda, A; Njoroge, M; Pflaumer, H; Rebollo-Lopez, MJ; Santos, G; Sanz, O; Seldon, R; Selenski, C; Simelane, SB; Sirgel, FA; Soares de Melo, C; Street, LJ; Taylor, D; Urones, B; van Helden, P; Warner, DF; Wilson, CR | 1 |
Baikova, IP; Giniyatullina, GV; Kataev, VE; Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE | 1 |
Malapati, P; Meda, N; Nallangi, R; Reshma Srilakshmi, R; Siva Krishna, V; Sriram, D | 1 |
Krishna, VS; Malapati, P; Nallangi, R; Srilakshmi, RR; Sriram, D | 1 |
Aiub, CAF; Araujo-Lima, CF; Boechat, N; Castelo-Branco, FS; Costa, TEMM; Costa-Lima, MM; de Lima, EC; Domingos, JLO; Felzenszwalb, I; Gomes, KM; Henriques, MG; Lourenço, MCS; Penido, C; Pinto, AC | 1 |
Alluri, KK; Gottapu, S; Reshma, RS; Sriram, D; Suraparaju, R | 1 |
Bimal, D; Bohra, K; Jain, R; Maity, J; Ponnan, P; Prasad, AK; Singh, B; Srivastava, S; Thirumal, M; Varma-Basil, M | 1 |
Banerjee, A; Chakraborti, AK; Dhameliya, TM; Pancholia, S; Panda, D; Sriram, D; Tiwari, R | 1 |
Jachak, SM; Krishna, VS; Kumar, G; Sriram, D | 1 |
Jachak, SM; Krishna, VS; Kumar, G; Sathe, A; Sriram, D | 1 |
Ahmad, Z; Amin, S; Bhat, BA; Bhat, ZS; Dar, MJ; Lone, AM; Maqbool, M; Rather, MA; Shairgojray, BA; Singh, P; Teli, B; Yousuf, SK | 1 |
Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P | 1 |
Ahmad, Z; Ara, T; Bhat, ZS; Maqbool, M; Rather, MA; Ul Lah, H; Yousuf, SK | 1 |
Eslamimehr, S; Franzblau, SG; Kong, Y; Kurosu, M; Lemieux, MR; Mitachi, K; Park, F; Pressly, JD; Siricilla, S; Wang, Y; Yang, D | 1 |
Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
AnkiReddy, S; Bharathi Reddy, K; Rao Sagurthi, S; Sabitha, G; Shiva Raju, K; Siva Krishna, V; Sriram, D | 1 |
Chang, L; Ding, C; Feng, LS; Gao, C; Wu, X; Xu, Z; Yan, XF; Zhao, F | 1 |
Kantevari, S; Krishna, VS; Marvadi, SK; Sriram, D | 2 |
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D | 1 |
da Silva Emery, F; de Melo, SMG; Fumagalli, F; Pavan, FR; Ribeiro, CM; Solcia, MC | 1 |
Akhter, M; Alam, MM; Ali, S; Deora, GS; Krishna, VS; Sharma, K; Sriram, D; Tanwar, O; Zaman, MS | 1 |
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Cole, ST; Georgiadis, MO; Ioannidou, V; Karakitsios, E; Kelly, JM; Komiotis, D; Kourbeli, V; Papanastasiou, I; Taylor, MC; Tsotinis, A; Vocat, A | 1 |
Bera, S; Mondal, D | 1 |
Esaulkova, YL; Kantevari, S; Krishna, VS; Marvadi, SK; Muryleva, AA; Sinegubova, EO; Sriram, D; Tentler, DG; Volobueva, AS; Zarubaev, VV | 1 |
Dušek, J; Hrabálek, A; Huszár, S; Jand'ourek, O; Karabanovich, G; Klimešová, V; Kočová Vlčková, H; Konečná, K; Konyariková, Z; Korábečný, J; Korduláková, J; Kučera, T; Mikušová, K; Pávek, P; Pávková, I; Pavliš, O; Roh, J; Savková, K; Stolaříková, J; Vávrová, K | 1 |
Baranyai, Z; Bősze, S; Janďourek, O; Krátký, M; Novotná, E; Stolaříková, J; Vinšová, J | 1 |
Mabhula, A; Singh, V | 1 |
Augustynowicz-Kopeć, E; Bielenica, A; Chrzanowska, A; Dobrowolski, M; Głogowska, A; Roszkowski, P; Stępień, K; Struga, M; Szulczyk, D | 1 |
Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
Krishna, VS; Sirim, MM; Sriram, D; Unsal Tan, O | 1 |
Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Şahin, O; Sarıpınar, E; Sriram, D | 1 |
Ginalska, G; Golus, J; Kazimierczak, P; Paneth, A; Przekora, A; Trotsko, N; Wujec, M | 1 |
Aguirre-Rentería, SA; Arredondo-Espinoza, E; Avalos-Alanís, FG; Carrizales-Castillo, JJJ; Del Rayo Camacho Corona, M; Garza-González, E; Hernández-Fernández, E; Rivas-Galindo, VM | 1 |
George, SE; Guddat, LW; Krishna, VS; Nallangi, R; Rekha, EM; Sai Prasad, DV; Sriram, D; Zheng, S | 1 |
Jayathirtha Rao, V; Kishore, G; Kumar, SB; Ravinder, M; Sriram, D; Yogeeswari, P | 1 |
Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Sriram, D | 1 |
Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D | 1 |
Chen, M; Jiang, W; Jiang, X; Li, D; Li, Y; Lin, Y; Liu, C; Si, S; Xu, Y; You, X; Zhang, J | 1 |
Cordeiro, R; Kachroo, M | 1 |
Dhawan, S; Girase, PS; Karpoormath, R; Kumar, V; Palkar, MB; Shinde, SR | 1 |
Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
Trotsko, N | 1 |
Araújo, HM; Flávia do Amaral Moura, C; Gonçalves Ferreira, VP; Lapa Montenegro Pimentel, LM; Melo de Oliveira, VN; Nascimento de Oliveira, R; Nicolete, R; Peixoto, ADS; Pena, LJ; Pessoa, CDÓ; Rathi, B; Rollin, P; Sharma, PP; Tatibouët, A; Versiani Dos Anjos, J | 1 |
Ahmad, MN; Chopra, S; Dasgupta, A; Gaikwad, NB; Kaul, G; Nanduri, S; Rani, B; Sahoo, SK; Shukla, M; Yaddanapudi, VM | 1 |
Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R | 1 |
Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
Ahmad, MN; Chopra, S; Dasgupta, A; Kaul, G; Nanduri, S; Sahoo, SK; Yaddanapudi, VM | 1 |
Angebault, M; Bonniot, JP; Homasson, JP; Parent, G; Salignac, P | 1 |
Martin, PD | 1 |
Bates, JH | 1 |
Tuli, SM | 1 |
Newton, RW | 1 |
Schröder, KH | 1 |
Springett, VH | 1 |
Burjanová, B; Dornetzhuber, V | 1 |
Fawcett, IW; Watkins, BJ | 1 |
Clarke, PD | 1 |
Allan, GW; Lees, AW; Smith, J; Tyrrell, WF | 1 |
Fergie, R; Jack, DB; Knepil, J; McLay, WD | 1 |
Pearson, JO | 1 |
Mitchison, DA | 5 |
Fox, W | 2 |
Warkany, J | 1 |
Santhanam, K; Venkitasubramanian, TA | 1 |
Sundaram, KS; Venkitasubramanian, TA | 1 |
Brodsky, ML; Michael, NL; Ow, CL; Pien, FD; Vennesland, K | 1 |
Alekseenko, AM | 1 |
Iwainsky, H; Reutgen, H; Sesser, I | 1 |
Víznerová, A | 1 |
Farer, LS; Long, MW; Snider, DE | 1 |
Harris, AA; Karakusis, P | 1 |
Loudon, RG | 1 |
Kozlova, NV; Kozulitsyna, TI | 1 |
Bek, E; Janowiec, M; Zwolska-Kwiek, Z | 1 |
Chan, WC; O'Mahoney, MG; Yu, DY; Yu, RY | 1 |
Abrarov, BA; Ganiev, AG; Iusman, ZI; Mirzakhalov, DK; Stoianovskiĭ, EA | 1 |
Alberghina, M; Palermo, F | 1 |
Duroux, P | 1 |
Broquié, G | 2 |
Grenville-Mathers, R | 1 |
Sutherland, AM | 6 |
Zierski, M | 9 |
Bodaness, RS | 1 |
Hanke, CW; Higaki, M; Izumi, AK | 1 |
Chan, SL | 1 |
van Geuns, HA | 1 |
Kuntz, HD; Rausch, V | 2 |
Spiess, H | 1 |
Girling, DJ | 3 |
Alexander, MR; Guernsey, BG | 1 |
Burckart, GJ; Ch'ien, LT; McKenzie, MS | 1 |
Radenbach, KL | 4 |
Aquinas, M | 2 |
Grosset, J; Perdrizet, S; Pretet, S | 1 |
Macdonald, JB | 1 |
Abensohn, MK; Kobayashi, GS; Marr, JJ; McDaniel, RE; Medoff, G; Spoon, DR | 1 |
Aber, VR; Dickinson, JM; Mitchison, DA | 1 |
Kunze, M; Sanabria de Isele, T; Vogt, A | 1 |
Stur, D; Thiel, W | 1 |
Tomaszkiewicz, L; Woźniak-Dubla, S | 1 |
Afanas'eva, IuP; Kuznetsova, VI | 1 |
Camargo, EE; Charache, P; Chen, MF; Hwangbo, CC; Kertcher, JA; McIntyre, PA; Wagner, HN | 1 |
Bach, VT; Thadepalli, H; Webb, DW | 1 |
Kittel, H | 1 |
Campbell, PB | 1 |
Peatfield, RC; Shawdon, HH | 1 |
Anastasatu, C; Plopeanu, D | 1 |
Eule, H | 2 |
Gow, JG | 3 |
Campbell, IA; Dyson, AJ | 2 |
Dutt, AK; Stead, WW | 5 |
Malègue, D; Tillement, JP | 1 |
Lebeau, B; Rochemaure, J | 1 |
Aluoch, JA | 1 |
Johnston, RF; Promisloff, RA | 1 |
Kuze, F; Lee, Y; Maekawa, N; Suzuki, Y | 1 |
Wipf, R | 1 |
Addington, WW | 1 |
Dawson, DJ; Woolcock, WJ | 1 |
Göbel, D; Jungbluth, H; Kropp, R; Matthiessen, W; Radenbach, KL; Wundschock, M | 1 |
Bialik, IB; Mamolat, AS | 1 |
Lange, W | 1 |
Papezhova, E; Toushek, I | 1 |
Balogh, F; Borthwick, WM; Mallo, N; Mazurek, L; Trnka, L; Victorov, J | 1 |
Kalweit, H; Lenk, S; Rothkopf, M | 1 |
Gill, GV; Nyirenda, R | 1 |
Kimbel, KH | 1 |
Austerhoff, A; Kindler, U; Knop, P | 1 |
Fallon, RJ | 1 |
Seaton, A | 1 |
Medici, TC; Steiner, A | 1 |
Dalet, F; Mallo, N; Villavicencio, H | 2 |
Donta, ST; Doty, DB; Goeken, JA; Lohr, DC | 1 |
Bobrowitz, ID | 3 |
Lauver, GL | 1 |
Heising, J; Seiferth, J | 1 |
Bammel, E; Kuntz, HD; Rausch, V | 1 |
Ginzburg, VS; Kalankhodzhaev, AA; Stoianovskiĭ, EA | 1 |
Lesnaia, AA | 1 |
Audet, PR; Johnston, RF | 1 |
Ehring, F | 1 |
Kanai, K; Kondo, E | 2 |
Phelps, DB; Reller, LB; Stratton, CW | 1 |
Korotaev, GA; Kozulitsyna, TM | 1 |
Utkin, VV | 2 |
Badalik, L; Kruty, R; Matula, F; Virsik, K | 1 |
Craig, RM; Neumann, TG; Poticha, S | 1 |
Kabuubi, JB | 1 |
Halpern, AA; Nagel, DA | 1 |
Chikanov, VI; Tatarinova, NV | 1 |
Aujard, Y; Beaufils, F; Caron, M; Choulot, JJ; Labrune, B | 1 |
Edman, DC; Farid, Z; Girgis, NI; Laughlin, LW; Watten, RH; Yassin, MW | 1 |
Ait Khaled, N; Benachenhou, A; Chaulet, P; Fekar, A; Virot, JP | 1 |
Kleber, FX | 1 |
Koerner, SK; Pinsker, KL | 1 |
Haubensak, K; Osterhage, HR | 1 |
Dickinson, JM; Mitchison, DA | 2 |
Fairshter, RD; Garlin, J; Randazzo, GP; Wilson, AF | 1 |
Cho, CT; D'Souza, BJ; Lansky, LL | 1 |
Beggs, WH | 1 |
Eĭsaev, BA; Rudoĭ, NM; Zankisova, IG | 1 |
MacGregor, RR; Mayock, RL | 1 |
Masztalerz, J | 2 |
Neubert, R | 1 |
Kumar, S; Mehta, JA; Trivedi, HL | 1 |
Buckingham, WB | 1 |
Navrotskiĭ, VV; Tarkhova, NV | 1 |
Dubois, P; Gyselen, A; Prignot, J | 1 |
Kasik, JE; Schuldt, S | 1 |
Hinshaw, HC | 1 |
Pilheu, JA | 1 |
Bek, E; Bergson, H; Kucharska, A; Strupczewska-Janusz, H; Zierski, M | 1 |
Bossaert, H; Geboes, K | 1 |
Arifkhanova, SI; Kondrat'eva, VI; Umarova, MK | 1 |
Rosenzweig, DY | 1 |
Mahlberg, FA; Müller, RW; Rodermund, OE | 1 |
Solomonraj, G; Thomas, BH | 1 |
Inaba, N; Kuze, F; Maekawa, N; Ohi, Y; Yamada, E; Yasubuchi, Y | 1 |
Draganiuk, KA | 1 |
Angelillo, VA; Scheinhorn, DJ | 1 |
Grundmann, E; Schmidt-Wilcke, HA; Wolfert, W | 1 |
Kuze, F; Maekawa, N; Takeda, S | 1 |
Frey, N; Legrand, M; Peltier, G; Teyssier, L | 1 |
Aoyagi, T | 1 |
Albengres, E; Breau, JL; Chrétien, J; Hirsch, A; Houin, G; Saltiel, JC; Tillement, JP | 1 |
Buchanan, N; van der Walt, LA | 1 |
Van Scoy, RE | 1 |
McDonald, RJ; Reichman, LB | 1 |
Czarnecki, J; Fafrowicz, B; Pokora, J; Przemyska, B; Srednicka-Zajac, D | 1 |
McConville, JH; Rapoport, MI | 1 |
Kozulitsyna, TI; Petrov, IV | 1 |
Kertselli, IuS; Pak, FP | 1 |
Lester, W | 2 |
Boman, G; Dahlström, G; Hanngren, A; Stavenow, S; Wiman, LG | 2 |
Alimov, ShA; Stoianovskiĭ, EA | 1 |
Cordero, O; Pacheco, CR; Pacheco, J; Sierra, D; Vázquez, E | 1 |
Fomicheva, NA; Sazonova, LV; Zinchuk, AS | 1 |
Cesarz-Fronczyk, M; Pregowski, W; Stanczuk, A; Znaniecka, H | 1 |
Collier, J; Joekes, AM; Philalithis, PE; Thompson, FD | 1 |
Kindler, U; Stiehl, G | 1 |
Repnitskaia, ZD | 1 |
Kozma, D; Lapis, K; Tompa, A | 1 |
Kharakter, ZhZ; Pavlenko, AV | 1 |
Frenzel, I; Neumeyer, D | 1 |
Mital, OP; Narang, RK; Sachan, AS | 1 |
Chandra, B | 1 |
Bek, E; Bergson, H; Kucharska, A; Szelagowicz, B; Zierski, M | 1 |
Harris, GD; Johnason, WG; Nicholson, D | 1 |
Angel, JH; Campbell, IA; Citron, K; Somner, AR | 1 |
Calvete, C; Cetrangolo, A; Dambrosi, A; Gonzalez Montaner, LJ; Leston, JM; Mosca, C; Szemzo, J | 1 |
Ammen, VK | 1 |
Simon, K | 1 |
Tala, E | 1 |
Grennan, DM; Sturrock, RD | 1 |
Somner, AR | 2 |
Colmers, RA; Wilkes, LL | 1 |
Karasek, M; Sosnowski, W; Tomaszkiewicz, L; Woźniak, L | 2 |
Johnson, J | 1 |
Haegi, V | 2 |
Francis, PB; Jay, SJ; Johanson, WG | 1 |
Drabkina, RO; Ginzburg, TS | 3 |
Irwin, RS; Parker, MD | 1 |
Beuscart, F; Carre, A; Ginestet, A; Jaillard, J; Perrard, C; Warembourg, H | 1 |
Eisaev, BA; Rudoi, NM | 2 |
Harris, GD; Johanson, WG; Nicholson, DP | 1 |
Israel, HL | 1 |
Lattimer, JK; Wechsler, M | 1 |
Kost, A; Moskwa, Z | 1 |
Dall, G; Jenkin, DJ | 1 |
McClement, JH | 1 |
Lake, KB; Van Dyke, JJ | 1 |
David, S; Fuchs, FF; Schaefer, G; Zervoudakis, IA | 1 |
Kucharska, A | 1 |
Hoose, C | 1 |
Chertkova, MA; Kharakter, ZhZ; Pavlenko, AV | 1 |
Vale, JR | 1 |
Firsova, LP; Liuboshenko, LA | 1 |
Gow, JG; O'Boyle, P | 1 |
Elliott, RC; Gunther, SF | 1 |
Jentgens, H | 3 |
Derichs, R; Kindler, U; Merholz, S | 1 |
Kindler, U; Knop, P; Merholz, T | 1 |
Mosakowska-Glińska, M; Zalewska-Kubicka, L; Zieliński, T | 1 |
Chen, YM; Lee, PY; Perng, RP; Su, WJ | 1 |
Kumar, L | 1 |
Benichou, P; Boyer, G; Darbas, H; Jean-Pierre, H; Rivière, M | 1 |
Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
Kimura, H; Kusaba, T; Nagasawa, K; Otsuka, T; Sakata, T; Tada, Y; Tsuda, Y | 1 |
Rüsch-Gerdes, S; Schaper, KJ; Seydel, JK | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
Ichiyama, S; Shimokata, K; Tsukamura, M; Yamori, S | 1 |
Blacklock, Z; Iredell, J; Whitby, M | 1 |
Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S | 1 |
Schmidt, M | 1 |
Nolan, CM | 1 |
Kikuchi, Y; Kimura, S; Mitamura, K; Oka, S; Shimada, K | 1 |
Sobel, JD; Vazquez, JA | 1 |
Blanc, JM; de Francisco, JE; Fumanal, L; Garcia Guzman, A; Valles, H | 1 |
Gokal, R; Johnson, RW; O'Donoghue, DJ; Short, CD | 1 |
Chotpitayasunonah, T; Jacobs, RF; Kelleher, K; Pope, S; Sunakorn, P | 1 |
Moore, DF; Wolfe, JM | 1 |
Annam, O; Duque, JP; Idigbe, EO; John, EK | 1 |
Hasegawa, T; Ishii, M; Tada, K | 1 |
Kovaleva, SI | 1 |
Pust, RE | 1 |
Malaviya, AN; Singh, S; Singh, YN | 1 |
Kleeberg, HH; Weyer, K | 1 |
Lalwani, AK; Lee, KC; Schecter, G; Tami, TA | 1 |
Lumb, R; Shaw, D | 1 |
Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG | 1 |
Adrados, M; Díaz, F; García Aguado, C; González Lahoz, JM; Laguna, F; Martínez, R; Puente, S | 1 |
Sadykov, AS | 1 |
Tsukamura, M; Yamori, S | 3 |
Bobarykin, VS | 1 |
Skakun, NP; Tabachuk, OE | 1 |
Barnes, L; Clancy, L; Collins, P | 1 |
Andreev, LP; Bogdalova, VE; Bondin, SV; Golanov, VS; Losin, EI; Meshcheriakov, VG; Ushakova, AG | 1 |
Cramer, G; Hamel, U; Roth, G; Wiesner, B | 1 |
Labrousse, V; Rastogi, N | 1 |
Alexander, M; Held, T; Mielke, M; Reichelt, A; Rössler, W | 1 |
Loboda, MV | 1 |
Hoffner, SE; Svenson, SB | 1 |
Tsukamura, M | 4 |
Barry, C; Coughlan, RJ; Deegan, RI; Foley-Nolan, AA; Foley-Nolan, D; Hone, R | 1 |
Chaisson, RE; Goodman, PC; Hopewell, PC; Sande, MA; Schecter, GF; Small, PM | 1 |
Gamzaeva, NF; Kalankhodzhaev, AA | 1 |
Eng, J; Hoel, T | 1 |
Actis, G; Alberico, G; Genovesio, L; Goitre, M; Mele, M; Molinaro, GC; Puiatti, P; Salvai, M | 1 |
Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM | 1 |
Finsterbush, A; Husseini, N; Mann, G; Shaul, J | 1 |
Kempf, HG | 1 |
Bhide, M; Madhukar, K; Prasad, CE | 1 |
Kuze, F | 2 |
Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM | 1 |
Byrne, C; Clancy, LJ; Costello, E; Kelly, P; O'Reilly, L | 1 |
Kaur, S; Kumar, B; Radotra, BD; Sharma, VK | 1 |
Carré, G; Hershfield, E; Jean-Baptiste, M; Long, R; Nelz, K; Parker, S; Scalcini, M; Wolfe, J | 1 |
Croughan, M; Harris, G; Rayner, A; Watt, B | 1 |
Stazi, C; Stazi, F | 1 |
Combs, DL; Geiter, LJ; O'Brien, RJ | 1 |
Agnew, RA; Bucknall, RC; Nisar, M; Watkin, SW | 1 |
Rasmussen, KL | 1 |
Campbell, IA | 1 |
Lode, H; Schaberg, T | 1 |
Sbarbaro, J | 1 |
Wu, QQ | 1 |
Dupuis, M; Rousseau, P | 1 |
Eriksen, NH; Jensen, TH; Magnussen, P; Skinhøj, P | 1 |
Chan, CY; Huang, YS; Lee, PY; Lee, SD; Lo, KJ; Ting, LP; Tsai, YT; Wang, YJ; Wu, JC; Yeh, PF | 1 |
Blichfeldt, P; Brinch, L; Eng, J; Mehl, A; Rostad, H | 1 |
Loos, U; Musch, E; Schwabe, HK | 1 |
Bosch Castañé, J; Carrascosa Lezcano, A; Castillo Salinas, F; Gussiñé Canadell, M; Montané Pasamontes, C; Pérez LaCasta, P; Sóle Mir, E | 1 |
Bozzette, S; Chiu, J; Heseltine, PN; Leedom, J; McCutchan, JA; Nussbaum, J; Tilles, JG; Young, LS | 1 |
Holdiness, MR | 3 |
Mitchison, DA; Nunn, AJ | 1 |
Barnum, HN | 1 |
Daramas, M; Jittinandana, A; Kecharanandana, P; Payanandana, W | 1 |
Chung, YM; Liu, JH; Sheu, SJ; Yeh, TS | 1 |
Aziz, A; Aziz, K; Ishaq, M; Siddiqi, SH | 1 |
Domingo, Z; Peter, JC | 1 |
Elghoul, MT; Joshi, RM; Rizghalla, T | 1 |
Ichiyama, S; Miyachi, T; Tsukamura, M | 1 |
Celle, G; Gesu, GP; Picciotto, A; Schito, GC; Testa, R; Varagona, G | 1 |
Sinha, PK; Thakur, CP | 1 |
Blanche, S; Bodemer, C; De Prost, Y; Durand, C; Teillac, D | 1 |
Gharpuray, MB; Kulkarni, DS; Kulkarni, V | 1 |
Andrzejczyk, Z; Janowiec, M; Marczewska, J | 1 |
Baumann, HR; Bohn, W; Brändli, O; Haegi, V; Villiger, B; Zäch, R | 1 |
Hammond, MD; Tonner, JA | 1 |
Bellon, G; Gallet, S | 1 |
Bakir, M; Doğanay, M; Dökmetaş, I | 1 |
Felten, MK | 1 |
Fischer, P; Merkel, S; Weinecke, W | 1 |
Felten, MK; van der Merwe, CA | 1 |
Bialasiewicz, AA; Lang, GK; Naumann, GO; Schönherr, U | 1 |
Heifets, LB; Iseman, MD; Lindholm-Levy, PJ | 1 |
Zeis, BM | 1 |
Leppert, D; Waespe, W | 1 |
Bolinger, AM; Levin, RH | 1 |
Houston, JB; Shaffer, JL | 1 |
Harman, EM | 1 |
Aeberhardt, G; Bernheim, J; Dautzenberg, B; Gallinari, C; Grosset, J; Lévy, A; Sors, C | 1 |
Ellis, ME; Tayoub, F | 1 |
Aluoch, JA; Babu Swai, O; Darbyshire, JH; Edwards, EA; Githui, WA; Nunn, AJ; Thiong'o, R | 1 |
Chang, SC; Hong, YP; Jin, BW; Kim, SC; Kim, SJ; Park, CD | 1 |
Woodley, CL | 1 |
Hawkins, JE | 1 |
Etzkorn, ET; Lillis, PK; McAllister, CK | 1 |
Mitchell, M; Rao, M; Steiner, M; Steiner, P | 1 |
Gibson, J | 1 |
Ayres, JG; Thomas, HE | 1 |
Nash, DR; Steele, LC; Steingrube, V; Wallace, RJ | 1 |
Ashtekar, DR; Fernandes, F; Khadse, BG; Shirodkar, MV | 1 |
Helbecque, DM; Laszlo, A; Tostowaryk, W | 1 |
Davis, JR; Libonati, JP; Siddiqi, SH; Stager, CE | 1 |
Anséhn, S; Hoffner, SE; Nilsson, LE | 1 |
Chang, CE; Heifets, LB; Lin, TP; Suo, J | 1 |
Hopewell, PC; Schecter, GF; Slutkin, G | 1 |
Acker, EJ; Bither, HD; Gezon, HM; Gibbs, HC; Hanson, LA; Jorgenson, RD; Thompson, JK | 1 |
Collins, CH; Uttley, AH | 1 |
Grosset, JH; Lecoeur, H; Truffot-Pernot, C | 1 |
Hara, Y; Okamoto, Y; Umeki, S | 1 |
Andrzejczyk, Z; Janowiec, M; Szwedowicz, I | 1 |
Ormerod, LP | 1 |
MacIntyre, D; Perros, P; Sim, DW | 1 |
Goldberger, MJ | 1 |
Baskin, GB; Gibson, SV; Watson, EA; Wolf, RH | 1 |
Ichiyama, S; Tsukamura, M | 1 |
Banks, J; Jenkins, PA | 1 |
Fox, H; Legmann, P; Levesque, M; Ollivier, C | 1 |
Hoffner, SE; Källenius, G; Svenson, SB | 1 |
Kim, I; Moon, MS; Park, YO; Woo, YK | 1 |
Saito, H; Tsukamura, M; Yasuda, Y; Yoshii, S | 1 |
Bek, E; Farer, LS; Graczyk, J; Snider, DE; Zierski, M | 1 |
Des Prez, RM; Sheller, JR | 1 |
Ahn, CH; Ahn, SS; Anderson, RA; Mammo, A; Murphy, DT | 1 |
Davidson, PT; Hanh, LQ | 1 |
Dong, SQ | 1 |
Corsello, BF | 1 |
Kishore, K; Rathi, R; Singhal, KC; Varshney, DP; Varshney, SC | 1 |
Knoester, H; Knol, K; van Aalderen, WM | 1 |
Heifets, LB; Lee, CN | 1 |
Horsfield, N; Ormerod, LP | 1 |
Behera, D; Gilhotra, R; Malik, SK | 1 |
Chow, SP; Collins, RJ; Ip, FK; Lau, JH; Luk, KD; Pun, WK; So, YC | 1 |
el-Attar, H; Israili, ZH; Rogers, CM | 1 |
Van Scoy, RE; Wilkowske, CJ | 2 |
Aubrey, M; Fam, AG | 1 |
Duraipandian, M; Nagarajan, M; Prabhakar, R; Ramachandran, P; Ramakrishnan, CV; Tripathy, SP | 1 |
Berkani, M; Chaulet, P; Darbyshire, JH; Fox, W; Nunn, A | 1 |
Burghard, G; Chenuet, J; Liard, R; Perdrizet, S; Petitjean, R; Pierau, F; Rempp, M | 1 |
Buss, WC; Spalding, CT | 1 |
Zhang, YD | 1 |
Onwubalili, JK; Scott, GM; Smith, H | 1 |
Baron, EJ; Young, LS | 1 |
Azuma, Y; Baba, H; Izuchi, R; Schinkai, A | 1 |
Ringelmann, R; Schmidt, M; Schönian, U | 1 |
McKenzie, DK; Mukerjee, CM | 1 |
Huchon, G; Marin, I; Sandron, D | 1 |
Bezel, R; Brändli, O; Häcki, M; Karrer, W; Röthlisberger, K; Rubin, S | 1 |
Gröschel, DH; Tarrand, JJ | 1 |
Behera, D; Malik, SK | 2 |
Blanco Quirós, A | 1 |
Hawkins, JE; Laszlo, A; Siddiqi, SH | 1 |
Boulahbal, F; Chaulet, P; Mazouni, L; Tazir, M | 1 |
Beckers, B; Lammers, A; Lang, HR; Schimke, D | 1 |
Leff, AR; Leff, DR | 1 |
Fragoso, MA; Murray, DL | 1 |
Geiseler, PJ; Maddux, MS; Manis, RD | 1 |
Lees, AW | 1 |
Banks, J; Jenkins, PA; Smith, AP | 1 |
Hof, DG; Neihart, RE | 1 |
Grozovskaia, MS | 1 |
Cowie, RL; Escreet, BC; Langton, ME | 1 |
Hansen, JE; Kampmann, JP; Kay, L; Kristensen, M; Skovsted, L; Svendsen, TL; Vergman, B | 1 |
Christensen, PB; Haase, J; Ingstrup, HM; Kock, K | 1 |
Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK | 1 |
Acharya, VN; Kudva, BT; Mehta, PJ; Retnam, VJ | 1 |
Kuznetsova, ZA | 1 |
Leggat, PO | 1 |
Pines, A | 4 |
Flemming, J; Virchow, C | 3 |
Rosenfeld, M | 1 |
Citron, KM | 2 |
Press, P | 1 |
Frenk, E; Smith, AJ; Walker, AE | 1 |
Hellström, PE; Mattson, K; Repo, UK | 1 |
Canetti, G; Gay, P; Le Lirzin, M | 1 |
Almeyda, J; Levantine, A | 1 |
Aquinas, M; Citron, KM | 1 |
Mühlberger, F | 1 |
Bajan, A; Havelka, C; Kopác, C; Maar, D | 1 |
Dorozhkova, IR; Volk, AV | 3 |
Hermann, P | 1 |
Riska, H | 1 |
Pätiälä, J; Tani, P | 1 |
Wehrheim, W | 1 |
Wessel-Aas, T | 1 |
Gabler, A | 1 |
Eule, H; Iwainsky, H; Krebs, A | 1 |
Brühl, P; Tümmers, H | 1 |
Wolinsky, E | 2 |
Iisalo, EJ; Pihlajamäki, KK; Syvälahti, EK | 1 |
Tousek, J; Trnka, L | 1 |
Boman, G; Ringberger, VA | 1 |
Boman, G; Calissendorff, B | 1 |
Byrd, RB; Gracey, DR; Kaplan, PD | 1 |
Bjartveit, K; Øvreberg, K | 1 |
Gerloff, W; Kalich, R; Mydlak, G; Nitschke, M; Reinhold, L; Ulber, H; Werner, E | 1 |
Shimizu, T | 1 |
Andrews, RH; Jenkins, PA; Marks, J; Pines, A; Selkon, JB; Somner, AR | 1 |
Wstepna, C | 1 |
Corbalán Trumbull, G | 1 |
Dickinson, JM | 1 |
Beggs, WH; Jenne, JW | 1 |
Braman, SS; Goldman, AL; Schwarz, MI | 1 |
Abbott, MR | 1 |
Lakshminarayan, S; Petty, TL; Pierson, DJ | 1 |
Raleigh, JW; Wichelhausen, R | 1 |
Reutgen, H | 1 |
Selkon, JB; Somner, AR; Walton, M; White, AB | 2 |
Bialik, IB; Klimenko, MT | 1 |
Lakshiminarayan, S; Sahn, SA | 1 |
Doster, BE; Murray, FJ; Newman, R; Woolpert, SF | 1 |
El'shanskaia, MP; Golyshevskaia, VI | 1 |
Swinburn, PD | 1 |
Chioléro, R | 1 |
Johnston, RF; Wildrick, KH | 1 |
Boytar-Papirnyik, V; Hobby, GL; Johnson, PM | 3 |
Goldberg, R; Rao, M; Steiner, M; Steiner, P | 1 |
Mison, P; Staflova, S; Trnka, L | 1 |
Dvoskin, MI; Gel'berg, SI | 1 |
Vejjajiva, A | 1 |
Slany, E | 1 |
Regli, J; Ziegler, WJ | 1 |
McDonald, HM; McDonald, PJ; Murray, CJ | 1 |
Rao, M; Steiner, M; Steiner, P; Victoria, M | 1 |
Berg, G; Kazemi, H; Stottmeier, K; Zack, MB | 1 |
Bates, JH; Hampton, JR | 1 |
Balázs, M; Entz, A; Kozma, D; Vámos, K; Vincze, E | 1 |
Marsenić, B; Panajotović, H | 1 |
Bartashevich, TA; Dushkevich, AK | 1 |
Brouet, G | 2 |
Deshayes, P; Desseauve, P; Houdent, G; Lemercier, JP; Morere, P; Simonin, JL | 1 |
Allan, GW; Fallon, RJ; Lees, AW; Smith, J; Tyrrell, WF | 2 |
Allan, WG; Aquinas, M; Fox, W; Girling, D; Horsfall, PA; Hung-Yan, W; Jenkins, PK; Tall, R | 1 |
Allan, GW; Fallon, RJ; Lees, AW; Smith, J; Tyrell, WF | 1 |
Poley, JR; Rudoy, R; Stuemky, J | 1 |
Amemiya, K; Kato, M; Komatsu, N; Nagumo, N; Saga, K | 1 |
Nagumo, N | 1 |
Charachon, R; Faivre, A; Junien-Lavillauroy, C; Roux, O | 1 |
Gartmann, J | 1 |
Cosemans, J; Gyselen, A; Lacquet, LM; Vandenbergh, E; Verbist, L | 1 |
Heaf, PJ | 1 |
Tani, P | 1 |
Lucchesi, M; Mancini, P; Matzeu, M | 1 |
Charles, A; Demonet, B; Germouty, J; Serizay, B | 1 |
Crofton, J | 3 |
Suzuki, T | 1 |
Jarniou, AP | 1 |
Makarevich, NM; Rudoĭ, NM | 1 |
Bethge, H | 1 |
Eagle, MC; Goldstein, E; LaCasse, ML | 1 |
Donomae, I; Fujita, S; Gomi, J; Hibino, S; Horai, Z | 1 |
Eulenberger, J; Mordasini, ER | 1 |
Duhurt, J; Gautier, H; Kauffmann, JP; Piéron, R | 1 |
Neumann, G | 1 |
Burgher, LW; Kass, I | 1 |
Barranger, C; Boury, G; Favre, M; Houdard, C; Lancastre, F; Le Fichoux, Y; Mafart, Y; Piéron, R | 1 |
Caulin, CH; Delavierre, PH; Freyer, M; Lebas, F; Segrestaa, JM | 1 |
Blanchon, B; Blanchon, F; Blanchon, P; Groseille, Y; Holler, A; Paillas, J | 1 |
Koĭfman, SG; Man'kovetskiĭ, EF; Sirota, DS; Vatsyk, MZ | 1 |
Clark, MA | 1 |
Fraley, EE; Gonzalez, R; Pergament, M | 1 |
Gol'dshteĭn, VD; Khodakevich, LIa; Rabukhin, AE | 1 |
Härö, AS; Hjaltested, OP; Nielsen, E | 1 |
Grosse-Brockhoff, F; Hausamen, TU; Peters, U | 1 |
Daynes, G | 1 |
Barbier, JP; Carnot, F; Cornet, A; Cornu, P; Dubrisay, J; Hirsch, JF | 1 |
Dmitrieva, LI; Koromaev, GA | 1 |
Mavrotskiĭ, VV | 1 |
Sagalovich, VIa; Tarasova, EF | 1 |
Boman, G | 1 |
Cordero, O; Pacheco, CR; Pacheco, Mde J; Sierra, D; Vázquez, E | 1 |
Jittinandana, A; Kecharanantana, P; Sriyabhaya, N | 1 |
Shabalova, LN; Shmelev, NA | 1 |
Hentschel, U | 1 |
Bielecki, T; Majchrzak, A; Mysakowska, H; Pizlo, S; Raczyński, R; Ropek, M; Sosnowski, K | 1 |
Grzywacz, W; Juchniewicz, M; Kowalczyk, H; Radecki, A | 1 |
Górecki, R; Stanek, S | 1 |
Kotowska, M; Zelski, S | 1 |
Chodera, B; Kańczugowski, W; Klimczyk, M; Krukowska-Grzezińska, A; Kubiaczyk, T | 1 |
Bayliss, CG | 1 |
Shiozawa, M | 1 |
Walker, AS | 1 |
Cosemans, J; Gyselen, A; Lacquet, L; Verbist, L | 1 |
Anschel, R; Eule, H; Fichtner, K; Ganguin, HG; Neumeyer, D; Pickroth, G | 1 |
Rybak, IuN | 1 |
Kalich, R; Reutgen, H | 1 |
Brocheriou, C; Guilbert, F; Oger, JP; Rigolet, D | 1 |
Thompson, JE | 1 |
Mattson, K | 2 |
Anastasatu, C; Bungeteanu, G; Sibila, S | 1 |
Mattson, K; Riska, N | 1 |
Aoyagi, T; Gomi, J | 1 |
Guerra Sanz, FJ | 1 |
Pniewski, T; Wislawska-Orlowska, B | 1 |
Kraan, JK; Mulder, RJ; Mulder-De Jong, MT; van Dijk, B | 1 |
Delli Veneri, F; Meola, G; Ninni, A; Nitti, V | 1 |
Dubra, F | 1 |
Corpe, R | 1 |
Feldmann, H; Kelleter, R | 1 |
Breuer, H; Nocke-Finck, L; Reimers, D | 1 |
Bignall, JR | 1 |
Nitti, V | 4 |
Fraga, H; Gerhardt, G; Gomes, O; Paz de Almeida, A; Santiago, AC | 1 |
Baculard, A; Bonnet, M; Dresh, C; Gerbeaux, J; Sultan, C | 1 |
Fostikov, B; Kovacević, M; Milutinović, R; Simic, B; Simić, V | 1 |
Brito, AA; Laborne Valle, JH; Poppe de Figueiredo, F; Tavares, PM; Trannin, PL | 1 |
Horsfall, PA | 1 |
Hobby, GL; Lenert, TF | 2 |
Dorken, E; Grzybowski, S; Schonell, M | 1 |
Berberich, R; Kläser, E; König, K; May, P; Oberhausen, E | 1 |
Eidus, L; Jeanes, CW; Jessamine, AG | 1 |
Baron, A; Constans, P; Coury, C; Parrot, R | 1 |
Darras, T; Gyselen, A; Mbete, S; Van Landuyt, H; Verbist, L | 1 |
Davidson, PT; Goble, M; Lester, W | 1 |
Eickeler, R; Zeilhofer, R | 1 |
Hyde, L | 1 |
Delepoulle, E; François, C; Grignet, JP; Pecqueur, G; Venel, JG; Wallaert, C | 1 |
Dürr, DK; Wissler, H | 1 |
Douma, J | 1 |
Evans, C; Proust, A | 1 |
Konno, K; Ogata, K; Oizumi, K; Sato, M; Yamada, S | 1 |
Kobayashi, T; Matsuda, T; Oka, S; Sasaki, M | 1 |
Mlczoch, F | 1 |
Sighart, H | 1 |
Anastasatu, C | 1 |
Schmidt, W | 1 |
Hendrikse, JC; Hulsebosch, HJ; Ruiter, D | 1 |
Papezová, E; Tousek, J | 1 |
Dölle, W | 1 |
Rudnicka, M; Szymaczek-Meyer, L; Westfal, I; Wiza, J | 1 |
Sosnowski, W; Tomaszkiewicz, L | 1 |
Cortez, LM; Pankey, GA | 1 |
Favez, G | 3 |
Rocklin, RE; Whitcomb, ME | 1 |
Gherman, M; Golli, V; Tufescu, R | 1 |
Pescetti, G; Porrino, F; Rodicchi, A | 1 |
Gastpar, H | 1 |
Rabukhin, AE | 1 |
Riordan, DC; Williams, CS | 1 |
Sitnikova, IuZ | 1 |
Bek, E; Bukalska, Z; Graczyk, J; Kucharska, A; Zierski, M | 1 |
Campbell, AH; Cowen, K; O'Connell, J; Verins, A | 1 |
Ambrosiani, S; Brignone, S | 1 |
Krohn, J | 1 |
Cramers, MK | 1 |
Johansson, R; Tegner, KB; Wiman, LG | 1 |
Hussels, H; Kroening, U; Magdorf, K | 1 |
Rasmussen, KN | 1 |
Dul'tseva, EG; Ershov, AI; Grigaliunas, AP; Vasil'eva, IR; Zolotareva, NI | 1 |
Gol'dshteĭn, VD; Prokhorov, EP | 1 |
Shukiurov, ShZ | 1 |
Orlowski, EH | 4 |
Poppe de Figueiredo, F | 1 |
Derrington, AW; Sage, RE | 1 |
Favez, G; Wiser, H | 1 |
Araszkiewicz, A; Cohen-Solal, L; Hioco, D; Miravet, L | 1 |
Kass, I; Nair, SV | 1 |
Grzybowshi, S | 1 |
Austerhoff, A; Kindler, U; Knieriem, HJ; Knop, P | 1 |
Barwick, DD; Thrush, DC | 1 |
Anastasatu, C; Barcan, F; Bercea, O; Cărpinişan, L; Cristea, M; Dinulică, E; Gheorghiu, M; Ghinescu, S; Iancovici, O; Marcovici, M; Stinghe, R | 1 |
Davidson, PT; Sahn, SA | 1 |
Kerby, G; Rauscher, CR; Ruth, WE | 1 |
Gerbeaux, J | 1 |
Ellorhaoui, M; Storch, W; Tauchnitz, C | 1 |
Menghini, P; Pozzi, E | 1 |
May, P; Schindler, E | 1 |
Krebs, A | 2 |
Trendelenburg, F | 1 |
Delli Veneri, F; Marra, A; Nitti, V | 1 |
Meissner, G | 1 |
Kraan, JK; Mulder, RJ; van Dijk, B | 1 |
Cosemans, J; Debrabandere, R; Devriendt, J; Gyselen, A; Lacquet, LM; Prignot, J; Simon-Pouthier, F; Verbist, L | 1 |
Wilson, TM | 1 |
Elo, R; Heinivaara, O; Tala, E; Wäre, M | 1 |
Ovreberg, K | 1 |
Hellström, PE; Repo, UK | 1 |
Riska, N | 1 |
Schütz, I | 1 |
Grassi, C | 2 |
Friess, JM; Guignon, JP; Lecoq, H; Lévy, A; Maman, P; Weill, G | 1 |
Freerksen, E | 3 |
Abderrahim, K; Benabdallah, L; Chaulet, P; Coucke, C; Grosset, J; Larbaoui, D; Oussedik, N | 1 |
Devine, CM; Mitchison, DA; Nunn, AJ; Tall, R | 1 |
El'nik, VI | 1 |
Oka, S | 1 |
Daniel, TM | 1 |
Boytar-Papirnyik, V; Hobby, GL; Johnson, PM; Wilber, J | 1 |
Centrella, G; Delli Veneri, F; Stefanelli, R | 1 |
Erhard, G | 1 |
Canetti, G; Grumbach, F; Le Lirzin, M | 1 |
Ninni, A; Nitti, V | 1 |
Pines, A; Raafat, H; Siddiqui, GM | 1 |
Hensel, J; Scheuch, V; Schröder, KH | 1 |
Steinbrück, PW | 1 |
Wallace, AT | 1 |
Chazalette, JP; Dutruge, J; Gilly, R; Viallier-Raynard, J | 1 |
Donaldson, R; Wallace, A | 1 |
David, HL | 1 |
Pregowski, W | 1 |
Doster, B; Ferebee, S; Murray, FJ; Newman, R | 1 |
Constans, P; Coury, C; Parrot, R | 1 |
Schaich, W | 1 |
Djurovic, V; Le Lirzin, M | 1 |
Mkrtchian, SV; Ushkin, VV | 1 |
Grumbach, F | 2 |
Azuma, Y; Baba, H; Takahashi, R | 1 |
Catena, E; De Michele, G; Delli Veneri, F; Marra, A; Nitti, V | 1 |
Ariji, F; Kumano, N; Madokoro, K; Oka, S; Yamaguchi, J | 1 |
Theile, U | 1 |
Anastasatu, K; Bercha, O; Kaufman, S; Sibila, S; Vais, F | 1 |
Houk, AN | 1 |
Radner, DB | 1 |
Nakagawa, H; Sunahara, S | 1 |
Corpe, RF; Sanchez, ES | 1 |
Gomez, F; Wolinsky, E; Zimpfer, F | 1 |
Hölzl, M | 1 |
Constans, P; Coury, C | 1 |
Gyselen, A; Verbist, L | 1 |
Ludes, H | 1 |
Dormer, BA; Salinger, PL | 2 |
Almansa de Cara, S | 1 |
Castellano, A; Cornudella, R; Garcia-Besada, JA | 1 |
Marr, JJ | 1 |
Mangion, PD; Schiller, KF | 1 |
Azevedo, DE; Ennes Filho, E; Sayeg, F | 1 |
Hong, CK | 1 |
Blaha, H; Petersen, KF; Urbanczik, G | 1 |
Kramer, R; Simon, K | 1 |
Kaminskaia, AA; Korotaev, GA; Shmelev, NA | 2 |
Tousek, J | 2 |
Rollier, F; Verbist, L | 1 |
Flemming, J; Oschkinat, F | 1 |
Lukas, W | 1 |
Verbist, L | 1 |
de Macedo, AV | 1 |
Alvarez, R; Estrada, A; Farga, V; Gay, O; Hiriart, M; Orrego, H; Santiviago, C; Sepúlveda, R; Zimmermann, I; Zúñiga, E | 1 |
Korotaev, GA; Kozulitsina, TI; Uvarova, OA | 1 |
Carratù, L; Natali, P; Sonaglioni, F | 1 |
Catena, E; Del Bono, M; Marsico, SA | 1 |
Gangemi, G; Tenore, G | 1 |
Alves, JP; Bethlem, N; de Andrade, EM; Dias, L; Franca, JL; Tavares, W; Tavares, WC | 1 |
Bowen, DI; Vaterlaws, AL | 1 |
Hokama, S | 1 |
Beacham, EG | 1 |
Hennebert, A | 1 |
Anschel, R; Kalich, R; Kandt, D; Pickroth, G | 1 |
Marécaux, L; Tricoire, J | 1 |
Favez, G; Willa, C | 1 |
Costa de Mello, B; Ibarra, JP; Mazza de Pratto, N | 1 |
Brun, J; Fougerat, J; Kalb, JC; Kofman, J; Perrin-Fayolle, M | 1 |
Strauss, I | 1 |
König, K; May, P | 1 |
Baumann, D | 1 |
Repo, UK | 1 |
Hetrick, C; Ras, R; Turri, M | 1 |
Jaroszewicz, W | 1 |
König, K | 1 |
Unholtz, K | 1 |
Gerbeaux, J; Hanoteau, J | 1 |
Repo, K; Riska, N | 1 |
Borthwick, WM | 1 |
Raab, WP | 1 |
Alekseeva, VM; Ivanova, ES; Kliuchareva, EA; Kubyshkina, VF; Rabukhin, AE | 1 |
Chenebault, J | 2 |
Carbonnelle, B; Corre, C; Leroux, MF; Norval, C; Oury, M; Parvery, F; Tuchais, E | 1 |
Kesztele, V; Niederkofler, J | 1 |
Kradolfer, F | 2 |
Gyselen, A | 1 |
Böszörményi, M | 2 |
Bazerque, E; Freijeiro, R; Ibarra, JP; Mello Aguerre, M; Pińeyro, J; Pintos Fuentes, R; Trenchi, A | 1 |
Yoshida, F | 1 |
Fukuhara, T; Mitsui, M; Sasaoka, A; Yoshida, F | 1 |
Tveit, J | 1 |
Kradolfer, F; Schnell, R | 1 |
Krylova, NP; Mkrtchian, SV; Poleshchuk, AK; Utkin, VV; Zankisova, IG | 1 |
Frey, N; Lesobre, R | 1 |
Boisvert, H; Le Lirzin, M | 1 |
Mitchell, RS | 1 |
Korotaev, GA; Kozulitsyna, TI | 1 |
Hertrick, C; Ras, R; Turri, M | 1 |
Daddi, G | 1 |
Cirianni, C; Cornia, G; Garimoldi, M; Ginesu, F; Grassi, C; Mandler, F; Perna, G; Pradella, F | 1 |
Trendelenburg, F; Virchow, C | 1 |
Boccitto, G; Sbampato, M; Sternini, N | 1 |
Daddi, G; Lucchesi, M; Mancini, P | 1 |
Nahum, LH | 1 |
Begg, KJ | 1 |
Bruart, J; Ducobu, J; Dupont, P; Laurent, M | 1 |
Fischer, V; Haubensak, K; Osterhage, HR | 1 |
Kalra, L; Mahanta, A; Maheshwari, MC; Mishra, NK | 1 |
Avant, ME; Carpenter, JL; Covelli, HD; Higbee, JW; McAllister, CK; Ognibene, AJ | 1 |
Janowiec, M; Zwolska-Kwiek, Z | 1 |
Buraglio, M; Eandi, M | 1 |
Fischer, P; Schilling, W | 1 |
Bollinelli, R | 1 |
Blumer, JL; Reed, MD | 1 |
Baker, RD; Hughes, S; Linaker, BD; Shaffer, JL; Turnberg, LA | 1 |
Bernadou, M; Cheminat, JC; Choffel, C; Decroix, G; Fréour, P; Guillet, P; Lemanissier, AF; Milleron, B; Molina, C; Roussel, G | 1 |
Pretet, S | 1 |
Cross, FS; Farer, LS; Long, MW; Snider, DE | 1 |
Snider, D | 1 |
Golubeva, VN; Iusman, ZI; Korotaev, GA; Margulis, NIu; Roslik, SM | 1 |
Nagami, P; Yoshikawa, TT | 2 |
Flenley, DC | 1 |
Carpenter, JL; Gorby, EW; Koch, JR; Neimes, RE; Obnibene, AJ; Perkins, WL | 1 |
Burghard, G; Cooreman, J; Grosset, J | 1 |
Janků, I; Papezová, E; Stastná, J; Tousek, J; Zítková, L | 1 |
Majewska-Zalewska, H; Rudnik, J | 1 |
Carroll, SR; Jenner, JR; Newson, SW | 1 |
Bach, VT; Thadepalli, H | 1 |
Borowy, ZJ; Deitel, M; Krajden, S; Ronald, AC; Saldanha, CF | 1 |
Kozlova, NV; Tynystanova, RI | 1 |
Arnau, J; Guardia, J; Lopez-Vivancos, J; Vilaseca, J | 1 |
Kozma, D; Mihalik, P | 1 |
Aram, H; Haas, H; Katz, M; Raz, I | 1 |
Boman, G; Löfdahl, CG; Sjögren, I; Skoogh, BE | 1 |
Chan, SL; Fan, ST; Ho, KK; Lau, WY; Wong, SH; Yiu, TF | 1 |
Bouveret, JP; Gerbeaux, J; Hanoteau, J; Houin, G; Tillement, JP | 1 |
Agzamov, RA; Arifkhanova, SI; Ginzburg, VS | 1 |
Ahn, CH; Ahn, SI; Ahn, SS; Hurst, GA; Lowell, JR | 1 |
Ait Khaled, N; Boulahbal, F; Chaulet, P; El Awadi, Z; Tazir, M | 1 |
Brändli, O; Fiala, W; Häcki, MA | 1 |
Hetrick, G; Humarau, H | 1 |
Jones, FL | 1 |
Chan, SL; Fan, ST; Ho, KK; Lau, WY; Poon, GP; Wong, SH; Yiu, TF | 1 |
Bisagni, L; Combetto, MG; Lanza, A | 1 |
Arena, G; Sesia, G | 1 |
Mazaev, MB | 1 |
Izumikawa, K; Koga, H; Nagasawa, M; Nakazato, H; Shigeno, H; Shigeno, Y; Suzuyama, Y; Tomita, H; Tomonaga, A; Yamaguchi, K | 1 |
Korotaev, GA; Margulis, NIu | 1 |
Gallofre López, M; Latorre Murillo, P; Massons Cirera, J; Sumalla Suñe, J | 1 |
Boulahbal, F; Chaulet, P; el Awadi, Z; Khaled, S; Tazir, M | 1 |
Daschner, F | 1 |
Balta, IuE; Chukanov, VI; Dorozhkova, IR; Karachunskiĭ, MA; Khomenko, AG | 1 |
Good, RC; Kilburn, JO; Laskowski, LF; Lusk, RH; Marr, JJ; Middlebrook, G; Reggiardo, Z; Snider, DE | 1 |
Amelio, M; Bardessono, F; Giorgis, GE; Moschini, MT | 1 |
Cooke, NJ; Curzon, PG; Page, RL; Wardman, AG; Williams, SE | 1 |
Campbell, IA; Hunter, AM; Kilpatrick, GS; Monie, RD; Rocchiccioli, K; White, J | 1 |
Fujita, NK; Yoshikawa, TT | 1 |
Xiao, XL | 1 |
Anderson, RH; Brown, FS; Burnett, JW | 1 |
Favez, G; Leuenberger, P | 1 |
Arseculeratne, SN; Dasan, P; Pinto, MR; Uragoda, CG | 1 |
Augé, C; Bussi, S; Lecocguic, Y; Pariente, R; Touaty, E | 1 |
Fairley, JA; King, AJ; Rasmussen, JE | 1 |
Brändli, O; Häcki, MA; Scheel, A; Stiefel, M | 1 |
Drăghicescu, T; Roman, IC; Socosan, I; Vainer, E | 1 |
Lowe, J; Pfau, A; Stein, H | 1 |
Esanbaev, DE; Ganiev, KG; Kirina, SB | 1 |
Banks, J; Campbell, IA; Hunter, AM; Jenkins, PA; Smith, AP | 1 |
Eichelbaum, M; Gläser, R; Hengstmann, J; Loos, U; Mackes, KG; Musch, E; Reetz, KP; Schwabe, HK | 1 |
Hopkins, SJ | 1 |
Moriarty, HJ; Scobie, BA | 1 |
Chiu, FT; Clarkson, AR; Need, AG; Phillips, PJ | 1 |
Bek, E; Zierski, M | 2 |
Sbarbaro, JA | 1 |
Johnson, MW; Layde, PM; Lyle, MA; Snider, DE | 1 |
Gavrilenko, VS; Shesterina, MV; Sokolova, GV; Tarasova, EF; Tregubov, IuG | 1 |
Batmanov, NIa; Bondarev, IM; Gavrilenko, VS; Shesterina, MV; Tarasova, EF | 1 |
Bek, E; Long, MW; Snider, DE; Zierski, M | 2 |
Pilipchuk, NS | 1 |
Angel, JH | 1 |
Raver, JM; Spagnolo, SV | 1 |
Engbaek, HC; Heckscher, T; Højgaard, C; Larsen, SO; Rasmussen, KN; Vergmann, B | 1 |
Thaler, H | 1 |
Casimir, MT; Fainstein, V; Papadopolous, N | 1 |
Andrzheiuk, NI; Chelnokova, NV; Medunitsyna, ND; Sagalovich, AV; Sagalovich, VIa | 1 |
Heifets, LB | 1 |
Hirasing, RA; van Bel, F | 1 |
Dautzenberg, B; Grosset, J; Sors, C | 1 |
Bonifazi, F; Gasparini, S; Sanguinetti, CM | 1 |
Nagami, PH; Yoshikawa, TT | 1 |
Castro-Parra, M; Dengler, HJ; Eichelbaum, M; Musch, E; von Sassen, W; Wang, JK | 1 |
Findlay, JM | 1 |
Bogaerts, Y; Elinck, W; Pauwels, R; van der Straeten, M; van Renterghem, D | 1 |
Danilova, NK | 1 |
DeYoung, DR; Roberts, GD; Zimmer, BL | 1 |
Campbell, IA; Griffiths, TM; Thomas, P | 1 |
Kozma, D; Lapis, K; Mihalik, P; Schaff, Z | 1 |
Mikayel, M; Pink, P | 1 |
Nash, DR; Steingrube, VA | 1 |
Chailleux, E; Kergueris, MF; Larousse, C; Le Normand, Y; Ordronneau, J | 1 |
Back, DJ; Breckenridge, AM; Crawford, FE; Hall, JM; MacIver, M; Orme, ML; Rowe, PH; Smith, E; Watts, MJ | 1 |
Oda, T | 1 |
Dengler, HJ; Greenblatt, DJ; Ochs, HR; Roberts, GM | 1 |
Korotaeva, TA; Petrova, GN; Sedunova, EA | 1 |
Jain, VK; Mathur, KC | 1 |
Bravo, G; Cabezudo, J; Martínez, R; Vaquero, J | 1 |
Keiner, F | 1 |
Górnicka-Wilczyńska, M; Krawczyk, Z; Pawlik, J; Pilarska-Machowicz, A; Pruszyńska, S; Sosnowski, W; Tomaszkiewicz, L; Wardowa, A; Woźniak, B | 1 |
Bilczak, Z; Czaplińska-Jóźwiak, E; Gaik, A; Kuczborska, Z; Swiatnicka, I; Swica, T; Szymański, A; Walecki, J; Zdawski, T | 1 |
Ershov, AI; Grigaliunas, AP; Guzeeva, SA; Sushkin, AG; Tikhonov, VA | 1 |
Dixon, JH | 1 |
Collins, CH; Yates, MD | 1 |
Bek, E; Long, M; Rogowski, J; Snider, D; Zierski, M | 1 |
Campbell, IA; Hunter, AM; Jenkins, PA; Smith, AP | 1 |
Beliakova, NK; Prosvirova, LA; Suleĭmanov, I; Umarov, B | 1 |
Andrew, OT; Hopewell, PC; Humphreys, MH; Schoenfeld, PY | 1 |
Iseman, MD | 1 |
Ortenberg, EA; Zhikhareva, AI | 1 |
Chulay, JD; Hendricks, LD; White, SW | 1 |
Chailleux, E; Kergueris, MF; Larousse, C; Le Normand, Y; Moigneteau, C; Ordronneau, J; Veyrac, MJ | 1 |
Bergan, S; Bjartveit, K; Laake, K | 1 |
Campbell, IA; Jenkins, PF; Williams, TD | 1 |
Palsson, G; Samuelson, G | 1 |
Kolesnikov, VV; Matviiakina, TS; Mikhaĭlov, VI | 1 |
Grushevskiĭ, ES; Iakovleva, LM; Poluianova, RP; Roslik, SM; Zhitnaia, VI | 1 |
Khomenko, AG | 2 |
Pongparit, S; Sunakorn, P; Wongrung, S | 1 |
Drápela, J; Papezová, E; Staflová, S; Tousek, J; Trnka, L; Zítková, L | 1 |
Melo, JC; Raff, MJ; Templeton, WC; Waterfill, DB | 1 |
Opl, G | 1 |
Wechsler, H | 1 |
Lauwasser, M; NcNeely, DJ; Shands, JW; Sutherland, GE | 1 |
Jay, SJ; Kiblawi, SS; Norton, J; Stonehill, RB | 1 |
Düren, M; Durgun, V; Göksoy, E; Uygun, N | 1 |
Babst, A; Cawthon, VL; Gee, B; Hadley, WK; Lancaster, MV; Madej, JJ; Sanders, CA; Yajko, DM | 1 |
Berning, SE; Elliott, AM; Iseman, MD; Peloquin, CA | 1 |
Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
de Villiers, CL; Macnab, MF | 1 |
Bownds, SE; Callister, SM; Kurzynski, TA; Norden, MA; Schell, RF | 1 |
Aspiroz, C; Gimeno, E; Gotor, MA; Guerrero, L; Mur, M; Romero, D | 1 |
Hatfull, GF; Jacobs, WR; Sarkis, GJ | 1 |
Groenewald, P; Lombard, CJ; Weyer, K; Zwarenstein, M | 1 |
Gómez Marín, JE; Portaels, F; Rigouts, L; Villegas Londoño, LE | 1 |
Choi, HY; Wong, CF; Wong, PC; Yew, WW | 1 |
Simonetti, MT; Tortoli, E | 1 |
Elufimova, VF; Iavorskiĭ, KM; Iukhimenko, NV; Mitinskaia, LA; Pogodaeva, NP | 1 |
Bohmer, PD; Macnab, MF; Seager, JR | 1 |
Angarano, G; Carbonara, D; Costa, D | 1 |
Kroegel, C; Schrappe, M; Wassermann, K | 1 |
Ausina, V; Castro, E; Coll, P; Hernández, L; Hernández-Flix, S; Sauret, J | 1 |
Dhamgaye, T; Mohanty, KC | 1 |
Gangadharam, PR; Jagannath, C; Reddy, VM | 1 |
Hill, AR; Hudak, A; Mateo, F | 1 |
Macnab, MF; Seager, JR | 1 |
Rao, S | 1 |
Nakasono, T; Ogata, H; Sugie, T; Sugita, H; Wada, M; Yosikawa, M; Yosiyama, T | 1 |
Karagöz, T; Kizkin, O; Partal, M; Sadoğlu, T; Tahaoğlu, K; Tor, M | 1 |
Anglaret, X; Lacassin, F; Leport, C; Longuet, P; Perronne, C; Saba, J; Vildé, JL | 1 |
Devred, P; Dubus, JC; Faure, F; Garnier, JM; Panuel, M; Piarroux, R; Unal, D | 1 |
García-Herola, A; García-Lázaro, M; Jurado, R; Kindelán, JM; Serrano, I; Torre Cisneros, J; Villanueva, JL | 1 |
Ageta, M; Kubo, H; Kubota, H; Nagamachi, S; Wada, S; Yamanaka, T | 1 |
Antoniskis, D; Barnes, PF; Davidson, PT; Jones, BE; Mercado, A; Otaya, M; Sian, S; Wang, F | 1 |
Arai, T; Baba, H; Ito, M; Kabe, J; Suzuki, T; Tagawa, K; Takahara, M; Toyota, E | 1 |
Greten, T; Hautmann, H; Huber, RM; Trauner, A | 1 |
Grassi, C; Peona, V | 1 |
Edelstein, H | 1 |
Bartok, AE; Dubé, M; Haghighat, D; Havlir, D; Kemper, CA; Leedom, JM; Sison, JP; Tilles, JG; Yangco, B; Yao, Y | 1 |
Alfalla, C; Butler, WR; Haas, WH; Hewlett, D; Horn, DL; Levine, A; Nayak, A; Opal, SM; Tan, E | 1 |
Bartok, AE; Camp, B; Deresinski, SC; Havlir, D; Kane, C; Kemper, CA; Lane, N | 1 |
Davaris, P; Papagiannopoulos, N; Patsouris, E; Ragos, B; Vairaktaris, E | 1 |
Suvanapha, R; Suwangool, P; Tantawichien, T | 1 |
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
Bryskier, A; Goh, KS; Rastogi, N | 1 |
Borish, LC; Matz, J; Rosenwasser, LJ; Routes, JM | 1 |
Aleksandrova, AE; Tschegoleva, RA; Vinogradova, TI | 1 |
Andreoli, A; Kohn, A; Luzi, C; Mangiarotti, R; Prantera, C | 1 |
Lawrie, BW; Newcombe, RG; Pullan, RD; Rhodes, J; Rhodes, P; Roberts, G; Srivastava, ED; Stone, R; Swift, GL; Wilkinson, S | 1 |
Delhomme, A; Flamand, JR; Greth, A | 1 |
Heurlin, N; Hoffner, SE; Källenius, G; Petrini, B; Svenson, SB | 1 |
Gusset, T; Rieder, HL; Salfinger, M | 1 |
Gordon, SM; Havlik, JA; Heifets, L; Horsburgh, CR; McGowan, JE; Metchock, B; Peloquin, CA; Thompson, SE | 1 |
Mukendi Kavulu, R; Tshilolo Mwepu, L | 1 |
Altman, C; Biour, M; Grangé, JD | 1 |
Classen, V; Degitz, K; Messer, G; Meurer, M; Schirren, H | 1 |
Fox, R; Gillespie, SH; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Saruni, AO; Uiso, LO | 1 |
Dickinson, JM; Guy, A; Mitchison, DA | 1 |
Bonk, S; Bromberg, A; Bromberg, R; Hanna, BA; Neville, K; Rom, WN | 1 |
Campbell, IA; Friend, JA; Jenkins, PA; Ormerod, LP; Prescott, RJ | 1 |
Elistratova, NA; Khalbaeva, IV; Koriakin, VA; Sokolova, GB; Ziia, AV | 1 |
Ellard, GA | 2 |
Dias, F; Hoffner, SE; Källenius, G; Martins, L; Michael, SG; Norberg, R | 1 |
Ernst, W; Gossmann, J; Kachel, HG; Peschke, B; Scheuermann, EH; Schoeppe, W | 1 |
David, HL; Rastogi, N | 1 |
Habot, B; Leibovitz, A; Rabinovitz, H; Rozenfeld, V; Schwartz, J; Stelian, J | 1 |
Jezierska-Anczuków, A; Zalewska-Schöntaler, N | 1 |
Aziah, AM; Faridza, MY; Jalleh, RD; Kuppusamy, I; Soshila, R | 1 |
Anagonou, SY; Foundohou, J; Gninafon, M; Josse, R; Kinde-Gazard, D; Tawo, L | 1 |
Powell, T | 1 |
Hjelm, U; Hoffner, SE; Källenius, G | 1 |
Gupta, PR; Gupta, RB; Sharma, TN; Singhal, B | 1 |
Herbert, D; Paramasivan, CN; Prabhakar, R | 1 |
Carroll, CP; Kim, JY; Opremcak, EM | 1 |
Passannante, MR; Reichman, LB; Restifo, RA | 1 |
Develioğlu, O; Gürgan, T; Urman, B; Yarali, H; Zeyneloğlu, H | 1 |
Bergmann, F; Fehrenbach, J; Jautzke, G; Mauch, H; Ruf, B; Schürmann, D | 1 |
Dhand, R; Ganguly, NK; Jaswal, S; Kohli, KK; Sethi, AK | 1 |
Tekavec, J; Trkanjec, Z | 1 |
Clark, JA; Margolis, DM | 1 |
Brosgart, C; Charlebois, E; Gary, D; Hadley, WK; Jacobson, MA; Northfelt, D; Sanders, CA; Yajko, D | 1 |
Delaney, V; Hong, JH; Sommer, B; Sumrani, N | 1 |
Asai, T; Hara, K; Kawano, S; Masumoto, H; Matsuse, A; Monden, J; Nakamura, H; Nakamura, Y; Shimoda, T | 1 |
Fahn, HJ; Hsu, HS; Huang, MH; Wang, LS; Wu, YC | 1 |
McColloster, P; Neff, NE | 1 |
Belfort, R; Muccioli, C | 1 |
Brummer, E; Deresinski, SC; Hamilton, JR; Kemper, CA; Sison, JP; Stevens, DA; Yao, Y | 2 |
Andrés Soler, J; González, F; Moreno, R; Pardo, F; Prada Alfaro, PL | 1 |
Aguilar, X; Fernández-Muixí, J; Gallego, M; Morera, J; Ribas, J; Richart, C; Ruiz, J; Teixidó, A | 1 |
Asnis, DS; Bresciani, AR; Cohn, M | 1 |
Brown, BA; Girard, WM; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Davey, JR; Kreder, HJ | 1 |
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
Radermecker, M | 1 |
Al Jarad, N; Barnes, NC; Demertzis, P; Empey, DW; Gaya, H; Hughes, DT; Jones, DJ; Rudd, RM; Wedzicha, JA | 1 |
Berger, L; Curram, J; Fox, R; Gillespie, SH; Gutmann, J; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Sam, N; Saruni, AO; Tillotson, G; Uiso, LO; Yates, M | 1 |
Birnbaum, J; Chan, SP; Rao, M; Steiner, P | 1 |
Aita, J; Barrera, L; Biglione, J; Largacha, C; Lopez, B; Rajmil, JC; Reniero, A; Ritacco, V; Weisburd, G | 1 |
Gubkina, MF | 1 |
Barry, P; Isselin, J; Regnard, PJ | 1 |
Mills, K; Wanger, A | 1 |
Das, PC; Radhakrishna, K; Rao, PL | 1 |
Morris, CD | 1 |
Broor, SL; Chaudhary, A; Kumar, N; Malhotra, V; Malik, VK; Puri, AS; Sachdev, A; Vij, JC | 1 |
Cengiz, K | 1 |
Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 2 |
Alland, D; Brudney, K; Crawford, JT; Frieden, TR; Fujiwara, PI; Hewlett, D; Kreisworth, BN; Maw, KL; Nivin, B; Sharp, V; Sherman, LF | 1 |
Begić-Janeva, A; Boricić, I; Brmbolić, BJ; Jevtović, DL; Ranin, JT; Salemović, DR | 1 |
Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
Kuijper, EJ; Prins, JM; Schultsz, C; van Soolingen, D | 1 |
Bryskier, A; Devallois, A; Goh, KS; Rastogi, N | 1 |
Duursema, L; Groenewoud, G; Hundt, HK; Middle, MV; Mogilnicka, EM; Müller, FO; Schall, R; Swart, KJ | 1 |
Paul, CR; Rabah, R; Rao, RB | 1 |
Belt, EL; Durrheim, DN | 1 |
Egawa, H; Inomata, Y; Kiuchi, T; Okajima, H; Sano, K; Satomura, K; Tanaka, K; Uemoto, S; Uyama, S; Yamaoka, Y | 1 |
Alvarez, L; Diliz, HS; Hernandez, A; Treviño, M; Zaragoza, RM | 1 |
Sarela, AI; Supe, AN | 1 |
Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T | 1 |
Colville, A; Crisp, AJ; Evans, AJ; Evans, SA; Johnston, ID | 1 |
Tanaka, E | 1 |
Ohgimi, T; Ohtake, M; Okuno, M; Saito, H; Yamamoto, S | 1 |
Heginbothom, ML; Magee, JT | 1 |
Chang, SY; Changchien, CC; Hsu, TY; Lin, JW; Ma, YY | 1 |
Bozóky, G; Góhér, I; Mohos, A; Ruby, E; Tóth, J | 1 |
Cohen, LB; Knowles, SR; Liu, BA; Shear, NH; Werb, MR | 1 |
Benator, DA; Gordin, FM; Kan, V | 1 |
Gabl, M; Hausdorfer, H; Kreczy, A; Pechlaner, S; Went, P | 1 |
Fuursted, K | 1 |
Cameron, DW; Gallicano, K; Garber, G; Oliveras, L; Rachlis, A; Sahai, J; Seguin, I; Swick, L; Tailor, S; Walker, S | 1 |
Siribaddana, SH; Wijesundera, A | 1 |
Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE | 1 |
Lin, S; Yan, S; Ye, H | 1 |
Jiang, M; Wang, S; Yang, T | 1 |
Asakura, H; Matsuda, T; Mizuhashi, K; Mizushima, N; Nakao, S; Takami, A; Yamazaki, H | 1 |
Barry, CE | 1 |
Elcock, M; Kent, JH; Maxwell, R; Meador, J; Onorato, I; Ridzon, R; Royce, S; Shefer, A; Smith, P; Valway, S; Weismuller, P; Woodley, C | 1 |
Bustreo, F; Laszlo, A; Rahman, M; Raviglione, M | 1 |
Balambal, R; Balasubramanian, R; Nagarajan, M; Paramasivam, CN; Prabhakar, R; Rajasambandam, P; Rangabashyam, N; Sundararaman, R; Tripathy, SP; Venkatesan, P | 1 |
Berhane, Y; Demissie, M; Gebeyehu, M | 1 |
Bilgiç, H; Ciftçi, F; Köylü, R; Pabuşçu, Y; Seber, O; Tozkoparan, E | 1 |
Hoban, DJ; Kabani, AM; Karlowsky, JA; Saunders, MH; Wolfe, JN; Zhanel, GG | 1 |
Cook, MB; Degnan, MT; Ferguson, RM; Franzblau, SG; Gilman, RH; Hernandez, A; Madico, G; McLaughlin, JC; Quenzer, VK; Torres, P; Witzig, RS | 1 |
Kuś, J; Michałowska-Mitczuk, D | 2 |
Boudville, IC; Snodgrass, I; Wong, SY | 1 |
Dautzenberg, B; Jouveshomme, S | 1 |
Devoto, FM; González, C; González, CD; Iannantuono, R; Sáenz, C; Serra, HA | 1 |
Beji, M; Ben Rhomdane, N; Daghfous, J; Louzir, B; Mtimet, B; Zouari, M | 1 |
Benzarti, M; Garrouche, A; Hayouni, A; Jerray, M; Klabi, N; Maalel, K | 1 |
Choi, BW; Hue, SH; Park, IW | 1 |
Rieder, HL; Trébucq, A | 1 |
Ali, SA; Amanullah, S; Arif, K; Khan, JA; Nayani, P; Siddiqui, I | 1 |
Amitani, R; Hitomi, S; Kuze, F; Matsumoto, H; Mizuno, H; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Yanagihara, K | 1 |
Clavel-Sérès, S; Goh, KS; Rastogi, N | 1 |
Finelli, L; Liu, Z; Shilkret, KL | 1 |
Bai, KJ; Chiang, CY; Chiang, IH; Lin, TP; Luh, KT; Suo, J; Yu, MC | 1 |
Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE | 1 |
Binkin, N; Bustreo, F; Chaulet, P; Cohn, DL; Kim, SJ; Lambregts-van Weezenbeek, CS; Laszlo, A; Nunn, P; Pablos-Méndez, A; Raviglione, MC; Rieder, HL | 1 |
Callister, SM; Kirk, SM; Mazurek, GH; Moore, AV; Schell, RF | 1 |
Gallemore, GH; Mehta, JB; Mejia, E; Ramsey, GF | 1 |
Autret, E; Carré, P; Jonville-Bera, AP; Lemarié, E; Radal, M; Van-Egroo, C | 1 |
Ivanyi, J; Moreno, C; Pasvol, G; Sjölund, A; Vordermeier, HM; Wilkinson, KA; Wilkinson, RJ | 1 |
Mansour, AM | 1 |
Bergmann, JS; Woods, GL | 1 |
Fodor, T; Lõrinczi, I; Vadász, I | 1 |
Okazawa, Y; Sato, N; Tanno, K; Yamazaki, T | 1 |
Chow, SK; Tong, FM | 1 |
Filippou, N; Ilias, I; Papachristou, K; Vassilikos, G | 1 |
Bercion, R; Kuaban, C | 1 |
Antia, NH; Dholakia, Y; Harboe, M; Mistry, NF; Sethna, KB | 1 |
Eladari, D; Klotz, F; Mbaye, PS; Sane, M; Talarmin, F | 1 |
Dass, A; Goyal, A; Mohan, H; Nagarkar, NM; Uppal, KS | 1 |
Bancel, B; Biron, F; Boibieux, A; Bouhour, D; Chidiac, C; Peyramond, D; Rode, A; Sève, P | 1 |
Domehl, C; Gismondo, MR; Nardi, G; Pfyffer, GE; Rüsch-Gerdes, S; Welscher, HM | 1 |
Bao, O; Diouf, B; Diouf, ML; Ka, MM; Mbengue, M; Moreira-Diop, T; Niang, A; Pouye, A | 1 |
Barber, TW; Currier, J; Ellner, JJ; Hafner, R; Hojczyk, P; Hooton, TM; Jacobs, MR; Limjoco, M; Parenti, DM; Powderly, WG; Simpson, G; van der Horst, C; Williams, PL | 1 |
Araki, J; Asai, S; Futsuki, Y; Tomari, S | 1 |
O'Flanagan, J; Syed, AA | 1 |
Horgen, L; Legrand, E; Rastogi, N | 1 |
de Jong, JJ; Endtz, HP; IJzermans, JN; van Gelder, T; Weimar, W | 1 |
Miyao, H; Okazawa, Y; Sato, N; Tanno, K; Yamashita, K; Yamazaki, T | 1 |
Childs, JM; Fish, DN; Malone, RS; Peloquin, CA; Spiegel, DM | 1 |
Aljada, IS; Amsterdam, D; Corriere, N; Crane, JK; Wagle, DG | 1 |
Autret, E; Jonville-Béra, AP; Martel, C; Mazaud, S; Olivier, C; Radal, M | 1 |
Ito, K; Mizutani, S; Ogata, H; Sugita, H; Wada, M; Yoshiyama, T | 1 |
Connolly, C; Davies, GR; McAdam, KP; Sturm, AW; Wilkinson, D | 1 |
Baello, BQ; Balagtas, ED; Cardano, RC; Co, VM; Mantala, MJ; Pascual, LG; Quelapio, ID; Rivera, AB; Tupasi, TE; Villa, LA | 1 |
Chang, SC; Chang, YL; Fang, CT; Hsieh, WC; Hsueh, PR; Luh, KT | 1 |
Duchin, JS; Goldberg, SV; Nolan, CM; Shields, T | 1 |
Chinchilla, D; Martorano, A; Rodriguez, E; Villanueva, C | 1 |
Coninx, R; de Haller, R; Debacker, M; Ismaelov, A; Mathieu, C; Meddings, DR; Mirzoev, F | 1 |
Amitani, R; Kimoto, T; Kuze, F; Matsumoto, H; Murayama, T; Niimi, A; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Watanabe, I | 1 |
Chang, CH; Chang, JP; Kao, CL | 1 |
Shemiakin, IG; Stepanshin, IuG; Stepanshina, VN | 1 |
Long, R; Scalcini, M | 1 |
Alwood, K; Bishai, WR; Blazes, D; Chaisson, RE; Coggin, W; Gachuhi, R; Sterling, TR | 1 |
Asai, S; Endou, T; Iwamoto, A; Nakamura, T; Takahashi, T; Yoshikawa, K | 1 |
Berning, SE; Gilljam, M; Larsson, LO; Peloquin, CA; Strandvik, B | 1 |
Barrière, V; Blétry, O; Bricaire, F; Caumes, E; Gepner, P | 1 |
Ayarza, R; Berdonces, P; Echeverría, MJ; Ibarretxebea, AB; Jiménez, MS; López de Goicoechea, MJ | 1 |
Kobashi, Y; Okimoto, N; Soejima, R | 1 |
Aleksandra, S; Ewa, AK; Jacek, Z; Magdalena, K; Paweł, R | 1 |
Stengel, W | 1 |
Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ | 1 |
Kuroda, F; Mizutani, F; Sasaki, Y; Wada, A; Yagi, T; Yamagishi, F | 1 |
Akçay, S; Arslan, H; Demirag, A; Gürdogan, K; Haberal, M; Kalpaklioglu, F; Oner-Eyüboglu, F | 1 |
Haberal, M; Kalpaklioglu, AF; Moray, G; Oner-Eyüboglu, AF | 1 |
Bergmann, JS; Fish, G; Woods, GL | 1 |
Musser, JM; Ramaswamy, S | 1 |
Piddock, LJ; Ricci, V; Williams, KJ | 1 |
Barker, J; Makatini, Z; Millard, J | 1 |
Aleixo-Dias, J; Antunes, AF; Antunes, ML; Pereira, MF; Raymundo, E; Rodrigues, MF | 1 |
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
Baruchin, AM; Nelly, P; Oren, S; Weiler, Z | 1 |
Daniel, N; Geiter, LJ; Grosset, J; Hejblum, G; Ji, B; Lounis, N; O'Brien, RJ; Szpytma, M; Truffot-Pernot, C; Vernon, A | 1 |
Baéz, J; Dye, C; Espinal, MA; Kam, KM; Khomenko, AG; Kim, SJ; Kochi, A; Migliori, GB; Raviglione, MC; Suarez, PG | 1 |
Achi, V; Coulibaly, G; Diagbouga, S; Domoua, K; N'Dathz, M; Ouedraogo, M; Ouedraogo, SM; Yapi, A | 1 |
Gerber, F; Herrmann, JL; Lagrange, PH; Lavergne, F; Poinsignon, Y; Simonney, N; Sousa, AO; Wargnier, A | 1 |
Horvath, JA; Talwani, R | 1 |
Mason, JO | 1 |
Kihara, Y; Otsuki, M | 1 |
Jasmer, RM; Small, PM | 1 |
Ebe, T; Sato, K | 1 |
Chagaluka, S; Drobniewski, F; Fine, PE; Glynn, JR; Jenkins, PA; Ngwira, B; Pönnighaus, JM; Warndorff, DK; Yates, M | 1 |
Aral, Y; Cakir, B; Demirbaş, B; Güler, S; Gürsoy, G; Odabaşi, E; Yönem, A | 1 |
Angeli, A; Fiorini, S; Gonzatto, I; Orlandi, F; Pasquali, R; Pivano, G; Saggiorato, E | 1 |
Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
Taniguchi, H | 1 |
Nakae, K; Nishiyama, M; Roosihermiatie, B | 1 |
Bartolini, L; Beer, J; Mattei, R; Savarino, A; Tortoli, E | 1 |
Chase, SE; Cynamon, MH; Lenaerts, AM | 1 |
Ewa, AK; Magdalena, K; Zofia, Z | 1 |
Dokouhaki, P; Heidary, A; Masjedi, MR; Mohammadi, F; Velayati, AA | 1 |
Erokhin, VV | 1 |
Casal, MJ; Ruiz, P; Zerolo, FJ | 1 |
Choi, IS; Huh, WS; Joh, JW; Kim, MK; Kim, SJ; Kim, SM; Ko, YH; Lee, BB; Lee, SK; Oh, HY; Park, JB; Peck, KR; Song, JH | 1 |
Gupta, HP; Gupta, R; Rathi, GL; Sharma, AK; Tolani, SL | 1 |
Asakuma, J; Asano, T; Hayakawa, M; Kawamoto, H; Kobayashi, H; Tanimoto, T | 1 |
Assengone-Zeh, Y; Kengue-Lechiombeka, PR; Loembe, PM; Mwanyombet-Ompounga, L | 1 |
Aguar Benito, MC; Arnedo Pena, A; González Morán, F; Marín Royo, M; Moreno Muñoz, R; Pardo Serrano, F; Prada Alfaro, P | 1 |
Cetin, M; Coban, AY; Gunaydin, M; Sanic, A | 1 |
Barberis, MC; Cannone, M; De Rosa, G; Delfino, M; Ferrara, G; Scalvenzi, M; Staibano, S | 1 |
Ormerod, P | 1 |
Akçali, O; Alici, E; Günal, I; Tatari, H | 1 |
Wada, M | 1 |
Cheon, SH; Dietze, R; Ellner, JJ; Hise, AG; Landen, K; Palaci, M; Phillips, M; Ribeiro, FC; Song, HY; Vinhas, S; Wallis, RS | 1 |
Arnadottir, T; Enarson, DA; Rieder, HL; Trébucq, A | 1 |
Bocanegra, R; Graybill, JR | 1 |
Block, JA; Co, H; Sequeira, W | 1 |
Abété, B; Scotté, M; Songné, B; Tchangaï-Walla, KL; Tignokpa, N; Valenti, P | 1 |
Baraia-Etxaburu, J; Ibarrola, M; Miguel Santamaría, J; Sánchez, R; Teira, R; Unzaga, J | 1 |
Khan, MY; Kinsara, AJ; Memish, Z; Osoba, AO; Samman, Y; Wali, S | 1 |
Huang, J; Huang, W; Jiaan, B; Lee, Y; Wang, J; Yu, C | 1 |
Brown, BA; Couch, LA; Girard, WM; Griffith, BE; Griffith, DE; Wallace, RJ | 1 |
Turgut, M | 1 |
Cheng, B | 1 |
Bowersox, J | 1 |
Bakare, NA; Ige, OM; Onadeko, BO | 1 |
Heginbothom, ML | 1 |
Asada, K; Inui, N; Kuwata, H; Matsuda, H; Nakamura, H; Nakamura, Y; Sennda, K; Suda, T; Suzuki, K; Tsuchiya, T; Yokomura, K | 1 |
Dorozhkova, IR; Medvedeva, IM; Popov, SA | 1 |
Abe, C; Aoyagi, T; Hirano, K; Wada, M | 1 |
Ellard, GA; Fourie, PB; Pillai, G; Smith, PJ | 1 |
Gamazkov, RV; Iagafarova, RK; Ivanova, LA | 1 |
Kirtane, MV; Muranjan, SN | 1 |
Gawkrodger, DJ; Green, ST; Strauss, RM | 1 |
Kam, KM; Yip, CW | 1 |
Long, R; Ollé-Goig, J; Scalcini, M | 1 |
Mauch, H; Nikolenko, EN; Roth, A; Skriagina, EM; Zalutskaia, OM | 1 |
Antunes, ML; Binkin, N; Camacho, M; Espinal, MA; Fusheng, Z; George, AG; Kim, SJ; Laserson, K; Martin-Casabona, N; Raviglione, MC; Simelane, P; Smith, I; Suarez, P; Tlali, RE; Weyer, K | 1 |
Hira, SK; Kura, MM | 1 |
Brandi, G; Celeste, AG; Salvaggio, L; Schiavano, GF; Sisti, M | 1 |
Al-Marri, MR | 1 |
McEwan, JA; McKendrick, MW; Mohsen, AH; Schmid, ML | 1 |
Chen, Z; Wang, H | 1 |
Bhardwaj, M; Gautam, RK; Kar, HK; Sharma, PK | 1 |
Cocco, MT; Congiu, C; De Logu, A; Onnis, V; Saddi, B; Schivo, ML | 1 |
Spedini, P | 1 |
Arjratanakul, W; Chaiprasert, A; Chierakul, N; Pattanakitsakul, SN; Tingtoy, N | 1 |
Boukriche, Y; Fantin, B; Masson, C; Zarrouk, V | 1 |
Hayashi, R; Kawasaki, A; Kobayashi, M; Maruyama, M; Shinoda, C | 1 |
Ding, D; Duanmu, HJ; Li, D; Peng, YL; Song, H; Wang, G; Wang, L; Xing, J; Zhang, G; Zhang, L; Zhang, Z | 1 |
Arnold, SM; Els, T; Kassubek, J; Lücking, CH; Oehm, E; Serr, A; Zucker, B | 1 |
Hoshinaga, K; Ishikawa, K; Izumitani, M; Maruyama, T; Shiroki, R | 1 |
Dosumu, EA | 1 |
Flaherty, JP; Gupta, SN; Shaw, JC | 1 |
Huang, TS; Huang, WK; Lee, SS; Liu, YC; Tu, HZ | 1 |
Bjune, G; Caugant, DA; Mariandyshev, AO; Sandven, P; Toungoussova, S | 1 |
Badsha, H; Chong, AP; Kong, KO; Teh, CL | 1 |
Carnelio, S; Rodrigues, G | 1 |
Isla, AM; Riaz, AA; Robshaw, P; Singh, A | 1 |
Ghebremichael, S; Hoffner, SE; Koivula, T; Krüüner, A; Mikelsaar, M; Pehme, L | 1 |
Al-Sayegh, MO; Al-Sharif, N; Osman, MM; Shaikh, MA; Singla, R | 1 |
Bambery, P; Bhatnagar, A; Khullar, M; Singh, S; Sud, A; Wanchu, A | 1 |
Guédénon, A; Hans-Moevi, A; Houessou, R; Ifebe, D; Johnson, RC; Kestens, L; Meyers, WM; Portaels, F | 1 |
Batra, V; Niazi, S; Zangrilli, JG | 1 |
Espinal, M; Laszlo, A; Rahman, M; Raviglione, M | 1 |
Bajaj, M; Bhutani, H; Kaur, H; Mariappan, TT; Pakhale, S; Singh, S | 1 |
Augustynowicz-Kopeć, E; Drozd, I; Jaworski, A; Klatt, M; Kostrzewa, E; Swiderska, A; Zwolska, Z | 1 |
Fujishima, M; Ibayashi, S; Iida, M; Ogasawara, T; Saku, Y; Sugimori, H | 1 |
Rodrigues, VS; Rossetti, ML; Silva, MS; Valim, AR | 1 |
Danilova, ID; Espinal, M; Grzemska, M; Migliori, GB; Punga, VV; Raviglione, MC | 1 |
Agrawal, S; Bhade, SR; Kaul, CL; Kaur, KJ; Panchagnula, R; Singh, I | 1 |
Bogadel'nikova, IV; Elistratova, NA; Kunichan, AD; Semenova, OV; Sokolova, GB; Zeliger, LR | 1 |
Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA | 1 |
Goldberg, SV; Nolan, CM | 1 |
Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M | 1 |
Doré, CJ; Jindani, A; Mitchison, DA | 1 |
Chang, SC; Hung, CC; Luh, KT; Sheng, WH; Wang, JT; Wang, JY | 1 |
Lee, JJ; Lee, TY; Park, HJ; Park, HY; Shin, KY; Woo, YN | 1 |
Agarwal, SK; Shah, AR; Shah, KV | 1 |
Martínez-Rossier, LA; Pérez-Guzmán, C; Torres-Cruz, A; Vargas, MH; Villarreal-Velarde, H | 1 |
Bonnaud, F; Zigani, A | 1 |
Menzies, D; Parisien, I; Pelletier, M; Rocher, I; Valiquette, C; Yee, D | 1 |
Delgadillo-Polanco, R; Enciso-Moreno, JA; Franzblau, SG; Luna-Herrera, J; Martínez-Cabrera, G; Parra-Maldonado, R; Quesada-Pascual, F; Torres-López, J | 1 |
Bjorvatn, B; Grewal, HM; Hmun, T; Htun, A; Jureen, R; Myint, H; Phyu, S; Ti, T | 1 |
Mohan, B; Sharda, N; Singh, S | 1 |
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
Cauchoix, B; Rakotoarisaonina, A; Rakotoherisoa, A; Rakotondramarina, D; Rakotonirina, V; Ralamboson, M; Ramarokoto, H; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsirahonana, O | 1 |
Beena, S; Pai, MR; Rao, KN | 1 |
Kumar, A; Malik, P; Mathur, MB; Prakash, G; Sharma, PM; Singh, RP | 1 |
Dekker, TG; Lötter, AP | 1 |
Danckwerts, MP; Ebrahim, S; Pillay, V | 1 |
Mohan, B; Singh, S | 1 |
Homma, S; Kawabata, M; Kishi, K; Kono, T; Kurosaki, A; Motoi, N; Nakata, K; Nakatani, T; Narui, K; Tanimoto, H; Tsuboi, E | 1 |
Campbell, IA; Jenkins, PA | 1 |
Kudzyte, I; Steponaviciene, D | 1 |
Nagai, H | 1 |
Akagawa, S; Baba, M; Kawabe, Y; Kurashima, A; Machida, K; Masuda, K; Mohri, M; Nagai, H; Nagayama, N; Tamura, A; Yotsumoto, H | 1 |
Hong, SJ; Kim, BS; Kim, HB; Kim, JH | 1 |
Fujikane, T; Fujita, Y; Fujiuchi, S; Matsumoto, H; Nakao, S; Okamoto, K; Sato, K; Shimizu, T; Takahashi, M; Takeda, A; Yahara, O; Yamazaki, Y | 1 |
Ahn, HC; Lee, YC | 1 |
Kuraoka, T; Murai, H; Nakao, R; Onari, Y; Taniwaki, M; Terada, M; Yamaoka, N | 1 |
Brown, RS; Farquharson, AA; Nasseri, S | 1 |
Agrawal, S; Kaul, CL; Panchagnula, R; Rungta, S; Sancheti, P | 1 |
Kobashi, Y; Matsushima, T | 3 |
Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B | 1 |
Ahmad, RN; Anwar, M; Butt, T; Karamat, KA; Kazmi, SY; Mahmood, A | 1 |
Agdamag, DM; Espantaleon, AS; Kageyama, S; Sangco, JC; Solante, R; Suzuki, Y | 1 |
Drlica, K; Lu, T | 1 |
Castro, A; Frisch, IB; Krastel, H; Kunze, AK; Meinck, HM | 1 |
Semenova, OV | 1 |
Chandrasekaran, V; Gurumurthy, P; Immanuel, C; Prabhakar, R; Ramachandran, G; Venkatesan, P | 1 |
Arevalo, J; Campos, PE; Holmes, KK; Hooton, TM; Nolan, CM; Sanchez, J; Suarez, PG; Ticona, E; Zavala, D | 1 |
Jankowska, R; Krecicki, T; Skrzydlewska-Kaczmarek, B; Zalesska-Krecicka, M; Zatonski, T | 1 |
Anagnostou, S; Costopoulos, C; Gitti, Z; Kontos, F; Maniati, M; Maniatis, AN; Nicolaou, S; Petinaki, E; Tselentis, I | 1 |
Schuh, A; Zeiler, G | 1 |
Hamada, H; Hamada, M; Hara, Y; Higaki, J; Katayama, H; Ogimoto, A; Saeki, H; Shigematsu, Y | 1 |
Chaudhary, H; Raghavendran, M; Srivastava, A | 1 |
Birinci, A; Coban, AY; Durupinar, B; Ekinci, B | 2 |
Cormican, LJ; Milburn, HJ; Schey, S | 1 |
Mitchison, DA; Prabhaker, R; Reetha, AM; Rehman, F; Santha, T; Sarma, GR | 1 |
Ahmed, I; Obaideen, AM; Rahman, NU; Shahat, AH; Zahman Au, Au | 1 |
Bhanu, NV; Cho, SN; Gomes, HM; Jordaan, AM; Kadival, GV; Khan, BK; Kulkarni, SP; Lee, H; Lim, KC; Mokrousov, I; Narvskaya, O; Schouls, LM; Singh, UB; Suffys, PN; van Soolingen, D; Victor, TC; Yap, SF | 1 |
Maartens, G; Texeira-Swiegelaar, C; Visser, ME | 1 |
Chimzizi, R; Gausi, F; Harries, AD; Salaniponi, FM | 1 |
Asencios-Solis, L; Bayona, J; Becerra, MC; Leo-Hurtado, E; Quispe-Torres, N; Salazar-Lindo, E; Vásquez-Campos, L | 1 |
Gausi, F; Harries, AD; Salaniponi, FM | 1 |
Ditto, AM; Story, RE | 1 |
Jiang, QW; Jiang, WL; Xu, B; Yang, BF; Zhou, PY | 1 |
Ahmedani, MY; Islam, N | 1 |
Karachunskiĭ, MA; Uvarova, TE | 1 |
Pinto, A; Sullivan, J; Yepes, JF | 1 |
Fujimura, M; Nakao, S; Nishizawa, Y; Tagami, A; Yamamori, C; Yasui, M | 1 |
Aydin, G; Keleş, I; Kendi, TK; Orkun, S | 1 |
Cirillo, DM; Frisicale, L; Marchiaro, G; Penati, V; Piana, F; Quaranta, M; Riccabone, A; Vaccarino, P | 1 |
Johansen, IS; Lundgren, B; Marjamäki, M; Sosnovskaja, A; Thomsen, VØ | 1 |
Avkan Oğuz, V; Cakmak, R; Erkut, M; Güneri, S; Ozgü, A; Oztop, A; Unsal, I | 1 |
Gelmanova, IE; Golubchikova, VT; Pavlova, VE; Peremitin, GG; Seung, KJ; Sirotkina, OB; Strelis, AK; Yanova, GV | 1 |
Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM | 1 |
Bhagavathy, S; Gurumurthy, P; Hemanth Kumar, AK; Mahilmaran, A; Padmapriyadarsini, C; Paramesh, P; Rajasekaran, S; Ramachandran, G; Ravichandran, N; Sekar, L; Swaminathan, S; Venkatesan, P | 1 |
Chacko, AG; Chandy, MJ; Moorthy, RK | 1 |
Gupta, S; Lal, S; Negi, SS | 1 |
Bhalla, P; Dhingra, VK; Hanif, M; Jain, SK; Rajpal, S; Yadav, A | 1 |
Leung, KT; Siu, YP; Tong, MK; Yung, CY | 1 |
Delgado, R; Lambert, ML; Michaux, G; Van der Stuyft, P; Volz, A | 1 |
Costa-de-Oliveira, S; Pina-Vaz, C; Rodrigues, AG | 1 |
Calonge, M; Torres, RM | 1 |
Ito, K; Ogata, H; Wada, M; Yoshiyama, T | 1 |
Moritaka, T; Nakanishi, N; Ueda, N | 1 |
Inoue, T; Maeda, Y; Maniwa, K; Sakuramoto, M; Taguchi, Y; Tanaka, E | 1 |
Bjune, G; Brantsaeter, AB; Farah, MG; Heldal, E; Steen, TW; Tverdal, A | 1 |
Belotserkovets, VG; Ubaĭdullaev, AM | 1 |
Echemendia, M; Lemus, D; Martin, A; Montoro, E; Palomino, JC; Portaels, F | 1 |
Hess, CL; Murphy, MS; Wolock, BS | 1 |
Hoeppner, VH; Jones, W; Marciniuk, DD; Ward, HA | 1 |
Cicenaite, J; Davidaviciene, E; Dewan, P; Johansen, I; Laserson, K; Sosnovskaja, A; Thomsen, V; Wells, C | 1 |
Bai, YJ; Luo, M; Wang, Y; Yan, XJ; Zhang, QH; Zhao, JR | 1 |
Shah, BA; Splain, S | 1 |
Ige, OM; Odaibo, GN; Olaleye, OD; Sogaolu, OM | 1 |
Callister, SM; DeCoster, DJ; Schell, RF; Vena, RM | 1 |
Choi, MS; Chung, MP; Kim, H; Koh, WJ; Kwon, OJ; Lee, BH; Suh, GY | 1 |
Fukuoka, A; Kasahara, K; Kimura, H; Mikasa, K; Murakawa, K; Narita, N; Okamura, H | 1 |
Bakker-Woudenberg, IA; van Agtmael, MA; van Soolingen, D; van Vianen, W; Verbrugh, HA | 1 |
Berthold, F; Ebeling, O; Handrick, W; Schwede, I; Wogawa, B | 1 |
De Potter, P; Levecq, LJ | 1 |
Abo, M; Fujimura, M; Honjyo, C; Nakao, S; Nishizawa, Y; Tagami, A; Yasui, M | 1 |
Bhutani, H; Chakraborti, AK; Jindal, KC; Singh, S | 1 |
Akselband, Y; Cabral, C; McGrath, P; Shapiro, DS | 1 |
Ashokraj, Y; Bhade, SR; Kaul, CL; Kaur, KJ; Kohli, G; Panchagnula, R; Singh, I; Varma, MV | 1 |
Endoh, M; Morozumi, S; Mukaigawa, J; Yanagawa, Y | 1 |
Agerton, TB; Bradford, WZ; Hopewell, P; Kenyon, TA; Lockman, S; Moeti, TL; Moffat, HJ; Oyewo, A; Peloquin, CA; Reingold, AL; Talbot, EA; Tappero, JW | 1 |
Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH | 1 |
Göpel, B; Götte, K | 1 |
Hamada, M; Ishimatsu, A; Iwata, Y; Kajiki, A; Kitahara, Y; Komori, M; Matsunaga, K; Nagata, N; Wakamatsu, K | 1 |
Catherinot, E; Gaillard, JL; Le Bourgeois, M; Sermet-Gaudelus, I | 1 |
Bai, GH; Koh, WJ; Kwon, OJ; Lew, WJ; Park, YK | 1 |
Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Holm, JP; Schram, AJ; van Altena, R | 1 |
Alosi, MM; Ruggeri, C; Scibilia, G; Valenzise, M; Wasniewska, M | 1 |
Dziadek, J; Korycka-Machała, M; Rumijowska-Galewicz, A | 1 |
Durmaz, R; Foxman, B; Gunal, S; Marrs, CF; Sanic, A; Yang, D; Yang, Z; Zhang, L | 1 |
Fujiwara, K | 1 |
Hafner, R; Peloquin, CA; Perlman, DC; Rainey, PM; Remmel, RP; Rosenkranz, S; Salomon, N; Segal, Y | 1 |
Gkiatas, K; Kararizos, G; Kararizou, E; Likomanos, D; Markou, I; Triantafyllou, N; Vassilopoulos, D; Zalonis, I; Zambelis, T | 1 |
Curry, K; Yoon, Y | 1 |
Izumi, S; Taniguchi, H | 3 |
Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
Esteban, J; Jiménez, MS; Ortiz, A | 1 |
Currie, GP; Devereux, G; Emmanuel, FX; Ford, D | 1 |
Listernick, R | 1 |
Bhutani, H; Jindal, KC; Singh, S | 1 |
Adke, R; Goswami, K; Valappil, SV | 1 |
Cohn, DL; Ellner, JJ; Johnson, JL; Kayanja, H; Luzze, H; Mugerwa, RD; Nsubuga, P; Nunn, P; Okwera, A; Whalen, CC | 1 |
Chakravarty, B; Chaudhury, K; Dam, P; Ganesh, A; Ghosh, S; Goswami, SK; Shirazee, HH | 1 |
Aggarwal, N; Aggarwaln, JK; Dhingra, VK; Jain, SK; Rajpal, S; Shadab, K | 1 |
Aksamit, TR; Catanzaro, A; Daley, CL; Garay, SM; Griffith, DE; Lam, PK; Ruoss, SJ | 1 |
Abe, C; Kobayashi, I; Mitarai, S | 1 |
Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
Alrajhi, AA | 1 |
Burger, A; Folb, PI; McIlleron, H; Norman, J; Smith, P; Wash, P | 1 |
Akgunes, A; Bilgin, K; Cetinkaya, E; Cihan, CC; Coban, AY; Durupinar, B; Uzun, M | 1 |
Ahmad, Z; Khuller, GK; Pandey, R; Sharma, S | 1 |
Boutemy, M; Bruniau, A; Devauchelle, B; Gbaguidi, C; Jounieaux, V; Mbuyamba, S; Moure, C; Testelin, S | 1 |
Hoffner, SE; Klintz, L; Werngren, J | 1 |
De Broucker, T; Martinez-Almoyna, L; Steichen, O | 1 |
La Rusca, I; Schonauer, F; Turner, A; Vuppalapati, G | 1 |
Bauer, TW; Fraser, TG; Hall, GS; Joyce, MJ; Kobayashi, N; Procop, GW; Tuohy, MJ | 1 |
Kokosali, K; Lloyd, RE | 1 |
Almeida, D; Bishai, WR; Grosset, JH; Nuermberger, E; Peloquin, CA; Rosenthal, I; Tyagi, S; Williams, KN | 1 |
Alland, D; Billman-Jacobe, H; Bobadilla del Valle, M; Bose, M; Brimacombe, M; Cavatore, M; Cave, MD; Chaves, F; Eisenach, KD; Fyfe, J; García-García, L; Guerrero, MI; Hazbón, MH; Lavender, C; León, CI; Murray, M; Ponce de León, A; Sifuentes-Osornio, J; Varma-Basil, M | 1 |
Elwood, RK; FitzGerald, JM; Moniruzzaman, A; Schulzer, M | 1 |
Barr, G; Grimard, F; Jacquet, V; Menzies, D; Morose, W; Oxlade, O; Schwartzman, K | 1 |
Babu, RB; Biswas, J; Kumarasamy, N; Sudharshan, S; Therese, L | 1 |
Chang, HC; Chen, J; Chen, SC; Hsieh, JT; Wu, WC | 1 |
Amirmozafari, N; Farnia, P; Ghadertotonchi, Z; Ghazi, F; Kamran, J; Masjedi, M; Mirsaedi, M; Mohammadi, F; Ramazanzadeh, R | 1 |
El-Sayed Zaki, M; Goda, T | 1 |
Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA | 1 |
Goldstein, HB; Siefring, RP | 1 |
Aziz, MA; Htun, A; Kluge, HH; Lwin, T; Mar, TT; Maung, W; Noe, P; Paramasivan, CN; Ti, T; Wright, A | 1 |
Chiani, Y; Imaz, MS; Mengatto, L | 1 |
Aufschild, J; Boehm, BO; Zenz, T | 1 |
Asimakis, P; Bilous, M; Jennings, A; Maloof, AJ | 1 |
Ecder, T; Erelel, M; Kocabay, G; Tutkun, IT | 1 |
Back, DJ; Bertel Squire, S; Chandler, B; Hartkoorn, RC; Khoo, SH; Owen, A; Ward, SA | 1 |
Folb, PI; Fourie, PB; Gabriels, GA; McIlleron, H; Smith, PJ | 1 |
Basinga, P; Fissette, K; Gasana, M; Gatabazi, J; Nyiramasarabwe, L; Nzabintwali, F; Pauwels, P; Portaels, F; Rigouts, L; Struelens, MJ; Umubyeyi, AN; Vandebriel, G; Zawadi, JP | 1 |
Cho, DI; Chun, BC; Ha, KY; Jeon, CH; Kim, EH; Kim, KT; Kim, MJ; Lee, JB; Lee, JH; Lee, JS; Park, DW; Shim, DM; Sohn, JW | 1 |
Burroughs, RF; Cho, S; Johnson, RP; Krivda, SJ; Xia, Y | 1 |
Boloorsaz, MR; Farnia, P; Khalilzadeh, S; Safavi, A; Velayati, AA | 1 |
Aydin, O; Bakir Ozbey, S; Helvaci, S; Kasapoğlu, F | 1 |
Bai, GH; Bai, JI; Chang, CL; Choi, YW; Kim, HJ; Kim, SJ; Lee, JK; Park, YK | 1 |
Alcaide, F; Aragón, LM; Borrell, S; Cardeñosa, E; Coll, P; Galán, JJ; Garrigó, M; Gonzalez-Martín, J; Martin-Casabona, N; Moreno, C; Salvado, M | 1 |
Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Touge, H; Yano, S | 1 |
Kurashima, A | 1 |
Hinrichs, R; Maetzke, J; Scharffetter-Kochanek, K; Sigge, A | 1 |
Augustynowicz-Kopeć, E; Zwolska, Z | 1 |
Bed, ST; Chottanapund, S; Eampokalap, B; Manosuthi, W; Sungkanuparph, S | 1 |
Gursoy, B; Ozturk, A; Sirmatel, F; Sirmatel, O; Yazgan, P; Zeyrek, FY | 1 |
Boeree, M; de Haas, P; de Lange, W; Dekhuijzen, R; Janssen, M; Ullmann, E; van Ingen, J; van Soolingen, D | 1 |
Goldschmidt-Clermont, P; Murdoch, D; Stout, J; Tabatabaei, N | 1 |
Detjen, A; Magdorf, K; Quarcoo, D; Thee, S; Wahn, U | 1 |
Kwon, SY; Lee, CT; Lee, JH; Lee, SW; Park, KU; Song, J; Um, SW; Yoon, HI | 1 |
Fonseca, Lde S; Giampaglia, CM; Hadad, DJ; Kritski, A; Marsico, AG; Martins, MC; Mello, FC; Palaci, M; Telles, MA; Vieira, GB; Vinhas, SA | 1 |
Bakker-Woudenberg, IA; de Steenwinkel, JE; Schiffelers, RM; Ten Kate, MT; van Agtmael, MA; van Vianen, W; Verbrugh, HA | 1 |
Otomo, K; Shi, R; Sugawara, I; Zhang, G; Zhang, J | 1 |
Chandramuki, A; Nagarathna, S; Rafi, W; Ravi, V; Venkataswamy, MM | 1 |
Bant, A; Markov, M; Nadir, A; Patel, K; Raeesy, A; Van Thiel, DH | 1 |
Beker, G; Cesur, S; Ceyhan, I; Coşkun, E; Gümüişlü, F; Güner, U; Ocak, F; Sayğan, MB; Tarhan, G | 1 |
Harada, Y; Kawakami, K; Kimura, Y; Koyama, K; Yamaryo, T | 1 |
Fissette, K; Kabedi, MJ; Kashongwe, M; Kayembe, JM; Mampasi, P; Mbaya, P; Mumba Ngoyi, D; Muyembe-Tamfum, JJ; Portaels, F; Verhaegen, J | 1 |
Al-Absi, AN; Al-Akhali, A; Fujiki, A; Masui, T; Mitarai, S; Mori, T; Ohkado, A; Otomo, K; Seita, A; Yamada, H; Yamada, N | 1 |
Hattori, T; Koyama, A; Mitarai, S; Otomo, K; Sato, A; Seki, M; Shishido, Y; Yano, I | 1 |
Kibadi, K | 1 |
Banerjee, R; Chimote, G | 1 |
Agrawal, D; DiMase, JD | 1 |
Chandramuki, A; Mani, R; Nagarathna, S; Rafi, W; Satishchandra, P; Veenakumari, HB | 1 |
Kurita, S; Nagatake, T; Oishi, K; Watanabe, H | 1 |
Gonda, H; Ida, N; Kinoshita, K; Oishi, T; Suganuma, N; Suzuki, R; Yamaguchi, I; Yamamoto, K | 1 |
Gelman, SS; Meyer, JJ | 1 |
Chung, MP; Kim, H; Kim, YH; Koh, WJ; Kwon, OJ; Lim, SY; Suh, GY | 1 |
Banks, J; Campbell, IA; Gelder, CM; Jenkins, PA; Prescott, RJ; Smith, AP | 1 |
Gomathy, P; Iliayas, S; Kumar, SR; Mathew, M; Narayanan, PR; Padmapriyadarsini, C; Sukumar, B; Swaminathan, S; Thomas, B; Triveni, C | 1 |
Kurashima, A; Mikami, J; Mita, M; Nishimura, T; Ohtawa, S; Saito, M; Suzuki, A | 1 |
Gupta, R; Gupta, S | 1 |
Diémé, C; Fall, I; Ndoye, M; Ngom, G | 1 |
Chaudhry, A; Jamshaid, M; Zaka-Ur-Rehman, Z | 1 |
Faruqi, S; Kastelik, JA; McGivern, DV | 1 |
Ahmad, MN; Hussain, R; Khan, GM; Khan, KA; Mirza, MK; uz-Zaman, M | 1 |
Awan, S; Dar, NR; Raza, N; Zafar, O | 1 |
Abunasser, J; Bandyopadhyay, T; Tetenta, S | 1 |
Dhanlaklshmi, M; Ethirajan, N; Padmavathy, L; Rao, LL | 1 |
Hoshino, H; Mitarai, S; Ogata, H; Ohmori, M; Okumura, M; Uchimura, K; Wada, M; Yoshiyama, T | 1 |
Apisarnthanarak, A; Apisarnthanarak, P; Khawcharoenporn, T; Kiratisin, P; Mundy, LM; Rakskul, P; Warnnissorn, N | 1 |
Hill, AT; Laurenson, IF; Murray, MP | 1 |
Bunmaprasert, T; Chiengthong, K; Luewan, S; Tongsong, T | 1 |
Opondo, EA | 1 |
El Nazir, B; Mahesh, B; McShane, D; Molloy, J; Shandilya, M | 1 |
Chida, K; Fujita, K; Hayakawa, H; Miwa, S; Murakami, M; Nakamura, H; Ohba, H; Shirai, M; Suda, T; Suzuki, Y | 1 |
Bradaric, A; Goic-Barisic, I; Karanovic, J; Mise, K; Tonkic, M; Vrsalovic, N | 1 |
Adhvaryu, MR; Reddy, N; Vakharia, BC | 1 |
Inge, LD; Wilson, JW | 1 |
Ani, AE; Dalyop, YB; Idoko, J; Pitmang, SL | 1 |
Kant, S; Mahajan, V; Natu, NK | 1 |
Gupta, A; Kumar, V; Sabat, D | 1 |
Acharya, PR; Baliga, P; Sahoo, R | 1 |
Daley, CL; Kasperbauer, SH | 1 |
Akgüneş, A; Bilgin, K; Coban, AY; Durupinar, B | 1 |
Gönlügür, T; Gönlügür, U; Hasbek, M; Katrancioğlu, O; Sapmaz, F | 1 |
Ho, YJ; Lee, CH; Lee, CL; Wei, YS | 1 |
Coelho, E; De Capitani, EM; Joaquim, OA; Nunes, EA; Panunto, AC; Ramos, Mde C | 1 |
Kanagaraj, A; Marthandam, LR; Meenakumari, P; Rajesh, A; Sriramakrishnan, V | 1 |
Borgdorff, MW; He, GX; Jiang, GL; Liu, YH; van den Hof, S; van der Werf, MJ; Wang, LX; Wang, SF; Xia, H; Zhao, YL | 1 |
Horcajada, JP; Pelfort, X; Puig, L; Salvadó, M | 1 |
Alcaide, F; Casas, S; Dorca, J; Gonzalez, L; Guerra, MR; Lopez, M; Santin, M | 1 |
Belknap, R; Kestler, M; Reves, R | 1 |
Kobashi, Y; Oka, M | 1 |
Barer, MR; Duddridge, M; Malkin, J; Perera, N; Shrimpton, A; Wiselka, M | 1 |
Kononets, AS | 1 |
de Reina, L; Duca, A; Ramos, A; Saucedo, G | 1 |
Ershova, NG; Gubkina, MF | 1 |
Dovgaliuk, IF; Ovchinnikova, IuE; Starshinova, AA | 1 |
Mavrogenis, AF; Papagelopoulos, PJ; Sakellariou, VI; Tsiodras, S | 1 |
Biscopink, RJ; Davis, TL; Naidu, VG; Tammineni, AK; Veerabagu, MP | 1 |
Bishai, WR; Cezar, MC; Chaisson, RE; Chaudhary, MA; Conde, MB; De Souza, GR; Efron, A; Graça, NP; Kritski, AL; Loredo, C; Ram, M | 1 |
Garg, R; Mehra, S; Prasad, R | 1 |
Alvarez-Espejo, T; Daza, R; Guzmán, MF; Ramos, A | 1 |
Bradford, WZ; Chideya, S; Hopewell, PC; Kenyon, TA; Moeti, TL; Peloquin, CA; Reingold, AL; Tappero, JW; Wells, CD; Winston, CA | 1 |
Bartacek, A; Borek, M; Panosch, B; Schütt, D | 1 |
Deftereos, S; Kantartzi, K; Kriki, P; Mourvati, E; Panagoutsos, S; Passadakis, P; Prassopoulos, P; Theodoridis, M; Thodis, E; Vargemezis, V | 1 |
Fukunaga, K; Hasegawa, N; Ishii, K; Ishizaka, A; Miyairi, M; Nishimura, T; Ohtani, S; Takeshita, K; Tasaka, S; Urano, T | 1 |
Alcaneses, MR; Boom, WH; Debanne, SM; Dietze, R; Eisenach, KD; Gitta, P; Hadad, DJ; Horter, L; Johnson, JL; Maciel, EL; Mugerwa, RD; Okwera, A; Quelapio, MI; Sewali, B; Tupasi, TE | 1 |
Arslan, Z; Babacan, F; Cimen, NO; Kurutepe, M; Ocak, K; Saygi, A | 1 |
Abughali, N; Auletta, J; Esper, F; LaBeaud, AD; Lancioni, C | 1 |
Angeby, KA; Chryssanthou, E; Giske, CG; Hoffner, SE; Juréen, P; Kahlmeter, G; Schön, T; Sturegård, E; Werngren, J | 1 |
Fisher, M; Hemingway, C; Innes, J; Scott, G; Solomon, T; Thwaites, G | 1 |
Chien, YJ; Lee, LN; Wang, JY; Yang, PC; Yu, CJ | 1 |
Byeon, JS; Choe, JW; Kim, JH; Kim, KJ; Myung, SJ; Park, SH; Yang, DH; Yang, SK; Ye, BD; Yoon, SM | 1 |
Hanna, LE; Narayanan, PR; Nayak, K; Subramanyam, S; Swaminathan, S; Venkatesan, P | 1 |
Dawson, A; Evans, EN; Harrison, NK; Jones, RM | 1 |
Detjen, A; Magdorf, K; Thee, S; Wahn, U | 1 |
Chiang, CY; Jou, R; Wu, MH; Yu, CY | 1 |
Gedikoğlu, S; Ozakin, C; Sinirtaş, M | 1 |
Bezerra, FA; Candéa, AL; Cardoso, LN; de Souza, MV; Ferreira, Mde L; Henriques, Md; Kaiser, CR; Lourenço, MC; Pais, KC | 1 |
Hong, BK; Kumar, C; Marottoli, RA | 1 |
Chinnaiyan, P; Iliayas, S; Menon, PA; Narayanan, PR; Narendran, G; Padmapriyadarsini, C; Ramachandran, R; Sakthivel, R; Santhanakrishnan, R; Suhadev, M; Swaminathan, S; Venkatesan, P | 1 |
Chauhan, DS; Gupta, AK; Katoch, VM; Sharma, R; Sharma, VD; Singh, M; Venkatesan, K | 1 |
Baraka, A; Cobelens, F; Egwaga, S; Grewal, P; Haag-Arbenz, V; Lwilla, F; Mkopi, A; Mshinda, H; Range, N; van Leth, F | 1 |
Deng, X; Fan, J; Ge, F; Guo, N; Jin, Q; Liu, S; Song, Y; Wang, X; Wu, X; Ye, H; Yu, L; Zeng, F | 1 |
Bame, R; Djella, S; Kuaban, C; Mouangue, L; Yomgni, C | 1 |
Gumbo, T | 1 |
García-Sepulcre, MF; Gutiérrez, F; Padilla, S; Ramos, JM; Rodríguez, JC | 1 |
Bennett, T; Rust, PA | 1 |
Aditya, NP; Madhusudhan, B; Patankar, S | 1 |
Baseke, J; Boom, WH; Charlebois, E; Chervenak, KA; Havlir, DV; Johnson, DF; Lancioni, C; Mahan, CS; Mayanja-Kizza, H; Mugerwa, RD; Walusimbi, M; Whalen, CC | 1 |
Bessong, PO; de Villiers, BE; Green, E; Hoosen, AA; Letsoalo, T; Nchabeleng, M; Ndip, RN; Obi, CL; Sein, PP | 1 |
Cansü, E; Erdogan, F; Ulusam, AO | 1 |
Ascenzi, P; Bevilacqua, N; Gullotta, F; Lauria, FN; Mancone, C; Notari, S; Pucillo, LP; Sergi, M; Tempestilli, M; Tripodi, M; Urso, R | 1 |
Baquero, F; Buitrago, LA; Burgos Revilla, J; Gómez García, I; Gómez Mampaso, E; Gómez Rodríguez, A; Molina, MR; Sampietro Crespo, A | 1 |
Guleria, K; Gupta, B; Vaid, N | 1 |
Jablenska, L; Lo, S; Toma, A; Uddin, J | 1 |
Nakamichi, N; Ogawa, K | 1 |
Başustaoğlu, AC; Ceyhan, I; Güllü, U; Kiliç, A; Kiliç, S; Simşek, H; Tarhan, G; Uçar, E; Yilmaz, S | 1 |
Baniasadi, S; Eftekhari, P; Fahimi, F; Masjedi, MR; Raoufy, MR; Tabarsi, P; Velayati, AA | 1 |
Chen, SL; Guo, WJ; Shieh, GR | 1 |
Agarwal, A; Arora, A; Kumar, S | 1 |
Allton, DR; Ballard, EA; Folio, L; Jesinger, RA; Lane, JW | 1 |
Chiu, YC; Feng, JY; Huang, SF; Lee, YC; Su, WJ | 1 |
Ermertcan, AT; Gençoğlan, G; İnanir, I; Özkütük, N; Öztürk, F; Temiz, P | 1 |
Arquinio, L; García-Gasalla, M; Losada, I; Sarasibar, H | 1 |
Elwood, RK; Fitzgerald, JM; Guo, N; Marra, CA; Marra, F | 1 |
Helbling, CA; Iizuka, T; Kuttenberger, J; Lieger, O; Smolka, W | 1 |
Aloui, N; Bousnina, S; Boussetta, K; Brini, I; Ghaffari, H; Jaubert, F; Tinsa, F | 1 |
Azevedo, F; Bettencourt, H; Ferreira, O; Morais, P; Nogueira, A | 1 |
Fujikawa, T; Izawa, K; Kagami, S; Kimura, H; Kitada, S; Maekura, R; Mori, M; Namba, Y; Sugano, T; Uenami, T; Yamaguchi, T; Yano, Y; Yokota, S; Yoneda, T | 1 |
Kafle, P; Kolade, V | 1 |
Aida, S; Nakano, Y; Nishio, K; Okabayashi, K; Shimada, H | 1 |
Delarbre, JM; Gravet, A; Habermacher, J; Lohmann, C; Moser, A; Schmitt, F; Souillard, N | 1 |
Heysell, SK; Houpt, ER; Keller, SJ; Moore, JL | 1 |
Martín, JM; Pérez, J; Renau, A; Ricart, JM | 1 |
Jeon, K; Koh, WJ; Kwon, OJ; Park, HY; Sim, YS; Suh, GY | 1 |
Altintas, AK; Beyazyildiz, E; Ozdal, PC; Ozdamar, Y; Ozkan, SS; Teberik, K | 1 |
Drechsler, A; Kirch, W | 1 |
Camara, P; Chevalier, B; Debonne, JM; Fabre, M; Gueye, M; Herve, V; Lefebvre, N; Margery, J; Mbaye, PS; Perrier-Gros-Claude, JD; Sane, M; Simon, F; Soler, C; Thiam, M | 1 |
Gulati, K; Ray, A; Vijayan, VK | 1 |
Azevedo, V; Barnard, M; Coetzee, D; Coetzee, G; Cox, HS; Goemaere, E; McDermid, C; Muller, O; Simpson, J; van Cutsem, G | 1 |
Alkhawaja, S; Khalifa, N; Tammam, N | 1 |
Alvarado, M; Morales, S; Pérez, J; Ramos, W; Vílchez, R | 1 |
Muro, H; Senda, H; Terada, S | 1 |
Fujita, M; Ikegame, S; Kajiki, A; Nakanishi, Y; Wakamatsu, K | 1 |
Alffenaar, JW; de Neeling, H; Simons, S; van de Kasteele, PJ; van der Laan, T; van der Werf, TS; van Soolingen, D | 1 |
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
Angrup, A; Banavaliker, JN; Bose, M; Kumar, S; Pathak, RK; Sharma, H; Varma-Basil, M | 1 |
Aydın, F; Bayramoğlu, G; Buruk, K; Dede, R; Dinç, U; Kaklıkkaya, N; Köse, T; Ozkul, G | 1 |
Bello, T; Chirinos, G; De Donato, M; de Waard, JH; Mendoza, R; Takiff, H | 1 |
Khajotia, R; Manthari, K | 1 |
Keino, H; Nakashima, C; Okada, AA; Taki, W; Watanabe, T | 1 |
Fortes-Alen, J; Gómez-Escolar, PF; Gómez-Seco, J; Presa-Abos, T; Rodríguez-Guzmán, MJ; Rodríguez-Nieto, MJ | 1 |
Agarwal, N; Kriplani, A; Kulshrestha, V; Rana, T; Singh, UB | 1 |
Fusama, M; Hamano, Y; Higa, S; Hosokawa, T; Igarashi, T; Kamide, Y; Kawamoto, K; Kuritani, T; Kuroiwa, T; Lin, Y; Maeda, K; Nakahara, H; Nishide, M | 1 |
Anyo, G; Burgos, M; Cook, SV; Enarson, DA; Jindani, A; Kim, SJ; Lienhardt, C; Nunn, AJ; Rigouts, L; Yorke-Edwards, V | 2 |
Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
Thakur, BK; Verma, S | 1 |
Alegre de Miquel, V; Martínez Casimiro, L; Vilata Corell, JJ | 1 |
Ha, KY; Oh, IS | 1 |
Anupurba, S; Gupta, A; Mohapatra, TM; Sen, MR | 1 |
Abes, FL; Abes, GT; Jamir, JC | 1 |
Hossain, A; Hossain, M; Islam, S; Khalil, I; Mottalib, A | 1 |
Abdurrahman, ST; Cuevas, LE; Dacombe, R; David, JS; Davies, PD; Ebisike, JN; Emenyonu, N; Lawson, L; Lawson, LO; Ouoha, JO; Parry, CM; Sogaolu, OM; Uzoewulu, GN; Yassin, MA | 1 |
Batchoun, R; Nimri, L; Samara, H | 1 |
Kononova, TE; Naslednikova, IO; Novitsky, VV; Serebryakova, VA; Urazova, OI; Vasilyeva, OA | 1 |
Enarson, DA; Jindani, A; Nunn, AJ | 1 |
Anand, A; Datye, AS; Inamdar, V; Iyer, R; Kale, V; Kanoj, DM; Khillare, KM; Manoj, MM; Pereira, M; Risbud, AR; Thakar, M; Tripathy, S | 1 |
da Silva Junior, GB; Daher, Ede F; de Oliveira, JL | 1 |
Amarti, A; Baybay, H; Bounouar, M; Chraibi, M; Gallouj, S; Harmouch, T; Mernissi, F; Meziane, M; Mikou, O | 1 |
Connolly, C; Friedland, G; Gandhi, N; Moodley, P; Shah, NS; Sturm, AW; Tayob, N; Zetola, N | 1 |
Achawal, S; Anderson, G; Lee, WY; Ling, M; Thaker, HK | 1 |
Fletcher, S; Lambie, M; Maundrell, J; Roberts, P; Stein, A | 1 |
Choi, WC; Hong, JH; Jeon, TJ; Kim, SY; Oh, TH; Seo, DD; Seo, JY; Shin, WC | 1 |
Gallo, A; Hurwitz, M; Hwang, C; Mojtahed, A; Whitney, J | 1 |
Baveja, CP; Bhalla, P; Gautam, H; Jha, H; Saini, S; Vidyanidhi, G | 1 |
Cen, S; Jia, PP; Li, XY; Liu, ZL; Wang, X; Yu, LY; Zhang, Q; Zhao, LL; Zhao, LX | 1 |
Coulter, C; Jia, Q; Jin, Q; Li, H; Li, L; Shi, D; Zhao, Y; Zhu, G | 1 |
Chen, L; Li, N; Liu, M; Zhang, H; Zhang, J | 1 |
Hsueh, PR; Huang, YT; Lai, CC; Liao, CH; Tan, CK | 1 |
Bouhasan, L; Consunji-Araneta, R; Higgins, R; Qing, G | 1 |
Colucci, G; Silzle, T; Solenthaler, M | 1 |
Kuwabara, K | 1 |
Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
Liu, Y; Zhang, J; Zhang, M | 1 |
da Costa, FS; de Lima, KM; de Morais, SC; de Oliveira Neves, AC; Porto, DL; Soares, GM | 1 |
Eide, GE; Kielland, LG; Naess, A; Sørnes, S; Vage, RA | 1 |
Aggarwal, N; Arya, A; Baghel, AS; Bose, M; Gupta, G; Nath, M; Parmar, VS; Pathak, R; Ponnan, P; Prasad, AK; Raj, HG; Tandon, R | 1 |
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Miyazaki, M; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
Malhotra, A; Manchanda, Y; Mittal, R; Ramam, M; Ramesh, V; Sharma, S; Tejasvi, T | 1 |
Bonkoungou, V; Carvalho, AC; Comelli, M; Cusato, M; Dembélé, SM; Kouanda, S; Matteelli, A; Nacanabo, R; Regazzi, M; Saleri, N; Villani, P | 1 |
Imanishi, H; Ishii, M; Mizuno, N; Nakagawa, K; Oshimo, T; Sowa, J; Tsuruta, D | 1 |
Cifuentes, C; García, M; Losada, I; Martín, C | 1 |
Biçmen, C; Demirci, M; Gül Yurtsever, S; Gündüz, AT; Ozkütük, N; Salman, S | 1 |
Aarnoutse, R; Boeree, M; Ijdema, D; Magis-Escurra, C; van den Boogaard, J | 1 |
Abe, M; Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M | 1 |
Adali, G; Çolak, Y; Enç, F; Kiziltaş, Ş; Öztürk, O; Tuncer, İ; Ulaşoğlu, C; Yorulmaz, E | 1 |
Hamilton, CD; Holland, DP; Sanders, GD; Stout, JE | 1 |
Beer, J; Emmrich, F; Rodloff, AC; Sack, U; Tessema, B | 1 |
González-Martín, J; Martínez, JA; Rey-Jurado, E; Tudó, G | 1 |
Angheben, A; Boriani, L; Gasbarrini, A; Luzi, CA; Marocco, S; Rigotti, S; Zorzi, C | 1 |
Chitnis, DS; Hemvani, N; Patidar, V | 2 |
Arévalo Gómez, A; Llinares Modejar, P; Sánchez Vidal, E; Servia Dopazo, M | 1 |
Brochot, P; Desplaces, N; Direz, G; Eschard, JP; Salmon, JH; Ziza, JM | 1 |
Becker, P; Dawson, R; Diacon, AH; Donald, PR; du Bois, J; Erondu, N; Ginsberg, AM; Narunsky, K; Spigelman, MK; van Niekerk, C; Venter, A | 1 |
Opremcak, EM | 1 |
Altpeter, E; Bodmer, T; Borrell, S; Böttger, EC; Bruderer, T; Calmy, A; Dubuis, O; Egger, M; Fehr, J; Fenner, L; Furrer, H; Gagneux, S; Jaton, K; Ninet, B; Pfyffer, GE; Siegrist, HH; Stalder, JM; Zwahlen, M | 1 |
Friedrich, C; Grundmann, K | 1 |
Cohen, T; Furin, J; Gegia, M; Kalandadze, I; Vashakidze, L | 1 |
Cajigas-Pezo, D; Lorenzo-Hernandez, A; Rentero-Martínez, Z; Vives-Rivero, GR | 1 |
Bhat, S; Kotian, M; Radhakrishna, M; Rao, S | 1 |
Sarkar, D; Sarkar, S | 1 |
Abdissa, A; Abdissa, K; Abebe, G; Agonafir, M; Apers, L; Colebunders, R; de-Jong, BC | 1 |
Hesseling, AC; Jordaan, A; Marais, BJ; Schaaf, HS; Seddon, JA; Victor, T | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Behera, D; Gupta, R; Jaiswal, A; Kumar, L; Murar, A; Puri, MM | 1 |
Gönlügür, U; Koşar, S; Mirici, A | 1 |
Almeida, D; Grosset, JH; Karakousis, PC; Mdluli, KE; Nuermberger, EL; Peloquin, CA; Rosenthal, IM; Tasneen, R; Zhang, M | 1 |
Floto, RA; Haworth, CS; Hill, UG | 1 |
Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J | 1 |
Peña-Santos, G; Ruiz-Moreno, JL | 1 |
Abeygunasekara, S; Chan, A; Findlay, A | 1 |
Benoit, JP; Bertrand, JB; Coignard, S; Cosson, MA; Goulvestre, C; Martin, C; Morand, PC; Moro, MR; Picard, C; Poyart, C; Silvera, S; Veziris, N | 1 |
Baker, B; Cotton, MF; Diacon, AH; Harper, C; Hesseling, A; Macingwana, L; Ngwane, AH; van Helden, P; Wiid, I | 1 |
Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Shin, SJ | 1 |
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B | 1 |
Chandran, PA; Ismail, R; Jalalonmuhali, M; Lee, CK; Lee, YY | 1 |
Cole, ST; Hartkoorn, RC; Lechartier, B | 1 |
Gołąb, R; Hryncewicz-Gwóźdź, A; Jankowska-Konsur, A; Maj, J; Plomer-Niezgoda, E; Pluciński, P; Woźniak, Z | 1 |
Ma, X; Nguyen, YH; Qin, L | 1 |
Kano, T; Matsushima, M; Sasaki, H; Sato, K; Takahashi, I; Yabe, I; Yamada, M | 1 |
Dejaegher, B; Kaale, E; Risha, PG; Shewiyo, DH; Smeyers-Verbeke, J; Vander Heyden, Y | 1 |
Abe, M; Ichiki, H; Sato, C; Ueda, S; Watanabe, A | 1 |
Balne, PK; Basu, S; Mittal, R; Sharma, S | 1 |
Adán, A; González-Martin, J; Keller, J; Llorenç, V; Mesquida, M; Pelegrín, L; Rey, A | 1 |
Aarnoutse, RE; Boeree, MJ; Burger, DM; Fillekes, Q; Kibiki, GS; Kisanga, ER; Kisonga, RM; Mleoh, L; Mtabho, CM; Ndaro, A; Semvua, HH; van den Boogaard, J; van der Ven, A | 1 |
Aggarwal, T; Sharma, C; Sharma, M; Sharma, V; Shekhar, S | 1 |
Barnard, M; Bosman, M; Coetzee, G; Gey Van Pittius, N; O'Brien, R; Streicher, E; van Helden, P; Warren, R | 1 |
González, C; Herrmann, E; Jajati, M; Kaplan, P; Monzón, D; Sáenz, C | 1 |
Aarnoutse, RE; de Groot, R; de Waard, JH; García, JF; Hermans, PW; López, D; Verhagen, LM; Warris, A | 1 |
Elson, I; Friedland, G; Gandhi, NR; Kreiswirth, BN; Mathema, B; Moll, AP; Moodley, P; Ramathal, M; Rothenberg, R; Shah, NS; Shashkina, E; Sturm, AW; Weissman, D | 1 |
Chigutsa, E; Denti, P; Karlsson, MO; Kirkpatrick, CM; Maartens, G; McIlleron, H; Patel, K; Visser, M | 1 |
Bonovas, S; Lytras, T; Panagiotopoulos, T; Spala, G | 1 |
Akçalı, A; Akman, T; Değirmenci, Y; Karatağ, O; Koşar, S; Sener, A | 1 |
Lu, J; Pang, Y; Song, Y; Wang, S; Wang, Y; Zhao, Y | 1 |
Lueangniyomkul, A; Mankatitham, W; Manosuthi, S; Manosuthi, W; Nilkamhang, S; Sukasem, C; Sungkanuparph, S; Thongyen, S | 1 |
Gao, HY; Lai, YX; Li, WP; Lian, ZQ; Wang, Q; Xu, J; Yang, JM; Yu, HJ; Zhang, AQ; Zhu, CX | 1 |
Albanna, AS; Cowan, D; Menzies, D; Smith, BM | 1 |
Gochi, M; Kaneko, Y; Kinoshita, A; Kuwano, K; Saitou, Z; Samejima, T; Seki, A; Seki, Y; Takeda, H | 1 |
Garg, K; Mohapatra, PR | 1 |
Coban, AY | 2 |
Agrela Rojas, E; Cuesta Hernández, M; Díaz Pérez, JÁ; Gómez Hoyos, E; Téllez Molina, MJ | 1 |
Chen, M; Fu, L; Jin, H; Liu, C; Lu, Y; Wang, B; Xu, J; Zhao, W; Zheng, M; Zhou, L; Zhu, H | 1 |
Abuljadayel, N; Al-Hajoj, S; Al-Herbwai, M; Al-Omari, R; Al-Thawadi, S; Alrabiah, F; Alrajhi, AA; Memish, Z; Raviglione, MC; Shoukri, MM; Varghese, B; Zignol, M; Zumla, A | 1 |
Hara, M; Hatta, T; Ohtani, M; Sawada, K; Segawa, H; Ueno, R | 1 |
Hishiki, H; Ichimoto, K; Ishiwada, N; Kinoshita, K; Kohno, Y; Nagasawa, K; Tokunaga, O | 1 |
Hong, G; Jeon, K; Jeong, BH; Kim, CK; Kim, SY; Koh, WJ; Kwon, OJ; Lee, SH; Park, HY; Shin, SJ | 1 |
Ali Aitbenasser, M; Benjelloun, A; Bouaity, B; Bouchentouf, R; Touati, M | 1 |
Achour, A; El Barni, R; Lahkim, M | 1 |
Feng, SY; Wang, HS; Wang, QL; Zhou, L | 1 |
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
Braga, JU; da Conceição, DA; Trajman, A | 1 |
Aarnoutse, RE; Boeree, MJ; Kibiki, GS; Mtabho, CM; Semvua, HH; Tostmann, A; van den Boogaard, J | 1 |
Boeree, MJ; Hoefsloot, W; Mouton, JW; van Ingen, J; van Soolingen, D | 1 |
Buu, TN; Cobelens, FG; Dung, NH; Huyen, MN; Kremer, K; Lan, NT; Tiemersma, EW; van Soolingen, D | 1 |
Liu, P; Liu, Y; Ma, A; Wei, Q; Wu, X; Zhou, Z; Zou, F | 1 |
Benson, SM; Narasimhamurthy, R | 1 |
Boerrigter, BG; van den Berk, GE; van Sandwijk, MS | 1 |
Camara, C; Furtado, A; Gerstoft, J; Katzenstein, TL; Lüneborg-Nielsen, M; Sodemann, M; Wejse, C | 1 |
Aboud, C; Algood, H; Boyd, AS; Braun, N; Burke, VE; Drake, WP; Isom, J; Kaminski, N; King, LE; Oswald-Richter, K; Pandit, KV; Richmond, BW; Taylor, T; Yu, C | 1 |
Denno, K; Horiki, M; Minoda, Y; Tada, K; Yano, K; Yoneda, M; Yoshida, T | 1 |
Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A | 1 |
Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S | 1 |
Bhadauria, M; Jaswal, A; Shrivastava, S; Shukla, S; Sinha, N | 1 |
Arpag, H; Babalik, A; Bakirci, N; Capaner, E; Dagyildizi, L; Kuyucu, T; Ulus, IH | 1 |
Cardone, M; Colasanti, P; Cordedda, M; Grande, A; Mozzillo, R; Zanchini, R | 1 |
Benzekri, A; Benzekri, L; El Amrani, F; Hassam, B; Khalil, F; Raffas, W; Tbatou, F | 1 |
Alland, D; Armakovitch, S; Armstrong, DT; Barry, CE; Chien, G; Cho, SN; Dorman, SE; Ellner, JJ; Joloba, ML; Lee, J; Mboowa, G; Mumbowa, F; Nakayita, G; Namaganda, C; Park, JA; Ssengooba, W; Via, LE; Yu, Y | 1 |
Arpag, H; Babalık, A; Bakirci, N; Çarpaner, E; Dagyildiz, L; Kuyucu, T; Ulus, IH | 1 |
Bark, CM; Boom, WH; Eisenach, KD; Gitta, P; Johnson, JL; Joloba, ML; Nsereko, M; Ogwang, S; Thiel, BA | 1 |
Özkaya, E | 1 |
Głowacki, J; Głowacki, M; Jagodziński, PP; Lehmann, TP; Misterska, E; Walczak, M | 1 |
Ahui, BJ; Aka-Danguy, E; Anon, JC; Bakayoko, AS; Brou-Gode, VC; Horo, K; Itchy, MV; Koffi, MO; Kouassi, AB; N'Gom, AS; N'Goran, NB | 1 |
Ando, H; Hang, NT; Hung, NV; Keicho, N; Kuwahara, T; Lien, LT; Sakurada, S; Thuong, PH; Thuy, TT | 1 |
Crownover, P; Jafri, I; Naqvi, A; O'Gorman, M; Wang, HF; Wang, R | 1 |
Chen, TC; Chou, LT; Huang, CC; Lai, AB; Wang, JH | 1 |
Chanez, P; Gouitaa, M; Neino Mourtala Mohamed, A; Tummino, C | 1 |
Chida, K; Hayakawa, H; Inui, N; Masuda, M; Miwa, S; Shirai, M; Shirai, T; Suda, T; Toyoshima, M; Yamada, T; Yasuda, K; Yokomura, K | 1 |
Berhan, A; Berhan, Y; Yizengaw, D | 1 |
Cheng, W; Fan, J; Guo, N; Jin, K; Li, W; Shi, Q; Tang, X; Wu, J; Yu, L; Yuan, P; Zhang, Y; Zhao, X | 1 |
Chouiter, A; Lebowitz, D; Malinverni, R; Wolter, L; Zenklusen, C | 1 |
Cho, SN; Jeon, K; Kim, SY; Koh, WJ; Kwon, OJ; Park, HY; Shin, SJ | 1 |
Arends, JE; Formanoy, E; Lam, HY | 1 |
Casal, M; Gutiérrez-Aroca, JB; Ruiz, P | 1 |
Cao, M; Gu, J; Li, Y; Liu, W; Ma, J; Ma, L; Mao, Y; Merle, C; Milligan, P; Wang, Q; Wu, W; Wubuli, A; Xiang, Y; Xin, X; Yang, L; Yao, X; Zhu, X | 1 |
Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Nakamura, S; Takazono, T; Yanagihara, K | 1 |
Aritomo, Y; Fujihara, S; Kamada, H; Kanaji, N; Katou, K; Kobara, H; Masaki, T; Mori, H; Nishiyama, N; Ono, M; Oryu, M; Rafiq, K | 1 |
Egelund, EF; Hunter, RP; Isaza, R; P Brock, A; Peloquin, CA | 1 |
Aono, A; Chikamatsu, K; Mitarai, S; Mizuno, K; Nishiyama, H; Sugamoto, T; Yamada, H | 1 |
Bhoi, SK; Kalita, J; Misra, UK; Prasad, S | 1 |
Pal, P; Patra, SK; Ray, S | 1 |
Almutairi, FE; Bourgea, J; Court, MH; Greenblatt, DJ; Hazarika, S; Klein, K; Kwara, A; Patten, CJ; Sheng, H; Zanger, UM | 1 |
Bhattacharya, S; Choudhury, S; Das, A; Das, SK; Pandit, S | 1 |
Cheng, S; Du, X; Gao, T; Goel, S; Harries, AD; Lin, Y; Wang, L; Xia, Y; Zhang, Z | 1 |
Bock, N; Bozeman, L; Goldberg, SV; Hamilton, CD; Heilig, CM; Hershfield, E; Kyle, RP; Narita, M; Reves, R; Tapy, JM; Wing, D | 1 |
Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK | 1 |
de Melo Guedes de Oliveira, HM; de Oliveira, MM; Delogo, KN; Dos Anjos, MJ; Kritski, AL; Mesquita, ED; Miranda, PF; Moraes, ML; Netto, AR; Ramalho, DM | 1 |
Fu, EQ; Jin, FG | 1 |
Chen, FC; Chen, YY; Dou, HY; Hsiung, CA; Huang, JM; Liao, YC; Lin, CH | 1 |
Akçay, A; Arslan, K; Dündar, M; İşcan, KM; Kanbur, M; Karabacak, M; Sarıca, ZS; Taşçıoğlu, N | 1 |
Fahy, R; Keane, J; Lyons, J; McDonnell, C; McLaughlin, AM; Vandenberghe, E | 1 |
Baykal, ES; Berktaş, M; Güdücüoğlu, H; Yaman, G | 1 |
Anupurba, S; Gupta, A; Kulkarni, S; Rastogi, N | 1 |
Crook, AM; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Murray, SR; Nunn, AJ; Pappas, F; Phillips, PP | 1 |
de Droogh, E; Groenen, G; Mathys, V; Soetaert, K; van de Vyvere, M | 1 |
Biadglegne, F; Rodloff, AC; Sack, U; Tessema, B | 1 |
Fang, F; Guo, J; Liu, Y; Qu, J; Yu, Q; Zhang, JH; Zhao, P | 1 |
Ghrew, MH; Gornasa, M; Lavery, K; O'Riordan, E; Walsham, A; Wilding, T | 1 |
Mokry, J; Porvaznik, I; Solovic, I | 1 |
Fujita, K; Hirai, T; Ichiyama, S; Ito, Y; Kubo, T; Maekawa, K; Mishima, M; Togashi, K | 1 |
Chigutsa, E; Gumbo, T; McIlleron, H; Pasipanodya, JG; Sirgel, FA; Smith, PJ; van Helden, PD; Visser, ME | 1 |
Bhatnagar, S; Faurholt-Jepsen, D; Friis, H; Grewal, HM; Kabra, SK; Lodha, R; Mukherjee, A; Saini, S; Singh, S; Singh, V | 1 |
Amukoye, E; Bah, B; de Jong, BC; Fielding, K; Gninafon, M; Horton, J; Kassa, F; Lapujade, O; Lienhardt, C; Lo, MB; Merle, CS; Mthiyane, T; N'Diaye, A; Odhiambo, J; Olliaro, PL; Perronne, C; Rustomjee, R; Sismanidis, C; Sow, OB | 1 |
Bateson, AL; Butcher, PD; Charalambous, S; Churchyard, GJ; Clouting, HE; Coleman, D; Geldenhuys, H; Harrison, TS; Hatherill, M; Jindani, A; Magweta, L; McHugh, TD; McIlleron, HM; Mitchison, DA; Mungofa, S; Nunn, AJ; Nyirenda, S; Phillips, PP; Shah, NA; Shepherd, J; van Dijk, JH; Zizhou, S; Zvada, SP | 1 |
Alobu, I; Oshi, DC; Oshi, SN; Ukwaja, KN | 2 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, SY; Koh, WJ; Lee, KS; Lee, NY; Park, HY; Shin, SJ | 1 |
Aleo, A; Bonura, C; Fasciana, T; Giammanco, A; Gomgnimbou, MK; Mammina, C; Refrégier, G; Sola, C | 1 |
Juneja, R; Kalakoti, P; Sahu, S; Sharma, K; Singh, V; Subramanian, PS | 1 |
Garcia-Rodriguez, F; Martinez-Longoria, CA; Rios-Solis, JE; Rubio-Perez, NE | 1 |
Cardoso, RF; Cortez, DA; da Silva, RZ; de Lima Scodro, RB; Ferracioli, KR; Lopes, MA; Siqueira, VL | 1 |
Fushimi, K; Matsui, H; Yamana, H; Yasunaga, H | 1 |
Bekele, D; Bekuretsion, Y | 1 |
Cai, X; Ding, X; Li, Y; Tan, S; Tan, Y | 1 |
Bakayoko, AS; Daix, AT; Domoua, K; Gbery, I; Kaloga, M; Kamagate, M; Kone, Z; Ohui, E | 1 |
Cho, YJ; Jeong, I; Lee, CT; Lee, JH; Park, JS; Song, J; Yoon, HI | 1 |
Aarnoutse, RE; Boeree, MJ; Burger, D; Dawson, R; Diacon, AH; du Bois, J; Gillespie, SH; Heinrich, N; Hoelscher, M; Magis-Escurra, C; McHugh, TD; Narunsky, K; Phillips, PP; Plemper van Balen, G; Rehal, S; van Ingen, J; van Soolingen, D; Venter, A | 1 |
Archuleta, S; Huggan, PJ; Molton, JS | 1 |
Hershow, RC; Huo, D; Jimenez, A; Johnson, W; Paul, W; Prachand, N; Rahimian, A; Ricks, PM; Wiebel, W | 1 |
Eckold, C; Evangelopoulos, D; Gillespie, SH; Honeyborne, I; Lipman, MC; McHugh, TD; Pym, A | 1 |
Arai, M | 1 |
Dereli, T; Kandıloglu, G; Turk, BG; Turkmen, M | 1 |
Ardrey, A; Davies, GR; Dzinjalamala, F; Mlotha, R; Molyneux, E; Ward, S; Waterhouse, D | 1 |
Burger, DA; Conradie, A; Dawson, R; Diacon, AH; Donald, PR; Eisenach, K; Everitt, D; Ive, P; Mendel, CM; Ntinginya, NE; Page-Shipp, L; Pym, A; Reither, K; Schall, R; Spigelman, M; van Niekerk, C; Variava, E; Venter, A; von Groote-Bidlingmaier, F | 1 |
Lipman, MC; Phillips, PP | 1 |
Reves, RR | 1 |
Chakraborty, S; Rhee, KY | 1 |
Braga, JU; Trajman, A | 1 |
Cobelens, FG; Gomez, GB; Joloba, M; Kasule, GW; Lukoye, D; Musisi, K; Ssengooba, W | 1 |
Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T | 2 |
Acuña-Villaorduña, C; Ayakaka, I; Dryden-Peterson, S; Fennelly, KP; Hosford, J; Jones-López, EC; Nakubulwa, S; Okwera, A; Reilly, N; Worodria, W | 1 |
Aprile, V; Centis, R; Costa, D; D'Ambrosio, L; Donateo, L; Fedele, A; Gillini, L; Migliori, GB; Pasanisi, G; Tundo, P | 1 |
Igari, H; Imasawa, T; Ishikawa, S; Kadomura, M; Mizuno, S; Nagayoshi, M; Nishimura, M; Noguchi, N; Yamagishi, F | 1 |
Barnes, GL; Carman, D; Chaisson, RE; Dawson, R; Dorman, SE; Efron, A; Gupte, N; Hoffman, J; McIlleron, H; Narunsky, K; Whitelaw, A | 1 |
Ayati Fard, SF; Bahrami Taghanaki, HR; Ghazvini, K; Salehi, M; Shakiba, A; Tavanaee Sani, A | 1 |
Arce-Mendoza, AY; Quintanilla-Siller, A; Rendon, A; Rodríguez-Castillo, JA; Rosas-Taraco, AG; Salinas-Carmona, MC | 1 |
Chi, X; Gao, C; Hu, YW; Huang, Z; Wang, Q; Zeng, T; Zheng, L | 1 |
Minemura, H; Munakata, M; Oshima, K; Saito, J; Tanino, Y; Yokouchi, H | 1 |
Abebe, M; Adane, K; Ameni, G; Aseffa, A; Bekele, S | 1 |
Hill, FJ; McCloskey, SJ; Sheerin, N | 1 |
Anandkumar, A; Balasubramanian, V; Datta, S; Karmarkar, M; Khandelwal, S; Kumar, N; Nanduri, R; Narayanan, S; Panduga, V; Prabhakar, KR; Rajagopalan, S; Ramachandran, V; Rao, N; Reddy, J; Saralaya, R; Shandil, R; Sharma, S; Singh, R; Solapure, S | 1 |
Hasan, R; Kadavigere, R; Kumar, S; Mathew, M | 1 |
Chowdhary, M; Kumar, RA; Narsinghani, U | 1 |
Shi, G; Zhang, L | 1 |
Escalon, JG; Hissong, E; Kaner, RJ; Legasto, AC; Momtahen, S; O'Beirne, SL; Port, JL; Schenck, EJ | 1 |
Davies, G; Dimba, A; Dzinjalamala, FK; Molyneux, EM; Molyneux, ME; van Oosterhout, JJ; Ward, S; Waterhouse, D; Zijlstra, EE | 1 |
Gao, T; Huang, X; Tan, QC; Tian, CL; Yang, M; Yao, Y; Yu, SY; Zhang, JT | 1 |
Izzatun, N; K, S; Lisdawati, V; M, M; Parwati, I; Puspandari, N; Ratnasari, L; Rif'ati, L; Soekarno, T | 1 |
Azami, R; Bawa, T; Haroon, N; Khan, S | 1 |
Bañuls, AL; Dang, DA; Duong, CM; Nguyen, HQ; Nguyen, HV; Nguyen, NA; Nguyen, VA; Tran, TH; Vu, TT | 1 |
Abuaku, BK; Chen, M; Deng, J; Li, W; Li, X; Su, C; Tan, H; Wang, M; Wen, SW; Xia, Y | 1 |
Baldin, VP; Caleffi-Ferracioli, KR; Cardoso, RF; Leite, CQ; Lopes, MA; Pagliotto, AD; Pavan, FR; Scodro, RB; Siqueira, VL | 1 |
Demiroz, AS; Dulgar, O; Ersen, E; Eskazan, AE; Oz, B; Turna, A; Tuzuner, N | 1 |
Cho, YJ; Kim, SJ; Lee, CT; Lee, JH; Lee, JY; Lee, YJ; Park, JS; Song, J; Yoon, HI | 1 |
Egan, D; Hennig, S; Kellerman, T; McIlleron, H; Naiker, S; Owen, A; Pym, A; Reddy, T; Wiesner, L | 1 |
Akiyama, M; Betsuyaku, T; Hasegawa, N; Ishii, M; Kohno, M; Namkoong, H; Suzuki, K; Takeuchi, T; Tasaka, S; Yagi, K | 1 |
Cowie, RL; Davis, JP; Field, SK; Fisher, DA; Jarand, J | 1 |
Ciesek, S; Hoeper, MM; Kielstein, JT; Kühn, C; Schmidt, JJ; Strunk, AK; Welte, T | 1 |
Hatakeyama, N; Kagawa, K; Machida, H; Naito, N; Ogushi, F; Ohno, A; Okano, Y; Shinohara, T; Takahashi, N; Wada, T; Yoshida, S | 1 |
Albuquerque, J; David, S; Duarte, EL; Gonçalves, G; Lavinha, J; Mateus, AR; Portugal, C; Sancho, L | 1 |
Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P | 2 |
Gie, RP; Graham, SM; Grzemska, M | 1 |
Akkus, E; Avcu, G; Duyu, M; Karapinar, B; Sahbudak Bal, Z; Vardar, F | 1 |
Betoudji, F; Lanoix, JP; Nuermberger, E | 1 |
Chan, HH; Mpe, J | 1 |
Ageshio, F; Fujikawa, T; Kagawa, H; Kitada, S; Maekura, R; Mori, M; Oshitani, Y; Saito, H; Sako, H; Yano, Y | 1 |
Lim, JI; Thomas, M | 1 |
Bekker, A; Donald, PR; Draper, HR; Hesseling, AC; McIlleron, HM; Murray, S; Schaaf, HS; van der Laan, L; Wiesner, L | 1 |
Chidiac, R; Dobler, CC; Jelfs, PJ; Williamson, JP | 1 |
Gotoh, H; Kurasima, A; Matsuda, S; Morimoto, K; Ogata, H; Okumura, M; Osawa, T; Sasaki, Y; Yanai, H; Yoshiyama, T | 1 |
Du, J; Fu, Y; Gao, J; Hu, D; Li, L; Li, Q; Li, X; Liu, F; Ma, L; Ma, Y; Tan, S; Zhang, L; Zhang, Y; Zhu, G | 1 |
Adamson, J; Almeida, DV; Ammerman, NC; Bester, LA; Dorasamy, A; Grosset, JH; Mgaga, Z; Moodley, C; Moodley, S; Ngcobo, B; Singh, SD; Swanson, RV | 1 |
Barbosa, AR; Caleffi-Ferracioli, KR; Cardoso, RF; García-Ramos, JC; Leite, CQ; Pavan, FR; Ruiz-Azuara, L; Siqueira, VL; Toledano-Magaña, Y | 1 |
Guo, Q; Liu, R; Pan, Y; Peng, Z; Xing, L; Yang, Z; Zhu, C | 1 |
Alonso, E; Batlle, M; Marcos, P; Martínez de Lagrán, I; Plana, A; Tomasa, T | 1 |
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
Adaramoye, OA; Adefisan, A; Adeyemi, O; Akanni, OO; Kehinde, AO; Oyinlola, I | 1 |
He, XC; Li, HC; Liu, Y; Yang, GR; Yu, CB; Zhang, XX; Zhao, JN | 1 |
Al-Efraij, K; Campbell, JR; Cook, VJ; Johnston, J; Marra, F; Mota, L | 1 |
Hamilton, CD; Holland, DP; Stout, JE | 1 |
Atwine, D; Bonnet, M; Borgulya, G; Burgos, M; Checkley, AM; de Fernandes, RA; de Patiño, IW; Dubash, F; Gonzales, T; Harrison, TS; Jindani, A; Mitchison, D; Patel, N; Shrestha, B | 1 |
Betai, S; Bhoi, SK; Kalita, J; Misra, UK | 1 |
Chang, MC; Chou, PH; Lin, CP; Liu, CL; Ma, HL; Wang, ST; Yu, WK | 1 |
Abe, T; Akahori, D; Enomoto, Y; Hasegawa, H; Koda, K; Matsui, T; Omae, M; Suda, T; Yokomura, K | 1 |
Imanishi, S; Kadota, N; Naito, N; Ogushi, F; Okano, Y; Shinohara, T; Takahashi, N; Taoka, T | 1 |
Akbal, AU; Birinci, A; Cayci, YT; Coban, AY; Durupinar, B; Uzun, M | 1 |
Günther, G; Hunter, C; Kibuule, D; Rennie, TW; Verbeeck, RK | 1 |
Aderaye, G; Aguwa, EN; Aseffa, A; Bedru, A; Chukwu, JN; Connolly, C; Ezechi, OC; Mebrahtu, T; Medhin, G; Onyebujoh, PC; Rida, W; Vahedi, M; Yamuah, LK; Yimer, G; Zumla, AI | 1 |
Baker, B; Chibale, K; Chouteau, F; de Kock, C; Macingwana, L; Madikane, E; Mmutlane, EM; Ngwane, AH; Panayides, JL; Parkinson, CJ; van Helden, P; Viljoen, A; Wiesner, L; Wiid, I | 1 |
Demissie, M; Hamusse, SD; Hussen, MS; Lindtjørn, B; Teshome, D | 1 |
Chande, N; MacDonald, JK; Parker, CE; Patton, PH | 1 |
Chen, SS; Guan, CX; Liu, HC; Liu, M; Liu, ZG; Song, Y; Wan, KL; Wan, L; Wu, YM; Xu, YJ; Zhao, XQ | 1 |
Geiter, L; Mallikaarjun, S; Paccaly, A; Patil, S; Petersen, C; Shoaf, SE; Wells, C | 1 |
Alameda, L; Chen, C; Ferrer, S; Ortega, F; Simonsson, US | 1 |
Daley, CL; Jeon, K; Jeong, BH; Kim, SY; Koh, WJ; Lee, SY; Moon, SM; Park, HY; Shin, SJ | 1 |
Chishiki, M; Horinosono, H; Kawakubo, Y; Maeshima, H; Sakiyama, M | 1 |
Bollela, VR; Ferro, JJ; Harrison, LH; Lisboa, M; Namburete, EI; Passeri, M; Pocente, R; Tivane, I | 1 |
Andersen, ÅB; Bahl, JM; Cohen, AS; Frimodt-Møller, N; Johansen, IS; Lundqvist, M; Prahl, JB | 1 |
Akbas, G; Akkoc, G; Atici, S; Bakir, M; Karaaslan, A; Kepenekli Kadayifci, E; Ocal Demir, S; Soysal, A; Yakut, N; Zeliha Cinel, L | 1 |
Choi, YS; Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Ki, CS; Kim, CK; Kim, DH; Kim, HK; Kim, J; Kim, SY; Koh, WJ; Lee, H; Lee, NY; Lee, SH; Moon, SM; Park, HY; Shin, SJ | 1 |
Andréjak, C; Chabot, F; Godbert, B; Hermann, J; Huet, D; Zordan, JM | 1 |
Blackmore, T; McNaughton, A; McNaughton, H | 1 |
He, JQ; Ji, GY; Liu, QQ; Sandford, AJ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM | 1 |
Dookie, N; Moodley, P; Sturm, AW | 1 |
Ahuja, V; Jain, S; Jullien, S; Ryan, H | 1 |
Patel, K; Patel, S; Vora, A | 1 |
Asres, A; Deressa, W; Jerene, D | 1 |
Aung, HL; Cook, GM; Crump, JA; Latt, KZ; Nyunt, WW; Samaranayaka, A; Thinn, KK; Tun, T | 1 |
Fernandes, SE; Laurenson, IF; Noble, DD; Velu, PP | 1 |
Ginalska, G; Sawicki, R; Sieniawska, E; Skalicka-Woźniak, K; Swatko-Ossor, M | 1 |
Bright-Thomas, RJ; Gondker, AR; Morris, J; Ormerod, LP | 1 |
Albert, A; Patel, H; Santos, MA | 1 |
Allen, SJ; Carlson, SL; Furukawa, NW; Haider, MZ; Lindquist, SW | 1 |
Balin, SO; Denk, A; Dogdu, O; Kara, SS; Kobat, MA | 1 |
Lesic, AR; Pesut, DP; Stevic, RS; Stjepanovic, MI | 1 |
Abdel-Hamid, MK; Abdelrahman, MH; Abdu-Allah, HH; Aboul-Fadl, T; Reshma, RS; Sriram, D; Yogeeswari, P; Youssif, BG | 1 |
Bartoletti, M; Bertuzzo, V; Cristini, F; Giannella, M; Lewis, RE; Martelli, G; Morelli, M; Pianta, P; Pinna, AD; Tadolini, M; Tedeschi, S; Viale, P | 1 |
Aarnoutse, R; Boeree, MJ; Charalambous, S; Churchyard, G; Colbers, A; Dawson, R; Diacon, AH; Gillespie, SH; Hanekom, M; Heinrich, N; Henne, S; Hoelscher, M; Hunt, RD; Kibiki, GS; Manyama, C; Mekota, A; Minja, LT; Mpagama, SG; Mtafya, B; Narunsky, K; Ntinginya, NE; Phillips, PPJ; Rehal, S; Reither, K; Sanne, I; Semvua, HH; van Balen, GP; Venter, A; Wallis, RS | 1 |
Baya, B; Belson, M; Coulibaly, N; Coulibaly, YI; Dao, S; Dembele, BPP; Diabate, S; Diallo, MH; Diallo, S; Diarra, B; Goita, D; Kone, A; Kone, B; M'Baye, O; Maiga, M; Murphy, RL; Orsega, S; Polis, MA; Saleeb, P; Sanogo, M; Sarro, YS; Siddiqui, S; Somboro, AM; Togo, ACG; Traore, B | 1 |
Cole, ST; Foscolos, AS; Foscolos, GB; Kolocouris, N; Papanastasiou, I; Tsotinis, A; Vocat, A | 1 |
Al-Shaer, MH; Elewa, H; Iqbal, F; Mansour, H; Salameh, P | 1 |
Mebrahtu, T; Weldegebreal, S | 1 |
Bañuls, AL; Contamin, L; Dang, AD; Nguyen, HQ; Nguyen, HV; Nguyen, NLT; Nguyen, NV; Nguyen, ST; Nguyen, VAT; Tran, THT; Vu, TT | 1 |
Mendel, C; Murray, S; Spigelman, M | 1 |
Kadota, JI; Kurashima, A; Suzuki, K | 1 |
Filipe, P; Machado, AP; Marcos-Pinto, A; Marques, T; Soares-de-Almeida, L | 1 |
Furuta, S; Furuya, H; Hirose, K; Ikeda, K; Miyachi, K; Nakajima, H; Nakamura, K; Sakagami, T; Suzuki, K; Tamachi, T | 1 |
Chen, G; He, JQ; Sandford, AJ; Wang, FJ; Wang, MG; Wang, Y; Wu, SQ; Xiang, X; Zhang, MM | 1 |
Curtis, N; Freyne, B | 1 |
Ahn, Y; Eun, BW; Kim, HJ; Ryoo, S; Yoon, HH | 1 |
Kubo, M; Omonge, E; Otieno, F; Shiruli, B | 1 |
Bakker-Woudenberg, IAJM; Davies, GR; de Knegt, GJ; de Steenwinkel, JEM; Dickinson, L; Evangelopoulos, D; McHugh, TD; Pertinez, H | 1 |
Du, J; Gao, J; Gao, M; Li, L; Liu, Y; Ma, L; Mi, F; Tang, S; Zhang, Y | 1 |
Khan, MI; Mahmood, N; Munir, S; Shahid, S | 1 |
Arora, S; Ghosh, B; Goel, N; Kumar, V | 1 |
Indumati, V; Krishnaswamy, D; Rajeshwari, V; Ramesh, A; Shantala, D; Shilpa, A; Vijay, V | 1 |
Chopra, KK; Hanif, M; Khanna, A; Shrivastava, D; Vashistha, H | 1 |
Feng, M; He, JQ; Zhang, M | 1 |
Ikeuchi, T; Kakite, S; Nakamatsu, S; Nakazaki, H; Takemoto, Y; Tokuyasu, H; Yamasaki, K | 1 |
Chellini, PR; Franco, PHC; Oliveira, MAL; Pianetti, GA | 1 |
Gleeson, F; Larson, A; Rajan, E | 1 |
Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Mouton, JW; Verbon, A | 1 |
Andreou, A; Gerhardy, B; Nagel, RA; Sellars, R | 1 |
Anupurba, S; Balgam, S; Fakir, NA; Gupta, A; Nema, V; Pal, SK; Pandey, D; Periera, M; Rathod, S; Sekar, G; Sinha, D; Sinha, P; SivaKumar, S; UmaDevi, KR | 1 |
Aarnoutse, RE; Boeree, MJ; Colbers, A; Gillespie, SH; Haraka, F; Hoelscher, M; Kibiki, GS; Logger, JGM; Magis-Escurra, C; Mpagama, SG; Mtabho, CM; Phillips, PPJ; Plemper van Balen, G; Reither, K; Semvua, HH; Sumari-de Boer, IM; Te Brake, LHM; van den Boogaard, J; Wattenberg, M | 1 |
Cohen, L; Guarner, J; Hunt, WR | 1 |
Andres, S; Feuerriegel, S; Havlicek, J; Labugger, I; Merker, M; Niemann, S; Rivera-Milla, E; Slickers, P | 1 |
Bay, ML; Besedovsky, H; Bongiovanni, B; Bottasso, O; Brandan, N; D'Attilio, L; Del Rey, A; Díaz, A; Dídoli, G; Fernández, RDV; Gardeñez, W; Kovalevski, L; Lioi, S; Nannini, LJ; Santucci, N | 1 |
DeJesus, MA; Ehrt, S; Engelhart, CA; Healy, C; Ioerger, TR; Lin, K; Park, SW; Rücker, N; Schnappinger, D; Wang, R; Wright, MG; Xu, W | 1 |
Buzibye, A; Castelnuovo, B; Corti, N; Fehr, J; Gutteck, U; Henning, L; Kambugu, A; Lamorde, M; Ledergerber, B; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A | 1 |
Al-Busaidi, I; Boggild, AK; Wong, D | 1 |
Chen, G; Feng, M; He, JQ; Ji, GY; Liu, QQ; Wang, Y; Wu, JC; Wu, SQ; Zhang, MM | 1 |
Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS | 1 |
He, XC; Li, HC; Liu, Y; Tao, NN; Yu, CB; Zhang, XX | 1 |
Giribhattanavar, P; Kumar, K; Patil, S; Sagar, C | 1 |
Duckett, SB; Green, GGR; Norcott, P; Rayner, PJ | 1 |
Boldrin, F; Espinosa, DM; Hernandez-Pando, R; Manganelli, R; Palù, G; Payan, JB; Pisu, D; Provvedi, R | 1 |
Baillie, T; Cho, D; Lee, CK; Moses, J; Sivasubramaniam, R; Tjokrowidjaja, A | 1 |
Chen, J; Chiang, CY; Innes, AL; Li, L; Xu, L | 1 |
Inagaki, Y; Ito, T; Kato, T; Ono, Y; Sawa, M | 1 |
Bonamonte, D; Costa, D; Fortarezza, F; Saracino, A | 1 |
Barbero, S; Davis, JL; Haynesworth, K; Jacobs, J; Jarlsberg, L; Lewinsohn, DM; Mathew, A; Nahid, P; Schorey, J; Segal, MR; Sigal, GB; Small, N; Wang, M; Weiner, M; Whitworth, WC | 1 |
Anukool, U; Butr-Indr, B; Gamngoen, R; Intorasoot, S; Jaresitthikunchai, J; Kasinrerk, W; Phaonakrop, N; Phunpae, P; Putim, C; Roytrakul, S; Tayapiwatana, C; Tharincharoen, CS; Tragoolpua, K | 1 |
de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J | 1 |
Huh, HJ; Jeon, K; Jeong, BH; Kim, S; Lee, H; Lee, NY; Park, HY | 1 |
Charfi, S; Ghorbel, A; Mnejja, M; Sellami, M | 1 |
Ameni, G; Medihn, G; Mersha, W; Tamirat, M; Teklu, T; Wondale, B | 1 |
Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
Hsia, YC; Naseri, A; Schallhorn, JM | 1 |
Antiabong, JF; Lekalakala, RM; Malinga, LA; Maningi, NE; Mbelle, NM | 1 |
Ahmed, AE; Al Ammari, M; Al Essa, M; Al Turaiki, A; Eltigani, SA; Kashkary, AM | 1 |
Manosuthi, W; Ruxrungtham, K; Siripassorn, K | 1 |
Deml, SM; Dionne, K; Martin, IW; Parrish, NM; Wengenack, NL | 1 |
Caminero Luna, JA; Cerezo Lajas, A; de Miguel Díez, J; Rodríguez Guzmán, MDC | 1 |
Abebe, M; Ameni, G; Aseffa, A; Desta, K; Tilahun, M; Yamuah, L; Zewude, A | 1 |
Bian, Y; Cao, J; Huang, C; Liu, L; Mi, Y; Miao, L; Shi, C; Ye, Z | 1 |
Battini, S; Mannava, MKC; Nangia, A | 1 |
Adane, K; Dinant, GJ; Spigt, M | 1 |
Alvarez-Uria, G; Midde, M | 1 |
Gundert-Remy, U; Mielke, H; Partosch, F; Stahlmann, R | 1 |
Agiboth, HKK; Angamuthu, P; Arasan, G; Ayyamperumal, M; Chandrasekaran, P; Chockalingam, C; Gopalan, N; Jayabal, L; Jayanthi, N; Kannabiran, BP; Kesavamurthy, B; Krishnamoorthy, V; Krishnaraja, R; Lakshman, S; Manoharan, T; Menon, PA; Murali, L; Narayanan, R; Palaniappan, AN; Ramachandran, R; Rathinam, P; Rathinam, S; Reddy, D; Santhanakrishnan, RK; Satagopan, K; Sathiyavelu, S; Selvachitiram, M; Sivaramakrishnan, GN; Suresh, C; Susaimuthu, S; Swaminathan, S; Tripathy, SP | 1 |
Chen, W; Gao, S; Wang, Z; Xi, Y; Xie, X; Yang, Y; You, C | 1 |
Ahuja, SD; Akkerman, OW; Arakaki-Sanchez, D; Ayakaka, I; Baghaei, P; Bang, D; Banurekha, VV; Bastos, M; Benedetti, A; Bonnet, M; Cattamanchi, A; Cegielski, P; Chien, JY; Cox, H; Dedicoat, M; Erkens, C; Escalante, P; Falzon, D; Fregonese, F; Galliez, RM; Garcia-Prats, AJ; Gegia, M; Gillespie, SH; Glynn, JR; Goldberg, S; Griffith, D; Jacobson, KR; Johnston, JC; Jones-López, EC; Khan, A; Koh, WJ; Kritski, A; Lan, ZY; Lee, JH; Li, PZ; Maciel, EL; Menzies, D; Merle, CSC; Munang, M; Narendran, G; Nguyen, VN; Nunn, A; Ohkado, A; Park, JS; Phillips, PPJ; Ponnuraja, C; Reves, R; Romanowski, K; Schaaf, HS; Seung, K; Skrahina, A; Soolingen, DV; Tabarsi, P; Trajman, A; Trieu, L; Viiklepp, P; Wang, JY; Yoshiyama, T | 1 |
Leong, BCS; Lightman, S; McCluskey, PJ; Tomkins-Netzer, O; Zhang, X | 1 |
Bax, HI; de Knegt, GJ; de Steenwinkel, JEM; Mourik, BC; Simonsson, USH; Svensson, RJ; Verbon, A | 1 |
Carrera-Pineda, R; Garcia-Luna, RC; Soto-Cabrera, E; Villamil-Osorio, LV | 1 |
Andersen, AB; Holden, IK; Johansen, IS; Kehrer, M; Svensson, E; Wejse, C | 1 |
Arslan, K; Ayca, B; Efe, SC; Karabag, T; Taner, U | 1 |
Al-Shaer, MH; Alghamdi, WA; Peloquin, CA | 1 |
Li, Q; Liu, W; Lu, M; Qian, HZ; Wang, K; Wang, L; Wu, L; Wu, Y; Xie, L; Zhao, G | 1 |
Aarnoutse, RE; Aguirre, S; Alffenaar, JW; Chaparro, G; Coronel, R; Gomez, R; Gonzalez, F; Huisman, J; Jongedijk, E; Kerkhoff, J; Magis-Escurra, C; Martial, LC; Martinez, N; Molinas, G; Pérez, D; Rodríguez, M; Roman, M; Touw, DJ | 1 |
Das, A; Das, SK | 1 |
Bollela, VR; Dippenaar, A; Feliciano, CS; Namburete, EI; Peronni, K; Rodrigues Plaça, J; Silva, WA; Warren, RM | 1 |
Gray, ME; Liu, PW; Wispelwey, B | 1 |
Guan, W; LaZhou, C; Lin, S; Shi, Y | 1 |
Chen, H; Song, X; Wang, W; Wu, S; Xiong, W; Yu, X | 1 |
Addise, D; Admasu, A; Amare, M; Beyene, D; Dagne, B; Mesfin, EA; Tesfaye, A; Tesfaye, E; Tessema, B; Yaregal, Z | 1 |
Ahmad, M; Ahmad, W; Akbar, HS; Akbar, MT; Jan, F; Khalid, A; Sadia, S; Wali, S | 1 |
Abrahem, R; Cao, R; Gyurjian, K; Islamoglu, H; Munjal, S; Teskey, G; Venketaraman, V; Zhong, L | 1 |
Allix-Béguec, C; Arandjelovic, I; Beckert, P; Bi, L; Bonnet, M; Bradley, P; Cabibbe, AM; Cancino-Muñoz, I; Caulfield, MJ; Chaiprasert, A; Cirillo, DM; Clifton, DA; Comas, I; Crook, DW; De Filippo, MR; de Neeling, H; Diel, R; Drobniewski, FA; Faksri, K; Farhat, MR; Fleming, J; Fowler, P; Fowler, TA; Gao, Q; Gardy, J; Gascoyne-Binzi, D; Gibertoni-Cruz, AL; Gil-Brusola, A; Golubchik, T; Gonzalo, X; Grandjean, L; Guthrie, JL; He, G; Hoosdally, S; Hunt, M; Iqbal, Z; Ismail, N; Johnston, J; Khanzada, FM; Khor, CC; Kohl, TA; Kong, C; Lipworth, S; Liu, Q; Maphalala, G; Martinez, E; Mathys, V; Merker, M; Miotto, P; Mistry, N; Moore, DAJ; Murray, M; Niemann, S; Omar, SV; Ong, RT; Peto, TEA; Posey, JE; Prammananan, T; Pym, A; Rodrigues, C; Rodrigues, M; Rodwell, T; Rossolini, GM; Sánchez Padilla, E; Schito, M; Shen, X; Shendure, J; Sintchenko, V; Sloutsky, A; Smith, EG; Snyder, M; Soetaert, K; Starks, AM; Supply, P; Suriyapol, P; Tahseen, S; Tang, P; Teo, YY; Thuong, TNT; Thwaites, G; Tortoli, E; van Soolingen, D; Walker, AS; Walker, TM; Wilcox, M; Wilson, DJ; Wyllie, D; Yang, Y; Zhang, H; Zhao, Y; Zhu, B | 1 |
Augustino, D; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kibiki, GS; Kivuyo, S; Mduma, E; Mfinanga, S; Mmbaga, B; Nicodemu, I; Peloquin, CA; Thomas, TA; Yeconia, A; Zagurski, T | 1 |
Acharya, N; Chattopadhyay, A; Sharma, A; Sharma, K | 1 |
Andres, S; Gröschel, MI; Hillemann, D; Kranzer, K; Merker, M; Niemann, S | 1 |
Ahn, H; Cho, YJ; Choi, HS; Choi, SM; Hahn, S; Han, J; Heo, EY; Hwang, YR; Jeong, I; Jo, YS; Joh, JS; Ki, J; Kim, DK; Kim, H; Kim, HS; Kim, J; Kim, SJ; Kwak, N; Lee, CH; Lee, J; Lee, JH; Lee, JK; Lee, JY; Lee, M; Lee, SH; Lee, SM; Lee, YJ; Lim, JN; Park, JH; Park, JS; Park, SS; Park, YS; Song, T; Yim, JJ; Yoon, HI | 1 |
Alarcón Guizado, VA; Alarcon, E; Cornejo Garcia, JG; Heldal, E; Mendoza Ticona, A; Moore, DAJ | 1 |
Tadele, H | 1 |
Ahmad, S; Al-Mutairi, NM; Eldeen, HS; Joseph, S; Mokaddas, E | 1 |
Kamii, Y; Kawashima, M; Kohno, S; Matsuki, M; Nagai, H; Nagoshi, S; Ohgiya, M; Ohta, K; Sato, A | 1 |
Allahyar Torkaman, MR; Amini, S; Hamzehloo, G; Hoffner, S; Mir, R; Mohsenpoor, M; Nasiri, MJ; Salehi, M; Sami Kashkooli, G; Shahraki, MS; Soleimanpour, S | 1 |
Aragón Fernández, C; Gomez-Pastrana, D; Morales Pérez, C; Pérez Escolano, E | 1 |
Ban, GY; Jeong, YJ; Kim, SH; Lee, SH; Park, HS; Shin, SS; Shin, YS; Ye, YM | 1 |
Ronald, BSM; Senthil Kumar, TMA; Sweetline Anne, N; Thangavelu, A | 1 |
Iwata, K; Nagata, M; Ohji, G | 1 |
Anh, LTN; Anh, NT; Bestrashniy, J; Britton, WJ; Fox, GJ; Hoa, NB; Hoa, NLP; Jan, S; Lung, T; Marks, GB; Nhung, NV | 1 |
Abd-Ellatief, RB; Hasanain, AFA; Nafee, AMA; Zayed, AAH | 1 |
Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS | 1 |
Ali, M; Mertaniasih, NM; Novita, BD; Pranoto, A; Soediono, EI | 1 |
Balganesh, T; Bhavani, PK; Gomathy, SN; Guleria, R; Jawahar, SM; Kumar, H; Natrajan, M; Padmapriyadarsini, C; Ponnuraja, C; Singh, M; Swaminathan, S | 1 |
Choe, J; Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Koh, WJ; Kwon, OJ; Lee, NY; Moon, SM | 1 |
Kabra, SK; Lodha, R; Mukherjee, A | 1 |
Li, QF; Li, YJ; Liao, Y; Luo, J; Wang, DM; Wu, GH; Xu, YH; Zhong, J; Zhu, M | 1 |
Dharmendra, S; Sharma, E; Sharma, JB; Sharma, S | 1 |
Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
Prasad, K; Vibha, D | 1 |
Aucamp, M; Geldenhuys, M; Liebenberg, W; Okaecwe, T; Stieger, N | 1 |
Feng, H; Fu, S; Li, X; Long, H; Su, Y; Wu, R; Xiao, R; Zhou, Y | 1 |
Andriescu, EC; Khetan, NG; Mazur, L; Smith, KC | 1 |
Bunte, A; Fätkenheuer, G; Jaspers, N; Jung, N; Lehmann, C; Maria Fünger, S; Mehrkens, D; Plum, G; Reimer, RP; Rybniker, J; Schmidt, M; Suárez, I | 1 |
Altmann, D; Brodhun, B; Glasauer, S; Haas, W; Hauer, B; Perumal, N | 1 |
Asaoka, M; Baba, T; Hagiwara, E; Katano, T; Kitamura, H; Komatsu, S; Ogura, T; Okuda, R; Sekine, A; Suido, Y | 1 |
Hashimoto, H; Inoue, Y; Kogure, Y; Nakagawa, T; Ogawa, K; Saito, AM; Sekimizu, M; Yagi, M | 1 |
Muntean, PE | 1 |
Akkerman, OW; Alffenaar, JC; Hak, E; Pradipta, IS; Van't Boveneind-Vrubleuskaya, N | 1 |
Bhatt, N; Davies, G; Gillespie, SH; Kibiki, GS; Ntinginya, NE; Sabiiti, W; Simonsson, USH; Svensson, RJ | 1 |
Abbara, A; Abubakar, I; Alexander, E; Booth, H; Bothamley, GH; Creer, DD; Davidson, JA; Harris, RJ; Kon, OM; Kunst, H; Lalor, MK; Lipman, MC; Loebinger, MR; Loutet, MG; Lozewicz, S; McHugh, TD; Milburn, HJ; Mohiyuddin, T; Palchaudhuri, P; Phillips, PPJ; Schmok, E; Stagg, HR; Taylor, L | 1 |
Crook, AM; Dawson, R; Diacon, AH; Gillespie, SH; McHugh, TD; Mendel, CM; Meredith, SK; Mohapi, L; Murphy, ME; Nunn, AJ; Phillips, PPJ; Singh, KP; Spigelman, M; Tweed, CD | 1 |
Altın, S; Hırçın Cenger, D; Kılıç, L; Yazısız, H; Yazısız, V | 1 |
Hagiya, H; Hamada, K; Hamaguchi, S; Hori, Y; Morii, E; Okuno, H; Tanaka, H; Tomono, K; Yoshida, H; Yoshikawa, H | 1 |
Esmail, H; Lipman, MC; Nunn, A; Walker, TM | 1 |
Hussain, W; Khadim, MT; Khurshid, U; Salim, S; Younis, S; Zaman, G | 1 |
Dang, L; Lei, Q; Lv, X; Wang, H; Zhao, Y; Zhou, J; Zhu, C | 1 |
Heyckendorf, J; Kalsdorf, B; Lange, C; Maurer, FP | 1 |
Bai, H; Jiao, L; Liu, T; Lu, X; Lv, Y; Song, J; Wu, Q; Wu, T; Ying, B; Zhao, Z | 1 |
Ambreen, A; Jamil, M; Mustafa, T; Rahman, MAU | 1 |
Daniel, BD; Grace, GA; Natrajan, M | 1 |
Cho, J; Han, SK; Kim, HJ; Kwak, N; Lee, CH; Lee, JS; Yim, JJ | 1 |
Andrade, BB; Arriaga, MB; Calvacante, S; Cordeiro-Santos, M; Durovni, B; Figueiredo, MC; Kritski, A; Peetluk, LS; Rebeiro, PF; Rolla, VC; Sterling, TR; Turner, MM | 1 |
Adiga, SK; Kalthur, G; Kalthur, SG; Kumari, S; Mutalik, S; Mutalik, SP; Nayak, G; Rao, A | 1 |
Costales-Álvarez, C; Fernández-García, M; Macías-Franco, S; Mayordomo-Colunga, J; Rozas-Reyes, P | 1 |
Bagtharia, R; Haque, AKM; Rawal, J | 1 |
Chu, N; Guo, H; Lin, J; Liu, H; Liu, X; Wu, L; Ye, Z; Zheng, L | 1 |
Mishra, DK; Murthy, SI; Pappuru, RR; Rathi, VM; Tyagi, M | 1 |
Bozeman, L; Burman, WJ; Chaisson, RE; Chang, KC; Chen, M; Cotton, M; Dooley, KE; Dorman, SE; Engle, M; Feng, PJ; Fletcher, CV; Goldberg, SV; Ha, P; Heilig, CM; Johnson, JL; Kurbatova, EV; Lessem, E; Metchock, B; Miro, JM; Nahid, P; Nhung, NV; Pettit, AC; Phillips, PPJ; Podany, AT; Purfield, AE; Robergeau, K; Samaneka, W; Scott, NA; Sizemore, E; Swindells, S; Vernon, A; Weiner, M | 1 |
Altin, S; Hircin Cenger, D; Uçarman, N; Yazisiz, H | 1 |
Burger, DA; Dawson, R; De Jager, VR; Diacon, AH; Everitt, D; Mendel, CM; Narunsky, K; Nedelman, J; Pappas, F; Vanker, N | 1 |
Ader, F; Berland, JL; Bryant, JE; Dumitrescu, O; Genestet, C; Ginevra, C; Hodille, E; Lina, G | 1 |
Beraldi-Magalhães, F; Boger, B; Cordeiro-Santos, M; de Fátima Cobre, A; de Liz, MV; Domingos, EL; Dos Santos, JMMF; Fachi, MM; Junkert, AM; Momade, DRO; Pontarolo, R; Vilhena, RO | 1 |
Khan, UM; Rittenberg, A | 1 |
Dolgushin, MV | 1 |
Domotenko, LV; Morozova, TP; Shemyakin, IG; Shepelin, AP | 1 |
Adachi, Y; Hayashi, S; Kagawa, T; Kobayashi, T; Kurahara, Y; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
Kasinathan, A; Palanisamy, S; Serane, VK | 1 |
Ahmadi, Q; Hayat, MS; Rahimi, BA; Rahimy, N; Wasiq, AW | 1 |
Choi, J; Dawson, R; de Jager, VR; Diacon, AH; Hutchings, J; Kim, J; Nam, K; van der Merwe, L; van Niekerk, C; Vanker, N | 1 |
Banerji, JS | 1 |
Huynh, J; Marais, BJ; Schaaf, HS; Thwaites, G | 1 |
De Sessions, PF; Hibberd, ML; Kwan, PKW; Lin, W; Naim, ANM; Paton, NI; Periaswamy, B | 1 |
Danna, BJ; Harvey, AW; Woc-Colburn, LE | 1 |
Guan, CX; Guo, Q; Jiang, Y; Li, GL; Li, MC; Liu, HC; Liu, ZG; Wan, KL; Wan, L; Wei, JH; Zhao, LL; Zhao, XQ | 1 |
Chesdachai, S; Katz, B; Sapkota, S | 1 |
Bongomin, F; Khan, SA; Oravec, T | 1 |
Gao, R; Guo, Y; Shen, X; Tan, G; Wang, H; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Blumberg, HM; Fekadu, A; Holland, DP; Manyazewal, T; Marconi, VC; Woldeamanuel, Y | 1 |
Fujita, K; Hayakawa, H; Ito, Y; Iwaizumi, E; Kanai, M; Kojima, S; Miwa, S; Ohba, H; Oshima, T; Shirai, M; Suda, T | 1 |
Kalita, J; Misra, UK; Pandey, PC; Singh, VK; Thomas, J | 1 |
Eller, P; Hackl, G; Hermann, J; Reisinger, AC; Vagena, FR | 1 |
Balakrishnan, S; Das, M; Manu, MS; Mehta, K; Neena, PS; Rakesh, PS; Satyanarayana, S; Sindhu, MP; Sunil Kumar, M; Valamparampil, MJ | 1 |
Desai, U; Doshi, K; Joshi, JM | 1 |
Berthier, C; Lellouch, AG; Lupon, E; Mansat, P; Martin-Blondel, G; Pollon, T | 1 |
Atanasova, Y; Bachiyska, E; Baykova, A; Todorova, Y; Yordanova, S | 1 |
Berger, T; Dean, P; Matt, M; Riney, L; Schlaudecker, E | 1 |
Xiao, K; Zhong, L | 1 |
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
Ceyhan, İ; Vezir, S | 1 |
Ahn, DJ; Kang, S; Kim, MK; Kim, SG; Kwon, JG; Lee, IH; Yang, CS | 1 |
Alva-Diaz, C; Esteban-Arias, D; López-Saavedra, A; Metcalf, T; Orellana-Tovar, I; Pacheco-Barrios, K; Rodriguez-López, E; Velásquez-Rimachi, V | 1 |
Aung, KJM; de Jong, BC; Decroo, T; Hossain, MA; Lempens, P; Meehan, CJ; Rigouts, L; Van Deun, A | 1 |
Eder, IB; Kunz, M; Simon, JC; Zimmerlich, S | 1 |
Basol, G; Gonlugur, T; Gonlugur, U | 1 |
Hosoda, C; Ishiguro, T; Kanegane, H; Shimizu, Y; Takayanagi, N | 1 |
Bottet, F; Calin, R; Gauthe, M; Jamme, M; Pialoux, G; Rondeau, E; Tamzali, Y | 1 |
Abi-Chahla, ML; Dauchy, FA; Desclaux, A; Ducours, M; Dutronc, H; Pointillart, V; Wirth, G | 1 |
Gálvez-López, R; García Salguero, AJ; Láinez-Ramos-Bossini, AJ; Pérez-García, MC; Rabadán-Caravaca, M; Ruiz-Carazo, E | 1 |
Chu, N; Du, Y; Guo, R; Han, X; Pang, Y; Wang, J; Wang, Q | 1 |
Anton, C; Bernardi, RM; Freitas, AA; Lemos, CX; Machado, FD; Silva, DR | 1 |
Alves, MDM; Bezerra, GH; Britto, MHMF; Carvalho, LD; Costa, VLDC; Honório, MLP; Rocha, KBF; Vechi, HT | 1 |
Einbeck, CO; Hunter, CJ; Yasukawa, K | 1 |
Khan, F; Sriaroon, C; Walter, J; Zeitler, K | 1 |
Andersson, DI; Bjarnemark, F; Brive, L; Glegola-Madejska, I; Godaly, G; Henderson, DI; Hjort, K; Krishnan, N; Millqvist Fureby, A; Puthia, M; Rao, KU; Robertson, BD; Sturegård, E; Tenland, E | 1 |
Bishai, W; Dawson, R; De Jager, V; Diacon, A; Donahue, K; Fletcher, CV; Hafner, R; Hogg, E; Miyahara, S; Sun, X; Swindells, S; Urbanowski, M | 1 |
Kaji, Y; Nakamura, O; Nomura, Y; Oka, K; Yamaguchi, K; Yamamoto, T | 1 |
Anderson, PL; Anthony, M; Brennan, L; Daley, CL; Martiniano, SL; Nick, JA; Sagel, SD; Wagner, BD; Wempe, MF | 1 |
Ali, RA; Anjum, AA; Arshad, U; Ashraf, M; Iqbal, A; Ishtiaq, S; Omer, MO; Rathore, AW; Zaman, M | 1 |
Ando, T; Kage, H; Matsumoto, Y; Nagase, T; Zokumasu, K | 1 |
Boeree, MJ; Danho, R; Hoefsloot, W; Kuipers, S; Pennings, LJ; Schildkraut, JA; Svensson, EM; van Ingen, J; Wertheim, HFL; Zweijpfenning, SMH | 1 |
Aarnoutse, R; Chabala, C; Chirehwa, M; Choo, L; Gibb, D; Hesseling, AC; Hissar, S; Kapasa, M; Kinikar, A; LeBeau, K; Mave, V; McIlleron, H; Mulenga, V; Palmer, M; Turkova, A; van der Zalm, M; Wiesner, L; Wobudeya, E; Zimba, KM | 1 |
Mistry, N; Oswal, V; Rao, S; Shaikh, A; Sriraman, K; Vaswani, S | 1 |
Karthikeyan, K; Premjith, R; Vijayasankar, P | 1 |
Bekker, A; Davies, G; Denti, P; Gonzalez-Martinez, C; Hesseling, AC; McIlleron, HM; Rabie, H; Svensson, EM; van der Laan, LE; van Rie, A; Wasmann, RE; Wiesner, L; Winckler, J; Zar, HJ | 1 |
Bollela, VR; Della Pasqua, O; Lanchote, VL; Nardotto, GHB; Rocha, A | 1 |
Bandere, D; Cirule, A; Grinberga, S; Igumnova, V; Kivrane, A; Krams, A; Pole, I; Pugovics, O; Ranka, R; Sevostjanovs, E; Viksna, A | 1 |
Enoki, Y; Hasegawa, N; Iketani, O; Kizu, J; Komeya, A; Matsumoto, K; Taguchi, K; Uno, S; Uwamino, Y | 1 |
Chong, YP; Jo, KW; Lee, JH; Park, YE; Shim, TS | 1 |
Kho, BG; Kim, TO; Kim, YI; Kwon, YS; Lee, JK; Lim, SC; Na, YO; Oh, HJ; Park, HK; Park, HY; Shin, HJ | 1 |
Kumari, D; Perveen, S; Sharma, R; Singh, K | 1 |
Maxwell, D; Patel, H; Sheikh, S; Skok, C | 1 |
Fujiwara, K; Furuuchi, K; Hanada, K; Kaburaki, S; Kurashima, A; Morimoto, K; Ohta, K; Shiraishi, Y; Tanaka, Y; Uesugi, F; Watanabe, F; Yoshiyama, T | 1 |
Arenivas, A; Balaji, S; Devaleenal D, B; Dooley, KE; Gadama, D; Giridharan, P; Gupta, A; Gupte, N; Inamdar, S; Khwaja, S; Kinikar, A; Mave, V; Mvalo, T; Nimkar, S; Paradkar, MS; Savic, R; Selladurai, E; Swaminathan, S; Thakur, KT; Valvi, C; Venkatesan, M; Wolf, L; Yadav Kattagoni, K | 1 |
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Chasweka, M; Chirambo, AP; Chitani, A; Corbett, EL; Davies, GR; Ghany, JF; Gordon, SB; Khoo, SH; Malamba, R; Mallewa, JE; McCallum, AD; Meghji, JZ; Mwandumba, HC; Pertinez, HE; Shani, D; Sheha, I; Sloan, DJ | 1 |
Anderson, R; Cholo, MC; Mashele, SA; Matjokotja, MT; Rasehlo, SSM; Steel, HC | 1 |
Byeon, SJ; Choi, JH; Chung, SJ | 1 |
Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F | 1 |
He, G; Jiang, X; Ning, H; Qiu, C; Shi, J; Wu, L; Wu, Z; Ye, X | 1 |
Anderson, G; Vinnard, C | 1 |
Alshaer, MH; Gratz, J; Heysell, SK; Houpt, ER; Justine, M; Kosek, M; Liu, J; Maro, A; Mduma, E; Mpagama, SG; Mujaga, B; Peloquin, CA; Rogawski McQuade, ET; Thomas, TA; Van Aartsen, D | 1 |
Chimbetete, T; Choshi, P; Lehloenya, R; Meintjes, G; Pedretti, S; Peter, J; Phillips, E; Porter, M; Smith, R | 1 |
Al-Rabeai, DB; Khudhair, GS; Mohammed, KAS | 1 |
Enoki, Y; Fukunaga, K; Hasegawa, N; Kizu, J; Matsumoto, K; Namkoong, H; Ozawa, T; Taguchi, K; Takahashi, Y; Takaya, R | 1 |
Wen, Y; Wu, X; Zhang, G | 1 |
Addise, D; Beyene, D; Merker, M; Mesfin, EA; Niemann, S; Shuaib, YA; Tesfaye, A; Tessema, B | 1 |
Bennie, M; Godman, B; Kruger, D; Kurdi, A; Meyer, JC; Schellack, N; Skosana, PP | 1 |
Kang, JY; Kim, HW; Kim, JS; Kim, JW; Kim, SK; Kim, YH; Lee, SH; Min, J; Yoon, HK | 1 |
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN | 1 |
Che, Y; Chen, Q; Chen, T; He, T; Lin, Y; Sang, G; Yang, T | 1 |
Doulla, B; Ershova, J; Heinrich, N; Hoelscher, M; Kilale, AM; Kingalu, A; Kisonga, R; Kondo, Z; Lema, Y; Lyamuya, E; Lyimo, J; Mfaume, SM; Mutayoba, BK; Ngowi, BJ; Nkiligi, E; Ntinginya, NE; Pletschette, M; Range, NS | 1 |
George, S; Gerbo, RM; Hartman-Adams, H | 1 |
Kilonzo, K; Lyamuya, F; Mremi, A; Sadiq, A; Temba, B; Urassa, D; Vara, P | 1 |
Ahmed, S; Biswas, JP; Das, BR; Haque, N; Hasan, M; Hasan, MS; Hossain, MA; Islam, A; Khan, MK; Nasreen, SA; Paul, SK | 1 |
Jiang, Y; Li, J; Shen, X; Wang, L; Xu, B; Yu, C; Zhang, Y; Zheng, X | 1 |
Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N | 1 |
Castel, S; Court, R; Joubert, A; Loveday, M; Norman, J; van der Merwe, M; Waitt, C; Wiesner, L; Zuma, P | 1 |
Hsiao, HC; Jou, R; Wu, SH; Xiao, YX | 1 |
Di Palma, M; Francis, JR; Globan, M; Hall, C; Hersch, N; Horan, K; Lopes, C; Meumann, EM; Pereira, HM; Ralph, AP; Sarmento, N | 1 |
Cáceres-Pérez, AR; Fariña, JB; Oliva, A; Santoveña-Estévez, A; Suárez-González, J | 1 |
Al Moujahid, A; Bletsis, PP; de Jong, T; van den Elskamp, IJ; Wink, FR | 1 |
Aarnoutse, RE; Agarwal, D; Alffenaar, JC; Antwi, S; Bang, ND; Bekker, A; Bell, DJ; Chabala, C; Choo, L; Davies, GR; Day, JN; Dayal, R; Denti, P; Donald, PR; Engidawork, E; Gafar, F; Garcia-Prats, AJ; Gibb, D; Graham, SM; Hesseling, AC; Heysell, SK; Idris, MI; Kabra, SK; Kinikar, A; Kumar, AKH; Kwara, A; Lodha, R; Magis-Escurra, C; Marais, BJ; Martinez, N; Mathew, BS; Mave, V; McIlleron, HM; Mduma, E; Mlotha-Mitole, R; Mpagama, SG; Mukherjee, A; Nataprawira, HM; Peloquin, CA; Pouplin, T; Ramachandran, G; Ranjalkar, J; Roy, V; Ruslami, R; Schaaf, HS; Shah, I; Singh, Y; Stevens, J; Sturkenboom, MGG; Svensson, EM; Swaminathan, S; Taxis, K; Thatte, U; Thee, S; Thomas, TA; Tikiso, T; Touw, DJ; Turkova, A; Velpandian, T; Verhagen, LM; Wasmann, RE; Winckler, JL; Yang, H; Yunivita, V | 1 |
Bhadauria, M; Nirala, SK; Rakshit, S; Sahu, N | 1 |
Asenjo-Redin, B; Mollov, A; Ojer-Zapata, M; Otano-Oroz, L | 1 |
He, W; Liu, D; Ou, X; Pei, S; Song, Z; Wang, S; Xia, H; Xing, R; Zhang, Z; Zhao, B; Zhao, Y | 1 |
Béranger, A; Gegia, M; Linh, NN; Mirzayev, F; Mohamed, A; Nahid, P; Radtke, K; Savic, RM; Schumacher, SG; Solans, BP | 1 |
Hatano, M; Igarashi, M; Kinoshita, N; Matsumoto, S; Matsunaga, S; Ozeki, Y; Samukawa, N; Tokudome, K; Tomita, S; Yamaguchi, T | 1 |
Avihingsanon, A; Balanag, VM; Burhan, E; Chew, KL; Cousins, C; Crook, AM; Dalay, VB; Djaharuddin, I; Kusmiati, T; Lee, SL; Lu, Q; Nunn, AJ; Papineni, P; Paton, NI; Pokharkar, Y; Ruslami, R; Sarin, R; Sekaggya-Wiltshire, C; Sugiri, JJR; Suresh, C; Veto, RS | 1 |
Chen, WY; Chen, YF; Huang, HM; Su, YC; Tsai, JM | 1 |
Gadgil, CJ; Ramachandran, A | 1 |
Cho, YJ; Kim, HJ; Kim, YW; Kwon, BS; Lee, CT; Lee, JH; Lee, YJ; Lim, SY; Park, JS; Song, MJ | 1 |
Arriaga-García, FJ; Herrera-Pérez, IG; Medellín-Garibay, SE; Milán-Segovia, RDC; Ortiz-Álvarez, A; Rodríguez-Báez, AS; Rodríguez-Pinal, CJ; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
Huang, C; Lin, Y; Tong, J; Wang, Y; Xu, B; Xu, Q; Yang, X | 1 |
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
Aalhoul, F; Cotton, F; Fage, D | 1 |
144 review(s) available for ethambutol and rifampin
Article | Year |
---|---|
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Mycobacterium tuberculosis; Rifamycins; Tuberculosis | 2009 |
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Isoniazid derivatives and their anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Isoniazid; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Triazole derivatives and their anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2017 |
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship; Tuberculosis | 2017 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Humans; Structure-Activity Relationship; Tetrazoles | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-resistance in
Topics: | 2019 |
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Tuberculosis | 2021 |
Antitubercular properties of thiazolidin-4-ones - A review.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Thiazolidines; THP-1 Cells; Vero Cells | 2021 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Advances in the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1976 |
The chemotherapy of pulmonary tuberculosis: a review.
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Dropouts; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
Mode of action of anti-tubercular drugs.
Topics: Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1977 |
Diagnosis and management of tuberculosis.
Topics: Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; BCG Vaccine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 1979 |
Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.
Topics: Ethambutol; Humans; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1977 |
[Tuberculosis in infancy nowadays (author's transl)].
Topics: BCG Vaccine; Child; Child, Preschool; Ethambutol; Germany, West; Humans; Infant; Infant, Newborn; Isoniazid; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1978 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver Function Tests; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
Tuberculosis: review of treatment failure, relapse and drug resistance.
Topics: Aminosalicylic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Drug treatment of tuberculous meningitis in childhood. A survey of current practices.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1979 |
Chemotherapy of tuberculosis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1976 |
Diagnosis, prevention and early therapy of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Mycobacterium tuberculosis; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Cardiovascular; Tuberculosis, Female Genital; Tuberculosis, Lymph Node; Tuberculosis, Male Genital; Tuberculosis, Meningeal; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Renal; United States | 1976 |
Case report and review of current treatment methods. Tuberculous spondylitis.
Topics: Adult; Debridement; Ethambutol; Humans; Isoniazid; Male; Rifampin; Spondylitis; Streptomycin; Tuberculosis, Spinal; Wound Healing | 1976 |
Failure of therapy for tuberculosis in human immunodeficiency virus infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 1992 |
[Chemoprophylaxis of tuberculosis (lecture)].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; BCG Vaccine; Child; Ethambutol; Humans; Infant, Newborn; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1992 |
Studies on the role of the mycobacterial cell envelope in the multiple drug resistance of atypical mycobacteria.
Topics: Calorimetry; Cell Membrane; Cell Wall; Drug Interactions; Drug Resistance, Microbial; Ethambutol; Isoniazid; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1991 |
[Genital tuberculosis in women].
Topics: Denmark; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Rifampin; Tuberculosis, Female Genital | 1990 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Contraindications; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1990 |
Adverse cutaneous reactions to antituberculosis drugs.
Topics: Acne Vulgaris; Adult; Amikacin; Antitubercular Agents; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pellagra; Pigmentation Disorders; Prothionamide; Pyrazinamide; Rifampin; Skin Diseases; Streptomycin; Thioacetazone | 1985 |
Chromatographic analysis of antituberculosis drugs in biological samples.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chromatography; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Kinetics; Monitoring, Physiologic; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Viomycin | 1985 |
Pulmonary disease caused by Mycobacterium terrae complex.
Topics: Chronic Disease; Ethambutol; Humans; Klebsiella Infections; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Time Factors | 1989 |
[Which treatment for primary tuberculosis?].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
Antituberculosis agents.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
CNS tuberculosis.
Topics: Biopsy; Cerebral Ventricles; Cerebrospinal Fluid; Ethambutol; Humans; Hyaluronoglucosaminidase; Isoniazid; Nervous System Diseases; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Meningeal | 1986 |
Respiratory pharmacology. Antituberculosis drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cyclosporins; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 1986 |
Contact dermatitis to antituberculosis drugs.
Topics: Aminosalicylic Acid; Antitubercular Agents; Cross Reactions; Dermatitis, Contact; Desensitization, Immunologic; Ethambutol; Humans; Isoniazid; Kanamycin; Rifampin; Skin Tests; Streptomycin | 1986 |
[Treatment of pleuropulmonary tuberculosis in 1985].
Topics: Aminoglycosides; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Thioamides; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1985 |
Tuberculosis--chemotherapy.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Rifampin; Self Medication; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1972 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1971 |
Therapeutics. XVII. "Reserve" drugs in the treatment of tuberculosis.
Topics: Chemical and Drug Induced Liver Injury; Costs and Cost Analysis; Drug Eruptions; Drug Resistance, Microbial; Ethambutol; Humans; Liver; Optic Neuritis; Rifampin; Thioacetazone; Tuberculosis | 1972 |
Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Eruptions; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Pyrazinamide; Rifampin; Skin; Stomatitis; Streptomycin; Thioacetazone; Viomycin | 1972 |
Tuberculosis.
Topics: Aminosalicylic Acids; Bronchitis; Cough; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Mass Screening; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1973 |
[Ocular toxicity of ethambutol].
Topics: Aged; Aminosalicylic Acids; Capreomycin; Chemical Phenomena; Chemistry; Color Perception; Drug Therapy, Combination; Ethambutol; Eye; Eye Diseases; Female; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary; Visual Acuity; Visual Fields | 1971 |
[Modern view points on the therapy of urogenital tuberculosis].
Topics: Antitubercular Agents; Capreomycin; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Kidney Function Tests; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nephrectomy; Rifampin; Tuberculosis, Urogenital | 1973 |
[Proceedings: Tuberculosis therapy. Review on today's knowledge, developmental trends and still open problems].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Germany, West; Humans; Isoniazid; Length of Stay; Rifampin; Streptomycin; Tuberculosis | 1973 |
New trends in the chemotherapy of tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Tuberculosis | 1974 |
The impact of chemotherapy on the care of patients with tuberculosis.
Topics: Antitubercular Agents; Aspirin; Bacteriological Techniques; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Length of Stay; Mycobacterium tuberculosis; Outpatient Clinics, Hospital; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Neuro-tuberculosis, An unsolved problem.
Topics: Adrenal Cortex Hormones; Brain Edema; Cerebral Angiography; Developing Countries; Ethambutol; Humans; India; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thailand; Tuberculosis, Meningeal | 1974 |
[Modern treatment of skin tuberculosis].
Topics: Cycloserine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Skin; Streptomycin; Time Factors; Tuberculosis, Cutaneous | 1974 |
Advances in the treatment of respiratory disorders.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aerosols; Asthma; Bronchitis; Chromones; Chronic Disease; Ethambutol; Humans; Mycoplasma Infections; Respiratory Insufficiency; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Tuberculosis; Tuberculosis, Pulmonary; Virus Diseases | 1969 |
[Current status of the antitubercular chemotherapy].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Isonicotinic Acids; Microbial Sensitivity Tests; Prognosis; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Chemoprevention and preventive chemotherapy of tuberculosis in adulthood (Review)].
Topics: Adult; Amides; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; False Negative Reactions; Female; Humans; Isoniazid; Isonicotinic Acids; Male; Placebos; Pregnancy; Recurrence; Rifampin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
Rifampin.
Topics: Adult; Aged; Animals; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Jaundice; Male; Mice; Middle Aged; Mycobacterium tuberculosis; Pregnancy; Rifampin; Thrombocytopenia; Tuberculosis, Pulmonary | 1972 |
Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
Topics: Aminosalicylic Acids; Animals; Culture Media; Ethambutol; Follow-Up Studies; Guinea Pigs; Half-Life; Humans; Isoniazid; Mycobacterium tuberculosis; Rabbits; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
New chemotherapeutic drugs and their associations.
Topics: Antitubercular Agents; Ethambutol; Humans; Phenylthiourea; Rifampin; Tuberculosis, Pulmonary | 1967 |
[Experimental chemotherapy of tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1969 |
[New drugs in antitubercular therapy].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; RNA Nucleotidyltransferases; Tuberculosis; Tuberculosis, Pulmonary | 1969 |
The John Barnwell Lecture. The chemotherapy of bacterial respiratory infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Bronchitis; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Pneumonia; Respiratory Tract Infections; Rifampin; Tuberculosis, Pulmonary | 1970 |
[Drug therapy of tuberculosis in the child].
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Female; Germany, West; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
[New anti-tubercular agents--rifampicin and ethambutol].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Guinea Pigs; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[New antitubercular drugs and their clinical use].
Topics: Administration, Oral; Age Factors; Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Fasting; Humans; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1971 |
Clinical pharmacology of antitubercular drugs.
Topics: Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Infant; Isoniazid; Rifampin | 1983 |
Pregnancy and tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Infant, Newborn; Isoniazid; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1984 |
Aging and tuberculosis.
Topics: Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital; United States | 1984 |
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
[Treatment of tuberculous meningitis in adults: current trends and problems].
Topics: Aminosalicylic Acid; Antitubercular Agents; Blood-Brain Barrier; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Injections, Spinal; Isoniazid; Optic Neuritis; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1982 |
Treatment of tuberculosis. The Mitchell lecture 1979.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Antituberculous drugs.
Topics: Antitubercular Agents; Chemical Phenomena; Chemistry; Ethambutol; Humans; Isoniazid; Kinetics; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
Tuberculosis.
Topics: Alcohol Drinking; Carrier State; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1980 |
Treatment of tuberculosis during pregnancy.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Hearing Disorders; Humans; Isoniazid; Limb Deformities, Congenital; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Tuberculous liver abscess treated by percutaneous infusion of antituberculous agents.
Topics: Administration, Cutaneous; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Liver Abscess; Middle Aged; Peritonitis, Tuberculous; Rifampin; Tuberculosis, Hepatic | 1994 |
[Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient].
Topics: AIDS-Related Opportunistic Infections; Ciprofloxacin; Drug Therapy, Combination; Esophageal Fistula; Ethambutol; Fistula; HIV-1; Humans; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1994 |
Mycobacterium marinum skin infections. Report of 31 cases and review of the literature.
Topics: Adult; Aged; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Bacterial | 1994 |
Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Cycloserine; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Mycobacterium tuberculosis; Rifampin | 1993 |
Outpatient management of tuberculosis.
Topics: Algorithms; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mass Screening; Population Surveillance; Pyrazinamide; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary; United States | 1996 |
Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin | 1997 |
New horizons in the treatment of tuberculosis.
Topics: Animals; Drug Design; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycolic Acids; Pyrazinamide; Rifampin; Tuberculosis | 1997 |
[Antitubercular chemotherapy].
Topics: Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Combinations; Ethambutol; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Patient Compliance; Patient Education as Topic; Pyrazinamide; Rifampin; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Short-course chemotherapy of tuberculosis with pyrazinamide].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1998 |
Mycobacterium malmoense infection. An unusual cause of wrist swelling.
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy, Needle; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tenosynovitis; Wrist | 1998 |
Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol.
Topics: Adolescent; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections; Nontuberculous Mycobacteria; Rifampin | 1999 |
[Molecular mechanisms of drug resistance of Mycobacterium tuberculosis].
Topics: Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Drug Resistance, Multiple; Ethambutol; Ethionamide; Fluoroquinolones; Genes, Bacterial; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymorphism, Genetic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Virulence | 1998 |
Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis, Tuberculous; Pyrazinamide; Rifampin | 2000 |
A current approach to the management of tuberculosis infection.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; BCG Vaccine; Ethambutol; Forecasting; Humans; Immunocompetence; Isoniazid; Mass Screening; Patient Compliance; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2000 |
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2001 |
Tubercular laryngeal abscess.
Topics: Abscess; Adult; Antitubercular Agents; Cefotaxime; Diclofenac; Drainage; Ethambutol; Humans; Hydrocortisone; Isoniazid; Laryngoscopy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Laryngeal | 2001 |
A hoarse voice: atypical mycobacterial infection of the larynx.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hoarseness; Humans; Isoniazid; Laryngeal Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyridoxine; Rifampin; Sputum; Staining and Labeling | 2001 |
Primary lingual tuberculosis: a case report with review of literature.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tongue Diseases; Tongue Neoplasms; Tuberculosis, Oral | 2002 |
[Resistant tuberculosis: a molecular review].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2002 |
[Tuberculosis].
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Ethambutol; France; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 2002 |
[Tuberculous pneumonia in children].
Topics: Administration, Oral; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Diagnosis, Differential; Ethambutol; Humans; Injections, Intravenous; Isoniazid; Lithuania; Male; Mycobacterium tuberculosis; Radiography, Thoracic; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2003 |
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin | 2003 |
[A case of successful desensitization therapy for isoniazid-induced pneumonitis].
Topics: Aged; Antibiotics, Antitubercular; Antitubercular Agents; Desensitization, Immunologic; Ethambutol; Humans; Isoniazid; Male; Pneumonia; Rifampin; Tuberculosis, Pulmonary | 2004 |
[Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Notification; Drug Therapy, Combination; Ethambutol; Female; Germany; Humans; Immunocompromised Host; Isoniazid; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Patient Isolation; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node | 2005 |
[Nontuberculous mycobacteria in cystic fibrosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2005 |
[Case of endometrial tuberculosis].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Endometrium; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Female Genital; Uterine Diseases; Vaginal Discharge | 2005 |
Mycobacterium marinum infection: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Forearm; Hand Dermatoses; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin Diseases, Bacterial | 2007 |
[Perspective of pulmonary MAC infection treatment].
Topics: Aminoglycosides; Antitubercular Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Evidence-Based Medicine; Humans; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2007 |
Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.
Topics: Aged; Antitubercular Agents; Central Nervous System Bacterial Infections; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Lymphadenitis; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Skin Diseases, Bacterial | 2007 |
Diffuse pachymeningitis due to Mycobacterium tuberculosis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Meningitis; Mycobacterium tuberculosis; Prednisone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2008 |
Diagnosis and treatment of infections due to Mycobacterium avium complex.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2008 |
Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review.
Topics: Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pacemaker, Artificial; Recurrence; Rifampin; Surgical Wound Infection; Tomography, X-Ray Computed; Tuberculosis | 2009 |
Tuberculous orchiepididymitis during 1978-2003 period: review of 34 cases and role of 16S rRNA amplification.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Combined Modality Therapy; Comorbidity; Epididymitis; Ethambutol; Exudates and Transudates; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Orchitis; Prostatitis; Pyrazinamide; Retrospective Studies; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Scrotum; Spain; Tuberculosis, Male Genital; Tuberculosis, Renal; Urine | 2010 |
Bronchiectatic air bronchograms in pulmonary tuberculosis: a case report and literature review.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bronchiectasis; Bronchoalveolar Lavage; Bronchoscopy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 2010 |
Primary tuberculosis of the TMJ: presentation of a case and literature review.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Temporomandibular Joint; Temporomandibular Joint Disorders; Treatment Outcome; Tuberculosis, Osteoarticular; Young Adult | 2010 |
[Not just a success story. On the history of tuberculosis treatment].
Topics: Antitubercular Agents; Ethambutol; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Medieval; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculin; Tuberculosis | 2012 |
Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; Pyrazinamide; Retreatment; Rifampin; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Non-tuberculous mycobacteria in cystic fibrosis.
Topics: Anti-Bacterial Agents; Comorbidity; Cystic Fibrosis; Drug Therapy, Combination; Ethambutol; Female; Humans; Macrolides; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prognosis; Respiratory Function Tests; Rifampin; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2012 |
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2013 |
[Tubercular abscess of the chest wall in the child].
Topics: Abscess; Adolescent; Antitubercular Agents; Biopsy; Combined Modality Therapy; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompetence; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sternum; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular | 2013 |
Isolated tuberculous liver abscess in an immunocompetent adult patient: A case report and literature review.
Topics: Aged; Antitubercular Agents; Biopsy; Blood Chemical Analysis; Drug Combinations; Ethambutol; Humans; Isoniazid; Laparotomy; Liver; Liver Abscess; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?
Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; Antitubercular Agents; Child; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Topics: Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Evolution, Chemical; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antitubercular Agents; Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Humans; Maintenance Chemotherapy; Methylprednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rifabutin; Rifampin; Secondary Prevention | 2016 |
Six-month therapy for abdominal tuberculosis.
Topics: Abdomen; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Time Factors; Tuberculosis, Gastrointestinal | 2016 |
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment.
Topics: Adolescent; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Ethambutol; Feasibility Studies; Female; Fluoroquinolones; Graft Rejection; Humans; Isoniazid; Liver Failure, Acute; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prognosis; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
Anti-tuberculosis drug resistance in Ethiopia: systematic review.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Prevalence; Public Health; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2017 |
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Antibiotics, Antitubercular; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Observational Studies as Topic; Outcome Assessment, Health Care; Pyrazinamide; Randomized Controlled Trials as Topic; Review Literature as Topic; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Mycobacterium Avium complex vertebral osteomyelitis in the absence of HIV infection: a case report and review.
Topics: Abscess; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Lumbosacral Region; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifampin | 2018 |
Development of new drug-regimens against multidrug-resistant tuberculosis.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Pharmacokinetics of First-Line Anti-Tubercular Drugs.
Topics: Age Factors; Antitubercular Agents; Child; Drug Overdose; Ethambutol; Food; Genotype; HIV Infections; Humans; Isoniazid; Malnutrition; Nutritional Status; Polymorphism, Genetic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2019 |
Female genital tuberculosis: Revisited.
Topics: Biopsy; Endoscopy; Ethambutol; Fallopian Tubes; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Rifampin; Tuberculosis, Female Genital | 2018 |
Severe disseminated tuberculosis in HIV-negative refugees.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Ethambutol; Fluorine Radioisotopes; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Pyrazinamide; Refugees; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Tuberculous meningitis in children: Clinical management & outcome.
Topics: Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Mycobacterium tuberculosis; Rifampin; Steroids; Treatment Outcome; Tuberculosis, Meningeal | 2019 |
Tuberculosis treatment in children: The changing landscape.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Central Nervous System; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2020 |
Diagnostic Challenges and Dilemmas in Tuberculous Meningitis.
Topics: Adult; Antitubercular Agents; Asthma; Ethambutol; Female; Headache; Hospitalization; Humans; Hydrocephalus; Isoniazid; Leukocytosis; Magnetic Resonance Imaging; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Somalia; Spinal Puncture; Tuberculosis, Meningeal; United States; Vision Disorders | 2020 |
Tuberculosis in 2019.
Topics: Antitubercular Agents; Ethambutol; Health Policy; Humans; India; Isoniazid; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Practice Guidelines as Topic; Pulmonologists; Pyrazinamide; Rifampin; Surveys and Questionnaires; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2020 |
Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review.
Topics: Antitubercular Agents; Blindness; Brain; Brain Diseases; Cerebellar Ataxia; Dexamethasone; Drug Therapy, Combination; Endemic Diseases; Ethambutol; Female; Glucocorticoids; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Nausea; Nystagmus, Pathologic; Peru; Pyrazinamide; Quadriplegia; Rifampin; Tomography, X-Ray Computed; Tuberculoma, Intracranial; Tuberculosis, Pulmonary; Vomiting; Young Adult | 2020 |
Mycobacterium marinum infection simulating chromomycosis: a case report.
Topics: Animals; Chromoblastomycosis; Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tenosynovitis | 2021 |
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance.
Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2022 |
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients.
Topics: Antitubercular Agents; Drug Resistance; Ethambutol; Humans; Isoniazid; Lasers; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin | 2023 |
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Ethambutol; HIV; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
266 trial(s) available for ethambutol and rifampin
Article | Year |
---|---|
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Radiography, Thoracic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Ethambutol plus isoniazid compared with rifampicin plus isoniazid in antituberculosis continuation treatment.
Topics: Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
The chemotherapy of pulmonary tuberculosis: a review.
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Patient Dropouts; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Infant, Newborn; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
[Bacteriostatic activity of the blood in pulmonary tuberculosis and its clinical significance].
Topics: Blood Bactericidal Activity; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1979 |
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1979 |
Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[Hepatoxic side-effects of rifampicin. A comparative clinical study].
Topics: Alanine Transaminase; Alcoholism; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Topics: Acetylation; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver Function Tests; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Hong Kong; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Treatment of open cavernous pulmonary tuberculosis (author's transl)].
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1979 |
[A pilot and a controlled study of the influence of ethambutol on serum urate concentration and uric acid clearance (author's transl)].
Topics: Alcoholism; Body Weight; Creatinine; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Uric Acid | 1979 |
Lymph node tuberculosis: a comparison of various methods of treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1977 |
Rifampicin in the treatment of tuberculous meningitis.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Male; Middle Aged; Rifampin; Tuberculosis, Meningeal | 1978 |
A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.
Topics: Antibody Formation; Body Weight; Clinical Trials as Topic; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1975 |
A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.
Topics: Age Factors; Clinical Trials as Topic; Ethambutol; Follow-Up Studies; Humans; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1976 |
Short-duration treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Dropouts; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
[Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1977 |
[Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
Topics: Chronic Disease; Drug Therapy, Combination; Ethambutol; Humans; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1976 |
Some aspects of tuberculous meningitis in Surabaya.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Indonesia; Infant; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1976 |
Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
Topics: ABO Blood-Group System; Blood Cell Count; China; Clinical Trials as Topic; Cycloserine; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Ethionamide; Hematocrit; Hemoglobins; Hong Kong; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1975 |
A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Purpura; Rifampin; Sputum; Tuberculosis, Pulmonary; Vision Disorders | 1975 |
Proceedings: Short course chemotherapy in pulmonary tuberculosis: a controlled trial by the British Thoracic and Tuberculosis Association. (A report from one of the three clinical co-ordinators).
Topics: Clinical Trials as Topic; Drug Evaluation; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1975 |
A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1992 |
Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1992 |
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amikacin; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 1992 |
[Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.
Topics: Adult; Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Data Interpretation, Statistical; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Multicenter Studies as Topic; Patient Compliance; Proportional Hazards Models; Pyrazinamide; Randomized Controlled Trials as Topic; Recurrence; Rifampin; Sputum; Survival Rate; Tuberculosis, Pulmonary; United States | 1990 |
The treatment of superficial tuberculous lymphadenitis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lymph Nodes; Prospective Studies; Rifampin; Tuberculosis, Lymph Node | 1990 |
Intracranial tuberculomas. An assessment of a therapeutic 4-drug trial in 35 children.
Topics: Adolescent; Antitubercular Agents; Brain Diseases; Child; Child, Preschool; Combined Modality Therapy; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1989 |
Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
Topics: Antiprotozoal Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Leishmaniasis, Visceral; Male; Metronidazole; Random Allocation; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Prospective Studies; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1989 |
Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis.
Topics: Adolescent; Child; Dapsone; Drug Combinations; Ethambutol; Female; Humans; Hypersensitivity, Delayed; Isoniazid; Male; Placebos; Prothionamide; Random Allocation; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1989 |
Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Random Allocation; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1985 |
Adrenal function in tuberculosis.
Topics: Acute Disease; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Hydrocortisone; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1988 |
Short course chemotherapy for lymph node tuberculosis: final report at 5 years. British Thoracic Society Research Committee.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Random Allocation; Rifampin; Tuberculosis, Lymph Node | 1988 |
Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Prothionamide; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Three chemotherapy studies of tuberculous meningitis in children.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1986 |
[Which is the best drug combination for the short-term therapy of tuberculosis? A prospective randomized study with 190 patients].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Prospective Studies; Pyrazinamide; Random Allocation; Rifampin; Tuberculosis, Pulmonary | 1985 |
[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1985 |
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1985 |
Rifampicin, myambutol, Isoxyl, and capreomycin as combination partners in animal experiments.
Topics: Animals; Antitubercular Agents; Capreomycin; Clinical Trials as Topic; Drug Combinations; Ethambutol; Mycobacterium Infections; Phenylthiourea; Rabbits; Rifampin; Tuberculosis | 1970 |
General considerations in intermittent drug therapy of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1971 |
Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of 2 years chemotherapy.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antitubercular Agents; Bilirubin; Capreomycin; Clinical Trials as Topic; Ethambutol; Female; Humans; Hypokalemia; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Potassium; Rifampin; Sputum; Tuberculosis, Pulmonary; Vision Disorders; Visual Acuity | 1972 |
[New antitubercular agents and their use in osteoarticular tuberculosis].
Topics: Antitubercular Agents; Capreomycin; Clinical Trials as Topic; Ethambutol; Rifampin; Tuberculosis, Osteoarticular | 1973 |
Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1974 |
Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Radiography; Rifampin; Skin Diseases; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1973 |
Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
Topics: Adolescent; Adult; Alanine Transaminase; Bacteriological Techniques; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leukocyte Count; Liver; Male; Middle Aged; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thioc
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Gastrointestinal Diseases; Humans; Isoniazid; Mycobacterium tuberculosis; Phenylthiourea; Pyridoxine; Recurrence; Rifampin; Streptomycin; Thrombocytopenia; Time Factors; Tuberculosis, Pulmonary | 1974 |
Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.
Topics: Alanine Transaminase; Antitubercular Agents; Bone Diseases; Chemical and Drug Induced Liver Injury; Colic; Drug Eruptions; Dyspnea; Ethambutol; Fever; Hong Kong; Humans; Jaundice; Purpura; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Co
Topics: Adolescent; Adult; Antibodies; Clinical Trials as Topic; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Dyspnea; Ethambutol; Female; Humans; Jaundice; Male; Middle Aged; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1974 |
Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis.
Topics: Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Phenylthiourea; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1968 |
The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Finland; Humans; Rifampin; Sputum; Tuberculosis, Pulmonary; Viomycin | 1969 |
[Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
Topics: Ethambutol; Humans; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary; Viomycin | 1971 |
Drug-induced heart failure in advanced pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Heart Failure; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Side effects of intermittent rifampicin.
Topics: Clinical Trials as Topic; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Rifampicin in the treatment of lung and kidney tuberculosis].
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Tuberculosis, Renal | 1972 |
Rifampicin blood serum levels and half-life during prolonged administration in tuberculous patients.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Analysis of Variance; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; Half-Life; Humans; Isoniazid; Kinetics; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Argentina; Clinical Trials as Topic; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prognosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
Topics: Administration, Oral; Adult; Age Factors; Alanine Transaminase; Clinical Trials as Topic; Drug Combinations; Drug Tolerance; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Sex Factors; Time Factors; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1972 |
[Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Estriol; Estrogens; Estrone; Ethambutol; Ethinyl Estradiol; Female; Humans; Isoniazid; Menstruation Disturbances; Pregnancy; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Editorial: Rifampicin or ethambutol in the routine treatment of tuberculosis.
Topics: Clinical Trials as Topic; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
Topics: Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Ethambutol; Humans; Isoniazid; Methods; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Topics: Antibody Formation; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kidney Function Tests; Liver Function Tests; Purpura, Thrombocytopenic; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Fate of patients treated with myambutol and Rifadin in the period of 1967-1969].
Topics: Chronic Disease; Clinical Trials as Topic; Ethambutol; Humans; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Yugoslavia | 1974 |
[Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
Topics: Adult; Antitubercular Agents; Brazil; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Male; Pilot Projects; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Humans; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Topics: Clinical Trials as Topic; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Fever; Gastrointestinal Diseases; Humans; Jaundice; Purpura, Thrombocytopenic; Respiratory Insufficiency; Rifampin; Skin Manifestations; Time Factors; Tuberculosis, Pulmonary | 1974 |
A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Cycloserine; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Hong Kong; Humans; Male; Microbial Sensitivity Tests; Pyrazinamide; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1974 |
A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy in Hong Kong: second report:-the results at 12 months.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Female; Hong Kong; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1974 |
A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
Topics: Adult; Alanine Transaminase; Antibodies; Ethambutol; Female; Fever; Humans; Jaundice; Male; Middle Aged; Nausea; Pain; Placebos; Pyrazinamide; Respiratory Tract Diseases; Rifampin; Skin Manifestations; Tuberculosis, Pulmonary | 1974 |
Methods of clinical evaluation of rifampicin-activity.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
[Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
Topics: Body Weight; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1969 |
Capreomycin, ethambutol and rifampicin. Clinical experience in Manchester.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Hypersensitivity; Drug Resistance, Microbial; England; Ethambutol; Humans; Hypocalcemia; Hypokalemia; Isoniazid; Kidney Diseases; Labyrinth Diseases; Magnesium; Rifampin; Streptomycin; Vision Disorders; Water-Electrolyte Balance | 1969 |
Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
Topics: Aged; Aminosalicylic Acids; Anti-Bacterial Agents; Berlin; Clinical Trials as Topic; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Hypocalcemia; Hypokalemia; Kidney Diseases; Middle Aged; Rifampin; Tetracycline; Tuberculosis, Pulmonary; Urea; Vision Disorders | 1969 |
Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Finland; Hearing Disorders; Humans; Kidney Diseases; Male; Middle Aged; Pneumothorax; Rifampin; Tuberculosis, Pulmonary; Vision Disorders | 1969 |
Preliminary results of the Norwegian coordinated therapy project 1968-1969.
Topics: Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Ethambutol; Exanthema; Humans; Norway; Rifampin; Vestibule, Labyrinth; Vision Disorders | 1969 |
Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis.
Topics: Adult; Aged; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Eosinophilia; Ethambutol; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary; Uric Acid; Vision Disorders | 1969 |
Hospital-based ambulatory treatment of tuberculosis with capreomycin, ethambutol, and-or rifampicin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Clinical Trials as Topic; Ethambutol; Finland; Humans; Physician-Patient Relations; Rifampin; Tuberculosis | 1969 |
A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. Preliminary results of the third cooperative study of the WATL.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
[Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
Topics: Adult; Antitubercular Agents; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Ethambutol; Female; Humans; Isonicotinic Acids; Male; Middle Aged; Rifampin; Tuberculosis | 1969 |
[Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
Topics: Adolescent; Adult; Aged; Algeria; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Ethambutol; Humans; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Computer-aided procedures in a multi-centre co-operative controlled clinical trial in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Computers; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Laboratories; Medical Records; Methods; Organization and Administration; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; United Kingdom | 1971 |
Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Liver; Pilot Projects; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1968 |
Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Clinical Trials as Topic; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Leukocyte Count; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Pain; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States; United States Public Health Service; Vertigo | 1971 |
Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Body Weight; Ethambutol; Ethionamide; Female; Hemoglobins; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
[Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
Topics: Adolescent; Adult; Aminosalicylic Acids; Blood Proteins; Drug Synergism; Ethambutol; Female; Humans; Kidney; Liver; Male; Middle Aged; Rifampin; Transaminases; Tuberculosis, Pulmonary | 1968 |
[Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
Topics: Adult; Body Weight; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1970 |
A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Liver Function Tests; Male; Rifampin; Tuberculosis, Pulmonary | 1971 |
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report).
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Recurrence; Remission, Spontaneous; Rifampin; Societies, Medical; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1980 |
Controlled trial of rifampicin and ethambutol in Crohn's disease.
Topics: Adult; Clinical Trials as Topic; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin | 1984 |
[Long-term results of a trial of short-term chemotherapy. French study 6.9.12].
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1983 |
[Short-term chemotherapy of tuberculosis. Cooperative French trial].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Random Allocation; Rifampin; Tuberculosis, Pulmonary; United States | 1984 |
Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
Topics: Adolescent; Adult; Algeria; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Rural Population; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Team-controlled study the effectiveness of chemotherapy with outpatients with fibrous-cavitary tuberculosis].
Topics: Ambulatory Care; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1984 |
A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1983 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Cooperative clinical trials of efficacy of chemotherapy of patients with fibro-cavernous tuberculosis].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Middle Aged; Rifampin; Tuberculosis, Pulmonary; USSR | 1982 |
[Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1980 |
A controlled trial of individually-adapted short-course chemotherapy versus two-year scheme in original treatment of pulmonary tuberculosis. Report after a five-year follow-up.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Intravenous rifampicin therapy in open tuberculosis].
Topics: Administration, Oral; Adult; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Injections, Intravenous; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1980 |
Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Intensive chemotherapy of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
[Complex hospital treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Poland; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
BTA short-course chemotherapy studies.
Topics: Clinical Trials as Topic; Ethambutol; Female; Hepatitis; Humans; Isoniazid; Liver Function Tests; Male; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; United Kingdom | 1981 |
Short-course chemotherapy. The Arkansas experience.
Topics: Adolescent; Adult; Aged; Arkansas; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1981 |
Nine-month chemotherapy for pulmonary tuberculosis.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Self Administration; Tuberculosis, Pulmonary | 1982 |
Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Topics: Adolescent; Adult; Aged; Alcoholism; Clinical Trials as Topic; Denmark; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1982 |
Chemotherapy for tuberculosis today.
Topics: Antitubercular Agents; Clinical Trials as Topic; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1982 |
Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Rifampin; Tuberculosis, Pulmonary | 1980 |
Factors influencing the effects of the initial phase of tuberculosis chemotherapy.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
Topics: Administration, Oral; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1994 |
Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Patient Compliance; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis | 1994 |
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1995 |
[Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV-1; Humans; Isoniazid; Los Angeles; Male; Mycobacterium tuberculosis; Patient Compliance; Prospective Studies; Pyrazinamide; Remission Induction; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1994 |
[Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clofazimine; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1994 |
Transient bacteremia due to Mycobacterium avium complex in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Life Tables; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifampin; Risk Factors; Survival Analysis | 1994 |
Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Crohn Disease; Dapsone; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Prospective Studies; Rifampin; Time Factors | 1994 |
Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.
Topics: Adolescent; Adult; Aged; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prednisolone; Rifampin; Time Factors; Treatment Outcome | 1994 |
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1993 |
[Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Topics: Antitubercular Agents; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1993 |
Controlled trial of short-course regimens of chemotherapy in the ambulatory treatment of spinal tuberculosis. Results at three years of a study in Korea. Twelfth report of the Medical Research Council Working Party on Tuberculosis of the Spine.
Topics: Adolescent; Adult; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Humans; Infant; Isoniazid; Longitudinal Studies; Middle Aged; Rifampin; Time Factors; Tuberculosis, Spinal | 1993 |
Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1993 |
Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Bacteremia; Clofazimine; Ethambutol; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1996 |
Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; Clofazimine; Colony Count, Microbial; Disease Models, Animal; Ethambutol; Humans; Liver; Mice; Mycobacterium avium-intracellulare Infection; Rifampin; Species Specificity; Spleen | 1996 |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors; Rifabutin; Rifampin; Streptomycin; Treatment Outcome | 1996 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
[Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Increased incidence of tuberculosis in patients undergoing hemodialysis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Cavity; Prognosis; Radiography; Renal Dialysis; Rifampin; Tuberculosis, Pulmonary | 1996 |
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Capsules; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Rifampin; Single-Blind Method; Tablets | 1995 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis | 1997 |
Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Gastrointestinal | 1997 |
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1997 |
Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bronchoscopy; Chi-Square Distribution; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Isoniazid; Lung; Male; Middle Aged; Prednisolone; Prospective Studies; Pyrazinamide; Radiography; Respiratory Function Tests; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1997 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1998 |
[Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1997 |
Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council W
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acid; Antitubercular Agents; Bone Transplantation; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Osteotomy; Radiography; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Spinal | 1999 |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Ethambutol; Female; Fluoroquinolones; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Survival Analysis; Treatment Outcome | 1999 |
[Results of treating patients with mycobacterial respiratory infections negative for HIV virus (retrospective study)].
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Treatment Outcome | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Time Factors; Treatment Outcome | 2000 |
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Opportunistic Infections; Prospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Topics: Adolescent; Adult; Antitubercular Agents; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Urban Health; World Health Organization | 2000 |
[Roxithromycin therapy of patients with mycobacterium avium complex lung infection].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Roxithromycin; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
Topics: Antibiotics, Antitubercular; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Colorimetry; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Quality Control; Reference Values; Rifampin; Therapeutic Equivalency; Tuberculosis; Urinalysis | 2001 |
Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Desensitization, Immunologic; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome; Treatment Outcome; Tuberculosis | 2001 |
Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Topics: Adolescent; Adult; Antitubercular Agents; Clinical Protocols; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Nigeria; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2002 |
Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Radiography, Thoracic; Rifampin; Sputum; Treatment Outcome | 2002 |
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
Topics: Analysis of Variance; Antibiotics, Antitubercular; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Therapeutic Equivalency; Time Factors; Tuberculosis | 2002 |
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore.
Topics: Adult; Antitubercular Agents; Dizziness; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Gastritis; Humans; Hypesthesia; Isoniazid; Male; Nausea; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2002 |
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Radiography; Recurrence; Rifampin; Sputum; Survival Analysis; Treatment Outcome | 2003 |
The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Topics: Adult; Aged; Antitubercular Agents; Bronchodilator Agents; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Theophylline; Time Factors; Tuberculosis, Pulmonary | 2003 |
Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol.
Topics: Administration, Oral; Adult; Analysis of Variance; Antitubercular Agents; Area Under Curve; Chemistry, Pharmaceutical; Clinical Protocols; Cross-Over Studies; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Ethambutol; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Therapeutic Equivalency; World Health Organization | 2003 |
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2003 |
[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 2003 |
Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2004 |
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Topics: Acetylation; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Ethambutol; Feces; Female; HIV Infections; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Phenotype; Pyrazinamide; Rifampin; Tuberculosis | 2004 |
[Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
Topics: Administration, Oral; Antitubercular Agents; Diabetes Complications; Ethambutol; Humans; Hypoglycemic Agents; Injections, Intralymphatic; Injections, Intramuscular; Insulin; Isoniazid; Liver Diseases; Lymphatic System; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2004 |
Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
Topics: Acne Vulgaris; Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 2004 |
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Therapeutic Equivalency; Tuberculosis | 2005 |
The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Half-Life; HIV Infections; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 2005 |
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Bronchiectasis; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Antitubercular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Eye Diseases; Female; Humans; Male; Microbial Sensitivity Tests; Recurrence; Retrospective Studies; Rifampin; Tuberculosis | 2007 |
Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Linear Models; Male; Mass Spectrometry; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 2007 |
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunotherapy; Male; Middle Aged; Opportunistic Infections; Rifampin; Tuberculosis, Pulmonary | 2008 |
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antitubercular Agents; Body Composition; Drug Therapy, Combination; Ethambutol; HIV Infections; HIV Seronegativity; Humans; Hypoalbuminemia; India; Isoniazid; Malnutrition; Nutritional Status; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Educational Status; Employment; Ethambutol; Humans; Isoniazid; Middle Aged; Pakistan; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2008 |
[Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Self Administration; Tuberculosis, Pulmonary | 2008 |
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Body Weight; Chemical and Drug Induced Liver Injury; Curcuma; Drug Therapy, Combination; Ethambutol; Female; Hemoglobins; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Patient Compliance; Plant Preparations; Pyrazinamide; Rifampin; Tinospora; Treatment Outcome; Tuberculosis | 2008 |
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Topics: Adult; Antitubercular Agents; Aza Compounds; Brazil; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Moxifloxacin; Multivariate Analysis; Pyrazinamide; Quinolines; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Patient Satisfaction; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Proportional Hazards Models; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Gastrointestinal; Young Adult | 2009 |
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Pyrazinamide; Rifampin; Tuberculosis; Viral Load | 2010 |
Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Directly Observed Therapy; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis; Young Adult | 2009 |
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Ethambutol; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Uganda; Viral Load; Young Adult | 2010 |
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Free Radical Scavengers; Humans; Isoniazid; Liver; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2010 |
Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Combinations; Ethambutol; Follow-Up Studies; Humans; Liver Diseases; Liver Function Tests; Middle Aged; Phytotherapy; Plant Preparations; Plants, Medicinal; Prospective Studies; Pyrazinamide; Rifampin; Single-Blind Method; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2010 |
Genital tuberculosis among infertile women and fertility outcome after antitubercular therapy.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Fertilization; Humans; Infertility, Female; Isoniazid; Laparoscopy; Polymerase Chain Reaction; Pregnancy; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Female Genital | 2011 |
Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2011 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Intention to Treat Analysis; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary; World Health Organization; Young Adult | 2011 |
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2012 |
Phase II dose-ranging trial of the early bactericidal activity of PA-824.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2012 |
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Organophosphonates; Oxazines; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.
Topics: Antimalarials; Bacterial Load; Bacteriological Techniques; Diagnostic Techniques, Respiratory System; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Topics: Adult; Antitubercular Agents; Area Under Curve; China; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Therapeutic Equivalency | 2013 |
Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
Topics: Adult; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Dietary Supplements; Drug Therapy, Combination; Ethambutol; Female; Guinea-Bissau; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Rifampin; RNA, Viral; Tuberculosis, Pulmonary; Vitamin D; Young Adult | 2013 |
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Azithromycin; CD4-Positive T-Lymphocytes; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Sarcoidosis; Severity of Illness Index; Single-Blind Method; Skin Diseases; Transcriptome; Treatment Outcome; Young Adult | 2013 |
Bioequivalence of fixed-dose combination Myrin®-P Forte and reference drugs in loose combination.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Ethambutol; Fasting; Female; Healthy Volunteers; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Singapore; Therapeutic Equivalency; Young Adult | 2013 |
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).
Topics: Administration, Oral; Administration, Rectal; Animals; Antitubercular Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Elephants; Ethambutol; Female; Isoniazid; Male; Pyrazinamide; Rifampin | 2014 |
Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspirin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Prednisolone; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2014 |
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Topics: Adult; Ambulatory Care Facilities; Antitubercular Agents; Canada; Directly Observed Therapy; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis; United States | 2014 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis.
Topics: Africa; Antitubercular Agents; Asia; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Latin America; Male; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Disinfection; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Sterilization; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial.
Topics: Adolescent; Antitubercular Agents; Body Height; Body Mass Index; Body Weight; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Ethambutol; Female; Humans; India; Infant; Isoniazid; Male; Micronutrients; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Zinc | 2014 |
A four-month gatifloxacin-containing regimen for treating tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Glucose; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Intention to Treat Analysis; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2014 |
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Clarithromycin; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Practice Guidelines as Topic; Republic of Korea; Retrospective Studies; Rifampin; Sputum | 2015 |
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Bacterial Load; Drug Dosage Calculations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2015 |
A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Drug Users; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Rifampin; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Tuberculosis | 2015 |
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pul
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Rifampin; South Africa; Sputum; Tanzania; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Effects on type 2 diabetes complicated with pulmonary tuberculosis: regiment of insulin, isoniazid, rifampicin, pyrazinamide and ethambutol versus the regiment plus Qi-boosting and Yin-nourishing decoction of Traditional Chinese Medicine.
Topics: Adult; Aged; Antitubercular Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethambutol; Female; Humans; Hypoglycemic Agents; Insulin; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2015 |
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Rifampin; Young Adult | 2015 |
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Coinfection; Ethambutol; Female; Gene Expression; HIV Infections; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Monte Carlo Method; Organic Anion Transporters; Polymorphism, Single Nucleotide; Pyrazinamide; Rifabutin; Rifampin; Sex Factors; Tuberculosis, Pulmonary | 2016 |
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Topics: Anti-Bacterial Agents; Area Under Curve; Coinfection; Drug Dosage Calculations; Ethambutol; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2016 |
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
Topics: Antitubercular Agents; Decision Support Techniques; Ethambutol; Humans; Isoniazid; Markov Chains; Pyrazinamide; Recurrence; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2016 |
Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Disability Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Pyrazinamide; Rifampin; Seizures; Time Factors; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2016 |
Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.
Topics: Adult; Africa; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
Topics: Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Ethambutol; Female; Healthy Volunteers; Humans; Isoniazid; Male; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2016 |
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Drug Administration Schedule; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Models, Statistical; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum | 2016 |
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Topics: Adamantane; Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Ethylenediamines; Female; Fluoroquinolones; Humans; Isoniazid; Male; Moxifloxacin; Pyrazinamide; Rifampin; South Africa; Tanzania; Tuberculosis, Pulmonary | 2017 |
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
Topics: Adult; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Isoniazid; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk; Tuberculosis, Pulmonary; Young Adult | 2017 |
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; CD4 Lymphocyte Count; Directly Observed Therapy; Drug Administration Schedule; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Male; Middle Aged; Patient Dropouts; Proportional Hazards Models; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viral Load | 2018 |
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Levofloxacin; Male; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial.
Topics: Adult; Antibiotics, Antitubercular; Contact Tracing; Cost-Benefit Analysis; Ethambutol; Family Characteristics; Female; Global Burden of Disease; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Vietnam | 2019 |
Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: A randomized, controlled, clinical study.
Topics: Adult; Antitubercular Agents; Cholecalciferol; Drug Therapy, Combination; Egypt; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Vitamins; Young Adult | 2019 |
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Topics: Adult; Antibiotics, Antitubercular; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; India; Isoniazid; Metformin; Multicenter Studies as Topic; Mycobacterium tuberculosis; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Tuberculosis, Pulmonary | 2019 |
Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label study.
Topics: Age Factors; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2019 |
Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic
Topics: Adult; Aged; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quality of Life; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Young Adult | 2019 |
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Linear Models; Male; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary; United Kingdom | 2019 |
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Equivalence Trials as Topic; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Moxifloxacin; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2020 |
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Linezolid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 2020 |
Telacebec (Q203), a New Antituberculosis Agent.
Topics: Administration, Oral; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Imidazoles; Isoniazid; Mycobacterium tuberculosis; Piperidines; Pyrazinamide; Pyridines; Rifampin; Tuberculosis, Pulmonary | 2020 |
Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Directly Observed Therapy; Electrical Equipment and Supplies; Equivalence Trials as Topic; Ethambutol; Ethiopia; Female; Follow-Up Studies; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Patient Acceptance of Health Care; Prospective Studies; Pyrazinamide; Randomized Controlled Trials as Topic; Rifampin; Self Administration; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2020 |
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2020 |
Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Toxic Optic Neuropathy | 2021 |
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial.
Topics: Adult; Antitubercular Agents; Child; Ethambutol; Humans; Levofloxacin; Rifampin; Standard of Care; Tuberculosis, Meningeal | 2022 |
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Topics: Antitubercular Agents; Diarylquinolines; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Linezolid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2023 |
1904 other study(ies) available for ethambutol and rifampin
Article | Year |
---|---|
Synthesis and antibacterial activity of 2,2'-dithiobis(benzamide) derivatives against Mycobacterium species.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Mice; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Structure-Activity Relationship; Sulfides | 1985 |
Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity.
Topics: Antitubercular Agents; Chromatography, Liquid; Diterpenes; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Turkey | 1997 |
A new class of antituberculosis agents.
Topics: Amides; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfones | 2000 |
Antituberculous activity of some aryl semicarbazone derivatives.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship | 2004 |
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Discovery of new antitubercular oxazolyl thiosemicarbazones.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiosemicarbazones | 2006 |
Search of antitubercular activities in tetrahydroacridines: synthesis and biological evaluation.
Topics: Acridines; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship | 2006 |
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Topics: Animals; Antitubercular Agents; Blood; Cell Line; Humans; In Vitro Techniques; Intracellular Membranes; Macrophages; Mammals; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium; Mycobacterium bovis; Mycolic Acids; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis | 2006 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents.
Topics: Alkylation; Antitubercular Agents; Chemical Phenomena; Chemistry, Physical; Computer Simulation; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Pyrimidines; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2007 |
N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity.
Topics: Agar; Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Chlorocebus aethiops; Drug Design; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Chemical; Molecular Conformation; Mycobacterium tuberculosis; Semicarbazides; Semicarbazones; Temperature; Vero Cells | 2007 |
Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Carbohydrate Conformation; Carbohydrate Sequence; Carbohydrates; Chemistry, Pharmaceutical; Drug Design; Molecular Sequence Data; Mycobacterium avium; Mycobacterium tuberculosis; Plant Extracts; Stachys; Staphylococcus aureus | 2007 |
Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines.
Topics: Animals; Antitubercular Agents; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Humans; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship | 2007 |
Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives.
Topics: Alkylation; Amino Alcohols; Antitubercular Agents; Cell Proliferation; Cells, Cultured; Glycosylation; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Ethambutol; Georgia (Republic); Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prevalence; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2008 |
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.
Topics: Antitubercular Agents; Bacterial Proteins; Codon; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Rifampin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Indoles; Microwaves; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cyclic GMP-Dependent Protein Kinases; Drug Resistance, Microbial; Mycobacterium; Mycobacterium tuberculosis; Phagosomes; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Topics: Alkanes; Animals; Antitubercular Agents; Cattle; Cell Line; Cell Survival; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Prenylation | 2009 |
Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sphingosine; Tuberculosis, Multidrug-Resistant | 2009 |
New approach for drug susceptibility testing: monitoring the stress response of mycobacteria.
Topics: Electric Impedance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Stress, Physiological | 2009 |
L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Catalysis; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proline; Thiazines | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.
Topics: Alleles; Antitubercular Agents; Codon; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Operon; Pentosyltransferases; Plasmids; Rifampin | 2010 |
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Carbohydrates; Chemistry, Pharmaceutical; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfides | 2009 |
1,3-Dipolar cycloaddition of C-aryl-N-phenylnitrones to (R)-1-(1-phenylethyl)-3-[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of enantiomerically pure spiroisoxazolidines.
Topics: Anti-Bacterial Agents; Drug Discovery; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Nitrogen Oxides; Oxazoles; Pyridones; Stereoisomerism | 2010 |
A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents.
Topics: Antitubercular Agents; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Spiro Compounds; Stereoisomerism; Thiazoles | 2010 |
Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Microbial Sensitivity Tests; Pyridines; Vero Cells | 2010 |
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.
Topics: Adult; Antitubercular Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Discovery; Ethambutol; Fluoroquinolones; Immunocompetence; Inhalation Exposure; Isoniazid; Linezolid; Mice; Mice, Inbred C57BL; Moxifloxacin; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Rifampin; Tuberculosis, Pulmonary | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation.
Topics: Antitubercular Agents; Cyclization; Indoles; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Oxindoles; Spiro Compounds; Stereoisomerism | 2010 |
A facile 1,3-dipolar cycloaddition of azomethine ylides to 2-arylidene-1,3-indanediones: synthesis of dispiro-oxindolylpyrrolothiazoles and their antimycobacterial evaluation.
Topics: Antitubercular Agents; Azo Compounds; Crystallography, X-Ray; Indans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Spiro Compounds; Stereoisomerism; Thiazoles; Thiosemicarbazones | 2010 |
Synthesis and anti-mycobacterial activities of triazoloquinolones.
Topics: Anti-Bacterial Agents; Candida; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium; Quinolones | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
Design, synthesis and antimycobacterial activity of cinnamide derivatives: a molecular hybridization approach.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Cinnamates; Drug Design; Microbial Sensitivity Tests; Mycobacterium; Nucleic Acid Hybridization; Vero Cells | 2011 |
A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Thiones | 2011 |
Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides.
Topics: Antibiotics, Antitubercular; Benzopyrans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Pyridines; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Galactose; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrans; Structure-Activity Relationship | 2011 |
Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction.
Topics: Antitubercular Agents; Carbazoles; Humans; Imines; Models, Molecular; Mycobacterium tuberculosis; Pyrans; Quinolines; Structure-Activity Relationship; Tuberculosis | 2011 |
A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation.
Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyrazolones; Water | 2011 |
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; NIH 3T3 Cells; Quinolines; Structure-Activity Relationship; Thiadiazoles; Tuberculosis | 2011 |
Stereochemical analysis of leubethanol, an anti-TB-active serrulatane, from Leucophyllum frutescens.
Topics: Antitubercular Agents; Circular Dichroism; Diterpenes; Mexico; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Plant Roots; Scrophulariaceae | 2011 |
A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies.
Topics: Anti-Bacterial Agents; Azoles; Candida albicans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents.
Topics: Animals; Antitubercular Agents; Camphor; Catalysis; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Phenols; Quinolines; Structure-Activity Relationship | 2012 |
Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.
Topics: 2,2'-Dipyridyl; Anions; Antitubercular Agents; Calixarenes; Guanidine; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Quaternary Ammonium Compounds; Tuberculosis | 2012 |
Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
Topics: Alkaloids; Antitubercular Agents; Benzylisoquinolines; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Resonance Spectroscopy; Menispermaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Extracts; Plant Roots; Tuberculosis, Multidrug-Resistant | 2012 |
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
Topics: Alpinia; Antibiotics, Antitubercular; Antitubercular Agents; Diarylheptanoids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Plant Extracts; Seeds | 2012 |
Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents.
Topics: Antifungal Agents; Antitubercular Agents; Bacteria; Benzothiazoles; Chemistry Techniques, Synthetic; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2012 |
A solvent free, four-component synthesis and 1,3-dipolar cycloaddition of 4(H)-pyrans with nitrile oxides: synthesis and discovery of antimycobacterial activity of enantiomerically pure 1,2,4-oxadiazoles.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Drug Discovery; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Piperidines; Pyrans; Stereoisomerism | 2012 |
The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Stereoisomerism; Uracil; Vero Cells | 2012 |
A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cycloaddition Reaction; High-Throughput Screening Assays; Microbial Sensitivity Tests; Pyrrolidines | 2013 |
Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates.
Topics: Amino Alcohols; Anti-Bacterial Agents; Antitubercular Agents; Chromones; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Spiro Compounds; Structure-Activity Relationship | 2013 |
Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Humans; Jurkat Cells; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Structure-Activity Relationship; Vero Cells | 2013 |
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2013 |
Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III.
Topics: Antitubercular Agents; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen; Pyridines | 2014 |
Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Benzofurans; Click Chemistry; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2014 |
Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
Topics: Acridines; Animals; Antitubercular Agents; Cell Line; Cyclization; Drug Design; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines | 2014 |
Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2014 |
Facile synthesis of benzonitrile/nicotinonitrile based s-triazines as new potential antimycobacterial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nicotinic Acids; Nitriles; Structure-Activity Relationship; Triazines | 2014 |
Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyridones; Structure-Activity Relationship | 2014 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Topics: Acetates; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship | 2014 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Topics: Acetamides; Animals; Bacterial Proteins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2014 |
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Benzoxazoles; Cell Line; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Structure-Activity Relationship; Tuberculosis | 2014 |
An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
Topics: Animals; Antitubercular Agents; Benzofurans; Benzothiazoles; Cell Line; DNA Gyrase; Dose-Response Relationship, Drug; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2014 |
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Quinolines; Structure-Activity Relationship | 2015 |
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Phenazines; Pyrrolidines; Quinolizidines; Structure-Activity Relationship; Tuberculosis; Vero Cells | 2014 |
Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors.
Topics: Alanine Dehydrogenase; Animals; Cell Line; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Macrophages; Mice; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2015 |
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proton-Translocating ATPases; Quinolines; Rats, Sprague-Dawley; Sulfonamides; Tuberculosis | 2015 |
Eremophilane Sesquiterpenes and Diphenyl Thioethers from the Soil Fungus Penicillium copticola PSU-RSPG138.
Topics: Animals; Antimalarials; Antineoplastic Agents; Biphenyl Compounds; Chlorocebus aethiops; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Penicillium; Plasmodium falciparum; Sesquiterpenes; Soil Microbiology; Sulfides; Thailand; Vero Cells | 2015 |
Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
Topics: Antitubercular Agents; DNA Gyrase; Drug Discovery; Humans; Mycobacterium smegmatis; Mycobacterium tuberculosis | 2015 |
Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Methane; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rats; Thiophenes; Vero Cells | 2015 |
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides | 2015 |
Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity.
Topics: Animals; Antitubercular Agents; Callyspongia; Drug Screening Assays, Antitumor; Humans; Marine Biology; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic | 2015 |
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Thiazoles | 2015 |
Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
Topics: Antitubercular Agents; Dioxanes; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; HEK293 Cells; Humans; Mycobacterium tuberculosis; Oxazoles; Structure-Activity Relationship | 2015 |
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea | 2016 |
Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Chlorocebus aethiops; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyrimidines; Triazoles; Tuberculosis; Vero Cells | 2015 |
Synthesis and evaluation of antibacterial and antitumor activities of new galactopyranosylated amino alcohols.
Topics: Amino Alcohols; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary; Pyrimidines; Schiff Bases; Structure-Activity Relationship | 2016 |
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Peptide Synthases; Structure-Activity Relationship; Thiazoles; Zebrafish | 2016 |
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
Topics: Animals; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; RAW 264.7 Cells | 2016 |
Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
Topics: Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship | 2016 |
Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
Topics: A549 Cells; Anti-Bacterial Agents; Antitubercular Agents; Cells; Coordination Complexes; Copper; Humans; Hydrazones; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship | 2016 |
Lovastatin Analogues from the Soil-Derived Fungus Aspergillus sclerotiorum PSU-RSPG178.
Topics: Animals; Aspergillus; Chlorocebus aethiops; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitory Concentration 50; KB Cells; Lovastatin; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium scrofulaceum; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Soil Microbiology; Thailand; Vero Cells | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Click Chemistry; Coumarins; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2016 |
Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors.
Topics: Alanine Dehydrogenase; Antitubercular Agents; Carbon-13 Magnetic Resonance Spectroscopy; Crystallography, X-Ray; Drug Design; Molecular Structure; Mycobacterium tuberculosis; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2016 |
Amphiphilic xanthones as a potent chemical entity of anti-mycobacterial agents with membrane-targeting properties.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Biological Availability; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Hydrophobic and Hydrophilic Interactions; Kinetics; Mycobacterium tuberculosis; Rats; Xanthones | 2016 |
Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis.
Topics: Alanine Dehydrogenase; Antitubercular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Structure-Activity Relationship; Thiophenes | 2016 |
Identification and optimization of a new series of anti-tubercular quinazolinones.
Topics: Animals; Antitubercular Agents; Cell Line; High-Throughput Screening Assays; Humans; Mice; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Quinazolinones; Structure-Activity Relationship | 2016 |
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Line, Tumor; Chemistry Techniques, Synthetic; Computer Simulation; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Pyrroles | 2017 |
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; RAW 264.7 Cells; Structure-Activity Relationship | 2017 |
Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives.
Topics: Amides; Animals; Antitubercular Agents; Liver; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Oxazoles; Rats; Structure-Activity Relationship | 2017 |
A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Indazoles; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship | 2017 |
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Solubility; Structure-Activity Relationship; Tetrazoles; Water | 2017 |
Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
Topics: Antitubercular Agents; Cell Survival; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship; Triazoles | 2017 |
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.
Topics: Administration, Oral; Animals; Antitubercular Agents; Blood Proteins; Drug Stability; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Mycobacterium tuberculosis; Proteomics; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
Topics: Antitubercular Agents; Azepines; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triterpenes | 2018 |
Lead identification and optimization of bacterial glutamate racemase inhibitors.
Topics: Amino Acid Isomerases; Animals; Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship | 2018 |
Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors.
Topics: Amino Acid Isomerases; Animals; Anti-Bacterial Agents; Benzoxazoles; Biofilms; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium; RAW 264.7 Cells; Structure-Activity Relationship; Zebrafish | 2018 |
New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrazines; Isoniazid; Macrophages; Mice; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2018 |
Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrans; Spiro Compounds; Structure-Activity Relationship; Thiophenes | 2018 |
Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2018 |
Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Topics: Animals; Antitubercular Agents; Carbanilides; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship; Thiazoles | 2018 |
Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Drug Design; HEK293 Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
Topics: Animals; Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; RAW 264.7 Cells; Structure-Activity Relationship | 2018 |
The synthesis, biological evaluation and structure-activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents.
Topics: | 2017 |
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.
Topics: | 2017 |
Synthesis and
Topics: | 2018 |
An antimycobacterial pleuromutilin analogue effective against dormant bacilli.
Topics: Administration, Oral; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Caco-2 Cells; Diterpenes; Female; Half-Life; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pleuromutilins; Polycyclic Compounds | 2018 |
Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Pyrroles; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Morpholines; Mycobacterium tuberculosis; Piperazine; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Triazoles | 2019 |
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
Topics: Amination; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Furans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2019 |
Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Synthesis of diphenoxyadamantane alkylamines with pharmacological interest.
Topics: Adamantane; Amines; Antitubercular Agents; Dose-Response Relationship, Drug; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2019 |
5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.
Topics: Antitubercular Agents; Antiviral Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Orthomyxoviridae; Structure-Activity Relationship | 2019 |
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dinitrobenzenes; Dose-Response Relationship, Drug; Drug Development; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2019 |
Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Topics: Antitubercular Agents; Carbamates; Hep G2 Cells; Humans; Isocitrate Lyase; Mycobacterium tuberculosis; Phenols; Salicylanilides; Tuberculosis | 2019 |
Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents.
Topics: Amines; Antitubercular Agents; Cell Death; Cell Line; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Tetrazoles | 2020 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Topics: Acrylonitrile; Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2020 |
Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Hydrazones; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiadiazoles | 2020 |
Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituents.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Thiazolidinediones; Vero Cells | 2020 |
Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from l-serine.
Topics: Animals; Antineoplastic Agents; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Serine; Vero Cells | 2020 |
Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
Topics: Amides; Animals; Antitubercular Agents; Biofilms; Cell Line; Dose-Response Relationship, Drug; Drug Development; Enzyme Inhibitors; HEK293 Cells; Humans; Ketol-Acid Reductoisomerase; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2020 |
Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived
Topics: | 2014 |
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiourea | 2020 |
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles | 2020 |
Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Halogenation; HEK293 Cells; Humans; Male; Mice; Mycobacterium tuberculosis; Oxazoles; Rats, Sprague-Dawley; Thiadiazoles; Tuberculosis, Multidrug-Resistant | 2021 |
Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Topics: Amination; Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Thiazoles; Tuberculosis | 2020 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
Topics: Alkynes; Animals; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Squamous Cell; Cell Line; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Discovery; Glycoconjugates; Humans; Lung Neoplasms; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2021 |
Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Chalcone; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esters; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2021 |
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells | 2022 |
Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant
Topics: | 2022 |
[Monitoring of antitubercular treatments. Value of the determination of serum gamma-glutamyl transpeptidase (gamma-GT)].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; gamma-Glutamyltransferase; Humans; Isoniazid; Liver; Rifampin | 1977 |
Tuberculosis in the 1980s: a case for short-course chemotherapy.
Topics: Animals; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Isoniazid; Mice; New Zealand; Pyrazinamide; Rifampin; Tuberculosis | 1979 |
Results of treatment of spinal tuberculosis by "middle-path" regime.
Topics: Abscess; Aminosalicylic Acids; Antitubercular Agents; Convalescence; Debridement; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Postoperative Care; Recurrence; Rest; Rifampin; Spinal Cord Compression; Spinal Fusion; Streptomycin; Thioacetazone; Tuberculosis, Spinal | 1975 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
Topics: Capreomycin; Culture Media; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin; Temperature; Thiosemicarbazones; Viomycin | 1975 |
The treatment of tuberculosis.
Topics: Aminosalicylic Acids; Capreomycin; Ethambutol; Ethionamide; Humans; Isoniazid; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1975 |
Editorial: Treatment of tuberculous meningitis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1976 |
[Sensitivity of m. kansasii strains to various antibiotics and chemotherapeutics in vitro and in vivo (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Drug Resistance, Microbial; Ethambutol; Gentamicins; Mice; Mycobacterium; Oleandomycin; Phenazines; Pyrazinamide; Rifampin; Species Specificity | 1975 |
Initial resistance of Mycobacterium tuberculosis in Northern Nigeria.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Nigeria; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1976 |
Fatal rifampicin-ethambutol overdosage.
Topics: Adult; Ethambutol; Humans; Male; Rifampin; Suicide | 1978 |
Short-course chemotherapy for tuberculosis.
Topics: Adult; Ambulatory Care; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1979 |
Basic mechanisms of chemotherapy.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1979 |
Antituberculous drugs.
Topics: Abnormalities, Drug-Induced; Antitubercular Agents; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; Female; Fetus; Hearing Disorders; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Tryptophan uptake by Mycobacterium tuberculosis H37Rv: effect of rifampin and ethambutol.
Topics: Biological Transport; Ethambutol; Kinetics; Mycobacterium tuberculosis; Rifampin; Tryptophan | 1978 |
Primary antituberculous drug resistance in Hawaii, 1957 to 1977.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Hawaii; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1978 |
[The use of mycobacteria in the estimation of the concentration of antibiotics, antimycotics and antituberculotics (author's transl)].
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacitracin; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Time Factors | 1978 |
[Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)].
Topics: Anti-Bacterial Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Mycobacterium tuberculosis; Pyrazinamide; Rifampin | 1979 |
Thoracic tuberculosis: clinical aspects.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Interactions; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mass Chest X-Ray; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary; United States | 1979 |
[Ultrastructural change in Mycobacterium tuberculosis under the influence of antibacterial preparations (a review of the literature)].
Topics: Antitubercular Agents; Cell Nucleus; Cell Wall; Cycloserine; Cytoplasm; Ethambutol; Intracellular Membranes; Isoniazid; Kanamycin; Microscopy, Electron; Microscopy, Electron, Scanning; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1979 |
Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974-1977.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Poland; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Renal failure during intermittent rifampicin therapy.
Topics: Acute Kidney Injury; Adult; Antibodies; Endothelium; Ethambutol; Fever; Fibrin; Humans; Immune Complex Diseases; Ischemia; Kidney Glomerulus; Kidney Tubules; Male; Necrosis; Rifampin; Tuberculosis, Pulmonary; Uremia | 1975 |
[Pott's disease. Medical treatment or medico-surgical treatment. Round-table discussion].
Topics: Abscess; Ethambutol; Humans; Intervertebral Disc; Isoniazid; Paraplegia; Rifampin; Spinal Fusion; Tuberculosis, Spinal | 1975 |
[Controlled rifampicin and ethambutol therapy of chronic destructive pulmonary tuberculosis in a rural district].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chronic Disease; Drug Therapy, Combination; Ethambutol; Humans; Middle Aged; Rifampin; Rural Population; Tuberculosis, Pulmonary; Uzbekistan | 1976 |
Analysis of metabolic changes in revertants of antibiotic-resistant micobacteria.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Extrachromosomal Inheritance; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Viomycin | 1975 |
[Surveillance and complications of antituberculosis chemotherapy].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Hematologic Diseases; Humans; Isoniazid; Liver; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Rheumatic Diseases; Rifampin; Streptomycin; Tuberculosis | 1979 |
[Treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1978 |
Tuberculosis in Britain today.
Topics: Emigration and Immigration; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United Kingdom | 1979 |
Gynecological tuberculosis in the west of Scotland.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Scotland; Streptomycin; Tuberculosis, Female Genital | 1979 |
Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Poland; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1978 |
Sporotrichoid Mycobacterium marinum infection in diabetes. Chemotherapy with rifampin and ethambutol.
Topics: Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Hand Dermatoses; Humans; Middle Aged; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious | 1978 |
Mycobacterium marinum infections treated with tetracycline.
Topics: 4-Aminobenzoic Acid; Adult; Ethambutol; Granuloma; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Streptomycin; Tetracycline | 1977 |
Recent advances in antituberculosis chemotherapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Tasks and possibilities in the near future of consultation bureaus for the prevention of tuberculosis].
Topics: Community Health Services; Ethambutol; History, 20th Century; Humans; Isoniazid; Netherlands; Rifampin; Transients and Migrants; Tuberculosis | 1978 |
[Current short-term chemotherapy of tuberculosis. Fundamentals, assumptions, drug combinations, plan of treatment and prospects].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1978 |
Mycobacterium tuberculosis resistance to rifampicin and ethambutol: a clinical survey.
Topics: Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Medication Errors; Middle Aged; Mycobacterium tuberculosis; Patient Compliance; Rifampin; Tuberculosis, Pulmonary | 1977 |
A rapid radiometric method for determining the sensitivity of clinical isolates of Mycobacterium tuberculosis to several chemotherapeutic agents.
Topics: Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; RNA, Bacterial; Streptomycin; Tritium; Uracil | 1977 |
Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Topics: Drug Interactions; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1977 |
[On the possibility of a rapid method for sensitivity testing of mycobacteria by determination of H3-uracil incorporation (author's transl)].
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium phlei; Mycobacterium tuberculosis; Rifampin; Tritium; Uracil | 1977 |
[Evaluation criteria of antitubercular drugs from microbiological view].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1977 |
[Drug sensitivity of tubercle bacilli to ethambutol and rifampicin determined by the Canetti proportional method].
Topics: Ethambutol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1977 |
[Bacterial isolation during chemotherapy of patients with pulmonary tuberculosis].
Topics: Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1977 |
Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Carbon Dioxide; Carbon Radioisotopes; Ethambutol; Formates; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidation-Reduction; Rifampin; Streptomycin | 1978 |
Antimicrobial activity of antituberculosis agents against anaerobic bacteria.
Topics: Actinomyces; Antitubercular Agents; Bacteria; Bacteroides; Bacteroides fragilis; Clostridium; Ethambutol; Eubacterium; Fusobacterium; Humans; Isoniazid; Microbial Sensitivity Tests; Peptococcus; Peptostreptococcus; Rifampin; Tuberculosis, Pulmonary | 1979 |
Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Chronic Disease; Dose-Response Relationship, Immunologic; Ethambutol; Female; Humans; Immunity, Cellular; In Vitro Techniques; Isoniazid; Lung Diseases; Lymphokines; Male; Middle Aged; Monocytes; Rifampin; Tuberculosis, Pulmonary; Zymosan | 1979 |
Five cases of intracranial tuberculoma followed by serial computerised tomography.
Topics: Adult; Brain Diseases; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1979 |
[Tuberculosis in Romania (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Romania; Statistics as Topic; Tuberculosis | 1979 |
[Therapy of tuberculosis].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Genitourinary tuberculosis: a 7-year review.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forecasting; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Urogenital | 1979 |
Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1979 |
Long-term results of medical treatment in Mycobacterium intracellulare infection.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium Infections, Nontuberculous; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Pharmacokinetics and metabolism of the principal antubercular drugs].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin | 1979 |
[Indications, dosage and combinations of the major antitubercular drugs].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1979 |
Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Kenya; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
Modern management of tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acid; Child; Cycloserine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin | 1979 |
[Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1979 |
The side effects and interactions of antituberculosis drugs.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Drug Interactions; Ethambutol; Female; Humans; Immunosuppression Therapy; Isoniazid; Optic Neuritis; Phenytoin; Pregnancy; Rifampin; Streptomycin; Thrombocytopenia | 1979 |
Pulmonary disease caused by Mycobacterium xenopi in an Australian man.
Topics: Australia; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyridoxine; Rifampin; Sputum; Tuberculosis, Pulmonary | 1979 |
[Rifampicin, ethambutol and drugs of the 2d series in chemotherapy of chronic cavernous tuberculosis of the lungs].
Topics: Adolescent; Adult; Antitubercular Agents; Chronic Disease; Ethambutol; Humans; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1979 |
[Pregnancy and pulmonary tuberculosis].
Topics: BCG Vaccine; Ethambutol; Female; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1979 |
[Remote results of chemotherapy in tuberculosis].
Topics: Czechoslovakia; Ethambutol; Humans; Oxazoles; Phenylthiourea; Prothionamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary | 1977 |
Principles of the chemotherapy of tuberculosis.
Topics: Aminosalicylic Acid; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1977 |
[Modern therapy and after-care in urogenital tuberculosis].
Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Ethambutol; Female; Genitalia, Male; Hospitalization; Humans; Isonicotinic Acids; Male; Nephrectomy; Rifampin; Streptomycin; Tuberculosis, Urogenital; Urogenital System | 1978 |
Twenty-five years experience of the drug treatment of tuberculosis of the female genital tract.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Female Genital | 1977 |
Stevens-Johnson syndrome due to rifampicin.
Topics: Adult; Drug Interactions; Ethambutol; Humans; Male; Rifampin; Stevens-Johnson Syndrome | 1977 |
[Toxicological evaluation criteria (secondary action aspects)].
Topics: Anti-Infective Agents; Cephalosporins; Chloramphenicol; Erythromycin; Ethambutol; Gentamicins; Humans; Isoniazid; Lincomycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Penicillins; Rifampin; Streptomycin; Sulfonamides; Tetracyclines | 1977 |
[Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
Topics: Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Liver Diseases; Male; Prospective Studies; Rifampin; Time Factors; Transaminases; Tuberculosis, Pulmonary | 1977 |
The treatment of tuberculous meningitis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1978 |
Diseases of the respiratory system: tuberculosis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Streptomycin; Tuberculosis | 1978 |
[New guidelines for pulmonary tuberculosis therapy].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Treatment of renal tuberculosis. I. Clinical and bacteriological patterns and results.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Radiography; Rifampin; Tuberculosis, Renal; Urine | 1978 |
Mycobacterium gordonae infection of a prosthetic aortic valve.
Topics: Aortic Valve; Endocarditis, Bacterial; Ethambutol; Heart Valve Prosthesis; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin | 1978 |
Choosing the correct drug combinations against tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Current status of the chemotherapy of tuberculosis. Part II.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Therapy of urogenital tuberculosis].
Topics: Ambulatory Care; Ethambutol; Female; Humans; Isoniazid; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications; Prothionamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Urogenital | 1978 |
[The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
Topics: Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Phospholipids; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Tolerance of rifampicin and ethambutol and their effects on liver function during treatment of patients with destructive lung tuberculosis].
Topics: Ethambutol; Humans; Liver; Liver Function Tests; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Manifestations of the pathomorphosis of destructive tuberculosis from using standby preparations (based on resection materials)].
Topics: Connective Tissue; Ethambutol; Humans; Lung; Rifampin; Tuberculosis, Pulmonary | 1978 |
Antituberculosis chemotherapy.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Neuritis; Rifampin; Streptomycin | 1978 |
Treatment of renal tuberculosis. II. Microbiological study of 271 renal tuberculous cavities.
Topics: Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Kidney; Rifampin; Tuberculosis, Renal | 1978 |
[Tuberculosis of the peripheral lymph nodes].
Topics: Adolescent; Adult; Ethambutol; Female; Germany, West; Humans; Inguinal Canal; Isoniazid; Male; Middle Aged; Neck; Rifampin; Tuberculin Test; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1978 |
[An attempt to work out highly efficient short-course regimens by model experiments in mouse tuberculosis (author's transl)].
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Rifampin; Streptomycin; Tuberculosis | 1978 |
Tuberculoid tenosynovitis and carpal tunnel syndrome caused by Mycobacterium szulgai.
Topics: Adult; Carpal Tunnel Syndrome; Debridement; Ethambutol; Hand; Humans; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tenosynovitis | 1978 |
[Interactions of reserve antitubercular agents in combined administration].
Topics: Amides; Drug Therapy, Combination; Ethambutol; Humans; Pyrazinamide; Rifampin; Thioamides; Tuberculosis, Pulmonary | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
[Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Topics: Drug Evaluation; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1978 |
Granulomatous hepatitis and pleuritis after ileal bypass for obesity.
Topics: Ethambutol; Female; Hepatitis; Humans; Ileum; Intestinal Absorption; Isoniazid; Jejunum; Middle Aged; Obesity; Phagocyte Bactericidal Dysfunction; Pleurisy; Rifampin | 1978 |
Tuberculosis in East Africans presenting with intra-thoracic lymphadenopathy.
Topics: Adult; Africa, Eastern; Asia; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Mediastinum; Middle Aged; Rifampin; Tuberculosis, Lymph Node; United Kingdom | 1978 |
Mycobacterium fortuitum infections: a review with two illustrative cases.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Rifampin; Surgical Wound Infection | 1978 |
[Blood serum ethambutol concentration in tuberculosis under different regimens of treatment].
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1978 |
[Tuberculosis of hematopoietic organs in the child. 2 cases with pulmonary involvement].
Topics: Adolescent; Child, Preschool; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Prognosis; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1978 |
[Results of a cooperative international questionnaire on the cost of antitubercular drugs].
Topics: Antitubercular Agents; Costs and Cost Analysis; Ethambutol; Ethionamide; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1978 |
[Absorption of anti-tuberculous drugs after gastric surgery (author's transl)].
Topics: Antitubercular Agents; Biological Availability; Ethambutol; Humans; Intestinal Absorption; Isoniazid; Postgastrectomy Syndromes; Rifampin | 1979 |
[Present status and treatment of urogenital tuberculosis].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Germany, West; Humans; Isoniazid; Long-Term Care; Male; Pregnancy; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1975 |
The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1975 |
Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1975 |
Tuberculous meningitis developing after six months of treatment of pulmonary tuberculosis. Complication of infection with a drug-resistant strain in a two-year-old child.
Topics: Blood Glucose; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Glucose; Humans; Isoniazid; Lung; Male; Mycobacterium tuberculosis; Radiography; Rifampin; Salicylates; Tuberculin Test; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1975 |
Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 1975 |
[Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
Topics: Chronic Disease; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Italy; Lung Diseases; Mycobacterium tuberculosis; Pneumonia; Poland; Postoperative Care; Rifampin; Time Factors; Tuberculosis, Pulmonary; Yugoslavia | 1975 |
[Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1976 |
[Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
Topics: Antitubercular Agents; Culture Media; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1976 |
Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis.
Topics: Acute Kidney Injury; Aged; Ethambutol; Female; Humans; Immunoglobulin Light Chains; Isoniazid; Male; Middle Aged; Proteinuria; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Renal | 1976 |
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
Topics: Animals; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1976 |
Modern medical management of pulmonary tuberculosis.
Topics: Alcoholism; Ethambutol; Fever; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[Effectiveness of intermittent therapy with ethambutol, rifampicin at the sanatorium stage of treatment of patients with destructive tuberculosis of the lungs].
Topics: Ethambutol; Hospitals, Special; Humans; Rifampin; Tuberculosis, Pulmonary; USSR | 1977 |
Rifampim-combined chemotherapy in coal worker's pneumoconio-tuberculosis.
Topics: Coal Mining; Drug Therapy, Combination; Ethambutol; Humans; Liver Function Tests; Pneumoconiosis; Radiography; Retrospective Studies; Rifampin; Sputum; Tuberculosis, Pulmonary | 1977 |
Why tuberculosis is still a health problem in the aged.
Topics: Age Factors; Aged; Ethambutol; Humans; Isoniazid; Nursing Homes; Patient Isolation; Radiography; Rifampin; Sputum; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[Anticoagulants in tuberculostatic therapy].
Topics: 4-Hydroxycoumarins; Aged; Drug Antagonism; Epididymitis; Ethambutol; Humans; Isoniazid; Male; Phenprocoumon; Rifampin; Thrombophlebitis; Tuberculosis, Male Genital | 1977 |
Management of tuberculosis: altered role of the primary care physician.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1977 |
[Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods].
Topics: Chronic Disease; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Rifampin; Tuberculosis, Pulmonary | 1977 |
Reactivation of tuberculosis in old age.
Topics: Adult; Aged; Child; Ethambutol; Female; Humans; Isoniazid; Male; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1977 |
[Condition of the liver in patients with chronic pulmonary tuberculosis receiving a combination of antibacterial drugs including rifampicin and ethambutol].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Liver; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1977 |
Tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
[A case of circumcision tuberculosis].
Topics: Child; Circumcision, Male; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Lymph Node; Tuberculosis, Male Genital | 1977 |
Drug interactions with isoniazid metabolism in rats.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Aspirin; Drug Interactions; Ethambutol; Ethanol; Injections, Intravenous; Isoniazid; Male; Phenobarbital; Rats; Rifampin; Time Factors; Tissue Distribution | 1977 |
[A study on the intensive chemotherapy for previously untreated pulmonary tuberculosis--comparison of two regimens, SM-INH-RFP and SM-INH-EB (author's transl)].
Topics: Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[Effectiveness of complex treatment of patients with destructive tuberculosis of the lungs at a specialized clinic].
Topics: Ethambutol; Hospitals, Special; Humans; Length of Stay; Rifampin; Tuberculosis, Pulmonary; USSR | 1977 |
Antituberculous therapy in pregnancy. Risks to the fetus.
Topics: Ethambutol; Female; Humans; Isoniazid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Risk; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[Halothane and antituberculous drugs--a hepatotoxic combination? (author's transl)].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Halothane; Hepatic Encephalopathy; Humans; Isoniazid; Middle Aged; Rifampin; Time Factors | 1977 |
[Sensitivities of atypical mycobacteria to various drugs. III. Sensitivities of M. intracellulare to antituberculous drugs in triple combinations (author's transl)].
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Mycobacterium; Nontuberculous Mycobacteria; Rifampin | 1977 |
[Clinical efficacy of intermittent chemotherapy with initial intensive regimen in original treatment for pulmonary tuberculosis. Report of the 18th series of controlled trial of chemotherapy (author's transl)].
Topics: Adult; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1977 |
[INH and rifampicin dosage at the beginning of tuberculosis treatment].
Topics: Drug Tolerance; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1977 |
[Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination (author's transl)].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Rifampin; Tuberculosis | 1977 |
[Clinical problems on the binding of protein to antituberculous drugs (author's transl)].
Topics: Adult; Aminosalicylic Acid; Animals; Antitubercular Agents; Blood Proteins; Ethambutol; Humans; Male; Protein Binding; Rats; Rifampin | 1977 |
[Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
Topics: Acetylation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Male; Optic Neuritis; Rifampin; Tuberculosis | 1977 |
The binding of antituberculous drugs to normal and kwashiorkor serum.
Topics: Aminosalicylic Acid; Antitubercular Agents; Blood Proteins; Child; Ethambutol; Ethionamide; Humans; In Vitro Techniques; Isoniazid; Kwashiorkor; Protein Binding; Rifampin; Streptomycin | 1977 |
Antituberculosis agents: isoniazid, rifampin, streptomycin, ethambutol.
Topics: Antibiotics, Antitubercular; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1977 |
Practical management and control of tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1977 |
[Gastric secretion in patients with pulmonary tuberculosis treated with rifampicin and ethambutol].
Topics: Adult; Aged; Ethambutol; Female; Gastric Juice; Humans; Male; Middle Aged; Rifampin; Secretory Rate; Tuberculosis, Pulmonary | 1977 |
Genitourinary tuberculosis: a study of short course regimens.
Topics: Adult; Aged; Antitubercular Agents; Calcinosis; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Middle Aged; Rifampin; Tuberculosis, Urogenital | 1976 |
[Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Tuberculosis management in the mid-1970s.
Topics: Ambulatory Care; Antitubercular Agents; Drug Resistance; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Self Medication; Sputum; Streptomycin; Time Factors; Tuberculosis; United States | 1976 |
[Experimental study of schedules for intermittent administration of rifampicin and ethambutol].
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; In Vitro Techniques; Mice; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Use of rifadin and ethambutol in pulmonary tuberculosis with concomitant diseases].
Topics: Adult; Aged; Asthma; Cholecystitis; Drug Tolerance; Ethambutol; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Peptic Ulcer; Rifampin; Tuberculosis, Pulmonary | 1976 |
Chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[Treatment of tuberculosis. A care program carried out by a working group in the Swedish Pulmonary Medical Society].
Topics: Ambulatory Care; Antitubercular Agents; Drug Interactions; Ethambutol; Eye Diseases; Female; Follow-Up Studies; Hospitalization; Humans; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Rifampicin in the treatment of chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Causes of untimely diagnosis of tuberculosis meningitis and the effectiveness of its treatment].
Topics: Adult; Child; Drug Evaluation; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Meningeal | 1976 |
Two cases of ethambutol nephrotoxicity.
Topics: Acute Kidney Injury; Aged; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Tuberculosis of peripheral lymph nodes (author's transl)].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1976 |
[Remote results of prophylactic examination of patients with chronic destructive pulmonary tuberculosis].
Topics: Adult; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1976 |
[The results of liver biopsies during rifampicin therapy (author's transl)].
Topics: Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Humans; Liver; Male; Middle Aged; Rifampin; Tuberculosis | 1976 |
[Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
Topics: Acetylcholine; Alanine Transaminase; Alkaline Phosphatase; Blood Proteins; Carbohydrate Metabolism; Cholinesterases; Chronic Disease; Ethambutol; Humans; Liver; Rifampin; Tuberculosis, Pulmonary | 1976 |
[Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Methods; Middle Aged; Periodicity; Rifampin; Tuberculosis, Pulmonary | 1976 |
Rifampicin--ethambutol in retreatment of pulmonary tuberculosis.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1976 |
Retreatment of chronic pulmonary tuberculosis with regimens including high and low doses of rifampicin in the intermittent phase recent and late results - a controlled comparison study.
Topics: Chronic Disease; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Poland; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1976 |
Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Texas | 1976 |
Short-course chemotherapy in pulmonary tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1976 |
Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1976 |
[Bronchoscopy in tuberculosis before and after treatment with NA 872].
Topics: Bromhexine; Bronchoscopy; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1975 |
[Therapy of tuberculosis with Rifampicin in childhood (author's transl)].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Pregnancy; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1975 |
[Current aspects in treatment of tuberculosis].
Topics: Adult; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1976 |
Polyarthritis, hepatitis and anti-native DNA antibodies after treatment with ethambutol and rifampicin.
Topics: Antibodies; Antibodies, Antinuclear; Antibody Specificity; Child; DNA; Ethambutol; Humans; Male; Mycobacterium Infections; Rifampin | 1976 |
[Pathomorphological assessment of therapeutic activity of rifampicin and ethambutol in experimental tuberculosis in white mice].
Topics: Animals; Drug Synergism; Ethambutol; Mice; Mice, Inbred BALB C; Rifampin; Tuberculosis, Pulmonary | 1975 |
Letter: Epanutin and isoniazid interaction.
Topics: Adult; Carbamazepine; Drug Interactions; Electroencephalography; Epilepsy; Ethambutol; Ethosuximide; Female; Humans; Isoniazid; Phenobarbital; Phenytoin; Rifampin | 1975 |
[New aspects of tuberculosis therapy].
Topics: Contraceptives, Oral; Ethambutol; Female; Humans; Isoniazid; Menstruation; Methods; Pulmonary Heart Disease; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1975 |
The course of untreated Mycobacterium kansasii disease.
Topics: Adult; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin; Vital Capacity | 1975 |
[Chemotherapeutic effect and pharmacokinetics of rifampicin and ethambutol].
Topics: Animals; Biological Availability; Dose-Response Relationship, Drug; Drug Evaluation; Ethambutol; Guinea Pigs; Mice; Rifampin; Tuberculosis, Pulmonary | 1975 |
Mycobacterium kansasii tendinitis and fasciitis. Report of a case treated successfully with drug therapy alone.
Topics: Ethambutol; Fascia; Humans; Inflammation; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Tendinopathy | 1975 |
[Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents].
Topics: Adult; Antitubercular Agents; Ethambutol; Functional Laterality; Humans; Isoniazid; Lipomatosis; Male; Rifampin; Syndrome; Tuberculosis, Pulmonary | 1975 |
[Organizaton and effectiveness of controlled intermittent outpatient treatment with ethambutol and rifadin in fibro-carvernous pulmonary tuberculosis].
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Hospital Administration; Humans; Middle Aged; Moscow; Outpatient Clinics, Hospital; Rifampin; Tuberculosis, Pulmonary | 1975 |
Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.
Topics: Adult; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium; Mycobacterium Infections; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors | 1975 |
Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
Topics: Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Ethambutol; Humans; Isoniazid; Rifampin; Risk; Tuberculosis, Pulmonary; United States | 1975 |
An evaluation of the current therapeutic regimen for renal tuberculosis.
Topics: Aminosalicylic Acids; Bilirubin; Color Perception; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kidney; Liver; Lung Diseases; Male; Rifampin; Tuberculosis, Renal; Visual Perception | 1975 |
[Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration].
Topics: Antitubercular Agents; Chronic Disease; Ethambutol; Follow-Up Studies; Humans; Methods; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1975 |
Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case.
Topics: Adolescent; Bone Diseases; Bone Neoplasms; Child; Diagnosis, Differential; Ethambutol; Hodgkin Disease; Humans; Isoniazid; Kanamycin; Male; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Radiography; Rifampin; Time Factors | 1975 |
Tuberculosis. Chemoprophylaxis and treatment.
Topics: Chemical and Drug Induced Liver Injury; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Patient Compliance; Rifampin; Streptomycin; Tuberculosis | 1975 |
Chemotherapy for aquarium granuloma.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Ethambutol; Female; Granuloma; Humans; Middle Aged; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Water Microbiology | 1975 |
Pregnancy and pulmonary tuberculosis.
Topics: Antitubercular Agents; BCG Vaccine; Birth Weight; Delivery, Obstetric; Ethambutol; Female; Humans; Isoniazid; New York City; Parity; Pneumothorax, Artificial; Pregnancy; Pregnancy Complications, Infectious; Rest; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1975 |
[Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Humans; Methods; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1975 |
[Liver function disorders in the course of continuous and intermittent treatment of patients with chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Liver; Liver Function Tests; Male; Methods; Rifampin; Tuberculosis, Pulmonary | 1975 |
[Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Rifampin; Sulfones; Tuberculosis | 1975 |
[Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Liver; Liver Function Tests; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1975 |
[Treatment of tuberculosis].
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1975 |
[Mechanism of the side effects of rifadin and ethambutol].
Topics: Adult; Aged; Drug Hypersensitivity; Ethambutol; Female; Humans; Male; Middle Aged; Protein Binding; Rifampin; Tuberculosis, Pulmonary | 1975 |
Genitourinary tuberculosis: study of 20 patients.
Topics: Adult; Aged; Calcinosis; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Middle Aged; Nephrectomy; Rifampin; Tuberculosis, Urogenital | 1976 |
Mycobacterium kansasii infection in the deep structures of the hand. Report of two cases.
Topics: Adult; Ethambutol; Female; Hand; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Synovectomy | 1976 |
[Anti-Tuberculous therapy with rifampicin and ethambutol during pregnancy (author's transl)].
Topics: Abnormalities, Drug-Induced; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Tuberculosis | 1976 |
[The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1976 |
[Combined rifampicin and ethambutol treatment of lupus vulgaris of the skin].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Lupus Vulgaris; Male; Middle Aged; Rifampin | 1976 |
Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Sex Factors; Taiwan; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1992 |
Rationale for chemotherapy of tuberculosis and current recommendations.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1992 |
[Activity of ethambutol, isoniazid and rifampicin on Corynebacterium urealyticum and Corynebacterium jeikeium].
Topics: Corynebacterium; Dose-Response Relationship, Drug; Ethambutol; France; Humans; In Vitro Techniques; Isoniazid; Rifampin | 1992 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Interactions; Ethambutol; Female; Humans; Hypertension; Isoniazid; Nicardipine; Nifedipine; Propranolol; Quinazolines; Rifampin | 1992 |
Development of effective drug combinations for the inhibition of multiply resistant mycobacteria, especially of the Mycobacterium avium complex.
Topics: Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifampin; Thioacetazone | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
Topics: Antitubercular Agents; Cell Division; Enviomycin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Rifampin; Streptomycin | 1992 |
Mycobacterium marinum infection: epidemiology and presentation in Queensland 1971-1990.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Environmental Exposure; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Occupational Exposure; Queensland; Recreation; Rifampin; Synovitis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
[Therapy of pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Inpatients; Isoniazid; Male; Outpatients; Pregnancy; Prothionamide; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1992 |
Clinical application of the polymerase chain reaction for a rapid diagnosis of Mycobacterium tuberculosis infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Base Sequence; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Molecular Sequence Data; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis | 1992 |
A case of disseminated Mycobacterium marinum infection in an immunocompetent patient.
Topics: Amputation, Surgical; Ethambutol; Female; Finger Injuries; Fractures, Bone; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Osteomyelitis; Rifampin; Skin Diseases, Bacterial; Water Microbiology; Wounds, Penetrating | 1992 |
[Cold tuberculous retropharyngeal abscess].
Topics: Abscess; Brachial Plexus Neuritis; Deglutition Disorders; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Neck; Rifampin; Tuberculosis | 1992 |
Pancreatic tuberculosis following renal transplantation.
Topics: Ethambutol; Female; Humans; Immunosuppression Therapy; Isoniazid; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pancreatic Diseases; Postoperative Complications; Rifampin; Transplantation, Homologous; Tuberculosis | 1992 |
Intensive short course chemotherapy for tuberculous meningitis.
Topics: Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Meningeal | 1992 |
Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty.
Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Mammaplasty; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Surgical Wound Infection | 1992 |
Resistance to antituberculosis drugs in treated patients in Lagos, Nigeria.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Nigeria; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1992 |
[Pulmonary infection caused by Mycobacterium gordonae (M. gordonae) in a healthy middle-aged male].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Pulmonary | 1992 |
Tuberculosis in the 1990's: resurgence, regimens, and resources.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Child; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; False Negative Reactions; Humans; Isoniazid; Pyrazinamide; Radiography, Thoracic; Rifampin; Risk Factors; Streptomycin; Tuberculosis; United States | 1992 |
Tubercular colitis in a patient with systemic lupus erythematosus: diagnosis by stool examination.
Topics: Adrenal Cortex Hormones; Adult; Colitis; Drug Therapy, Combination; Ethambutol; Feces; Female; Humans; Lupus Erythematosus, Systemic; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1992 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement.
Topics: Black or African American; Black People; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; South Africa; Streptomycin; Tuberculosis | 1992 |
Contemporary management of cervical tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Biopsy, Needle; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Neck; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Sputum; Streptomycin; Tuberculin Test; Tuberculosis, Lymph Node | 1992 |
Mycobacterium bovis (BCG) vaccination. Progressive disease in a patient asymptomatically infected with the human immunodeficiency virus.
Topics: Adult; BCG Vaccine; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Mycobacterium bovis; Rifampin; Tuberculosis | 1992 |
AIDS and tuberculosis in Spain. A report of 140 cases.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Prospective Studies; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Substance Abuse, Intravenous; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
[Effectiveness of the treatment of patients with fibrous-cavernous pulmonary tuberculosis].
Topics: Adult; Aged; Combined Modality Therapy; Drug Resistance, Microbial; Ethambutol; Female; Hemoperfusion; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Prednisolone; Pulmonary Fibrosis; Rifampin; Time Factors; Tuberculosis, Pulmonary; Wound Healing | 1991 |
Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex.
Topics: Antitubercular Agents; Cell Membrane Permeability; Drug Resistance, Microbial; Ethambutol; Microbial Sensitivity Tests; Mycobacterium avium Complex; Polysorbates; Rifampin; Streptomycin; Sulfadimethoxine | 1991 |
[Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
Topics: Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Wound Healing | 1991 |
[Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Liver; Liver Function Tests; Male; Rats; Rifampin | 1991 |
Erythema induratum (Bazin's disease).
Topics: Aged; Erythema Induratum; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculin Test | 1991 |
[Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
Topics: Adolescent; Adult; Drug Resistance, Microbial; Ethambutol; Female; Humans; L Forms; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1991 |
[Standardized controlled antitubercular therapy and results in 755 patients].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1991 |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
Topics: Cell Division; Cells, Cultured; Clarithromycin; Drug Combinations; Erythromycin; Ethambutol; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium; Rifampin | 1991 |
[Tuberculosis of the larynx, oral cavity and pharynx].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy; Ethambutol; Humans; Isoniazid; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Oral | 1991 |
Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Drug Resistance, Microbial; Ethambutol; Florida; HIV Infections; Humans; Isoniazid; New York City; Rifampin; Tuberculosis, Pulmonary | 1991 |
[A differential method of pharmacological prevention of tuberculosis in children in a sanatorium].
Topics: Adolescent; Carrier State; Child; Ethambutol; Health Resorts; Humans; Isoniazid; Respiratory Tract Infections; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary; Ukraine | 1991 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
From the Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.
Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Florida; HIV Infections; Humans; Isoniazid; Middle Aged; New York City; Rifampin; Tuberculosis, Pulmonary | 1991 |
Skeletal tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Spinal Diseases; Time Factors; Tuberculosis, Osteoarticular | 1991 |
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1991 |
Radiometric and conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Carbon Radioisotopes; Ethambutol; Isoniazid; Isotope Labeling; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1991 |
Cutaneous tuberculosis: atypical skin lesions in immunodepressed patients.
Topics: Adult; Colitis, Ulcerative; Ethambutol; Humans; Isoniazid; Prednisone; Rifampin; Sulfasalazine; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1990 |
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
[Pitfalls in the diagnosis of tuberculous arthritis].
Topics: Adolescent; Adult; Aged; Arthritis, Infectious; Arthritis, Rheumatoid; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Joint Prosthesis; Male; Middle Aged; Rifampin; Tuberculosis, Osteoarticular | 1991 |
[Laryngeal tuberculosis today. A case report].
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Laryngoscopy; Larynx; Rifampin; Tuberculosis, Laryngeal | 1991 |
Tuberculosis of the lacrimal gland.
Topics: Adolescent; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lacrimal Apparatus; Rifampin; Streptomycin; Tuberculosis, Ocular | 1991 |
[Drug therapy of intractable Mycobacterium infections].
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis | 1990 |
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Ethambutol; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1990 |
The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Fluorescent Antibody Technique; Guinea Pigs; Humans; Injections, Subcutaneous; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1990 |
Cutaneous inoculation tuberculosis in laboratory personnel.
Topics: Accidents, Occupational; Adolescent; Adult; Ethambutol; Female; Humans; Injections; Isoniazid; Laboratory Infection; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Cutaneous | 1990 |
Antituberculous drug resistance in central Haiti.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Haiti; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1990 |
Use of a radiometric technique for rapid sensitivity testing of mycobacteria in Scotland: the first year's experience.
Topics: Carbon Radioisotopes; Culture Media; Drug Resistance, Microbial; Egg Proteins; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Radiometry; Rifampin; Scotland | 1990 |
[Tuberculosis: a disease that is difficult to eradicate. Description of a case].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis; Tuberculosis, Lymph Node | 1990 |
Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine.
Topics: Acetylation; Arthritis, Rheumatoid; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Peripheral Nervous System Diseases; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enviomycin; Ethambutol; Humans; Isoniazid; Mycobacterium; Mycobacterium Infections; Ofloxacin; Rifampin; Viomycin | 1990 |
[Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains].
Topics: Antitubercular Agents; Enviomycin; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifampin; Streptomycin | 1990 |
Effectiveness of multidrug therapies in tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Preliminary report of short-course tuberculosis of the spine].
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Spinal | 1990 |
Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.
Topics: Aminosalicylic Acid; Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Rifampin; Streptomycin | 1990 |
Tuberculous meningitis. 23 cases from a 12-year period (1976-1987).
Topics: Adolescent; Adult; Blood Cell Count; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Prednisone; Pyridoxine; Retrospective Studies; Rifampin; Tuberculosis, Meningeal | 1990 |
Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
Topics: Carrier State; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Hepatitis B; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Hairy cell leukemia and Mycobacterium malmoense infection].
Topics: Adult; Bone Marrow; Cycloserine; Doxycycline; Ethambutol; Humans; Leukemia, Hairy Cell; Male; Mycobacterium Infections; Rifampin | 1990 |
[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Topics: Acetylation; Administration, Oral; Ethambutol; Humans; Isoniazid; Metabolic Clearance Rate; Mixed Function Oxygenases; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1990 |
[Six-month treatment of pulmonary tuberculosis in children. Review of 11 cases].
Topics: Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Rifampin; Spain; Tuberculosis, Pulmonary | 1990 |
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amikacin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Intravenous; Male; Mycobacterium avium-intracellulare Infection; Rifampin; Vomiting | 1990 |
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1986 |
Cost savings from alternative treatments for tuberculosis.
Topics: Ambulatory Care; Antitubercular Agents; Botswana; Cost-Benefit Analysis; Ethambutol; Humans; Isoniazid; Patient Compliance; Retrospective Studies; Rifampin; Thioacetazone; Tuberculosis | 1986 |
180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Thioacetazone; Tuberculosis, Pulmonary | 1988 |
Macular subretinal neovascularization in choroidal tuberculosis.
Topics: Choroid; Ethambutol; Female; Fluorescein Angiography; Fundus Oculi; Humans; Isoniazid; Macula Lutea; Middle Aged; Neovascularization, Pathologic; Photography; Retina; Retinal Diseases; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Ocular; Visual Acuity | 1989 |
Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis | 1989 |
Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
Topics: Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Libya; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1989 |
Superiority of enviomycin or streptomycin over ethambutol in initial treatment of lung disease caused by Mycobacterium avium complex.
Topics: Clinical Protocols; Drug Combinations; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Streptomycin; Viomycin | 1989 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1989 |
Antimycobacterial chemotherapy in inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium; Rifampin; Sulfasalazine | 1989 |
[Disseminated Mycobacterium marinum infection].
Topics: Child, Preschool; Clofazimine; Consanguinity; Drug Therapy, Combination; Ethambutol; Female; Hepatomegaly; Humans; Immunity, Cellular; Joint Diseases; Mycobacterium Infections; Rifampin; Skin Diseases; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Isoniazid; Leprosy, Borderline; Leprosy, Lepromatous; Male; Rifampin; Tuberculosis, Osteoarticular | 1989 |
[Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Gentamicins; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Species Specificity | 1989 |
Treatment of tuberculous meningitis in adults with a combination of isoniazid, rifampicin and streptomycin: a prospective study.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nervous System Diseases; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1989 |
Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Dapsone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prothionamide; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 1989 |
[Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1989 |
Sclerokeratitis caused by Mycobacterium marinum.
Topics: Adult; Corneal Transplantation; Ethambutol; Eye Injuries; Humans; Keratitis; Male; Minocycline; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Scleral Diseases; Skin Tests | 1989 |
Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects.
Topics: Drug Interactions; Drug Synergism; Ethambutol; Mycobacterium avium; Rifabutin; Rifampin; Rifamycins | 1988 |
Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro.
Topics: Antitubercular Agents; Ethambutol; In Vitro Techniques; Isoniazid; Luminescent Measurements; Neutrophils; Oxidation-Reduction; Peroxidase; Pyrazinamide; Rifampin; Streptomycin | 1988 |
Neurotoxicity of antituberculous drugs in a patient without active tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Optic Atrophy; Peripheral Nervous System Diseases; Rifampin | 1988 |
Treatment of nontuberculous mycobacterial infections in pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections; Rifabutin; Rifampin; Rifamycins; Streptomycin | 1988 |
The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration.
Topics: Adult; Crohn Disease; Drug Interactions; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1985 |
Pulmonary problems of pregnancy.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Drug Therapy, Combination; Ethambutol; Female; Heparin; Humans; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Infectious; Pulmonary Embolism; Rifampin; Theophylline; Tuberculosis, Pulmonary | 1985 |
[Routine use of 6-month antitubercular treatment in 300 patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1986 |
Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures.
Topics: Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Rifampin; Streptomycin | 1986 |
Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 1986 |
Tuberculosis in Korea. The relationship between prior therapy and drug resistance.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Korea; Microbial Sensitivity Tests; Military Personnel; Mycobacterium tuberculosis; Rifampin; Risk; Streptomycin; Tuberculosis, Pulmonary; United States | 1986 |
Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampin.
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Humans; Infant; Infant, Newborn; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Pulmonary | 1986 |
Drug-resistant tuberculosis in Sierra Leone.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sierra Leone; Streptomycin; Tuberculosis | 1986 |
The Birmingham Tuberculosis Drug Resistance Register, 1956-1983.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Microbial; Emigration and Immigration; England; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Registries; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Topics: Anti-Bacterial Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Streptomycin; Sulfamethoxazole | 1986 |
A rapid method for the evaluation of new antituberculous agents.
Topics: Antitubercular Agents; Carbon Dioxide; Ethambutol; Guanidines; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Scintillation Counting; Streptomycin; Succinimides; Thiazoles; Time Factors | 1987 |
Proficiency testing of conventional drug susceptibility tests of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Ethambutol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1987 |
Direct antimicrobial drug susceptibility testing of Mycobacterium tuberculosis by the radiometric method.
Topics: Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Rifampin; Sputum; Streptomycin | 1988 |
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP.
Topics: Adenosine Triphosphate; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Isoniazid; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Radiometry; Rifampin; Streptomycin; Time Factors | 1988 |
Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan.
Topics: Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Osmolar Concentration; Rifampin; Streptomycin; Tuberculosis; United States | 1988 |
The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; San Francisco; Sputum; Time Factors; Tuberculosis, Pulmonary | 1988 |
Identification and control of paratuberculosis in a large goat herd.
Topics: Animals; Disease Outbreaks; Ethambutol; Female; Goats; Immunodiffusion; Isoniazid; Male; Paratuberculosis; Rifampin; Sex Factors; Weight Loss | 1988 |
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1988 |
[New and future drugs in pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1988 |
Management and outcome of pulmonary tuberculosis in adults notified in England and Wales in 1983. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Antitubercular Agents; Bangladesh; Drug Administration Schedule; England; Ethambutol; Female; Follow-Up Studies; Hospitalization; Humans; India; Isoniazid; Male; Pakistan; Patient Acceptance of Health Care; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Wales | 1988 |
[A case of Mycobacterium kansasii lung infection developed after treatment of Mycobacterium gordonae lung infection].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 1988 |
[Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
Topics: Animals; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; In Vitro Techniques; Isoniazid; Mice; Mycobacterium; Mycobacterium Infections; Rifampin | 1988 |
A retrospective comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Radiography; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1988 |
Psoas abscess due to retroperitoneal tuberculous lymphadenopathy.
Topics: Abscess; Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Muscular Diseases; Retroperitoneal Space; Rifampin; Time Factors; Tuberculosis, Lymph Node | 1988 |
Multidrug chemotherapy of tuberculosis in rhesus monkeys.
Topics: Animals; Antitubercular Agents; Disease Outbreaks; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Macaca; Macaca mulatta; Male; Monkey Diseases; Mycobacterium bovis; Radiography; Rifampin; Tuberculosis | 1988 |
Drugs for tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis | 1988 |
[Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period].
Topics: Antitubercular Agents; Enviomycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Streptomycin | 1988 |
Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1987 |
[Peritoneal tuberculosis. Apropos of a case report].
Topics: Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Peritonitis, Tuberculous; Rifampin; Tomography, X-Ray Computed | 1987 |
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
Topics: Adult; Antitubercular Agents; Child; Culture Media; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Streptomycin | 1987 |
Conservative treatment of tuberculosis of the thoracic and lumbar spine in adults and children.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Lumbar Vertebrae; Male; Middle Aged; Rifampin; Thoracic Vertebrae; Tuberculosis, Spinal | 1987 |
[Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Ofloxacin; Oxazines; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children.
Topics: Adult; Age Factors; Blood Cell Count; Blood Urea Nitrogen; Child; Creatinine; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lactation; Liver; Mycobacterium bovis; Pregnancy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculin; Tuberculosis | 1986 |
[Observations on the effect of PZA, EB and RFP on uric acid metabolism].
Topics: Adolescent; Adult; Arthritis; Drug Therapy, Combination; Ethambutol; Female; Gout; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Uric Acid | 1986 |
New approach to treatment of pulmonary and extrapulmonary tuberculosis. Possible ramifications of cutaneous mycobacterial infections.
Topics: Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1987 |
Serum concentration and urinary elimination of ethambutol administered alone and in combination with rifampin in patients of pulmonary tuberculosis.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1986 |
Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.
Topics: Cervical Vertebrae; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Pyrazinamide; Rifampin; Tuberculosis, Spinal | 1987 |
Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Osmolar Concentration; Radiometry; Rifampin; Streptomycin | 1987 |
Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1987 |
Tuberculous pleural effusion and lymphadenitis treated with rifampin-containing regimen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pleural Effusion; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Pleural | 1987 |
Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Debridement; Ethambutol; Female; Hand; Humans; Male; Middle Aged; Mycobacterium Infections; Physical Therapy Modalities; Prognosis; Prospective Studies; Rifampin; Tenosynovitis; Wound Healing; Wrist | 1987 |
Pharmacokinetics of antituberculosis drugs in patients.
Topics: Adult; Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1987 |
Antituberculous agents.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1987 |
A case of clinically unsuspected Mycobacterium marinum infection.
Topics: Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections; Rifampin | 1987 |
[Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Topics: Adult; Algeria; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Transients and Migrants; Tuberculosis, Pulmonary | 1986 |
[Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; France; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Toxic overdose of isoniazid, rifampicin and ethambutol.
Topics: Acidosis; Adult; Alanine Transaminase; Aspartate Aminotransferases; Ethambutol; Female; Humans; Isoniazid; Renal Dialysis; Rifampin; Seizures | 1986 |
[Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
Topics: Adolescent; Adult; Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Rural Population; Sputum; Tuberculosis, Pulmonary | 1986 |
Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Respiratory Distress Syndrome; Rifampin; Tuberculosis, Pulmonary | 1986 |
Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Tuberculosis | 1986 |
[Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Topics: Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1986 |
[Preventive chemotherapy in tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Tuberculosis, Pulmonary | 1986 |
Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
Topics: Adolescent; Adult; Aged; Asia, Southeastern; Australia; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Prospective Studies; Pyrazinamide; Refugees; Rifampin; Tuberculosis, Pulmonary | 1985 |
Gynaecological tuberculosis: analysis of a personal series of 710 cases.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Ethambutol; Fallopian Tube Diseases; Female; Humans; Isoniazid; Middle Aged; Ovarian Diseases; Rifampin; Tuberculosis, Female Genital; Uterine Diseases | 1985 |
Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.
Topics: Culture Media; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Streptomycin | 1985 |
Short course chemotherapy for tuberculosis of lymph nodes.
Topics: Adolescent; Adult; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Lymph Node | 1985 |
The action of antituberculosis drugs in short-course chemotherapy.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sterilization; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1985 |
[Chemotherapeutic treatment of pulmonary tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Hydrazines; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1985 |
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.
Topics: Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Rifampin; Streptomycin | 1985 |
Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria.
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Fluorescent Antibody Technique; Isoniazid; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1985 |
Tuberculosis control practices in major metropolitan health departments in the United States. 3. Standard of practice in 1984.
Topics: Adolescent; Adult; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Health Facilities; Health Policy; Health Surveys; Humans; Isoniazid; Public Health Administration; Rifampin; Tuberculosis; United States | 1985 |
Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Medical Research Council Tuberculosis and Chest Diseases Unit.
Topics: Adolescent; Adult; Drug Therapy, Combination; England; Ethambutol; Female; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary; Wales | 1985 |
Mycobacterium marinum infection in a 4-year-old child.
Topics: Axilla; Child, Preschool; Combined Modality Therapy; Drainage; Elbow; Ethambutol; Female; Humans; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Infectious; Wrist | 1985 |
Dosage of antituberculous drugs in obese patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Obesity; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Miliary | 1985 |
Tuberculosis of the female genital tract.
Topics: Adult; Aminosalicylic Acid; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Female Genital | 1985 |
Chemotherapeutic agents in pulmonary tuberculosis with special reference to isoniazid-ethambutol continuation therapy.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1985 |
Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Patient Compliance; Rifampin; Sputum; Tuberculosis, Pulmonary | 1985 |
Successful nonsurgical treatment of tuberculous empyema in an irreducible pleural space.
Topics: Administration, Oral; Aged; Antitubercular Agents; Empyema, Tuberculous; Ethambutol; Female; Humans; Isoniazid; Punctures; Rifampin; Tuberculosis, Pleural | 1985 |
Clinical experience with short-course chemotherapy in patients with tubercular pleural effusion and lymphadenitis.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymphadenitis; Male; Middle Aged; Pleural Effusion; Rifampin; Time Factors; Tuberculosis | 1985 |
[Effect of rifampicin and ethambutol on indices of the sympathoadrenal system in patients with recurrent pulmonary tuberculosis].
Topics: Adrenal Glands; Adult; Catecholamines; Chronic Disease; Ethambutol; Female; Humans; Male; Middle Aged; Recurrence; Rifampin; Sympathetic Nervous System; Tuberculosis, Pulmonary | 1985 |
Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Random Allocation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1985 |
Influence of rifampicin and isoniazid on the kinetics of phenytoin.
Topics: Acetylation; Adult; Aged; Ethambutol; Female; Half-Life; Humans; Isoniazid; Kinetics; Male; Middle Aged; Phenotype; Phenytoin; Rifampin; Tuberculosis, Pulmonary | 1985 |
Cerebellar tuberculoma: a rare disease in an industrialized country.
Topics: Cerebellar Diseases; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Radiography; Rifampin; Tuberculoma | 1985 |
Adult tuberculous meningitis: comparative study of different chemotherapeutic regimens.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Meningeal | 1985 |
[Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Middle Aged; Recurrence; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1985 |
Tuberculous infection.
Topics: Adolescent; Adult; Africa, Eastern; Aged; Costs and Cost Analysis; Delayed-Action Preparations; Developing Countries; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Rural Population; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1971 |
Rifampicin and thrombocytopenia.
Topics: Alcoholism; Aspartate Aminotransferases; Bilirubin; Chronic Disease; Ethambutol; Humans; Liver Cirrhosis; Male; Melena; Middle Aged; Recurrence; Rifampin; Sputum; Thrombocytopenia; Tuberculosis, Pulmonary | 1971 |
Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Thioacetazone; Tuberculosis, Pulmonary | 1971 |
Clinical results of rifampicin treatment.
Topics: Administration, Oral; Adult; Aged; Capreomycin; Chronic Disease; Drug Combinations; Ethambutol; Female; Humans; Kanamycin; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Oxytetracycline; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Recent developments in the treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1972 |
[Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1971 |
New drugs in tuberculosis.
Topics: Capreomycin; Chemical and Drug Induced Liver Injury; Drug Combinations; Ethambutol; Gastrointestinal Diseases; Rifampin; Tuberculosis | 1971 |
Permeability of tuberculous cavities to antituberculosis drugs.
Topics: Adult; Antitubercular Agents; Capreomycin; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Lung; Middle Aged; Mycobacterium tuberculosis; Permeability; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1972 |
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
Topics: Adolescent; Adult; Africa, Northern; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Ethnicity; Female; France; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary; Viomycin | 1972 |
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Thrombocytopenia; Viomycin | 1973 |
[Dihydrostreptomycin as a factor inducing L-forms in Mycobacterium tuberculosis].
Topics: Cycloserine; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; L Forms; Mycobacterium tuberculosis; Penicillins; Rifampin | 1972 |
Supervised ambulatory treatment of tuberculosis with brief initial hospitalization.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Aminosalicylic Acids; Capreomycin; Convalescence; Disability Evaluation; Drug Therapy, Combination; Ethambutol; Female; Finland; Hospitalization; Humans; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Self Medication; Sex Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
PAS.
Topics: Aminosalicylic Acids; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
Topics: Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Ethambutol; Ethionamide; Finland; Humans; Isoniazid; Patient Dropouts; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
[Tuberculosis drug therapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors | 1973 |
[Induction of L-forms of Mycobacterium tuberculosis under the action of ethambutol, ethionamide and their combinations with some antibiotic and tuberculostatic drugs].
Topics: Cycloserine; Dihydrostreptomycin Sulfate; Drug Combinations; Ethambutol; Ethionamide; Humans; L Forms; Mycobacterium tuberculosis; Penicillins; Rifampin | 1973 |
[Phases of morphogenesis of L forms of Mycobacterium tuberculosis, developing on exposure to antibiotics and tuberculostatic agents].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; L Forms; Mycobacterium tuberculosis; Penicillins; Rifampin | 1973 |
[Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl)].
Topics: Capreomycin; Drug Resistance, Microbial; Ethambutol; Female; Germany, West; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Urogenital | 1973 |
[Therapy of urogenital tuberculosis. Urological aspects].
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Synergism; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Male; Radiography; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1974 |
Nontuberculous mycobacterial infections of man.
Topics: Capreomycin; Child; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Lung Diseases; Lymphadenitis; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Sputum; Streptomycin | 1974 |
Letter: Rifampicin and drug metabolism.
Topics: Aminosalicylic Acids; Contraceptives, Oral; Ethambutol; Female; Growth Hormone; Half-Life; Humans; Isoniazid; Liver; Rifampin; Streptomycin; Tolbutamide | 1974 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Binding of rifampicin by human plasma proteins.
Topics: Adult; Aged; Aminosalicylic Acids; Blood Proteins; Carbon Radioisotopes; Chromatography, Thin Layer; Dialysis; Ethambutol; Female; Fibrinogen; gamma-Globulins; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Rifampin; Serum Albumin; Streptomycin; Tuberculosis | 1974 |
A case of irreversible bilateral optic damage after ethambutol therapy.
Topics: Aged; Capreomycin; Electroretinography; Ethambutol; Humans; Male; Optic Atrophy; Optic Neuritis; Rifampin; Scotoma; Time Factors; Tuberculosis, Pulmonary; Visual Fields; Vitamin B Complex | 1974 |
Treatment of pulmonary tuberculosis.
Topics: Capreomycin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cycloserine; Depression; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Kanamycin; Kidney Diseases; Optic Neuritis; Patient Education as Topic; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
A national therapy project for drug resistant pulmonary tuberculosis.
Topics: Adult; Aged; Capreomycin; Creatinine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Norway; Rifampin; Time Factors; Transaminases; Tuberculosis, Pulmonary; Vision Disorders | 1974 |
[Comparative determinations of Mycobacterium resistance using the vertical diffusion test and the proportion method (economical test)].
Topics: Aminosalicylic Acids; Capreomycin; Diffusion; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin | 1974 |
Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
Topics: Capreomycin; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Mycobacterium tuberculosis; Paromomycin; Rifampin; Sulfisoxazole; Tuberculosis; Viomycin | 1974 |
Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
Topics: Adult; Aged; Capreomycin; Drug Resistance, Microbial; Drug Therapy, Combination; England; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary; Wales | 1974 |
[2d day of round-table conference on "perfected methods of antibacillary treatment of pulmonary tuberculosis"].
Topics: Aminosalicylic Acids; Chronic Disease; Congresses as Topic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Poland; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Advances in the therapy of tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Male; Middle Aged; Pyrazines; Rifampin; Tuberculosis, Pulmonary | 1970 |
New drugs against tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mice; Rifampin; Tuberculosis, Pulmonary | 1969 |
The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
Topics: Animals; Ethambutol; Ethionamide; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis | 1969 |
Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
Topics: Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kinetics; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Steroid-responsive hypercalcemia in disseminated bone tuberculosis.
Topics: Acute Disease; Adult; Clavicle; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Hypercalcemia; Isoniazid; Male; Military Medicine; Mycobacterium tuberculosis; Phosphates; Prednisone; Radiography; Rifampin; Streptomycin; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1973 |
A survey of mycobacterial isolates from the Randwick Chest Hospital, Sydney, in an 18-month period, 1970 to 1971.
Topics: Adult; Aged; Aminosalicylic Acids; Australia; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1973 |
Endobronchial tuberculosis.
Topics: Aged; Bronchial Diseases; Bronchoscopy; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Tracheal Diseases; Tuberculosis | 1973 |
Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
Topics: Aminosalicylic Acids; Bacteriophage Typing; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Male; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; Urease | 1973 |
[Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phosphorus Radioisotopes; Rifampin; Streptomycin | 1973 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aged; Aminosalicylic Acids; Diarrhea; Drug Resistance, Microbial; England; Ethambutol; Headache; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro].
Topics: Drug Resistance, Microbial; Ethambutol; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1973 |
Tuberculosis in a patient after renal transplantation.
Topics: Adult; Azathioprine; Bacteriuria; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Male; Mycobacterium tuberculosis; Postoperative Complications; Prednisone; Rifampin; Sputum; Transplantation, Homologous; Tuberculin Test; Tuberculosis, Pulmonary | 1973 |
[Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
Topics: Animals; Drug Resistance, Microbial; Ethambutol; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Tuberculosis in Acukland.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethnicity; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Mycobacterium tuberculosis; New Zealand; Rifampin; Sex Factors; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1973 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States | 1974 |
Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn.
Topics: Antitubercular Agents; Child; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; New York City; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. II. The role of rifampicin and other drugs in the dependent or independent action of drug associations in vitro.
Topics: Antitubercular Agents; Aspirin; Culture Media; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Microbial; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1974 |
[Antimycobacterial effect of ethambutol and rifampin in vitro and determination of sensitivity of Mycobacterium tuberculosis].
Topics: Animals; Birds; Ethambutol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Avian; Tuberculosis, Pulmonary | 1974 |
[Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
Topics: Adaptation, Physiological; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Long-Term Care; Rifampin; Streptomycin; Transaminases; Tuberculosis | 1974 |
Antibiotics, antiseptics and tubercle bacilli.
Topics: Aminosalicylic Acids; Anti-Infective Agents, Local; Antitubercular Agents; DNA-Directed RNA Polymerases; Drug Therapy, Combination; Ethambutol; Folic Acid; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; RNA, Messenger; RNA, Transfer; Streptomycin | 1974 |
Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972.
Topics: Adolescent; Aminosalicylic Acids; Antibiotics, Antitubercular; Child; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiography; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
The effect of radiation on microbiologic characteristics of M tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cell Survival; Chromosomes, Bacterial; Cycloserine; Dose-Response Relationship, Radiation; Drug Resistance, Microbial; Ethambutol; Ethionamide; Freezing; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Preservation, Biological; Pyrazinamide; Radiation Genetics; Rifampin; Streptomycin | 1974 |
Ambulatory management of tuberculosis.
Topics: Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Resistance, Microbial; Ethambutol; Humans; Infant; Isoniazid; Kidney Function Tests; Liver Function Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Hepatic damage in patients treated with rifampicin (author's transl)].
Topics: Aspartate Aminotransferases; Biopsy; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasm; Drug Therapy, Combination; Ethambutol; Humans; Long-Term Care; Microscopy, Electron; Middle Aged; Mitochondria, Liver; Rifampin | 1974 |
[Neutralization of the sputum in newly detected patients with pulmonary tuberculosis treated during the years 1967 to 1970].
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1974 |
[Change in drug resistance of Mycobacterium tuberculosis in experimental studies].
Topics: Animals; Anti-Bacterial Agents; Culture Techniques; Drug Resistance, Microbial; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Nitrofurans; Rifampin; Streptomycin | 1974 |
[Cooperative study of short-term antibacillary treatments in 14 French centers].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pregnancy; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Algodystrophy associated with antitubercular chemotherapy: 22 cases].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Niacinamide; Pyrazinamide; Reflex Sympathetic Dystrophy; Rifampin; Tuberculosis; Vitamin B Deficiency | 1969 |
[Contribution of the new antibiotics to phthisiological therapy].
Topics: Adult; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
Topics: Adolescent; Adult; Aged; Bilirubin; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Transaminases | 1971 |
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
Topics: Bilirubin; Drug Eruptions; Drug Hypersensitivity; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Transaminases; Tuberculosis, Pulmonary | 1972 |
Isoniazid administration and liver injury.
Topics: Aminosalicylic Acids; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Child; Drug Eruptions; Ethambutol; Fever; Humans; Isoniazid; Liver; Male; Pain; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Effect of schizophyllan in experimental tuberculosis].
Topics: Animals; Antitubercular Agents; Basidiomycota; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethambutol; Glycosaminoglycans; Liver; Lung; Lymph Nodes; Male; Mice; Polysaccharides; Rifampin; Spleen; Streptomycin; Tuberculosis | 1973 |
[Effects of schizophyllan on the fate of Mycobacterium tuberculosis within macrophages and lungs of mice (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Ethambutol; Glycosaminoglycans; Lung; Macrophages; Male; Mice; Mycobacterium tuberculosis; Phagocytosis; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Facial paralysis caused by tubercular otitis. Current therapeutic possibilities].
Topics: Adult; Ethambutol; Facial Paralysis; Female; Humans; Isoniazid; Male; Otitis; Rifampin; Tuberculosis | 1974 |
[Treatment with new antitubercular agents].
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis; Viomycin | 1968 |
The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1968 |
[Drug sensitivity of the so-called atypical mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Morpholines; Mycobacterium; Pyrazinamide; Pyrazines; Rifampin; Streptomycin; Viomycin | 1968 |
[How to oversee the treatment of tuberculosis?].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Long-Term Care; Male; Medication Errors; Middle Aged; Rifampin; Streptomycin; Tuberculosis | 1970 |
Treatment of patients with drug-resistance in economically developed countries.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Costs and Cost Analysis; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1969 |
[Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitubercular Agents; Body Weight; Ethambutol; Ethionamide; Injections, Intramuscular; Kanamycin; Lung; Mice; Organ Size; Pyrazinamide; Rifampin; Spleen; Tuberculosis; Viomycin | 1971 |
[Thoughts on pulmonary tuberculosis in the aged].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Hypothyroidism; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
Topics: Antitubercular Agents; Bacteriological Techniques; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Viomycin | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Tuberculostatics. General adverse effects].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Neomycin; Oxytetracycline; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1972 |
[Electroencephalographic changes and antitubercular treatments].
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Aminosalicylic Acids; Antitubercular Agents; Drug Interactions; Electroencephalography; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Sex Factors; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Duration of the after-control of the tuberculous patients following the termination of the treatment].
Topics: Adolescent; Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Thiosemicarbazones; Time Factors; Tuberculosis, Pulmonary; Viomycin | 1972 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
[Cold thoracic abscess due to Histoplasma duboisii. Treatment using rifampicin].
Topics: Abscess; Adult; Diagnosis, Differential; Ethambutol; Fluorescent Antibody Technique; Histoplasma; Histoplasmosis; Humans; Isoniazid; Male; Rifampin; Skin Tests; Thorax; Tuberculosis | 1973 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[Encapsulating peritonitis: diagnostic and etiologic problems].
Topics: Adrenal Cortex Hormones; Adult; Ethambutol; Female; Humans; Isoniazid; Laparotomy; Middle Aged; Peritonitis; Peritonitis, Tuberculous; Radiography, Abdominal; Radiography, Thoracic; Rifampin; Tuberculosis, Gastrointestinal | 1973 |
[The liver and rifampicin].
Topics: Bilirubin; Biopsy; Chemical and Drug Induced Liver Injury; Drug Interactions; Ethambutol; Humans; Isoniazid; Liver; Phosphoric Monoester Hydrolases; Rifampin; Transaminases; Tuberculosis | 1973 |
[Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
Topics: Adult; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Evaluation; Ethambutol; Ethionamide; Female; Hospitals, Special; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary; Viomycin | 1974 |
Recent trends in tuberculosis care.
Topics: Aftercare; Alcoholism; Aminosalicylic Acids; Ethambutol; Hospitals, Special; Humans; Isoniazid; Occupational Health Services; Patient Education as Topic; Population Surveillance; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Virginia | 1974 |
Atypical mycobacteriosis of the urinary tract. A case report of extensive disease caused by the Battey bacillus.
Topics: Ethambutol; Female; Humans; Isoniazid; Middle Aged; Minnesota; Mycobacterium; Mycobacterium Infections; Radiography, Abdominal; Rifampin; Streptomycin; Urinary Tract Infections; Urography; Urologic Diseases | 1974 |
[Intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Survey of the tuberculosis problem in the Nordic countries. Are BCG vaccination and mass screening necessary?].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; BCG Vaccine; Ethambutol; Female; Humans; Iceland; Infant, Newborn; Isoniazid; Male; Mass Chest X-Ray; Middle Aged; Registries; Retrospective Studies; Rifampin; Scandinavian and Nordic Countries; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1974 |
[Toxic effect of rifampicin and ethambutol on liver in white mice].
Topics: Animals; Ethambutol; Liver; Mice; Mice, Inbred BALB C; Rifampin | 1974 |
Intermittent chemotherapy for adults with tuberculosis.
Topics: Administration, Oral; Adult; Drug Resistance, Microbial; Ethambutol; Humans; Injections, Intramuscular; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1974 |
[The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
Topics: Administration, Oral; Adult; Antitubercular Agents; Digitoxin; Drug Therapy, Combination; Ethambutol; Humans; Hydroxylation; Intestinal Absorption; Isoniazid; Kidney Tubules; Kinetics; Liver; Middle Aged; Protein Binding; Radioimmunoassay; Rifampin; Tuberculosis | 1974 |
[Current therapy of pulmonary tuberculosis].
Topics: Anti-Bacterial Agents; Convalescence; Drug Therapy, Combination; Ethambutol; Hospitals, Special; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Hematopoietic tuberculosis].
Topics: Bone Marrow; Bone Marrow Examination; Cholestasis; Erythema; Ethambutol; Humans; Isoniazid; Leukopenia; Male; Middle Aged; Neutropenia; Peritonitis, Tuberculous; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Osteoarticular; Tuberculosis, Splenic; Vitamin B Complex | 1974 |
[Clinico-radiographic dynamics of chronic destructive forms of pulmonary tuberculosis during treatment with ethambutol and rifampicin].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Evaluation; Ethambutol; Female; Humans; Male; Middle Aged; Radiography; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
Topics: Adrenal Cortex; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Intermittent method of using rifadin in chronic destructive pulmonary tuberculosis].
Topics: Adult; Aged; Ambulatory Care; Drug Evaluation; Ethambutol; Hospitalization; Humans; Middle Aged; Radiography; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Chronic Disease; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Determinations of concentration of tuberculostatics].
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Methods; Rifampin; Streptomycin | 1974 |
[Rifampycine in the treatment of chronic pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Evaluation; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
[A clinico-electrophysiologic study of ethambutol and rifampicin during long-term treatment].
Topics: Adolescent; Adult; Brain Diseases; Electroencephalography; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Proposals for a standard therapy of cutaneous tuberculosis].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Cutaneous | 1974 |
[Results of treatment of chronic tuberculosis with rifampicin and ethambutol at the sanatoria run by the Railroad Health Services].
Topics: Chronic Disease; Drug Therapy, Combination; Ethambutol; Humans; Occupational Medicine; Railroads; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Effect of ethambutol and rifampicin on sputum conversion in chronically infectious patients].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Ethambutol; Humans; Middle Aged; Rifampin; Sputum; Tuberculosis, Pulmonary | 1974 |
[Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Methods; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Methods; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
[Bacteriological analysis of patients treated with rifampicin and ethambutol under hospital and ambulatory conditions in Poznan in the years 1969-1972 with special reference to methods of patient surveillance].
Topics: Adult; Chronic Disease; Ethambutol; Humans; Middle Aged; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1974 |
Experiences with rifampicin.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Tuberculosis | 1974 |
The impact of rifampicin on the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1974 |
Experiences with rifampicin.
Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Tuberculosis | 1974 |
[Present status and future of indication of surgical treatment for pulmonary tuberculosis in relationship to progress of chemotherapy].
Topics: Ethambutol; Follow-Up Studies; Humans; Methods; Prognosis; Rifampin; Tuberculosis, Pulmonary | 1974 |
Drugs used in the management of tuberculosis. IV. Secondary tuberculostatic agents.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Rifampin; Tuberculosis | 1973 |
[ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Combinations; Ethambutol; Female; Humans; Male; Middle Aged; Patient Dropouts; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pilot Projects; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
Topics: Adult; Aged; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Silicotuberculosis; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Functional state of the adrenal cortex in patients with pulmonary tuberculosis during treatment with rifampin and ethambutol].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adult; Endopeptidases; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Rapid visual test for the determination of drug resistance in comparison with the economic test].
Topics: Culture Media; Drug Resistance, Microbial; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Suspensions; Time Factors | 1974 |
[A case of mandibular tuberuclosis].
Topics: Biopsy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mandibular Diseases; Middle Aged; Rifampin; Sarcoidosis; Tuberculosis, Osteoarticular | 1972 |
The predictability of hypersensitivity to anti-tuberculous drugs.
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Blood Sedimentation; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Leukocyte Count; Lymphocytes; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Side effects of rifampicin. A clinical study.
Topics: Acute Disease; Acute Kidney Injury; Adult; Ambulatory Care; Amylases; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hematologic Diseases; Humans; Isoniazid; Liver; Male; Pancreatitis; Prednisolone; Recurrence; Rifampin; Stimulation, Chemical; Streptomycin; Transaminases; Tuberculosis, Pulmonary | 1973 |
Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Topics: Acute Kidney Injury; Adolescent; Cycloserine; Drug Therapy, Combination; Dyspnea; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Headache; Humans; Purpura, Thrombocytopenic; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
A trial of intermittent rifampicin and ethambutol in retreatment regimens.
Topics: Adult; Cells, Cultured; Cerebral Hemorrhage; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Purpura, Thrombocytopenic; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1973 |
The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
Topics: Ambulatory Care; Drug Therapy, Combination; Ethambutol; Female; Headache; Humans; Male; Nausea; Purpura, Thrombocytopenic; Rifampin; Tuberculosis, Pulmonary; Vomiting | 1973 |
Intermittent rifampicin treatment of tuberculosis.
Topics: Drug Therapy, Combination; Ethambutol; Fever; Headache; Humans; Isoniazid; Kidney Diseases; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
Topics: Adult; Body Weight; Drug Therapy, Combination; Ethambutol; Exanthema; Female; Fever; Follow-Up Studies; Gastrointestinal Diseases; Hemorrhage; Humans; Male; Middle Aged; Pain; Pyrazinamide; Recurrence; Rifampin; Shock; Sputum; Time Factors; Tuberculosis, Pulmonary | 1973 |
Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Topics: Body Weight; Drug Therapy, Combination; Ethambutol; Female; Fever; Headache; Humans; Male; Nausea; Pain; Purpura, Thrombocytopenic; Rifampin; Time Factors; Tuberculosis, Pulmonary; Vomiting | 1973 |
Clinical aspects of side effects on intermittent rifampicin regimen.
Topics: Acute Kidney Injury; Antibodies; Drug Therapy, Combination; Ethambutol; Fever; Headache; Hemorrhage; Humans; Liver Function Tests; Nausea; Purpura, Thrombocytopenic; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1973 |
Haematological changes during intermittent treatment with rifampicin.
Topics: Antibody Formation; Blood Cell Count; Blood Platelets; Cerebral Hemorrhage; Dyspnea; Ethambutol; Humans; Immunoglobulins; Liver Function Tests; Male; Middle Aged; Prednisone; Purpura, Thrombocytopenic; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Rhinoscleroma with tracheobronchial spread].
Topics: Antitubercular Agents; Diagnosis, Differential; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Klebsiella pneumoniae; Middle Aged; Rhinitis; Rhinoscleroma; Rifampin; Streptomycin; Vitamin D | 1973 |
[BCG infection of hematopoietic organs with cellular immune deficiency].
Topics: Adolescent; Adrenal Cortex Hormones; Anemia; Antibodies; BCG Vaccine; Biopsy; Bone Marrow Diseases; Ethambutol; Female; Fever; Hepatomegaly; Humans; Immunity, Cellular; Immunoglobulins; Immunologic Deficiency Syndromes; Iron; Isoniazid; Leukocyte Count; Lymph Nodes; Lymphocytes; Lymphopenia; Mycobacterium bovis; Mycobacterium Infections; Rifampin; Splenic Diseases; Splenomegaly; Tuberculin Test | 1974 |
Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs.
Topics: Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1972 |
[Isotope clearance examinations in patients with urogenital tuberculosis].
Topics: Chromium Isotopes; Diuresis; Edetic Acid; Ethambutol; Female; Humans; Iodohippuric Acid; Isoniazid; Radioisotope Renography; Rifampin; Time Factors; Tuberculosis, Urogenital | 1972 |
Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Drug Resistance; Ethambutol; Female; Humans; Leukocyte Count; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1972 |
A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
Topics: Adolescent; Adult; Aged; Bilirubin; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Jaundice; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Tuberculosis, Pulmonary | 1972 |
Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Bilirubin; Blood Proteins; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Radiography; Rifampin; Sputum; Transaminases; Tuberculosis, Pulmonary | 1972 |
The antituberculosis efficacy of rifampin in 136 patients.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Intermittent chemotherapy in pulmonary tuberculosis--current aspects.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Long-Term Care; Methods; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Critical concentration for definition of rifampicin resistance of tubercle bacilli].
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1972 |
[Comparative data from an experimental-clinical study of new antituberculosis drugs].
Topics: Antitubercular Agents; Carbanilides; Ethambutol; Humans; Mycobacterium tuberculosis; Phenylthiourea; Piperazines; Rifampin; Streptomycin; Sulfides; Thiosemicarbazones; Tuberculosis, Pulmonary | 1972 |
[Chemotherapy of tuberculosis demonstrated on the model-example of exudative tubercular pleurisy].
Topics: Adrenal Cortex Hormones; Ethambutol; Humans; Isoniazid; Long-Term Care; Models, Biological; Pleurisy; Rifampin; Tuberculosis, Pleural | 1973 |
Rifampin in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Treatment of INH resistant tuberculo-pneumoconiosis with the rifampicin-ethambutol combination].
Topics: Drug Combinations; Drug Resistance, Microbial; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Rifampin; Silicotuberculosis; Sputum | 1972 |
[Treatment of tuberculosis in childhood].
Topics: Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1972 |
[Modern view on drug therapy of tuberculosis].
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1972 |
The Australian rifampicin trial.
Topics: Adult; Aged; Costs and Cost Analysis; Drug Resistance, Microbial; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections; Rifampin; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 1972 |
Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1972 |
A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Topics: Adolescent; Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Preventive treatment of tuberculosis].
Topics: Antitubercular Agents; Communicable Disease Control; Disease Reservoirs; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculin Test; Tuberculosis, Pulmonary | 1972 |
[Ambulatory chemotherapy of tuberculosis].
Topics: Ambulatory Care; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Outpatient Clinics, Hospital; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Progress and prospects in chemotherapy of pulmonary tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
Topics: Adult; Ethambutol; Female; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Therapy of tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1972 |
[Studies on results of rifampicin treatment after surgical failure].
Topics: Adult; Ethambutol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Pneumonectomy; Rifampin; Thoracoplasty; Tuberculosis, Pulmonary | 1972 |
The treatment of tuberculosis of the skin with a combination of rifampicin, ethambutol and isoniazid.
Topics: Aged; Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Cutaneous | 1972 |
Ethambutol in therapy of complicated tuberculosis.
Topics: Adolescent; Adult; Aged; Drug Combinations; Drug Tolerance; Ethambutol; Female; Follow-Up Studies; Hepatitis A; Humans; Liver; Liver Function Tests; Male; Meningitis; Middle Aged; Pelvic Inflammatory Disease; Rifampin; Spondylitis; Sputum; Tuberculosis, Pulmonary | 1973 |
[Toxicity of antitubercular agents for the liver].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin | 1973 |
[Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
Topics: Animals; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Methods; Rifampin; Tuberculosis | 1973 |
[Bacteriologic results of treatment with rifampicin and ethambutol administered continuously or intermittently in experimental tuberculosis in white mice].
Topics: Animals; Drug Synergism; Ethambutol; Methods; Mice; Mice, Inbred BALB C; Rifampin; Tuberculosis, Pulmonary | 1973 |
Mycobacterium marinum infections of the hand. Report of three cases and review of the literature.
Topics: Debridement; Ethambutol; Female; Hand Dermatoses; Hand Injuries; Humans; Inflammation; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin; Synovectomy; Water Microbiology | 1973 |
[Antitubercular activity and concentrations of rifampicin and ethambutol in the organs].
Topics: Animals; Disease Models, Animal; Ethambutol; Mice; Rifampin; Tuberculosis | 1973 |
[Treatment of pulmonary, pleural and vertebral tuberculosis].
Topics: Dexamethasone; Drug Hypersensitivity; Ethambutol; Glomerular Filtration Rate; Humans; Isoniazid; Pleural Effusion; Pyridoxine; Rifampin; Tuberculosis, Pulmonary; Tuberculosis, Spinal | 1973 |
Transfer factor therapy in a patient with progressive primary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Cell Migration Inhibition; Ethambutol; Female; Humans; Immunity, Cellular; Immunity, Maternally-Acquired; Isoniazid; Lectins; Lymphocytes; Macrophages; Pyrazinamide; Radiography; Rifampin; Splenectomy; Streptodornase and Streptokinase; Streptomycin; Thymidine; Tritium; Tuberculin Test; Tuberculosis, Pulmonary | 1973 |
[Etiopathogenic and therapeutical considerations on a case of primary multiple resistance to tuberculostatics].
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Current aspects of the therapy of lymph node tuberculosis].
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Lymphadenitis; Male; Rifampin; Tuberculosis, Lymph Node | 1973 |
[Treatment of laryngeal tuberculosis (author's transl)].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis, Laryngeal | 1973 |
[Use of rifampicin in tuberculosis].
Topics: Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Jaundice; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Rifampicin in the treatment of tuberculosis].
Topics: Administration, Oral; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1973 |
Mycobacterium marinum (atypical acid-fast bacillus) infections of the hand.
Topics: Adolescent; Adult; Amputation, Surgical; Debridement; Diagnosis, Differential; Ethambutol; Female; Fingers; Hand; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Osteomyelitis; Rifampin; Skin Diseases, Infectious; Skin Ulcer; Synovitis; Tuberculosis | 1973 |
[Treatment of meningeal tuberculosis with ethambutol and rifampicin].
Topics: Adult; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Meningeal | 1973 |
[Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
Topics: Chronic Disease; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1973 |
Initial treatment of tuberculosis with rifampicin.
Topics: Adult; Aminosalicylic Acids; Drug Therapy, Combination; Eosinophils; Ethambutol; Female; Humans; Isoniazid; Leukocyte Count; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1973 |
[Case of miliary tuberculosis complicated by severe pneumomediastinum and pneumothorax].
Topics: Child, Preschool; Drainage; Ethambutol; Humans; Isoniazid; Male; Mediastinal Emphysema; Pneumothorax; Rifampin; Streptomycin; Tuberculosis, Miliary | 1973 |
[Modern tuberculosis therapy].
Topics: Aminosalicylic Acids; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mass Screening; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Skin tuberculosis].
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyridoxine; Rifampin; Tuberculosis, Cutaneous; Ultraviolet Therapy | 1973 |
Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Chronic Disease; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Gastrointestinal Diseases; Humans; Kidney; Liver; Male; Mental Disorders; Middle Aged; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary; Vertigo; Vision Disorders | 1973 |
Ethambutol and rifampicin serum levels in children: second report on the combined administration of ethambutol and rifampicin.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Humans; Rifampin; Time Factors | 1973 |
[Statement on tuberculosis treatment].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Ethambutol; Ethionamide; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones | 1973 |
[Use of ethambutol in the treatment of pulmonary tuberculosis].
Topics: Adult; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
[Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1973 |
[Chemotherapy of atypical mycobacterioses (author's transl)].
Topics: Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium Infections; Rifampin; Sulfamethoxazole; Trimethoprim | 1973 |
[Modern treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Recurrence; Rifampin; Streptomycin; Sweden; Tuberculosis | 1973 |
[Short-term chemotherapy of pulmonary tuberculosis without previous treatment (results up to July 20th, 1972)].
Topics: Drug Therapy, Combination; Ethambutol; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1973 |
Opportunistic cutaneous Mycobacterium marinum infection mimicking Mycobacterium ulcerans in lymphosarcoma.
Topics: Aged; Diagnosis, Differential; Ethambutol; Female; Humans; Lymphoma, Non-Hodgkin; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious | 1973 |
[Side effects of tuberculostatics (author's transl)].
Topics: Adult; Antitubercular Agents; Drug Hypersensitivity; Ear; Ethambutol; Female; Humans; Isoniazid; Liver; Male; Polyneuropathies; Rifampin; Streptomycin; Thrombocytopenia | 1973 |
[Effects of rifampicin and ethambutol on calcium metabolism in the rat].
Topics: Animals; Calcium; Calcium Metabolism Disorders; Calcium Radioisotopes; Ethambutol; Feces; Hydroxyproline; Hypocalcemia; Intestinal Absorption; Male; Rats; Rifampin | 1973 |
Some of the less known side effects of Rifampin in therapy of tuberculosis.
Topics: Antibody Formation; Drug Therapy, Combination; Ethambutol; Fever; Humans; In Vitro Techniques; Lymphocytes; Rifampin; Thrombocytopenia | 1974 |
Editorial: Rifampin in the treatment of tuberculosis.
Topics: Canada; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1974 |
[Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Cholestasis; Clinical Enzyme Tests; Drug Therapy, Combination; Ethambutol; Fatty Liver; Female; Humans; Isoniazid; Liver Diseases; Liver Function Tests; Male; Middle Aged; Necrosis; Rifampin; Sulfobromophthalein; Tuberculosis, Pulmonary | 1974 |
Three patients with intracranial tuberculomas with unusual features.
Topics: Adolescent; Aminosalicylic Acids; Brain Diseases; Dexamethasone; Diabetic Coma; Electroencephalography; Emigration and Immigration; Ethambutol; Female; Headache; Humans; Hydrocephalus; India; Isoniazid; Male; Papilledema; Pyrazinamide; Radionuclide Imaging; Rifampin; Streptomycin; Technetium; Tuberculoma; United Kingdom | 1974 |
[Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1974 |
Ethambutol in pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Fetus; Follow-Up Studies; Growth; Humans; Infant; Infant, Newborn; Isoniazid; Mice; Pregnancy; Pregnancy Complications, Infectious; Rabbits; Rats; Rifampin; Tuberculosis, Pulmonary | 1974 |
Mycobacterium tuberculosis infection of the middle ear.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Otitis Media; Pyridoxine; Rifampin; Tuberculosis; Tuberculosis, Meningeal | 1974 |
A ten-year clinical experience with Mycobacterium kansasii.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin | 1974 |
[Treatment of primary tuberculosis].
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Antibody Formation; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunity, Cellular; Infant; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1974 |
[Chronic tuberculous meningitis in a case of known Mycobacterium kansasii infection].
Topics: Adult; Burns; Cell Count; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Lymphocytes; Male; Mycobacterium; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Uveitis | 1974 |
Blood levels of rifampicin in liver diseases.
Topics: Ethambutol; Humans; Isoniazid; Jaundice; Liver; Liver Diseases; Rifampin; Sulfobromophthalein; Tuberculosis, Pulmonary | 1974 |
[Treatment of tuberculous praevesical ureteral strictures (author's transl)].
Topics: Adult; Antitubercular Agents; Cortisone; Ethambutol; Female; Humans; Isoniazid; Methods; Middle Aged; Rifampin; Tuberculosis, Urogenital; Ureteral Diseases; Ureteral Obstruction | 1974 |
[Mode of action of "tuverculostatics". Consequences for the therapy].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1968 |
Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Streptomyces; Streptomycin; Tuberculosis | 1969 |
Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; United States; United States Department of Veterans Affairs | 1969 |
[Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Germany, West; Hospitals, Convalescent; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1969 |
Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
Topics: Animals; Ethambutol; Ethionamide; Follow-Up Studies; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Rifampin; Spleen; Streptomycin; Tuberculosis | 1969 |
In vivo bactericidal activity of rifampicin in combination with other antimycobacterial agents.
Topics: Animals; Antitubercular Agents; Ethambutol; Guinea Pigs; Isoniazid; Mycobacterium tuberculosis; Rifampin; Spleen; Streptomycin | 1969 |
Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1970 |
[Sensitivity of M. tuberculosis and atypical mycobacteria to ethambutol, capreomycin and rifampicin].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Species Specificity | 1969 |
The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1969 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
Topics: Aminosalicylic Acids; Antitubercular Agents; Dosage Forms; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Population Surveillance; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Veterans | 1970 |
Quantitative bacteriology in the clinical testing of new antituberculosis drugs.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteriological Techniques; Ethambutol; Humans; Male; Mycobacterium tuberculosis; Phenazines; Rifampin; Sputum; Tuberculosis, Pulmonary | 1969 |
[Current state of primary tuberculosis in children in Rhone department].
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; France; Humans; Infant; Mycobacterium tuberculosis; Radiography; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
Drug-resistant pulmonary tuberculosis treated with ethambutol, a rifamycin and a riminophenazine (B663).
Topics: Adolescent; Culture Media; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Male; Mycobacterium tuberculosis; Phenazines; Pyruvates; Rifampin; Sputum; Tuberculosis, Pulmonary | 1970 |
Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.
Topics: Culture Media; Drug Resistance, Microbial; Ethambutol; Genetics, Microbial; Isoniazid; Mutation; Mycobacterium tuberculosis; Probability; Rifampin; Streptomycin | 1970 |
[Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
Topics: Adult; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Internal medicine treatment of pulmonary tuberculosis].
Topics: Ambulatory Care; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Long-Term Care; Prednisolone; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Military Personnel; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Genito-urinary tuberculosis. A study of the disease in one unit over a period of 24 years.
Topics: Aminosalicylic Acids; Calcinosis; Drug Synergism; Epididymitis; Ethambutol; Female; Humans; Hypertension, Renal; Isoniazid; Kidney Calculi; Male; Mycobacterium tuberculosis; Nephrectomy; Prednisolone; Rifampin; Streptomycin; Tuberculosis, Urogenital; Ureteral Obstruction; Urinary Bladder; Urinary Diversion; Urine | 1971 |
Rifampicin with ethambutol for drug-resistant tuberculosis.
Topics: Adult; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[A study of the composition of rifampicin- and ethambutol-resistant variants of wild strains of M. tuberculosis, cultivated on Loewenstein-Jensen medium].
Topics: Culture Media; Drug Resistance, Microbial; Ethambutol; Genetic Variation; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 1971 |
[Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Culture Media; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Activity of rifampicin on experimental tuberculosis in mice. The development of resistance to rifampicin. Therapeutic effects of combinations of different drugs with rifampicin].
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Mice; Mycobacterium tuberculosis; Rifampin; Time Factors; Tuberculosis | 1970 |
Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
Topics: Administration, Oral; Adolescent; Adult; Aminosalicylic Acids; Animals; Culture Media; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Guinea Pigs; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium tuberculosis; Organ Size; Rifampin; Spleen; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1971 |
Rifampicin in the treatment of previously untreated pulmonary tuberculosis.
Topics: Age Factors; Drug Combinations; Ethambutol; Female; Gastric Juice; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
Long-term results with rifampicin together with ethambutol and-or other drugs in the treatment of tuberculosis with cultures resistant to the standard drugs.
Topics: Adult; Aged; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1971 |
Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Animals; Drug Resistance, Microbial; Ethambutol; Female; Humans; Injections, Intramuscular; Isoniazid; Liver Function Tests; Male; Middle Aged; Mycobacterium tuberculosis; Pyridoxine; Radiography; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Mode of action of antituberculous agents and ultrastructure of mycobacteria.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Isoniazid; Kanamycin; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1971 |
Re-treatment of pulmonary tuberculosis with rifampin and ethambutol.
Topics: Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Therapy of acute pericarditis].
Topics: Adrenal Cortex Hormones; Analgesics; Cardiac Tamponade; Drainage; Ethambutol; Humans; Isoniazid; Pericarditis; Punctures; Rifampin; Tuberculosis, Cardiovascular | 1972 |
[Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
Topics: Chronic Disease; Ethambutol; Evaluation Studies as Topic; Follow-Up Studies; Humans; Rifampin; Tuberculosis, Pulmonary | 1972 |
Rifampin: its role in the treatment of tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary; United States; United States Public Health Service | 1972 |
Changing concepts in treatment of tuberculosis.
Topics: Aminosalicylic Acids; Ethambutol; Hospitals, Special; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary; United States | 1972 |
Metabolic study and controlled clinical trials of rifampin.
Topics: Adult; Aged; Amides; Aminosalicylic Acids; Ethambutol; Female; Humans; Hydrogen-Ion Concentration; Isoniazid; Isonicotinic Acids; Male; Middle Aged; Rifampin; Saliva; Streptomycin; Sulfides | 1972 |
Rifampin in initial treatment of advanced pulmonary tuberculosis.
Topics: Administration, Oral; Adult; Aged; Ethambutol; Female; Humans; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1972 |
Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol.
Topics: Adolescent; Agglutination Tests; Biopsy; Ethambutol; Humans; Male; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious | 1972 |
[A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
Topics: Adult; Ethambutol; Ethionamide; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1972 |
[Therapy of female genital tuberculosis].
Topics: Ethambutol; Female; Glucocorticoids; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Salpingitis; Tuberculosis, Female Genital | 1972 |
[Efficiency of interrupted therapy of tuberculosis (experimental study)].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Methods; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[New methods in the treatment of pulmonary tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Hospitalization; Humans; Rest; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?].
Topics: Animals; Antitubercular Agents; Belgium; Congo; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Methods; Mice; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Drug therapy of pulmonary tuberculosis].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Isoniazid; Rest; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chronic Disease; Drug Combinations; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Evaluation Studies as Topic; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1972 |
Recent developments in the treatment of infectious diseases. V. Management of tuberculosis in the community hospital.
Topics: Aminosalicylic Acids; Cross Infection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sanitation; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Disseminated tuberculosis complicated by pancytopenia.
Topics: Anemia, Aplastic; Biopsy; Ethambutol; Female; Humans; Isoniazid; Liver; Middle Aged; Rifampin; Tuberculosis, Miliary | 1971 |
[Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
Topics: Adolescent; Adult; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
Ethambutol versus streptomycin.
Topics: Ethambutol; Humans; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Comparative study: Streptomycin, Isoniazid (Ethambutol) vs. Rifampicin, Isoniazid (Ethambutol)].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Newer therapeutic possibilities in the treatment of chronic open pulmonary tuberculosis].
Topics: Antitubercular Agents; Chronic Disease; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Antitubercular agents in hepatitis].
Topics: Antitubercular Agents; Chronic Disease; Ethambutol; Hepatitis; Humans; Liver Diseases; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Our experience with Rifampicin].
Topics: Ethambutol; Female; Humans; Male; Rifampin; Tuberculosis; Tuberculosis, Meningeal | 1971 |
Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1971 |
[Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
Topics: Chronic Disease; Drug Synergism; Ethambutol; Evaluation Studies as Topic; Humans; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Topics: Adult; Aminosalicylic Acids; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
Topics: Adult; Aged; Chronic Disease; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Rifampin; Sputum; Tuberculosis, Pulmonary | 1971 |
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
Topics: Alanine Transaminase; Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Ethambutol; Humans; Isoniazid; Liver; Liver Diseases; Liver Function Tests; Rifampin; Time Factors | 1971 |
Serum levels after administration of rifampicin.
Topics: Drug Combinations; Ethambutol; Food Deprivation; Humans; Isoniazid; Rifampin; Sarcina; Time Factors | 1971 |
Analytical study of the treatment of 18 cases of chronic open pulmonary tuberculosis with secondary resistance to rifampicin.
Topics: Adult; Aged; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1971 |
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. I. Variation of the rifampicin serum levels (947 determinations).
Topics: Analysis of Variance; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Sarcina; Time Factors; Tuberculosis, Pulmonary | 1971 |
Rifampicin in the treatment of chronic and polyresistant tuberculosis.
Topics: Adult; Chronic Disease; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Male; Middle Aged; Pneumoconiosis; Pulmonary Fibrosis; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1971 |
[Treatment of tuberculosis resistant to 1st line drugs with rifampycin and ethambutol, twice a week, with an initial supplement of kanamycin].
Topics: Drug Resistance, Microbial; Ethambutol; Female; Humans; Kanamycin; Male; Rifampin; Tuberculosis, Pulmonary | 1971 |
Problems of drug resistance in tuberculosis--the newer anti-tuberculosis drugs.
Topics: Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Tuberculosis; United Kingdom; United States | 1971 |
[Healing processes in experimental tuberculosis treated with rifampicin and ethambutol].
Topics: Animals; Ethambutol; Guinea Pigs; Rabbits; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
Topics: Chronic Disease; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Combination therapy of pulmonary tuberculosis using rifampicin and ethambutol].
Topics: Drug Synergism; Ethambutol; Humans; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1969 |
[The role of rifampicin in the treatment of recent tubercular processes].
Topics: Adolescent; Adult; Aminosalicylic Acids; Chronic Disease; Ethambutol; Humans; Male; Middle Aged; Radiography; Rifampin; Time Factors; Tuberculosis, Lymph Node; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1968 |
[Preliminary observations on the therapeutic use of rifampicin at the sanatorial hospital G. Ciaccio in Catanzaro].
Topics: Adolescent; Adult; Aminosalicylic Acids; Drug Synergism; Ethambutol; Female; Humans; Male; Middle Aged; Radiography; Rifampin; Tuberculosis, Pulmonary | 1968 |
[Diphasic treatment of pulmonary tuberculosis in children using rifamycin, ethambutol and isoniazid].
Topics: Child; Child, Preschool; Drug Synergism; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1970 |
Toxic amblyopia due to ethambutol in a case of drug resistant pulmonary tuberculosis.
Topics: Adult; Amblyopia; Color Vision Defects; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Female; Humans; Rifampin; Tuberculosis, Pulmonary; Visual Acuity | 1971 |
An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
Topics: Administration, Oral; Animals; Drug Synergism; Ethambutol; Ethionamide; Female; Isoniazid; Mice; Mice, Inbred Strains; Rifampin; Tuberculosis | 1971 |
Rifampicin.
Topics: Bronchitis; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Economics, Medical; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1969 |
Drugs in the treatment of tuberculosis--1969.
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
Topics: Antitubercular Agents; Chronic Disease; Drug Synergism; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1969 |
First experience with rifampicin in retreatment of resistant cases.
Topics: Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1969 |
[3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
Topics: Adult; Anthracosilicosis; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1969 |
Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Microbial Sensitivity Tests; Rifampin; Tuberculosis, Pulmonary | 1969 |
[Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
Topics: Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tooth Diseases; Tuberculosis; Tuberculosis, Pulmonary | 1969 |
[Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
Topics: Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Male; Phenylthiourea; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1969 |
[Preliminary report on the results of retreatment with rifomycin AMP and ethambutol].
Topics: Drug Synergism; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1969 |
[Antitubercular chemotherapy and the progress realized by various new drugs].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Middle Aged; Pyrazines; Rifampin; Tuberculosis | 1969 |
Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Lung; Mice; Rifampin; Spleen; Tuberculosis, Pulmonary | 1969 |
Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
Topics: Bilirubin; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Sputum; Tuberculosis, Pulmonary | 1969 |
[Conservative treatment of renal tuberculosis].
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Renal | 1969 |
[Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Drug Resistance, Microbial; Ethambutol; Female; Humans; Microbial Sensitivity Tests; Peptides; Rifampin; Tuberculosis, Urogenital | 1969 |
[Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[New drugs. 3].
Topics: Antitubercular Agents; Ethambutol; Rifampin; Streptomyces | 1970 |
[Current views on drug treatment of tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Rifampin; Tuberculosis | 1970 |
[New concepts on the treatment of pulmonary tuberculosis].
Topics: Ethambutol; Humans; Rifampin; Socioeconomic Factors; Tuberculosis, Pulmonary | 1970 |
[Therapeutic effect of Rifampicin on re-treatment cases of pulmonary tuberculosis].
Topics: Adult; Drug Synergism; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1970 |
[Modifications in chemotherapy].
Topics: Drug Synergism; Drug Therapy; Drug Tolerance; Ethambutol; Humans; Rifampin; Time Factors | 1970 |
The action of rifampin alone and in combination with other antituberculous drugs.
Topics: Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Drug therapy of urogenital tuberculosis].
Topics: Aminosalicylic Acids; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Urogenital | 1970 |
[Modern chemotherapy of tuberculosis].
Topics: Adolescent; Adult; Age Factors; Antitubercular Agents; Berlin; Child; Child, Preschool; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Humans; Infant; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis | 1970 |
[New drugs in the treatment of primary tuberculosis].
Topics: Aminosalicylic Acids; Child; Child, Preschool; Ethambutol; Female; France; Humans; Isoniazid; Male; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1970 |
[Current views on drug treatment of tuberculosis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1970 |
Present position of urinary tuberculosis.
Topics: Adolescent; Adult; Age Factors; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Renal; Tuberculosis, Urogenital; Urinary Bladder | 1970 |
Renal effects of antituberculous antibiotics.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Antitubercular Agents; Body Weight; Ethambutol; Female; Injections, Intraperitoneal; Kanamycin; Kidney; L-Lactate Dehydrogenase; Leucyl Aminopeptidase; Male; Rats; Rifampin; Streptomycin | 1970 |
[Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isonicotinic Acids; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1970 |
[A new and powerful anti-tubercular drug: rifampicin].
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Infusions, Parenteral; Isoniazid; Rifampin; Streptomyces; Tuberculosis | 1970 |
[Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1970 |
[A new and powerful anti-tubercular drug: rifampicin].
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Ethambutol; Humans; Infusions, Parenteral; Isoniazid; Rifampin; Streptomyces; Tuberculosis | 1970 |
[Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
Topics: Adolescent; Adult; Aged; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1970 |
Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
Topics: Administration, Oral; Animals; Drug Combinations; Ethambutol; Ethionamide; Evaluation Studies as Topic; Isoniazid; Mice; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
Rifampicin in retreatment and original treatment cases of pulmonary tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Report on the therapeutic results obtained with rifampicin.
Topics: Aminosalicylic Acids; Chronic Disease; Drug Combinations; Ethambutol; Humans; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Consequences of the development of new antituberculous drugs for the treatment of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis | 1970 |
[Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].
Topics: Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1970 |
[New aspects of medical therapy of pulmonary tuberculosis].
Topics: BCG Vaccine; Ethambutol; Humans; Rest; Rifampin; Tuberculosis, Pulmonary | 1970 |
Report on experiences with ethambutol.
Topics: Chronic Disease; Cycloserine; Drug Combinations; Ethambutol; Ethionamide; Humans; Phenylthiourea; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Experimental therapy with rifampicin.
Topics: Animals; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Mice; Mycobacterium Infections; Phenylthiourea; Rifampin; Streptomycin; Time Factors; Tuberculosis | 1970 |
[Standard therapy of tuberculosis].
Topics: Antitubercular Agents; Body Weight; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis | 1971 |
[Symposium: chemotherapy including new antitubercular agents].
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1971 |
[Changing picture of tuberculosis during a decade].
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1971 |
The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
Topics: Animals; Cell Count; Chronic Disease; Disease Models, Animal; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Lung; Mice; Placebos; Rifampin; Streptomycin; Tuberculosis | 1971 |
[New antitubercular preparations rifampicin and ethambutol].
Topics: Adult; Ethambutol; Humans; Microbial Sensitivity Tests; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
[The rational basis for the treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tuberculosis | 1971 |
[Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
Topics: Adolescent; Adult; Drug Synergism; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Number of rifampicin- and ethambutol-resistant variants in strains of atypical mycobacteria pathogenic for man, on Loewenstein-Jensen media].
Topics: Culture Media; Drug Resistance, Microbial; Ethambutol; Genetic Variation; Microbial Sensitivity Tests; Mycobacterium; Rifampin | 1971 |
"Control of tuberculosis" up-to-date.
Topics: Aminosalicylic Acids; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis | 1971 |
[Experimental study of rifampicin and ethambutol].
Topics: Animals; Blood Bactericidal Activity; Ethambutol; Guinea Pigs; Humans; In Vitro Techniques; Isoniazid; Mice; Microbial Sensitivity Tests; Rabbits; Rifampin; Tuberculosis | 1971 |
Rifampicin-ethambutol in the treatment of resistant pulmonary tuberculosis.
Topics: Chronic Disease; Drug Synergism; Ethambutol; Humans; Rifampin; Tuberculosis, Pulmonary | 1971 |
[Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
Topics: Culture Techniques; Cycloserine; Ethambutol; Humans; Isoniazid; Monocytes; Phenylthiourea; Pyrazines; Rifampin; Tuberculosis, Pulmonary | 1967 |
[Rifampicin in experimental tuberculosis].
Topics: Animals; Ethambutol; Ethionamide; Isoniazid; Mice; Models, Biological; Rifampin; Tuberculosis, Pulmonary | 1968 |
Chemotherapy regimens used in retreatment of pulmonary tuberculosis: combination of ethambutol, thioamides and capreomycin or rifampycin.
Topics: Antitubercular Agents; Ethambutol; Humans; Isonicotinic Acids; Rifampin; Sputum; Tuberculosis, Pulmonary | 1968 |
[Chemotherapy of tuberculosis today with special consideration of capreomycin, ethambutol and rifampicin].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Tuberculosis | 1968 |
[Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Empyema, Tuberculous; Ethambutol; Humans; Isonicotinic Acids; Kidney Function Tests; Liver Function Tests; Lung Diseases; Middle Aged; Morpholines; Pyrazines; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1968 |
[Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
Topics: Animals; Body Weight; Drug Synergism; Ethambutol; Guinea Pigs; Isoniazid; Rifampin; Tuberculosis | 1968 |
Chemotherapy of drug-resistant tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Rifampin; Tuberculosis | 1969 |
New drugs active against tuberculosis.
Topics: Animals; Ethambutol; Female; Humans; Mice; Rifampin; Tuberculosis | 1969 |
[Colloquium on class II antitubercular agents].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin | 1969 |
[Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Drug Synergism; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1969 |
Addendum on serum levels.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Phenazines; Pyrazinamide; Rifampin; Streptomycin | 1967 |
Tuberculosis in chronic renal failure.
Topics: Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Mycobacterium avium; Rifampin; Tuberculosis | 1980 |
Acute isoniazid/ethambutol/rifampicin overdosage.
Topics: Acute Disease; Adult; Drug Synergism; Ethambutol; Humans; Isoniazid; Male; Rifampin | 1982 |
Positive histological tuberculous findings despite stable sterility of the urine on culture: results of 111 nephrectomies and partial nephrectomies.
Topics: Capreomycin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Nephrectomy; Retrospective Studies; Rifampin; Tuberculosis, Renal | 1980 |
Brain-stem tuberculoma: an unusual presentation.
Topics: Adult; Brain Diseases; Brain Stem; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Rifampin; Tomography, X-Ray Computed; Tuberculoma | 1982 |
Drug-resistant Mycobacterium tuberculosis in Korean isolates.
Topics: Adult; Capreomycin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Korea; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
[Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
Topics: Antitubercular Agents; Capreomycin; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; In Vitro Techniques; Mycobacterium; Rifampin; Viomycin | 1983 |
[Antitubercular agents].
Topics: Antimetabolites; Antitubercular Agents; DNA; Ethambutol; Ethionamide; Folic Acid Antagonists; Humans; Isoniazid; Rifampin; RNA; Tuberculosis, Pulmonary | 1984 |
[Therapeutic results in lung diseases caused by atypical mycobacteria].
Topics: Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Erythromycin; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Current treatment of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
Guidelines for short-course tuberculosis chemotherapy. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control Atlanta, Ga.
Topics: Centers for Disease Control and Prevention, U.S.; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis; United States | 1980 |
Antituberculosis drug resistance in south Texas.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Microbial; Ethambutol; Female; Hispanic or Latino; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sex Factors; Streptomycin; Texas; Tuberculosis, Pulmonary | 1983 |
[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine].
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1983 |
Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
Topics: Administration, Oral; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kinetics; Male; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Results of intermittent treatment of tuberculosis and Mycobacteria shedding in children].
Topics: Adolescent; Child; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1983 |
Treatment of septic arthritis due to Mycobacterium kansasii.
Topics: Adult; Arthritis, Infectious; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin | 1984 |
Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; beta-Lactamases; Cephalosporins; Chloramphenicol; Clindamycin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Penicillins; Rifampin; Spectinomycin; Tetracyclines | 1980 |
Treatment of tuberculous masses in the neck.
Topics: Adolescent; Adult; Aminosalicylic Acid; Antitubercular Agents; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Neck; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 1984 |
[Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethambutol; Mice; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1984 |
Contralateral pleural effusion during chemotherapy for tuberculous pleurisy.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pleural Effusion; Prednisone; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pleural | 1984 |
[Liver and kidney damage in rifampicin and ethambutol treatment].
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Ethambutol; Hepatitis, Alcoholic; Humans; Kidney; Liver; Male; Rifampin; Tuberculosis, Pulmonary | 1984 |
Sporotrichoid Mycobacterium marinum infection. Report of a ten-year case.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Leg Dermatoses; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 1984 |
[Tuberculosis treatment today].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
The management of urinary tuberculosis--a logical approach.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Urogenital | 1984 |
Management of tuberculosis in elderly persons.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Tuberculosis, Urogenital | 1984 |
[Changes in the isoniazid inactivation index during antituberculosis treatment in children].
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Erythromycin; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Combined effect of tuberculosis and pesticides on the morphofunctional status of the liver].
Topics: Animals; Chemical and Drug Induced Liver Injury; Drug Interactions; Ethambutol; Liver; Organothiophosphorus Compounds; Rabbits; Rifampin; Tuberculosis | 1983 |
Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
[Comparison of 3 6-month chemotherapy regimes in pulmonary tuberculosis in routine practice in Algiers. 18th-month results].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
Topics: Ambulatory Care; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Hospitalization; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1983 |
An overview of tuberculosis in the 1980s.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Patient Education as Topic; Pregnancy; Rifampin; Tuberculosis | 1983 |
The treatment of urinary tuberculosis.
Topics: Adult; Aged; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Kidney; Male; Methods; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Urogenital; Ureter; Urinary Bladder; Urinary Tract; Urography | 1984 |
Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
Topics: Animals; Antitubercular Agents; Chronic Disease; Cycloserine; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Kanamycin; Liver; Lung; Male; Mice; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Spleen; Time Factors | 1984 |
[Evolution of the treatment of tuberculosis].
Topics: Ambulatory Care; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Patient Compliance; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1984 |
[Female genital tuberculosis, a changing reality].
Topics: Amenorrhea; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Rifampin; Tuberculosis, Female Genital | 1984 |
[Urinary tuberculosis today].
Topics: Calcinosis; Diagnosis, Differential; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Italy; Male; Pyelonephritis; Rifampin; Tuberculosis, Urogenital; Ureteral Calculi; Ureteral Obstruction; Urinary Tract Infections; Urine | 1984 |
[Efficacy of different methods of treating experimental cavernous tuberculosis of a single kidney].
Topics: Animals; Drug Therapy, Combination; Ethambutol; Isoniazid; Rabbits; Rifampin; Tuberculosis, Renal | 1984 |
[A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Meningitis of uncertain etiology].
Topics: Adult; Cryptococcus; Cryptococcus neoformans; Ethambutol; Female; Humans; Isoniazid; Meningitis; Mycobacterium tuberculosis; Rifampin | 1980 |
[L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; L Forms; Male; Middle Aged; Mycobacterium tuberculosis; Prothionamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Short-course treatment regimens for patients with tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Rapid drug-susceptibility testing of Mycobacterium tuberculosis.
Topics: Aminosalicylic Acid; Carbon Dioxide; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1981 |
[Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Italy; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Tuberculosis: who should prescribe?
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Medication Errors; Middle Aged; Rifampin; Streptomycin | 1982 |
Survey of pulmonary tuberculosis in south and west Wales (1976-8).
Topics: Adolescent; Adult; Aged; Aminosalicylic Acid; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Wales | 1982 |
[A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)].
Topics: Drug Resistance, Microbial; Ethambutol; Kanamycin; Mycobacterium tuberculosis; Prothionamide; Rifampin | 1981 |
Cutaneous tuberculosis.
Topics: Adult; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Cutaneous; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1982 |
Present chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1982 |
Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
Topics: Adolescent; Child; Drug Resistance, Microbial; Ethambutol; Female; Humans; In Vitro Techniques; Male; Mycobacterium tuberculosis; Rifampin; Sri Lanka; Tuberculosis, Pulmonary | 1982 |
[Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mice; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sputum; Tuberculosis, Pulmonary | 1982 |
Disseminated cutaneous Mycobacterium marinum infection.
Topics: Ethambutol; Female; Humans; Infant; Isoniazid; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Infectious | 1983 |
[Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1983 |
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1983 |
Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy.
Topics: Antitubercular Agents; Chromosome Aberrations; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lymphocytes; Metaphase; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1983 |
Reactivated musculoskeletal tuberculosis with concomitant asymptomatic genitourinary infection.
Topics: Arthrodesis; Ethambutol; Female; Hip Joint; Humans; Isoniazid; Joint Diseases; Knee Joint; Middle Aged; Radionuclide Imaging; Recurrence; Rifampin; Shoulder Joint; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular; Tuberculosis, Renal | 1983 |
[Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
Topics: Adolescent; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1983 |
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 1983 |
Chemotherapy of tuberculosis: TB or not TB?
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Treatment of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis | 1982 |
Pseudomembranous colitis in a patient on rifampicin and ethambutol.
Topics: Biopsy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Ethambutol; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Renal | 1980 |
Rifampicin associated renal dysfunction during antituberculous therapy.
Topics: Acute Kidney Injury; Bicarbonates; Creatinine; Ethambutol; Female; Glycosuria; Humans; Hypokalemia; Male; Middle Aged; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Liver damage following antituberculous therapy].
Topics: Adult; Alcoholism; Chemical and Drug Induced Liver Injury; Ethambutol; Fatty Liver; Humans; Isoniazid; Male; Rifampin | 1982 |
Cavitary lung infection caused by Mycobacterium flavescens.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Melanoma; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1982 |
Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare.
Topics: Drug Synergism; Ethambutol; Ethionamide; Microbial Sensitivity Tests; Mycobacterium; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1982 |
Tuberculous pericarditis developing during chemotherapy.
Topics: Child; Ethambutol; Humans; Isoniazid; Male; Pericarditis, Tuberculous; Prednisone; Rifampin; Streptomycin; Tuberculosis, Cardiovascular; Tuberculosis, Pulmonary | 1982 |
[Duration of the treatment of tuberculosis in 1981].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1982 |
[Clinically primary tuberculosis of the tongue].
Topics: Ethambutol; Humans; Isoniazid; Lung; Male; Middle Aged; Mouth Mucosa; Radiography; Rifampin; Tongue Diseases; Tuberculosis; Tuberculosis, Oral | 1982 |
Adverse drug reactions in TB therapy: risks and recommendations.
Topics: Adult; Age Factors; Aged; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Evaluation; Ethambutol; Humans; Isoniazid; Kidney Diseases; Middle Aged; Optic Neuritis; Rifampin; Risk; Streptomycin; Tuberculosis | 1982 |
Postmenopausal tuberculosis of the female genital tract.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Menopause; Middle Aged; Rifampin; Tuberculosis, Female Genital | 1982 |
[Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].
Topics: Acetylation; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1982 |
Medical management of gastrointestinal tuberculosis.
Topics: Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Gastrointestinal | 1982 |
Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
Topics: Aged; Alcoholism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pulmonary Emphysema; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Rifampicin and ethambutol in the chemotherapy of cavernous and fibrous-cavernous renal tuberculosis].
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Humans; Kidney; Middle Aged; Preoperative Care; Rifampin; Tuberculosis, Renal; Ureteral Diseases | 1982 |
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Rifampin; Streptomycin | 1982 |
Antituberculosis drug levels after jejunoileal bypass.
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Ileum; Isoniazid; Jejunum; Middle Aged; Obesity; Postoperative Complications; Rifampin; Tuberculosis, Pulmonary | 1982 |
[Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
Topics: Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kinetics; Liver; Rifampin; Transaminases | 1982 |
[The treatment of bone tuberculosis with special reference to tuberculous spondylitis].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Radiography; Rifampin; Spondylitis; Streptomycin; Tuberculosis, Spinal | 1982 |
In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
Topics: Antitubercular Agents; Dimethyl Sulfoxide; Drug Interactions; Ethambutol; Ethionamide; Isoniazid; Mycobacterium; Mycobacterium avium; Nontuberculous Mycobacteria; Rifampin; Streptomycin | 1982 |
[Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
Topics: Acetylation; Acetyltransferases; Adult; Aged; Drug Therapy, Combination; Enzyme Induction; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1980 |
The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.
Topics: Adolescent; Adult; Ethambutol; Ethinyl Estradiol; Female; Humans; Isoniazid; Kinetics; Norethindrone; Norethindrone Acetate; Rifampin; Sex Hormone-Binding Globulin; Tuberculosis | 1980 |
The treatment of tuberculosis of the female genital tract with rifampicin, ethambutol, and isoniazid.
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Female Genital | 1981 |
[Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Diazepam interaction with antituberculosis drugs.
Topics: Adult; Antitubercular Agents; Blood Proteins; Diazepam; Drug Interactions; Ethambutol; Female; Humans; Isoniazid; Kinetics; Male; Protein Binding; Rifampin | 1981 |
[Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
Topics: Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1981 |
Current concept of short-term chemotherapy of tuberculosis.
Topics: Drug Combinations; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 1981 |
Conservative management of mesencephalic tuberculoma. Case report.
Topics: Adult; Brain Diseases; Ethambutol; Humans; Male; Mesencephalon; Rifampin; Tuberculoma | 1981 |
[Liver damage from tuberculosis treatment].
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Liver; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1981 |
[Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Evaluation; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1981 |
Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Poland; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 1981 |
Non-tuberculous mycobacterial infection of the tendon sheaths in the hand. A report of six cases.
Topics: Adult; Ethambutol; Female; Hand; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Tendons | 1981 |
Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.
Topics: Drug Resistance, Microbial; Ethambutol; Microbial Sensitivity Tests; Mycobacterium; Nontuberculous Mycobacteria; Rifampin | 1981 |
Preliminary results of six-month regimens studied in the United States and in Poland.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Poland; Rifampin; Time Factors; Tuberculosis, Pulmonary; United States | 1981 |
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.
Topics: Adult; Aged; Aminosalicylic Acid; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
[Treatment of advanced and complicated variants of osteoarticular tuberculosis with rifampin and ethambutol].
Topics: Adolescent; Adult; Aged; Child; Ethambutol; Female; Humans; Jaundice; Male; Middle Aged; Rifampin; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1981 |
Tuberculosis in patients with end-stage renal disease.
Topics: Adult; Aged; Ethambutol; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin; Risk; Tuberculosis | 1980 |
Tuberculosis in the elderly: treating the "white plague".
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Rifampin; Risk; Streptomycin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary; United States | 1980 |
[Evaluation of the nature of the hepatotoxic action of isoniazid, rifamicin, ethambutol and their combinations against a background of prolonged alcohol administration].
Topics: Animals; Drug Interactions; Ethambutol; Ethanol; Isoniazid; Lipid Metabolism; Liver; Male; Rats; Rifampin; Seasons; Time Factors | 1980 |
Leishmaniasis: a case history and treatment failure with rifampin.
Topics: Adult; Ethambutol; Humans; Isoniazid; Leishmaniasis; Male; Rifampin | 1980 |
Tuberculosis therapy and enzyme induction in man.
Topics: Acetylation; Adult; Aged; Antipyrine; Antitubercular Agents; Enzyme Induction; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Phenotype; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Side effects of antitubercular drugs leading to discontinuation of drug therapy].
Topics: Adolescent; Adult; Age Factors; Aged; Aminosalicylic Acid; Antitubercular Agents; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Rifampin; Sex Ratio; Streptomycin | 1980 |
Neutropenia with each standard antituberculosis drug in the same patient.
Topics: Aged; Agranulocytosis; Antibiotics, Antitubercular; Ethambutol; Humans; Isoniazid; Leukocyte Count; Male; Neutropenia; Neutrophils; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Pulmonary tuberculosis in 3 Swedish children].
Topics: Adolescent; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Radiography; Rifampin; Sweden; Tuberculosis, Pulmonary | 1980 |
[Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Middle Aged; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
[Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
Topics: Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Principles of rational tuberculosis chemotherapy].
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Humans; Isoniazid; Mice; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
Short course chemotherapy in tuberculous meningitis: a pilot trial.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Child; Child, Preschool; Ethambutol; Humans; Infant; Isoniazid; Pilot Projects; Rifampin; Streptomycin; Time Factors; Tuberculosis, Meningeal | 1980 |
[New aspects of chemotherapy of tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1980 |
A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; Heroin Dependence; Hong Kong; Humans; Isoniazid; Male; Opioid-Related Disorders; Opium; Prisoners; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1980 |
Clinical approach to the choice of antimicrobial therapy, case #20, Part B: Fever in pregnancy.
Topics: Adult; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Tuberculosis, Pulmonary | 1980 |
[Epidemiology, diagnosis, and treatment of renal tuberculosis. A report of 213 cases].
Topics: Ethambutol; Female; Humans; Isoniazid; Male; Nephrectomy; Prothionamide; Rifampin; Streptomycin; Tuberculosis, Renal; Urine; Urography | 1980 |
Update on chemotherapy of renal tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Renal | 1980 |
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1980 |
Heat treatment for certain chronic granulomatous skin infections.
Topics: Adult; Aged; Chronic Disease; Ethambutol; Female; Granuloma; Hot Temperature; Humans; Iodides; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Infectious; Sporotrichosis | 1980 |
Fever response of patients on therapy for pulmonary tuberculosis.
Topics: Alcoholism; Antitubercular Agents; Bacterial Infections; Drug Therapy, Combination; Ethambutol; Female; Fever; Humans; Isoniazid; Lung; Male; Middle Aged; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1981 |
Tuberculosis of the breast.
Topics: Adult; Aged; Antitubercular Agents; Combined Modality Therapy; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy, Segmental; Mastitis; Middle Aged; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1995 |
Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colorimetry; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema.
Topics: Aged; Antitubercular Agents; Chronic Disease; Empyema, Tuberculous; Ethambutol; Humans; Male; Ofloxacin; Pleural Effusion; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Relapse rates in tuberculosis patients.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1995 |
Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Flow Cytometry; Fluoresceins; Formaldehyde; Humans; Hydrolysis; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 1995 |
Drugs for tuberculosis.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
[Tuberculous splenic abscess in an immunocompetent patient].
Topics: Abscess; Adolescent; Ethambutol; Female; Humans; Isoniazid; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Splenic | 1995 |
L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria.
Topics: Bacterial Typing Techniques; Base Sequence; Drug Resistance, Microbial; Ethambutol; Genes, Insect; Genes, Reporter; Genetic Vectors; Genome, Viral; Isoniazid; Luciferases; Lysogeny; Molecular Sequence Data; Mycobacteriophages; Mycobacterium; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Streptomycin; Transcription, Genetic | 1995 |
Tuberculosis drug resistance in the Western Cape.
Topics: Adolescent; Adult; Aged; Drug Resistance, Multiple; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis | 1995 |
[Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
Topics: Antitubercular Agents; Bacteriological Techniques; Colombia; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Models, Genetic; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prospective Studies; Rifampin; Rural Population; Streptomycin; Tuberculosis, Pulmonary; Urban Population | 1995 |
Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement.
Topics: Aged; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Humans; Isoniazid; Pulmonary Eosinophilia; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis, Miliary | 1995 |
Radiometric susceptibility testing of Mycobacterium xenopi.
Topics: Amikacin; Ciprofloxacin; Ethambutol; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Radiometry; Rifabutin; Rifampin; Streptomycin | 1995 |
Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; HIV Infections; Humans; Isoniazid; Italy; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
[Therapy of tuberculosis in the adult].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1995 |
Hypersensitivity to multiple drugs streptomycin, rifampicin and ethambutol: an unusual presentation.
Topics: Adult; Drug Eruptions; Ethambutol; Humans; Male; Rifampin; Streptomycin | 1995 |
Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide.
Topics: Cell Line; Cell Wall; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Ethambutol; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Permeability; Rifampin; Streptomycin | 1995 |
Transient exacerbation of tuberculous lymphadenitis during chemotherapy in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Leukocyte Count; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 1994 |
Treating tuberculosis with one combination drug.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Patient Compliance; Pyrazinamide; Rifampin; Tuberculosis | 1994 |
Serum alfa-one antitrypsin (AAT) in tubercular lymphadenitis.
Topics: alpha 1-Antitrypsin; Blood Sedimentation; Ethambutol; Isoniazid; Prognosis; Rifampin; Tuberculosis, Lymph Node | 1994 |
High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 1994 |
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fever; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 1994 |
[Pulmonary tuberculosis in infants. Apropos of 6 cases].
Topics: BCG Vaccine; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary | 1994 |
Rifampin-induced severe thrombocytopenia in a patient with pulmonary tuberculosis.
Topics: Adult; Drug Administration Schedule; Ethambutol; Humans; Isoniazid; Male; Rifampin; Thrombocytopenia; Tuberculosis, Pulmonary | 1994 |
TB treatment: yesterday, today and ... tomorrow.
Topics: Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clinical Protocols; Drug Monitoring; Ethambutol; Humans; Infant; Isoniazid; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prospective Studies; Radiography; Recurrence; Rifampin; Sputum | 1994 |
Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.
Topics: Adult; AIDS-Related Opportunistic Infections; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin; Superinfection; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Mycobacterial cervical lymphadenitis. A clinicopathological study of 3 cases.
Topics: Aged; Diagnosis, Differential; Ethambutol; Female; Follow-Up Studies; Humans; Hyperplasia; Isoniazid; Lymph Nodes; Middle Aged; Neck; Rifampin; Tuberculosis, Lymph Node | 1994 |
Tuberculosis in renal transplant recipients.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Lymph Nodes; Male; Middle Aged; Mycobacterium tuberculosis; Postoperative Complications; Rifampin; Sputum; Tuberculosis, Pulmonary | 1994 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
Topics: Amikacin; Clofazimine; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin | 1994 |
Oral desensitization to rifampin and ethambutol in mycobacterial disease.
Topics: Administration, Oral; Aged; Clinical Protocols; Desensitization, Immunologic; Drug Administration Schedule; Drug Eruptions; Ethambutol; Humans; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Rifampin | 1994 |
[Cephalosporins as possible methods of etiotropic therapy of tuberculosis].
Topics: Animals; Cefazolin; Cefotaxime; Cells, Cultured; Cephalosporins; Culture Media; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 1993 |
An outbreak of tuberculosis in a captive herd of Arabian oryx (Oryx leucoryx): management.
Topics: Animals; Antelopes; Disease Outbreaks; Ethambutol; Female; Isoniazid; Male; Pregnancy; Rifampin; Saudi Arabia; Tuberculosis, Pulmonary | 1994 |
Mycobacterium avium complex develop resistance to synergistically active drug combinations during infection.
Topics: Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Time Factors | 1994 |
[Incidence of resistance of tuberculosis bacteria in Switzerland].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Drug Resistance, Microbial; Ethambutol; Humans; Incidence; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Rifampin; Switzerland; Tuberculosis, Multidrug-Resistant | 1993 |
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Drug Monitoring; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 1993 |
[Tuberculosis of the central nervous system: value of early polychemotherapy. Apropos of 2 cases].
Topics: Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Prednisolone; Rifampin; Tuberculosis, Meningeal | 1993 |
[Hepatic toxicity of antitubercular agents. Role of different drugs. 199 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 1993 |
Successful treatment of erythema induratum of bazin following rapid detection of mycobacterial DNA by polymerase chain reaction.
Topics: DNA, Bacterial; Erythema Induratum; Ethambutol; Female; Humans; Isoniazid; Leg Dermatoses; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin | 1993 |
Turning intermittent regimens into daily regimens using blister-packs. An exploration in murine tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Administration Schedule; Drug Packaging; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Pyrazinamide; Rifampin; Tuberculosis | 1993 |
The third epidemic--multidrug-resistant tuberculosis.
Topics: Adult; Age Factors; Comorbidity; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Ill-Housed Persons; Isoniazid; Male; Minority Groups; Mycobacterium tuberculosis; New York City; Rifampin; Sex Factors; Streptomycin; Substance Abuse, Intravenous; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Unemployment | 1994 |
Chemotherapy of tuberculosis for patients with renal impairment.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau.
Topics: Drug Resistance, Microbial; Ethambutol; Guinea-Bissau; Humans; In Vitro Techniques; Isoniazid; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1993 |
Antituberculous drugs in kidney transplant recipients treated with cyclosporine.
Topics: Aged; Antitubercular Agents; Cyclosporine; Drug Interactions; Ethambutol; Humans; Isoniazid; Kidney Transplantation; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1993 |
From the Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
Isolated tuberculous pericarditis still exists: a case history.
Topics: Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pericarditis, Tuberculous; Rifampin | 1993 |
[Analysis of drug sensitivity of M. tuberculosis strains isolated from patients treated for tuberculosis in 1982-1991].
Topics: Adult; Child; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Species Specificity; Streptomycin; Tuberculosis | 1993 |
A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
Topics: Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Malaysia; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1993 |
[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Topics: Benin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
A persistent cellulitis.
Topics: Aged; Cellulitis; Drug Therapy, Combination; Ethambutol; Hand; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 1993 |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins | 1993 |
CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
Topics: Adult; Centers for Disease Control and Prevention, U.S.; Child; Drug Therapy; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; United States | 1993 |
Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Hospitals, Special; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1993 |
Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors | 1993 |
Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Infant; Isoniazid; Mycobacterium tuberculosis; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1993 |
Antibiotic-resistant tuberculous choroiditis.
Topics: Aged; Anti-Bacterial Agents; Choroiditis; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Prednisone; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Ocular; Uveitis; Visual Acuity | 1993 |
Preventive therapy for the patient with both universal indication and contraindication for isoniazid.
Topics: Adult; Contraindications; Delphi Technique; Drug Therapy, Combination; Ethambutol; Female; Hepatic Encephalopathy; Humans; Isoniazid; Liver Transplantation; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1993 |
Pelvic-peritoneal tuberculosis with elevated serum and peritoneal fluid Ca-125 levels. A report of two cases.
Topics: Adnexal Diseases; Adult; Antigens, Tumor-Associated, Carbohydrate; Ascitic Fluid; Diagnosis, Differential; Ethambutol; Female; Humans; Infertility, Female; Isoniazid; Menopause; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Uterine Diseases | 1993 |
Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antitubercular Agents; Bisexuality; CD4-CD8 Ratio; Ethambutol; Female; HIV Seropositivity; Homosexuality; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Treatment Failure; Treatment Outcome; Tuberculosis | 1993 |
Intracellular levels and extracellular release of lysosomal enzymes from peripheral blood monocytes in pulmonary tuberculosis patients.
Topics: Acetylglucosaminidase; Adolescent; Drug Therapy, Combination; Ethambutol; Female; Glucuronidase; Humans; Isoniazid; Latex; Lysosomes; Male; Middle Aged; Monocytes; Reference Values; Rifampin; Tuberculosis, Pulmonary | 1993 |
Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987.
Topics: Antitubercular Agents; Croatia; Drug Therapy, Combination; Drug Utilization; Ethambutol; Hospitals, Special; Humans; Isoniazid; Pulmonary Medicine; Pyridoxine; Rifampin; Tuberculosis, Pulmonary | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial | 1993 |
Mycobacterial infections in renal allograft recipients.
Topics: Drug Therapy, Combination; Ethambutol; HIV Seropositivity; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Mycobacterium Infections; New York; Postoperative Complications; Pyrazinamide; Rifampin; Transplantation, Homologous | 1993 |
[Interesting case of pulmonary alveolar proteinosis].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchoalveolar Lavage; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pulmonary Alveolar Proteinosis; Rifampin; Tuberculosis, Pulmonary | 1995 |
Management of primary chest wall tuberculosis.
Topics: Abscess; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Combined Modality Therapy; Debridement; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Suppuration; Thoracic Diseases; Thoracic Neoplasms; Treatment Outcome; Tuberculosis | 1995 |
Presumed ocular and central nervous system tuberculosis in a patient with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Chorioretinitis; Drug Therapy, Combination; Ethambutol; Female; Fundus Oculi; HIV-1; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Meningeal; Tuberculosis, Ocular; Visual Acuity | 1996 |
[Resistance of Mycobacterium tuberculosis in the province of Castellón].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Microbial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin | 1996 |
[Efficacy and tolerance of the treatment of tuberculosis in the aged].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Isoniazid; Male; Rifampin; Risk Factors; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 1996 |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin | 1996 |
Total hip arthroplasty complicated by tuberculous infection.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Hip Joint; Hip Prosthesis; Humans; Isoniazid; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radiography; Range of Motion, Articular; Reoperation; Rifampin; Tuberculosis, Osteoarticular | 1996 |
[Antitubercular agents].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; History, 20th Century; Humans; Isoniazid; Rifampin; Streptomycin | 1996 |
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Resistance; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1996 |
Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Microbial Sensitivity Tests; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina.
Topics: Acquired Immunodeficiency Syndrome; Adult; Argentina; Chronic Disease; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
[Effectiveness of regional lymphotropic therapy in combined treatment of tuberculosis in adolescents].
Topics: Adolescent; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Guinea Pigs; Humans; Injections, Intralymphatic; Isoniazid; Kanamycin; Male; Radiography; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
Mycobacterial tenosynovitis of the flexor tendons of the hand. A report of five cases.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Carpal Tunnel Syndrome; Combined Modality Therapy; Ethambutol; Female; Hand; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Tenosynovitis; Tuberculosis | 1996 |
Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1996 |
Rectal stricture: a complication of tuberculosis.
Topics: Antitubercular Agents; Child; Colectomy; Constriction, Pathologic; Ethambutol; Female; Humans; Isoniazid; Rectal Diseases; Rifampin; Sigmoid Diseases; Tuberculosis, Gastrointestinal | 1996 |
The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis.
Topics: Aged; Antitubercular Agents; Black People; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1996 |
Diagnosis and outcome of isolated rectal tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Proctoscopy; Rectal Diseases; Rifampin; Treatment Outcome; Tuberculosis, Gastrointestinal | 1996 |
In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Isoniazid; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Rifamycins; Tuberculosis | 1996 |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Lung; Male; Mice; Mycobacterium avium Complex; Rifampin; Rifamycins; Spleen; Tuberculosis | 1996 |
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Blotting, Southern; Cause of Death; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Ethambutol; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Polymorphism, Restriction Fragment Length; Proportional Hazards Models; Rifampin; Sputum; Streptomycin; Survival Analysis; Tuberculosis, Multidrug-Resistant | 1996 |
Focal tuberculosis of the liver with local hemorrhage in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ethambutol; Granuloma; Histocytochemistry; Homosexuality, Male; Humans; Isoniazid; Liver; Male; Mycobacterium; Pyrazinamide; Rifampin; Tuberculosis | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium bovis; Mycobacterium Infections; Pyrazinamide; Rifampin | 1996 |
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Drug Combinations; Ethambutol; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin | 1996 |
Unusual presentation of intra-abdominal tuberculosis.
Topics: Antitubercular Agents; Child; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Peritonitis, Tuberculous; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
Tuberculosis control programme guidelines--treatment regimens.
Topics: Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Humans; Isoniazid; Optic Neuritis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; South Africa; Streptomycin; Tuberculosis | 1996 |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
Topics: Adult; Antibiotics, Antitubercular; Drug Interactions; Ethambutol; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Isoniazid; Liver Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Rifampin; Streptomycin; Tacrolimus; Tuberculosis | 1996 |
Tuberculosis and renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Kidney Transplantation; Male; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Time Factors; Tuberculosis | 1996 |
Tuberculous perianal ulcers.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 1996 |
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin | 1996 |
Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cause of Death; Ethambutol; Female; Follow-Up Studies; Hemoptysis; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1996 |
Esophagomediastinal fistula as a complication of tuberculous mediastinal lymphadenitis.
Topics: Adult; Antibiotics, Antitubercular; Esophageal Fistula; Ethambutol; Female; Fistula; Humans; Isoniazid; Mediastinal Diseases; Pyrazinamide; Radiography, Thoracic; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 1996 |
Pyrolysis mass spectrometry: a predictor of clinical response to treatment in pulmonary opportunist mycobacterial infection: preliminary work with M. malmoense.
Topics: Ethambutol; Humans; Lung Diseases; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium Infections; Opportunistic Infections; Rifampin | 1997 |
Vulvovaginal tuberculosis: a case report.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Vulvovaginitis | 1997 |
[Hematologic abnormalities in pulmonary tuberculosiss].
Topics: Anemia; Antitubercular Agents; Ethambutol; Hematologic Diseases; Humans; Leukopenia; Pancytopenia; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1997 |
Pancreatic insufficiency due to antituberculous therapy.
Topics: Antitubercular Agents; Chronic Disease; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Exocrine Pancreatic Insufficiency; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
Flexor tenosynovitis in the hand caused by Mycobacterium malmoense: a case report.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Fingers; Follow-Up Studies; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Synovectomy; Tenosynovitis | 1997 |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin | 1997 |
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Diarrhea; Ethambutol; Female; HIV Infections; HIV Seropositivity; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin | 1997 |
Autoimmune haemolytic anaemia responding to anti-tuberculous treatment.
Topics: Adult; Anemia, Hemolytic; Antitubercular Agents; Autoimmune Diseases; Biopsy; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1997 |
[Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1996 |
[CT scanning and treatment of intracranial tuberculoma].
Topics: Adolescent; Animals; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Parietal Lobe; Pyrazinamide; Rabbits; Retrospective Studies; Rifampin; Streptomycin; Tomography, X-Ray Computed; Tuberculoma, Intracranial | 1996 |
Pneumonitis and eosinophilia induced by ethambutol.
Topics: Aged; Antitubercular Agents; Eosinophilia; Ethambutol; Humans; Isoniazid; Lymphocyte Activation; Male; Pneumonia; Rifampin | 1997 |
Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California.
Topics: Adolescent; California; Cohort Studies; Disease Outbreaks; Drug Resistance, Multiple; Ethambutol; Ethionamide; Female; Humans; Infectious Disease Transmission, Vertical; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Schools; Skin Tests; Sputum; Streptomycin; Tuberculosis | 1997 |
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Topics: Antitubercular Agents; Clinical Laboratory Information Systems; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Population Surveillance; Quality Assurance, Health Care; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1997 |
Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
Topics: Antitubercular Agents; Cross-Sectional Studies; Developing Countries; Drug Resistance, Multiple; Drug Therapy, Combination; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant | 1997 |
Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Lymph Nodes; Lymphatic Diseases; Male; Neck; Pleural Effusion; Prednisolone; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Tuberculosis, Miliary | 1997 |
Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.
Topics: Amikacin; Antitubercular Agents; Carbon Dioxide; Colony Count, Microbial; Ethambutol; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifabutin; Rifampin | 1998 |
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Coloring Agents; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Peru; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis; Xanthenes | 1998 |
[Reasons for chronic expectoration--case reports].
Topics: Adult; Aged; Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Secondary Prevention; Sputum; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports].
Topics: Adult; Antitubercular Agents; Bronchial Fistula; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
Drug-resistant tuberculosis in Singapore, 1995 to 1996.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Case-Control Studies; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Recurrence; Rifampin; Singapore; Streptomycin; Tuberculosis, Multidrug-Resistant | 1997 |
Risk factors for hepatotoxicity induced by antituberculosis drugs.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Streptomycin | 1997 |
[Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Purpura; Pyrazinamide; Rifampin; Streptomycin; Thrombocytopenia; Tuberculosis, Pulmonary | 1995 |
[Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tunisia | 1996 |
Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Medical Records; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1998 |
Physician compliance with national tuberculosis treatment guidelines: a university hospital study.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Hospitals, University; Humans; Isoniazid; Mycobacterium tuberculosis; Pakistan; Physicians; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Sputum; Surveys and Questionnaires; Tuberculosis; World Health Organization | 1998 |
A resected case of Mycobacterium szulgai pulmonary disease.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Bacteriolysis; Cell Membrane Permeability; Colony Count, Microbial; Drug Combinations; Drug Resistance, Multiple; Electrophoresis, Polyacrylamide Gel; Ethambutol; Indicators and Reagents; Microscopy, Electron, Scanning Transmission; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Ruthenium Red; Staphylococcus | 1997 |
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Ethambutol; HIV Seropositivity; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Patient Compliance; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Topics: Adult; Age Distribution; Aged; Antitubercular Agents; Confidence Intervals; Ethambutol; Female; Humans; Incidence; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; New Jersey; Odds Ratio; Population Surveillance; Pyrazinamide; Rifampin; Risk Factors; Sex Distribution; Streptomycin; Tuberculosis, Multidrug-Resistant | 1998 |
Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 1998 |
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Ethambutol; Global Health; Humans; Isoniazid; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
Topics: Agar; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Flow Cytometry; Fluoresceins; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin | 1998 |
Drug-resistant tuberculosis of the brain in a two-year-old child.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Brain Diseases; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hip Joint; Humans; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1998 |
[Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
Topics: Aged; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Female; Humans; Isoniazid; Male; Middle Aged; Pruritus; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy.
Topics: Adolescent; Adult; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; BCG Vaccine; Cell Division; Cells, Cultured; Epitopes, T-Lymphocyte; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Lipoproteins; Male; Middle Aged; Mycobacterium tuberculosis; Peptides; Pleural Effusion; Pyrazinamide; Rifampin; T-Lymphocytes; Tuberculin; Tuberculosis | 1998 |
Optic disk tubercle.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fluorescein Angiography; Fundus Oculi; Granuloma; Humans; Isoniazid; Male; Optic Disk; Papilledema; Rifampin; Tuberculosis, Ocular; Vision Disorders | 1998 |
Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
Topics: Antitubercular Agents; Centers for Disease Control and Prevention, U.S.; Culture Media; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin; United States | 1998 |
Drug-resistant tuberculosis in Budapest.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Hungary; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP].
Topics: Adenosine Triphosphate; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1998 |
Primary tuberculous tracheitis.
Topics: Antitubercular Agents; Cough; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Respiratory Sounds; Rifampin; Tracheal Stenosis; Tracheitis; Tuberculosis, Pulmonary | 1998 |
[Cutaneous leukocytoclastic vasculitis in a patient with pulmonary tuberculosis].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Skin Diseases, Vascular; Tuberculosis, Pulmonary; Vasculitis, Leukocytoclastic, Cutaneous | 1998 |
[Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Topics: Adolescent; Adult; Antitubercular Agents; Cameroon; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Disease Notification; Drug Administration Schedule; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1998 |
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; HIV Infections; Humans; Isoniazid; Liver Function Tests; Pyrazinamide; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1995 |
Tuberculosis of the pyriform fossa--a rare entity.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laryngoscopy; Male; Pharyngeal Diseases; Pharyngeal Neoplasms; Pyrazinamide; Radiography; Rifampin; Tuberculosis; Tuberculosis, Laryngeal; Tuberculosis, Pulmonary | 1998 |
[Hepatic tuberculosis: a case with pseudotumours form].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 1998 |
Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.
Topics: Antitubercular Agents; Bacteriological Techniques; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
[Tuberculosis among hemodialysis patients in Dakar, apropos of 2 cases].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Hallucinations; Humans; Isoniazid; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Renal Dialysis; Rifampin; Senegal; Streptomycin; Tuberculosis | 1998 |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; Rifampin | 1999 |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Foot; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Postoperative Complications; Rifampin; Skin Diseases, Bacterial | 1999 |
[Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Renal Dialysis; Rifampin | 1999 |
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Mycobacterium bovis; Osteomyelitis; Pyrazinamide; Rifampin; Tuberculosis, Spinal; Urinary Bladder Neoplasms | 1999 |
-Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Humans; Isoniazid; Male; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 1998 |
[Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Acceptance of Health Care; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1999 |
Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; South Africa; Sputum; Treatment Outcome; Tuberculosis | 1999 |
Drug-resistant tuberculosis in the Philippines.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Philippines; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1999 |
Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Compliance; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1999 |
Cutaneous tuberculosis: efficient therapeutic response in a case with multiple lesions.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Foot Dermatoses; Hand Dermatoses; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous | 1999 |
First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Azerbaijan; Dietary Supplements; Ethambutol; Humans; Isoniazid; Logistic Models; Male; Mycobacterium tuberculosis; Patient Compliance; Pilot Projects; Prisoners; Prisons; Rifampin; Sputum; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 1999 |
Tuberculous pseudoaneurysm of the femoral artery: a case report.
Topics: Aged; Aged, 80 and over; Anastomosis, Surgical; Aneurysm, False; Aneurysm, Ruptured; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Femoral Artery; Humans; Isoniazid; Magnetic Resonance Angiography; Male; Rifampin; Tuberculosis, Cardiovascular | 1999 |
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
Topics: Antitubercular Agents; Developing Countries; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization | 1999 |
Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Time Factors; Tuberculosis | 1999 |
Pulmonary nodule mimicking lung cancer in a human immunodeficiency virus type-1 infected patient.
Topics: Acquired Immunodeficiency Syndrome; Adenocarcinoma; Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Isoniazid; Lung Neoplasms; Male; Pyrazinamide; Rifampin; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 1999 |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease.
Topics: Adolescent; Adult; Antitubercular Agents; Biological Availability; Clarithromycin; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mycobacterium avium-intracellulare Infection; Pregnancy; Rifampin; Tuberculosis, Pulmonary | 1999 |
[Current aspects of spinal tuberculosis: apropos of 16 case reports].
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 1999 |
[Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin | 1999 |
[A case of pulmonary infectious disease due to Mycobacterium szulgai].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 1999 |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteriological Techniques; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin Diseases, Bacterial; Sporotrichosis | 1999 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence | 1999 |
The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules.
Topics: Antitubercular Agents; Capsules; Chemistry, Pharmaceutical; Colorimetry; Drug Combinations; Ethambutol; Isoniazid; Pyrazinamide; Rifampin; Tablets | 1999 |
[A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
Topics: Acute Kidney Injury; Aged; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis, Pulmonary | 1999 |
Mycobacterial infections in solid organ transplant recipients.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium Infections; Organ Transplantation; Postoperative Complications; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Socioeconomic Factors; Time Factors; Turkey | 1999 |
Unusual clinical manifestation of tuberculosis in a renal transplant recipient.
Topics: Adult; Antitubercular Agents; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Kidney Transplantation; Liver; Liver Function Tests; Postoperative Complications; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis | 1999 |
Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
Topics: Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Streptomycin | 2000 |
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium smegmatis; Mycobacterium tuberculosis; Permeability; Polysorbates; Rifampin | 2000 |
Reply to Davis and colleagues: Twice weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Pulmonary | 1999 |
Anti-tuberculosis drug resistance in Portugal.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Population Surveillance; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
Diagnosis and treatment of cervical tuberculous lymphadenitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Biopsy, Needle; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Neck Dissection; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2000 |
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Streptomycin; Tuberculosis | 2000 |
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Topics: Antitubercular Agents; Dominican Republic; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Global Health; Hong Kong; Humans; Isoniazid; Italy; Korea; Peru; Program Evaluation; Retrospective Studies; Rifampin; Risk; Russia; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2000 |
[Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antitubercular Agents; Cote d'Ivoire; Ethambutol; Female; Humans; Isoniazid; Male; Medical History Taking; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody-Producing Cells; Antigen-Antibody Complex; Antitubercular Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
Treatment of large macular choroidal tubercle improves vision.
Topics: Antitubercular Agents; Choroid Diseases; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fluorescein Angiography; Fundus Oculi; Humans; Isoniazid; Macula Lutea; Middle Aged; Rifampin; Tuberculosis, Miliary; Tuberculosis, Ocular; Vision, Ocular | 2000 |
Interaction of gliclazide and rifampicin.
Topics: Aged; Antibiotics, Antitubercular; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Ethambutol; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2000 |
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
Topics: Adult; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Malawi; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2000 |
Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Mass Index; Body Weight; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leptin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 1999 |
Tubercular involvement of the thyroid gland: a report of two cases.
Topics: Abscess; Aged; Aged, 80 and over; Antitubercular Agents; Biopsy, Needle; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Mycobacterium tuberculosis; Rifampin; Thyroid Diseases; Tuberculosis, Endocrine | 1999 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Indonesia; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2000 |
Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Carbon Dioxide; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Time Factors | 2000 |
Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Colony-Forming Units Assay; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Pyrazinamide; Rifampin; Rifamycins; Tuberculosis | 2000 |
[Primary and acquired drug resistance of tuberculosis bacilli in Poland].
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Poland; Rifampin; Sex Distribution; Species Specificity; Tuberculosis, Multidrug-Resistant | 1999 |
Treatment of tuberculosis: a well-standardised protocol.
Topics: Adult; Child; Clinical Protocols; Ethambutol; France; Humans; Isoniazid; Pyrazinamide; Rifampin; Time Factors; Tuberculosis; United Kingdom; United States; World Health Organization | 2000 |
Chromosomal aberrations and micronuclei in lymphocytes of patients before and after exposure to anti-tuberculosis drugs.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Case-Control Studies; Cell Nucleus; Chromosome Aberrations; Ethambutol; Female; Humans; Isoniazid; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Middle Aged; Pyrazinamide; Rifampin; Streptomycin | 2000 |
[The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethambutol; Guinea Pigs; Isoniazid; Lung; Microscopy, Electron; Rabbits; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2000 |
Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method.
Topics: Drug Resistance, Microbial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 2000 |
Tuberculous abscess of the graft in a renal transplant recipient after chronic rejection: case report.
Topics: Abscess; Adult; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Graft Rejection; Humans; Isoniazid; Kidney Transplantation; Nephrectomy; Pyrazinamide; Reoperation; Rifampin; Tuberculosis | 2000 |
Tuberculosis after renal transplantation.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; India; Isoniazid; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Pyrazinamide; Pyridoxine; Retrospective Studies; Rifampin; Time Factors; Tuberculosis; Tuberculosis, Pulmonary | 2000 |
Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Kidney Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2000 |
[Early anterolateral surgery for tuberculosis of the lower cervical spine with neurological complications in adult. Our experience in Gabon].
Topics: Adult; Antitubercular Agents; Cervical Vertebrae; Combined Modality Therapy; Debridement; Emergencies; Ethambutol; Follow-Up Studies; Gabon; Humans; Isoniazid; Kyphosis; Paraplegia; Physical Therapy Modalities; Pyrazinamide; Quadriplegia; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2000 |
[Evolution of drug-resistant Mycobacterium tuberculosis in the province of Castellón. 1992-1998].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Risk Factors; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant | 2000 |
A comparison of the E-test and proportion methods for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Time Factors | 2000 |
Facial granulomatous diseases: a study of four cases tested for the presence of Mycobacterium tuberculosis DNA using nested polymerase chain reaction.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Face; Female; Granulomatous Disease, Chronic; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Rosacea; Tuberculosis, Cutaneous | 2001 |
A step forward in the evidence-based treatment of opportunist mycobacteria.
Topics: Antibiotics, Antitubercular; Ethambutol; Evidence-Based Medicine; Humans; Mycobacterium Infections; Opportunistic Infections; Practice Guidelines as Topic; Rifampin; United Kingdom | 2001 |
Effect of preoperative chemotherapy on the outcome of surgical treatment of vertebral tuberculosis: retrospective analysis of 434 cases.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Patient Selection; Premedication; Preoperative Care; Recurrence; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Spinal | 2001 |
A whole blood bactericidal assay for tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Blood; Blood Bactericidal Activity; Culture Media; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Quinolines; Rifampin | 2001 |
Tuberculosis treatment: dangerous regimens?
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; World Health Organization | 2001 |
Treatment alternatives for Mycobacterium kansasii.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Drug Interactions; Drug Therapy, Combination; Ethambutol; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Survival Analysis | 2001 |
Osteoarticular tuberculosis: current diagnosis and treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium; Osteoarthritis, Knee; Pyrazinamide; Rifampin; Streptomycin; Synovial Fluid; Tuberculosis, Osteoarticular | 2000 |
[Buruli ulcer in Togo: 21 cases].
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Curettage; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Transplantation; Time Factors; Togo | 2001 |
[Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Aminosalicylic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Streptomycin; Treatment Refusal | 2001 |
Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Pyrazinamide; Rifampin; Saudi Arabia; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
Efficacy of chemotherapy for prostatic tuberculosis-a clinical and histologic follow-up study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biopsy; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Palpation; Prostate-Specific Antigen; Prostatic Diseases; Rifampin; Treatment Outcome; Tuberculosis, Male Genital | 2001 |
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Rifampin; Streptomycin; Treatment Outcome | 2001 |
Multifocal extensive spinal tuberculosis (Pott's disease) involving cervical, thoracic and lumbar vertebrae.
Topics: Antitubercular Agents; Cervical Vertebrae; Ethambutol; Female; Humans; Isoniazid; Lumbar Vertebrae; Middle Aged; Pyrazinamide; Quadriplegia; Rifampin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Spinal | 2001 |
Advances in prevention and treatment of MAC.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
Topics: Antitubercular Agents; Ethambutol; Humans; In Vitro Techniques; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Opportunistic Infections; Predictive Value of Tests; Rifampin; Treatment Outcome | 2001 |
[Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Monitoring; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium bovis; Mycobacterium kansasii; Mycobacterium tuberculosis; Rifampin; Russia; Streptomycin | 2001 |
[A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
Topics: Ethambutol; Humans; Isoniazid; Japan; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Streptomycin | 2001 |
[Lymphotropic therapy with antitubercular agents in the treatment of tuberculous epididymitis].
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Epididymitis; Ethambutol; Humans; Injections, Intralymphatic; Injections, Intramuscular; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Male Genital; Ultrasonography | 2001 |
Rifampicin allergy confirmed by an intradermal test, but with a negative patch test.
Topics: Antitubercular Agents; Diagnosis, Differential; Drug Eruptions; Ethambutol; False Negative Reactions; Female; Humans; Intradermal Tests; Isoniazid; Middle Aged; Patch Tests; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Rifampin | 2001 |
Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Topics: Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Female; Hong Kong; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Mycobacterium tuberculosis; Population Surveillance; Prevalence; Retrospective Studies; Rifampin; Sex Distribution; Streptomycin; Time Factors; Tuberculosis, Multidrug-Resistant | 2001 |
Treatment of tuberculosis in Haiti.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Haiti; Health Services Research; Humans; Isoniazid; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2001 |
[Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin | 2001 |
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
Topics: Adolescent; Adult; Africa; Age Factors; Americas; Antibiotics, Antitubercular; Asia; Child; Child Welfare; Child, Preschool; Drug Resistance, Multiple; Ethambutol; Europe; Female; HIV; HIV Infections; Humans; Infant; Infant Welfare; Infant, Newborn; Male; Middle Aged; Multivariate Analysis; Population Surveillance; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant | 2001 |
Efficacy of macrolides used in combination with ethambutol, with or without other drugs, against Mycobacterium avium within human macrophages.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cells, Cultured; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin | 2001 |
Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Clinical Protocols; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Mass Screening; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Population Surveillance; Qatar; Retrospective Studies; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
[Observations of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; L Forms; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Norfloxacin; Rifampin; Streptomycin | 2001 |
Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
Topics: Adult; Alopecia; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lichenoid Eruptions; Pyrazinamide; Rifampin; Scalp Dermatoses; Tuberculosis, Gastrointestinal | 2001 |
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
Topics: Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Chlorocebus aethiops; Clofazimine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Vero Cells | 2002 |
Tuberculosis presenting as immune thrombocytopenic purpura.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Autoimmune Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Middle Aged; Mycobacterium tuberculosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Pyridoxine; Rifampin; Tuberculosis | 2002 |
Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
Topics: Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 2001 |
[Efficacy of the sparfloxacin-ethambutol combination in a case of cerebral tuberculosis].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Rifampin; Tuberculosis, Central Nervous System | 2002 |
[A case of polymyositis complicated with pulmonary tuberculosis concerned with steroid resistance due to rifampin administration].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Polymyositis; Prednisolone; Rifampin; Tuberculosis, Pulmonary | 2001 |
Sample survey of drug-resistant tuberculosis in Henan, China, 1996.
Topics: Adult; Aged; China; Data Collection; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2002 |
Tuberculous meningoencephalitis in HIV-seronegative patients: variety of clinical presentation and impact on diagnostics and treatment.
Topics: Adult; Aged; Antitubercular Agents; Brain; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Meningeal | 2001 |
Mycobacterium tuberculosis infection of bilateral cervical lymph nodes after renal transplantation.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neck; Rifampin; Tacrolimus; Tuberculosis, Lymph Node | 2001 |
Erythema nodosum associated with reactivation tuberculous lymphadenitis (scrofula).
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leg; Mycobacterium tuberculosis; Neck; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2002 |
Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2002 |
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Risk Factors; Russia; Socioeconomic Factors; Streptomycin; Tuberculosis, Pulmonary | 2002 |
Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clarithromycin; Cyclophosphamide; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Leg; Lupus Erythematosus, Systemic; Muscle, Skeletal; Mycobacterium haemophilum; Mycobacterium Infections; Mycophenolic Acid; Rifampin | 2002 |
Tuberculosis of the pancreas diagnosed with needle aspiration.
Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Pancreas; Pancreatic Diseases; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2002 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Drug Administration Schedule; Drug Resistance, Bacterial; Ethambutol; Female; Genetics, Microbial; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2002 |
Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Saudi Arabia; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Citrulline; Drug Administration Schedule; Enzyme Inhibitors; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Nitric Oxide; Nitrites; Pyrazinamide; Rifampin; T-Lymphocyte Subsets; Tuberculosis | 2002 |
Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin | 2002 |
Atypical mycobacterial osteomyelitis in a non-AIDS patient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifampin; Thoracic Vertebrae | 2002 |
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin; World Health Organization | 2002 |
Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure anti-tuberculosis drugs and their combinations.
Topics: Adsorption; Antitubercular Agents; Darkness; Drug Combinations; Drug Stability; Ethambutol; Excipients; Isoniazid; Light; Pyrazinamide; Rifampin; Temperature; Water | 2002 |
[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Poland; Prevalence; Prospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Solitary pontine tuberculoma.
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Pons; Radiography; Rifampin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Pulmonary | 2002 |
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Administration Schedule; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Recurrence; Rifampin; Russia; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant | 2002 |
[Myrin P in the combined treatment of tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2002 |
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci).
Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2002 |
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin | 2002 |
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Confidence Intervals; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Probability; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2003 |
Prognosis of tuberculous meningitis in adults in the era of modern antituberculous chemotherapy.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Leukocyte Count; Male; Mycobacterium tuberculosis; Prognosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Meningeal | 2002 |
Role of early endourologic management of tuberculous ureteral strictures.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Chi-Square Distribution; Constriction, Pathologic; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nephrectomy; Nephrostomy, Percutaneous; Rifampin; Stents; Time Factors; Treatment Outcome; Tuberculosis, Renal; Ureter; Ureteral Obstruction | 2002 |
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Follow-Up Studies; Humans; India; Isoniazid; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Ethambutol; Female; HIV Seropositivity; Humans; Incidence; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Rifampin; Risk Factors; Tuberculosis, Pulmonary | 2003 |
Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis.
Topics: Agar; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Probability; Rifampin; ROC Curve; Sensitivity and Specificity; Streptomycin | 2003 |
Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Topics: AIDS-Related Opportunistic Infections; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Myanmar; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Ethambutol; Isoniazid; Pharmacopoeias as Topic; Pyrazinamide; Reference Standards; Rifampin; Tablets; United States | 2003 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Madagascar; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; National Health Programs; Population Surveillance; Prospective Studies; Recurrence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Urban Health | 2002 |
Choroidal tuberculoma in miliary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Ethambutol; Fluorescein Angiography; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular; Ultrasonography | 2003 |
Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2003 |
Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Topics: Administration, Oral; Antibiotics, Antitubercular; Antitubercular Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Feasibility Studies; Humans; Isoniazid; Powders; Pyrazinamide; Rifampin; Tuberculosis | 2003 |
A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Drug Combinations; Drug Labeling; Drug Packaging; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Pilot Projects; Pyrazinamide; Rifampin; Tablets; Time Factors; Tuberculosis | 2003 |
[Pulmonary cryptococcosis combined with pulmonary tuberculosis].
Topics: Cryptococcosis; Diabetes Complications; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Rifampin; Thoracic Surgery, Video-Assisted; Tuberculosis, Pulmonary | 2003 |
[Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Ethambutol; Female; Humans; Incidence; Isoniazid; Japan; Male; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Time Factors | 2003 |
Rapid oral desensitization to isoniazid, rifampin, and ethambutol.
Topics: Administration, Oral; Antibiotics, Antitubercular; Antitubercular Agents; Child; Desensitization, Immunologic; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Rifampin; Time Factors | 2003 |
[An adult case of tuberculous meningitis].
Topics: Adult; Antitubercular Agents; Cytokines; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Prognosis; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Miliary | 2003 |
[Remission of pulmonary alveolar proteinosis during antituberculosis chemotherapy].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pulmonary Alveolar Proteinosis; Remission Induction; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2003 |
Bilateral bone loss of the maxilla.
Topics: Adult; Alveolar Bone Loss; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Diseases; Pyrazinamide; Rifampin; Tuberculosis, Oral | 2003 |
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin | 2003 |
Frequency and antibiotic susceptibility pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Ethambutol; Humans; Isoniazid; Lymph Nodes; Mycobacterium tuberculosis; Pleural Effusion; Rifampin; Streptomycin; Suppuration; Tuberculosis | 2003 |
[Quality control of culture media for mycobacterium drug sensitivity tests].
Topics: Antitubercular Agents; Culture Media; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Quality Control; Rifampin; Streptomycin | 2003 |
Characterization of clinical isolates of Mycobacterium tuberculosis resistant to drugs and detection of RpoB mutation in multidrug-resistant tuberculosis in the Philippines.
Topics: Codon; DNA-Directed RNA Polymerases; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Phenotype; Philippines; Retrospective Studies; Rifampin; Seroepidemiologic Studies | 2003 |
In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotics, Antitubercular; Antitubercular Agents; Capreomycin; Cycloserine; Drug Combinations; Ethambutol; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin | 2003 |
[Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Optic Nerve Diseases; Photophobia; Pyrazinamide; Rifampin; Risk Factors; Risk Management; Spinal Cord Diseases; Treatment Outcome; Tuberculosis, Lymph Node | 2003 |
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Area Under Curve; Body Weight; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Staphylococcus aureus; Time Factors | 2003 |
Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Interviews as Topic; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Peru; Prevalence; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2003 |
Laryngeal tuberculosis.
Topics: Acetylcysteine; Adult; Antitubercular Agents; Epiglottis; Ethambutol; Female; Granuloma, Laryngeal; Humans; Isoniazid; Mycobacterium; Rifampin; Tuberculosis, Laryngeal | 2004 |
Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis | 2004 |
[Septic loosening of a Wagner revision stem provoked by Mycobacterium tuberculosis].
Topics: Acetabulum; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Arthroplasty, Replacement, Hip; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prosthesis Failure; Prosthesis-Related Infections; Pyrazinamide; Radioimmunoassay; Reoperation; Rifampin; Synovial Fluid; Time Factors; Titanium; Tuberculosis | 2003 |
Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome Assessment, Health Care; Practice Guidelines as Topic; Rifampin; Saliva; Sex Distribution; Streptomycin | 2004 |
[Cardiac tamponade with paroxysmal atrial flutter controlled by antituberculous therapy].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Atrial Flutter; Cardiac Tamponade; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Tuberculosis | 2004 |
Retrovesical tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Biopsy, Fine-Needle; Child; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Laparotomy; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Urogenital; Ultrasonography, Interventional; Urination Disorders | 2004 |
Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin | 2004 |
G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Granulocyte Colony-Stimulating Factor; Humans; Iatrogenic Disease; Isoniazid; Male; Neutropenia; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 2004 |
Cranial-epidural tuberculosis presenting as a scalp swelling.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Edema; Epidural Space; Ethambutol; Frontal Bone; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Parietal Bone; Pyrazinamide; Rifampin; Scalp; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2004 |
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2004 |
Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Peru; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis | 2004 |
Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Topics: Administration, Oral; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Weight; Communicable Disease Control; Drug Therapy, Combination; Drug Utilization Review; Ethambutol; Female; Guideline Adherence; Hospital Records; Hospitals, Public; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Registries; Rifampin; Tuberculosis, Pulmonary | 2004 |
A 32-year-old man with tuberculosis, fever, and rash.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Hypersensitivity; Ethambutol; Exanthema; Fever; Humans; Isoniazid; Liver; Liver Failure; Male; Pyrazinamide; Pyridoxine; Rifampin; Skin; Tuberculosis, Pulmonary | 2004 |
[Study on the epidemiology and determinants of drug-resistant tuberculosis in northern rural area of Jiangsu province].
Topics: Adult; Antitubercular Agents; China; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; Incidence; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Rural Health; Streptomycin; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2004 |
Cervical spine tuberculosis.
Topics: Adolescent; Antitubercular Agents; Cervical Vertebrae; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Spinal | 2004 |
Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay.
Topics: Antitubercular Agents; Color; Ethambutol; Ethylenediamines; Free Radical Scavengers; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Nitrate Reductases; Nitrates; Nitrites; Oxidation-Reduction; Potassium Compounds; Rifampin; Sensitivity and Specificity; Streptomycin; Sulfanilamides; Time Factors | 2004 |
[Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
Topics: Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Diabetes Complications; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Sputum; Tuberculosis, Pulmonary; World Health Organization | 2004 |
Tuberculosis: medical management update.
Topics: Adult; Antitubercular Agents; Child; Dental Staff; Ethambutol; Humans; Infectious Disease Transmission, Patient-to-Professional; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Oral; Tuberculosis, Pulmonary | 2004 |
Multifocal osteoarticular tuberculosis: a case report.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Joints; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Osteoarticular | 2005 |
Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
Topics: Antibiotics, Antitubercular; Ascitic Fluid; Bronchoalveolar Lavage Fluid; Cerebrospinal Fluid; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Pleural Effusion; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Urine | 2004 |
Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Topics: Antitubercular Agents; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sampling Studies; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2004 |
[The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Turkey | 2004 |
The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Topics: Antitubercular Agents; Directly Observed Therapy; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Siberia; Tuberculosis, Pulmonary | 2004 |
The transpedicular approach in the management of thoracic spine tuberculosis: a short-term follow up study.
Topics: Abscess; Adolescent; Adult; Aged; Antitubercular Agents; Braces; Combined Modality Therapy; Curettage; Debridement; Decompression, Surgical; Disease Progression; Drainage; Ethambutol; Female; Follow-Up Studies; Humans; Immobilization; Isoniazid; Kyphosis; Male; Middle Aged; Movement Disorders; Pyrazinamide; Radiography; Recovery of Function; Retrospective Studies; Rifampin; Severity of Illness Index; Spinal Cord Compression; Thoracic Vertebrae; Treatment Outcome; Tuberculosis, Spinal | 2004 |
Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 2003 |
Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2003 |
Successful kidney re-transplantation in a patient with previous allograft kidney tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Immunosuppression Therapy; Isoniazid; Kidney Transplantation; Male; Opportunistic Infections; Pyrazinamide; Reoperation; Rifampin; Tuberculosis, Renal | 2004 |
Tuberculosis control and the private health sector in Bolivia: a survey of pharmacies.
Topics: Antitubercular Agents; Bolivia; Communicable Disease Control; Community Pharmacy Services; Cooperative Behavior; Drug Prescriptions; Ethambutol; Humans; Isoniazid; Pharmacies; Prescription Fees; Private Sector; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16.
Topics: Antibiotics, Antitubercular; DNA, Bacterial; Ethambutol; Flow Cytometry; Fluorescent Dyes; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2005 |
Macular edema as the only ocular finding of tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Macular Edema; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Sputum; Tuberculin Test; Tuberculosis, Ocular | 2004 |
[Miss-management in treatment failure of pulmonary tuberculosis].
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Directly Observed Therapy; Drug Therapy, Combination; Empyema, Tuberculous; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Compliance; Quality of Health Care; Retrospective Studies; Rifampin; Risk Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Case of pulmonary tuberculosis in late stage of pregnancy].
Topics: Adult; Antitubercular Agents; Cesarean Section; Cross Infection; Drug Therapy, Combination; Ethambutol; Female; Hospitals, General; Humans; Infant, Newborn; Infection Control; Isoniazid; Patient Isolation; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2004 |
[Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Radiography, Thoracic; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Cohort Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Norway; Patient Compliance; Pyrazinamide; Registries; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary | 2005 |
Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Formazans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Nitrate Reductases; Oxazines; Rifampin; Sensitivity and Specificity; Streptomycin; Tetrazolium Salts; Xanthenes | 2005 |
Mycobacterium marinum infections of the upper extremity.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Hand; Hand Injuries; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Retrospective Studies; Rifampin | 2005 |
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Topics: Capreomycin; Cycloserine; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam | 2005 |
High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ethambutol; Female; Humans; Isoniazid; Lithuania; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Random Allocation; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2005 |
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Codon; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Multifocal osteoarticular tuberculosis.
Topics: Adult; Antitubercular Agents; Bone and Bones; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Knee; Male; Pain; Pyrazinamide; Radiography; Radius; Rifampin; Treatment Outcome; Tuberculosis, Osteoarticular; Weight Loss; Wrist | 2005 |
Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
Topics: Antitubercular Agents; Ethambutol; Flow Cytometry; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Rifampin; Tuberculosis | 2005 |
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Topics: Adult; Antitubercular Agents; Carrier State; Case-Control Studies; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Incidence; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors | 2005 |
Tuberculous peritonitis developing during chemotherapy for pulmonary and intestinal tuberculosis: a case report.
Topics: Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Laparoscopy; Male; Middle Aged; Peritonitis, Tuberculous; Rifampin; Time Factors; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2005 |
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 2005 |
[Pulmonary infection due to Mycobacterium malmoense].
Topics: Azithromycin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2005 |
Solitary choroidal tuberculoma in an immunocompetent patient.
Topics: Adult; Antitubercular Agents; Choroid Diseases; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fluorescein Angiography; Humans; Immunocompetence; Isoniazid; Male; Rifampin; Tuberculin Test; Tuberculoma; Tuberculosis, Ocular | 2005 |
[Two cases of pulmonary infection by Mycobacterium abscessus in which drug susceptibility testing results conflicted with clinical courses].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Male; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin | 2005 |
Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
Topics: Amides; Antibiotics, Antitubercular; Antitubercular Agents; Catalysis; Chromatography, High Pressure Liquid; Drug Combinations; Ethambutol; Isoniazid; Picolinic Acids; Pyrazinamide; Rifampin; Spectrophotometry, Ultraviolet | 2005 |
Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Topics: Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Ethambutol; Flow Cytometry; Gels; Humans; Isoniazid; Microbial Sensitivity Tests; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microspheres; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2005 |
[Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Isoniazid; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin | 2005 |
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
Topics: Adult; Antitubercular Agents; Botswana; Comorbidity; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2005 |
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens.
Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin | 2005 |
[Two cases of Mycobacterium szulgai pulmonary disease in the elderly].
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Male; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 2005 |
Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
[Two pregnant immigrant women with tuberculous peritonitis].
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fetal Death; Humans; Isoniazid; Peritonitis, Tuberculous; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrazinamide; Rifampin | 2005 |
[Tuberculoma complicating tuberculous meningitis: description of one paediatric case].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Magnetic Resonance Imaging; Prednisone; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Meningeal | 2005 |
The effect of ethambutol on mycobacterial cell wall permeability to hydrophobic compounds.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Membrane Permeability; Cell Wall; Erythromycin; Ethambutol; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Sitosterols | 2005 |
Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay.
Topics: Alleles; Antitubercular Agents; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2005 |
[A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease].
Topics: Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Magnetic Resonance Imaging; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tomography, X-Ray Computed | 2005 |
Paraneoplastic limbic encephalitis presenting as acute viral encephalitis.
Topics: Acute Disease; Acyclovir; Anti-Bacterial Agents; Anticonvulsants; Carcinoma, Renal Cell; Cerebrospinal Fluid; Diagnosis, Differential; Drug Therapy, Combination; Electroencephalography; Encephalitis, Viral; Enoxaparin; Ethambutol; Follow-Up Studies; Herpesvirus 1, Human; Humans; Isoniazid; Limbic Encephalitis; Limbic System; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Middle Aged; Nephrectomy; Neuropsychological Tests; Paraneoplastic Syndromes, Nervous System; Phenytoin; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2005 |
Concurrence of granular cell tumor and Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bronchoscopy; Ethambutol; Granular Cell Tumor; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2005 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |
Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Reagent Strips; Rifampin; Streptomycin | 2005 |
Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
Topics: Adolescent; Antitubercular Agents; Chemoprevention; Contact Tracing; Disease Transmission, Infectious; Ethambutol; Female; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Tuberculosis, Pulmonary | 2005 |
A 2-year-old girl with an abnormal gait.
Topics: Antitubercular Agents; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Gait Ataxia; Humans; Isoniazid; Osteomyelitis; Physical Examination; Pyrazinamide; Rifampin; Tuberculosis, Spinal | 2005 |
Drug-drug interaction studies on first-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Ethambutol; Hot Temperature; Humidity; Isoniazid; Mass Spectrometry; Pyrazinamide; Rifampin | 2005 |
Pelvic cocoon: an unusual pelvic mass.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Laparotomy; Peritonitis, Tuberculous; Rifampin; Treatment Outcome | 2006 |
Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Recurrence; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Uganda | 2006 |
Role of latent genital tuberculosis in repeated IVF failure in the Indian clinical setting.
Topics: Adult; Antitubercular Agents; Endometrium; Ethambutol; Female; Fertilization; Fertilization in Vitro; Humans; India; Infertility, Female; Polymerase Chain Reaction; Pregnancy; Pregnancy Rate; Pyrazinamide; Rifampin; Tuberculosis, Female Genital | 2006 |
Adverse drug reactions observed during DOTS.
Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; India; Isoniazid; Male; Middle Aged; National Health Programs; Patient Compliance; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 2004 |
[BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
Mycobacterium tuberculosis in a Saudi Arabian hospital.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Saudi Arabia; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2006 |
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
Topics: Adult; Antitubercular Agents; Area Under Curve; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2006 |
Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
Topics: Agar; Antitubercular Agents; Blood; Culture Media; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2006 |
Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Topics: Alginates; Animals; Antitubercular Agents; Area Under Curve; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Ethambutol; Female; Glucuronic Acid; Hexuronic Acids; Isoniazid; Male; Mice; Nanostructures; Pyrazinamide; Rifampin; Tissue Distribution | 2006 |
[Tuberculosis of the submandibular gland: a case report].
Topics: Antitubercular Agents; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Submandibular Gland Diseases; Tuberculosis, Oral | 2006 |
Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Culture Media; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Reference Standards; Rifampin; Sensitivity and Specificity | 2006 |
[Isoniazid induced neuropathy: consider prevention].
Topics: Acetylation; Achilles Tendon; Adult; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Ethambutol; Female; Guinea; Hepatitis B, Chronic; HIV Infections; Humans; Hypesthesia; Inactivation, Metabolic; Isoniazid; Peripheral Nervous System Diseases; Reflex, Abnormal; Rifampin; Tuberculosis, Pulmonary; Vitamin B 6; Vitamin B 6 Deficiency | 2006 |
Mycobacterium avium infection involving skin and soft tissue of the hand treated by radical debridement and reconstruction in addition to multidrug chemotherapy.
Topics: Combined Modality Therapy; Debridement; Ethambutol; Forearm; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Postoperative Care; Rifampin; Skin Diseases, Bacterial; Skin Ulcer; Surgical Flaps | 2006 |
The use of real-time polymerase chain reaction for rapid diagnosis of skeletal tuberculosis.
Topics: Antitubercular Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Femur; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Osteolysis; Pyrazinamide; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Tuberculosis, Osteoarticular | 2006 |
[A case of Mycobacterium intracellulare infection with chronic empyema].
Topics: Aged, 80 and over; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Empyema; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifampin; Streptomycin; Tomography, X-Ray Computed | 2006 |
Tuberculous cervical lymphadenitis: an unusual case.
Topics: Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Granuloma, Giant Cell; Humans; Isoniazid; Lymphadenitis; Middle Aged; Neck; Rifampin; Tuberculosis, Lymph Node | 2006 |
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Pyrazinamide; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2006 |
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
Topics: Alleles; Antibiotics, Antitubercular; Antitubercular Agents; Biological Evolution; DNA Mutational Analysis; DNA, Bacterial; DNA, Intergenic; Ethambutol; Gene Deletion; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2006 |
Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotics, Antitubercular; British Columbia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigration and Immigration; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.
Topics: Antitubercular Agents; Cost of Illness; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Haiti; Health Care Costs; Humans; Isoniazid; Program Evaluation; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; World Health Organization | 2006 |
Ocular tuberculosis in acquired immunodeficiency syndrome.
Topics: Abscess; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Child; Conjunctival Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Panophthalmitis; Pyrazinamide; Retinal Diseases; Retrospective Studies; Rifampin; Tuberculosis, Central Nervous System; Tuberculosis, Ocular; Tuberculosis, Pulmonary | 2006 |
The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Topics: Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Guideline Adherence; Humans; Incidence; Japan; Male; Middle Aged; Mycobacterium avium Complex; Retrospective Studies; Rifampin; Sputum; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Penile tuberculosis associated with monoclonal gammopathy of undetermined significance.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Paraproteinemias; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Male Genital | 2006 |
Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients.
Topics: Adult; Afghanistan; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2006 |
Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
Topics: Adult; Antitubercular Agents; Bacteriophages; Biological Assay; Culture Media; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Prospective Studies; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2007 |
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed | 2006 |
Latent pelvic tuberculosis reactivating in a postmenopausal woman: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Hepatitis, Autoimmune; Humans; Hysterectomy; Isoniazid; Ovariectomy; Recurrence; Rifampin; Tuberculosis, Female Genital | 2006 |
National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Cross-Sectional Studies; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Myanmar; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin | 2006 |
Sir, I turned much darker!
Topics: Addison Disease; Adult; Antitubercular Agents; Ethambutol; Germany; Humans; Hydrocortisone; Hyperpigmentation; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Endocrine | 2006 |
Mycobacterium tuberculosis presenting as chronic red eye.
Topics: Adolescent; Antitubercular Agents; Chronic Disease; Conjunctivitis, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Ocular | 2006 |
Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Hemianopsia; Humans; Isoniazid; Kidney Failure, Chronic; Male; Optic Neuritis; Renal Dialysis; Rifampin; Tuberculosis | 2006 |
Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Cells, Cultured; Colorimetry; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Phagocytosis; Quinolines; Rifampin; Spectrometry, Fluorescence; Tuberculosis; Xanthenes | 2007 |
Modification to improve efficiency of sampling schedules for BA/BE testing of FDC anti-tuberculosis drugs.
Topics: Antitubercular Agents; Area Under Curve; Biological Availability; Blood Specimen Collection; Ethambutol; Humans; Isoniazid; Pyrazinamide; Quality Assurance, Health Care; Rifampin; South Africa; Therapeutic Equivalency | 2007 |
Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Health Surveys; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Rwanda; Streptomycin; Tuberculosis, Pulmonary; Warfare | 2007 |
Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals.
Topics: Adult; Antitubercular Agents; Combined Modality Therapy; Decompression, Surgical; Drug Therapy, Combination; Ethambutol; Female; Hospitals, Teaching; Humans; Isoniazid; Korea; Male; Middle Aged; Retrospective Studies; Rifampin; Severity of Illness Index; Spinal Fusion; Treatment Outcome; Tuberculosis, Spinal | 2007 |
[A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Zidovudine | 2007 |
Primary and acquired drug resistance in childhood tuberculosis.
Topics: Adolescent; Afghanistan; Antitubercular Agents; Child; Child Welfare; Ethambutol; Female; Gastric Juice; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Refugees; Retrospective Studies; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2006 |
[Case report: tuberculosis of parotid gland].
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Lymph Node Excision; Male; Parotid Diseases; Parotid Gland; Pyrazinamide; Radiography; Rifampin; Tuberculosis | 2007 |
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Ethambutol; Humans; Isoniazid; Korea; Middle Aged; Prevalence; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacteriological Techniques; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2007 |
[Case of liver tuberculosis requiring differentiation from liver metastasis of cancer].
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Liver Neoplasms; Lymphatic Metastasis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Lymph Node | 2007 |
[Centrofacial granulomatous inflammation].
Topics: Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Skin; Time Factors; Treatment Outcome; Tuberculin Test | 2007 |
[Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].
Topics: Antitubercular Agents; Capreomycin; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; Poland; Population Surveillance; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2007 |
Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antitubercular Agents; Comorbidity; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Rifampin; Streptomycin; Thailand; Tuberculosis, Multidrug-Resistant | 2007 |
Tuberculous sacro-ileitis: two cases and radiological findings.
Topics: Abscess; Adult; Antitubercular Agents; Arthritis, Infectious; Brucellosis; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Radiography; Rifampin; Sacroiliac Joint; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Ultrasonography | 2007 |
Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Etanercept; Ethambutol; Humans; Immunoglobulin G; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Receptors, Tumor Necrosis Factor; Rifampin; Sputum; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2007 |
Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Autoanalysis; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Streptomycin | 2007 |
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Delivery Systems; Ethambutol; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Specific Pathogen-Free Organisms; Tuberculosis | 2007 |
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Tuberculosis | 2007 |
Comparative evaluation of BACTEC 460TB system and Lowenstein-Jensen medium for the isolation of M. tuberculosis from cerebrospinal fluid samples of tuberculous meningitis patients.
Topics: Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Meningeal | 2007 |
Liver and pancreatic injury induced by antituberculous therapy.
Topics: Adult; Antitubercular Agents; Biopsy; Chemical and Drug Induced Liver Injury; Cholangiopancreatography, Endoscopic Retrograde; Ethambutol; Female; Follow-Up Studies; Humans; Pancreatitis; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2007 |
[Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Turkey | 2007 |
[Case of fatal liver failure due to anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Liver Failure; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2007 |
[Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Cross-Sectional Studies; Democratic Republic of the Congo; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Yemen | 2007 |
Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
Topics: Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium bovis; Rifampin; Streptomycin; Tuberculosis | 2007 |
[Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case report with a 6-year follow-up].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Chloramines; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy; Metronidazole; Mycobacterium ulcerans; Nitrofurantoin; Pleurisy; Prednisolone; Pyrazinamide; Recurrence; Rifampin; Skin Transplantation | 2008 |
Evaluation of antitubercular drug insertion into preformed dipalmitoylphosphatidylcholine monolayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antitubercular Agents; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Isoniazid; Membranes, Artificial; Rifampin; Surface Properties | 2008 |
Tuberculosis peritonitis.
Topics: Aged; Antitubercular Agents; Dominican Republic; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Peritonitis; Rhode Island; Rifampin; Tuberculosis | 2007 |
Drug susceptibility profiling of tuberculous meningitis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Infant; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant | 2008 |
[A case of pulmonary infection due to Mycobacterium chelonae treated by lobectomy after a long course of oral antimicrobial agents].
Topics: Antibiotics, Antitubercular; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Rifampin; Tuberculosis, Pulmonary | 2007 |
[A surgically treated case of ileus caused by small intestinal tuberculosis during treatment for pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Ileal Diseases; Ileus; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2007 |
Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Leukemia, Lymphocytic, Chronic, B-Cell; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Osteomyelitis; Rifampin | 2008 |
Treatment of isoniazid-resistant pulmonary tuberculosis.
Topics: Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Medical Audit; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
[Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2008 |
Exanthematous allergic drug reactions due to four chemically unrelated drugs.
Topics: Adult; Antibiotics, Antitubercular; Anticonvulsants; Antitubercular Agents; Erythema; Ethambutol; Exanthema; Female; Humans; Phenobarbital; Phenytoin; Pruritus; Rifampin | 2008 |
[Tuberculosis dactylis: a case report].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Child; Drug Therapy, Combination; Ethambutol; Female; Fingers; Humans; Isoniazid; Pyrazinamide; Radiography; Rifampin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Osteoarticular | 2008 |
Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
Topics: Antibiotics, Antitubercular; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Thoracic Surgery, Video-Assisted; Tuberculosis, Pulmonary; Vasculitis | 2008 |
Isolated tuberculous thyroiditis as solitary thyroid nodule.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Thyroid Nodule; Thyroiditis, Suppurative | 2008 |
Papulonecrotic tuberculids associated with uveitis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Glucocorticoids; Humans; Isoniazid; Male; Ophthalmic Solutions; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Cutaneous; Tuberculosis, Ocular; Uveitis | 2008 |
Two faces of MAC-induced lung disease.
Topics: Aged; Azithromycin; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Psoriasiform lupus vulgaris.
Topics: Adolescent; Antitubercular Agents; Biopsy; Buttocks; Child; Disease Progression; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Pyrazinamide; Pyridoxine; Rifampin; Tuberculin Test; Vitamin B Complex | 2008 |
Spinal tuberculosis in pregnancy.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Labor, Induced; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Thoracic Vertebrae; Thoracotomy; Tuberculosis, Spinal | 2008 |
Diagnostic challenges of intestinal tuberculosis in a patient with chronic diarrhoea: case report.
Topics: Adult; Antitubercular Agents; Chronic Disease; Diarrhea; Ethambutol; Humans; Isoniazid; Laparotomy; Male; Pyrazinamide; Rifampin; Tuberculosis, Gastrointestinal | 2008 |
One to make the diagnosis. A case of non tuberculous mycobacterial mastoiditis in a nine year old female.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Ethambutol; Female; Humans; Ireland; Isoniazid; Mastoiditis; Nontuberculous Mycobacteria; Pyrazinamide; Rifampin | 2008 |
Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2008 |
Long-term course and treatment of a cutaneous BCG infection.
Topics: Accidents, Occupational; Adult; Antitubercular Agents; BCG Vaccine; Ethambutol; Female; Humans; Isoniazid; Leg; Mycobacterium bovis; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous; Wrist | 2008 |
Update on the treatment of tuberculosis.
Topics: Antitubercular Agents; Comorbidity; Directly Observed Therapy; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis | 2008 |
Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Nigeria; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Rifampicin, ethambutol and pyrazinamide-induced thrombocytopenia.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Male; Pyrazinamide; Rifampin; Thrombocytopenia | 2008 |
Scapholunate dissociation: a rare presentation of TB wrist in a case of multi-focal skeletal tuberculosis.
Topics: Adolescent; Antitubercular Agents; Arthritis, Infectious; Arthrodesis; Carpal Joints; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lunate Bone; Pyrazinamide; Radiography; Range of Motion, Articular; Rifampin; Scaphoid Bone; Tuberculosis, Osteoarticular | 2008 |
An unusual case of a pleural effusion with an abdominal mass.
Topics: Adult; Antitubercular Agents; Drainage; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Tuberculosis, Renal | 2008 |
[Susceptibility testing of Mycobacterium tuberculosis isolates to primary antituberculous drugs on chocolate agar: a preliminary study].
Topics: Agar; Antitubercular Agents; Coloring Agents; Culture Media; Erythrocytes; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Rosaniline Dyes; Streptomycin | 2008 |
[Sternal tuberculosis].
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Debridement; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Sternum; Tuberculosis, Osteoarticular | 2008 |
Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty.
Topics: Aged; Antitubercular Agents; Arthroplasty, Replacement, Knee; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Taiwan; Tuberculosis, Osteoarticular | 2009 |
Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
Tuberculous liver abscess.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Liver Abscess; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Hepatic | 2008 |
Prevalence of tuberculosis drug resistance in 10 provinces of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Reproducibility of Results; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization | 2008 |
[Pain, swelling, and progressive weakness of the left knee over 6 years].
Topics: Accidents, Traffic; Antitubercular Agents; Arthritis, Infectious; Disease Progression; Ethambutol; Humans; Isoniazid; Knee Injuries; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2008 |
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Recurrence; Retrospective Studies; Rifampin; Streptomycin | 2009 |
[Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2008 |
Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Behcet Syndrome; Bursitis; Elbow; Ethambutol; Female; Humans; Immunocompromised Host; Infliximab; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2009 |
[Drug-resistant pulmonary tuberculosis at the penitentiaries].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Prisoners; Rifampin; Russia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2008 |
[Cerebellar soap bubble lesions and mediastinal lymph nodes].
Topics: Adult; Antitubercular Agents; Brain Abscess; Cerebellar Diseases; Combined Modality Therapy; Craniotomy; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Mediastinum; Pyrazinamide; Rifampin; Tuberculosis, Central Nervous System; Tuberculosis, Lymph Node | 2009 |
[Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
[Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].
Topics: Adolescent; Age Factors; Antibiotics, Antitubercular; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Prothionamide; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2009 |
Late Mycobacterium bovis spondylitis after intravesical BCG therapy.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Drug Therapy, Combination; Epidural Abscess; Ethambutol; Humans; Isoniazid; Lumbar Vertebrae; Male; Mycobacterium bovis; Osteolysis; Osteomyelitis; Rifampin; Spinal Fusion; Treatment Outcome; Tuberculosis, Spinal | 2009 |
Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Coccidioides; Coccidioidomycosis; Endosonography; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Itraconazole; Lymph Nodes; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Isoniazid induced gynaecomastia: a case report.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gynecomastia; Humans; Isoniazid; Male; Mammography; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2009 |
[Fever and thin-walled cavitary lung lesions].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Fever; Humans; Isoniazid; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pyrazinamide; Radiography; Rifampin; Sputum; Tuberculosis, Pulmonary | 2009 |
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Serum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.
Topics: Diabetic Nephropathies; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Renal Dialysis; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 2009 |
Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchiectasis; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Agar; Antitubercular Agents; Chi-Square Distribution; Child; Ethambutol; Ethionamide; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Radiometry; Regression Analysis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Turkey | 2009 |
Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Azithromycin; Child, Preschool; Combined Modality Therapy; Contact Tracing; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Ethambutol; Fever of Unknown Origin; Humans; Immunocompromised Host; Isoniazid; Lymphopenia; Male; Mycobacterium tuberculosis; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Vincristine | 2009 |
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2009 |
British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
Topics: Adenosine Deaminase; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Cerebrospinal Fluid; Child; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spinal Puncture; Tuberculin Test; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tuberculosis, Spinal | 2009 |
Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Proportional Hazards Models; Pyrazinamide; Retrospective Studies; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Analysis of Variance; beta 2-Microglobulin; Biomarkers; CD4-Positive T-Lymphocytes; Cell Count; Enzyme-Linked Immunosorbent Assay; Ethambutol; Humans; India; Isoniazid; Neopterin; Pyrazinamide; Receptors, Tumor Necrosis Factor, Type I; Rifampin; Tuberculosis | 2009 |
Co-existence of organising pneumonia in a patient with Mycobacterium avium intracellulare pulmonary infection.
Topics: Bronchoscopy; Emphysema; Ethambutol; Female; Glucocorticoids; Humans; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonia; Prednisolone; Rifampin; Tomography, X-Ray Computed | 2009 |
Rifampicin serum levels in childhood tuberculosis.
Topics: Administration, Oral; Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Body Surface Area; Child; Child, Preschool; Drug Dosage Calculations; Drug Therapy, Combination; Ethambutol; Humans; Practice Guidelines as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2009 |
Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Observer Variation; Predictive Value of Tests; Quality Assurance, Health Care; Quality Control; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2009 |
[Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Radiometry; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin | 2009 |
Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Rifampin; Structure-Activity Relationship; Tuberculosis | 2009 |
"MAC" attack.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Rheumatoid; Azithromycin; Drug Therapy, Combination; Ethambutol; Female; Glucocorticoids; Humans; Immunocompromised Host; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisone; Rifampin; Skin Diseases, Bacterial | 2009 |
Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ethambutol; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Ionophores; Isoniazid; Membrane Transport Proteins; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Rifampin; Streptomycin; Stress, Physiological; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oleanolic Acid; Rifampin; Tuberculosis | 2010 |
Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Cameroon; Child; Confidence Intervals; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2009 |
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
Topics: Antitubercular Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy.
Topics: Adult; Antitubercular Agents; Crohn Disease; Ethambutol; Humans; Immunosuppressive Agents; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Skin; Tumor Necrosis Factor-alpha | 2010 |
An uncommon cause for a common complaint.
Topics: Anti-Bacterial Agents; Carpal Tunnel Syndrome; Clarithromycin; DNA, Bacterial; Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Occupational Exposure; Rifampin; Rivers; Tenosynovitis | 2009 |
Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy.
Topics: Animals; Antimalarials; Drug Therapy, Combination; Ethambutol; Isoniazid; Malaria; Mice; Plasmodium berghei; Rifampin; Survival Analysis; Treatment Outcome | 2010 |
Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Factors; South Africa; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2010 |
Incision infection with Mycobacterium tuberculosis after total hip arthroplasty without any primary tuberculosis focus.
Topics: Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Ethambutol; Female; Hip Dislocation, Congenital; Hip Prosthesis; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Prosthesis-Related Infections; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Determination of antituberculosis drug concentration in human plasma by MALDI-TOF/TOF.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; Humans; Pyrazinamide; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin | 2010 |
Dysuria: don't take it lightly.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Dysuria; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis, Female Genital; Tuberculosis, Renal; Urine | 2011 |
Nasolacrimal tuberculosis: case report highlighting the need for imaging in identifying and managing it effectively.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Endoscopy; Ethambutol; Female; Humans; Isoniazid; Lacrimal Apparatus Diseases; Nasolacrimal Duct; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular | 2010 |
Advanced shoulder joint tuberculosis treated with débridement and closed continuous irrigation and suction: a report of 2 cases.
Topics: Antitubercular Agents; Debridement; Drug Therapy, Combination; Ethambutol; Exercise Therapy; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Range of Motion, Articular; Rifampin; Shoulder Joint; Suction; Therapeutic Irrigation; Treatment Outcome; Tuberculosis, Osteoarticular | 2010 |
[Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
Topics: Adult; Antitubercular Agents; Child; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Turkey | 2010 |
Female extrapulmonary genital tuberculosis: full-term deliveries after 4 years of follow-up.
Topics: Abdominal Pain; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Laparoscopy; Pregnancy; Pregnancy Outcome; Rifampin; Tuberculosis, Female Genital | 2010 |
A survey of prescribing pattern for osteoarticular tuberculosis: orthopaedic surgeons' and infectious disease experts' perspective.
Topics: Antitubercular Agents; Congresses as Topic; Ethambutol; Humans; Infectious Disease Medicine; Isoniazid; Ofloxacin; Orthopedics; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Osteoarticular | 2009 |
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Sensitivity and Specificity; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Pott's disease with scrofuloderma and psoas abscess misdiagnosed and treated as hidradenitis suppurativa.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Diagnostic Errors; Ethambutol; Hidradenitis Suppurativa; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Psoas Abscess; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Spinal | 2011 |
[Onset of neurological symptoms during tuberculosis treatment: description of two cases].
Topics: Adult; Aged, 80 and over; Antitubercular Agents; Aphasia; Child, Preschool; Drug Therapy, Combination; Dystonia; Ethambutol; Facial Pain; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Nigeria; Prednisone; Pyrazinamide; Reflex, Abnormal; Rifampin; Tremor; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Miliary | 2010 |
Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
Topics: Antitubercular Agents; British Columbia; Ethambutol; Female; Humans; Isoniazid; Longitudinal Studies; Male; Middle Aged; Pyrazinamide; Quality of Life; Retrospective Studies; Rifampin; Sickness Impact Profile; Tuberculosis, Pulmonary | 2010 |
Mediastina Tuberculosis mass in a three-month-old boy.
Topics: Adrenal Cortex Hormones; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Male; Mediastinal Diseases; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis | 2010 |
A nodulo-ulcerative lesion on the nose.
Topics: Aged, 80 and over; Antitubercular Agents; Chronic Disease; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Nose Diseases; Pyrazinamide; Rifampin; Skin Ulcer; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
A case of acute and severe thrombocytopenia due to readministration of rifampicin.
Topics: Acute Disease; Antitubercular Agents; Ethambutol; Female; Humans; Humerus; Middle Aged; Rifampin; Severity of Illness Index; Thrombocytopenia; Tuberculosis, Osteoarticular | 2011 |
Scrofula.
Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Sentinel Lymph Node Biopsy; Tuberculosis, Lymph Node | 2010 |
[A case of tuberculous pleurisy with transient new intra-pulmonary lesions during anti-tuberculosis therapy].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Lung; Male; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Young Adult | 2010 |
[Culture and susceptibility testing of mycobacteria with VersaTREK].
Topics: Algorithms; Antitubercular Agents; Automation; Bacteriological Techniques; Culture Media; Ethambutol; Humans; Isoniazid; Manometry; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Staining and Labeling; Streptomycin; Time Factors | 2011 |
Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cohort Studies; Drug Monitoring; Ethambutol; Female; Government Programs; Humans; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Virginia; Young Adult | 2010 |
Granulomatous lesion on the face successfully treated with antitubercular therapy.
Topics: Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Facial Dermatoses; Female; Granuloma; Humans; Isoniazid; Mycobacterium Infections; Pyrazinamide; Rifampin; Skin Diseases, Bacterial | 2010 |
Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2010 |
The use of the QuantiFERON-tuberculosis gold test in the diagnosis of ocular tuberculosis.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Fluorescein Angiography; Humans; Interferon-gamma Release Tests; Isoniazid; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular; Vision Disorders | 2010 |
[Urinary bladder tuberculosis and Bacillus Calmette-Guérin instillation: reduced efficacy of bisoprolol in hypertension].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Antihypertensive Agents; Antitubercular Agents; BCG Vaccine; Bisoprolol; Blood Pressure; Carcinoma, Transitional Cell; Cardiac Complexes, Premature; Combined Modality Therapy; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Enzyme Induction; Ethambutol; Humans; Isoniazid; Male; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Rifampin; Tuberculosis, Urogenital; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 2010 |
[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Hospitals, University; Humans; Immunocompromised Host; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Senegal; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Topics: Adolescent; Adult; Antibiotics, Antitubercular; Comorbidity; Cross-Sectional Studies; Epidemics; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Multivariate Analysis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2010 |
Mycobacterium marinum infection after infliximab therapy.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Ethambutol; Granuloma; Humans; Infliximab; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Treatment Outcome | 2010 |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Hospitals; Humans; Isoniazid; Male; Meningoencephalitis; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2011 |
Flexor tenosynovitis caused by Mycobacterium arupense.
Topics: Aged; Antitubercular Agents; Diagnosis, Differential; DNA Probes; Drug Therapy, Combination; Ethambutol; Fingers; Humans; Male; Mycobacterium Infections; Postoperative Care; Rifampin; Tenosynovitis | 2011 |
A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Desensitization, Immunologic; Ethambutol; Female; Humans; Isoniazid; Lymphocyte Activation; Middle Aged; Pyrazinamide; Radiography; Retreatment; Rifampin; Tuberculosis, Pleural | 2011 |
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.
Topics: Acetamides; Antitubercular Agents; Ethambutol; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India.
Topics: Adult; Antitubercular Agents; Directly Observed Therapy; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
[Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Polymerase Chain Reaction; Respiratory System; Rifampin; Streptomycin; Tuberculosis; Turkey | 2011 |
[Susceptibility of M. tuberculosis to antituberculosis drugs as determined by two methods, in Sucre state, Venezuela].
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Sequence Data; Morbidity; Mutation, Missense; Mycobacterium tuberculosis; Nitrate Reductase; Point Mutation; Prevalence; Rifampin; Sequence Alignment; Sequence Homology, Nucleic Acid; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Venezuela | 2010 |
An apparently healthy young man with a peculiar-looking chest radiograph.
Topics: Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Ethambutol; Fever; HIV Seropositivity; Humans; Isoniazid; Male; Pleural Effusion; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2011 |
Interferon-gamma release assay in tuberculous scleritis.
Topics: Adult; Aged; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunoassay; Interferon-gamma; Isoniazid; Leukocytes; Male; Rifampin; Scleritis; Tuberculosis, Ocular | 2011 |
[Pulmonary paragonimiasis].
Topics: Adult; Animals; Anthelmintics; Antitubercular Agents; Caulobacteraceae; Delayed Diagnosis; Ecuador; Ethambutol; Food Parasitology; Gram-Negative Bacterial Infections; Granuloma; Hemoptysis; Humans; Isoniazid; Lung Diseases, Parasitic; Male; Paragonimiasis; Pneumonia, Bacterial; Praziquantel; Pyrazinamide; Radiography; Rifampin; Spain; Tuberculosis, Pulmonary | 2011 |
A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2011 |
BCG-induced lupus vulgaris complicated by squamous cell carcinoma in a 7-year-old child.
Topics: Antitubercular Agents; BCG Vaccine; Carcinoma, Squamous Cell; Child; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Lymphatic Metastasis; Male; Pyrazinamide; Rifampin; Skin Neoplasms; Treatment Outcome | 2011 |
Verrucous plaque on the thigh.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Thigh; Treatment Outcome; Tuberculosis, Cutaneous | 2011 |
Case report: Lower extremity sparganosis in a bursa.
Topics: Aged; Animals; Antitubercular Agents; Bursa, Synovial; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Rifampin; Soft Tissue Neoplasms; Sparganosis; Sparganum; Tibia; Treatment Outcome | 2011 |
Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India.
Topics: Antitubercular Agents; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Predictive Value of Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin | 2011 |
The variable clinical presentation of tuberculosis otitis media and the importance of early detection.
Topics: Adolescent; Adult; Audiometry, Pure-Tone; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Otitis Media, Suppurative; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2011 |
Drug susceptibility pattern of Mycobacterium tuberculosis isolates against conventional anti-tuberculosis drugs in Dhaka, Bangladesh.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Young Adult | 2011 |
Resistance to first-line tuberculosis drugs in three cities of Nigeria.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Cities; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nigeria; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Urban Health; Young Adult | 2011 |
Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Adult; Antitubercular Agents; Cohort Studies; DNA Mutational Analysis; Ethambutol; Humans; Isoniazid; Jordan; Microbial Sensitivity Tests; Molecular Typing; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2011 |
[Apoptosis-inducing action of antituberculosis drugs of the main group in vitro].
Topics: Antitubercular Agents; Apoptosis; Ethambutol; Humans; Isoniazid; Lymphocytes; Rifampin; Tuberculosis, Pulmonary | 2010 |
Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
Topics: Adult; Antitubercular Agents; Communicable Disease Control; Directly Observed Therapy; Enzyme-Linked Immunosorbent Assay; Ethambutol; HIV Seronegativity; HIV Seropositivity; Humans; India; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2011 |
Tuberculosis-associated chronic kidney disease.
Topics: Antitubercular Agents; Ethambutol; Fever; Humans; Isoniazid; Kidney Failure, Chronic; Male; Pyrazinamide; Renal Dialysis; Rifampin; Tuberculosis; Young Adult | 2011 |
Multifocal tuberculosis revealed by multiple cutaneous gummas in the immunocompetent.
Topics: Antitubercular Agents; Clavicle; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Isoniazid; Male; Morocco; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculosis, Cutaneous; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary; Young Adult | 2011 |
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; South Africa; Streptomycin | 2011 |
Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.
Topics: Antitubercular Agents; Aza Compounds; Biopsy; Brain; Cerebrospinal Fluid; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Histocytochemistry; Humans; Isoniazid; Magnetic Resonance Imaging; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Multidrug-Resistant; Young Adult | 2011 |
Mycotic aneurysm of the aorta as a complication of Bacillus Calmette-Guérin instillation.
Topics: Administration, Intravesical; Aged; Aneurysm, Infected; Antibiotics, Antitubercular; Aorta, Abdominal; Aortic Aneurysm, Abdominal; BCG Vaccine; Carcinoma, Transitional Cell; England; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Mycobacterium bovis; Mycobacterium Infections; Rifampin; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2011 |
[A case of tuberculous peritonitis developed during chemotherapy for tuberculous pleurisy as paradoxical response].
Topics: Adenosine Deaminase; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Peritonitis, Tuberculous; Pleural Effusion; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pleural | 2011 |
Acute liver failure in a pediatric patient with disseminated tuberculosis.
Topics: Antifungal Agents; Antitubercular Agents; Child; Coccidioidomycosis; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Isoniazid; Liver Failure, Acute; Male; Pyrazinamide; Recovery of Function; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Drug susceptibility of Mycobacterium tuberculosis in patients with AIDS at a tertiary care hospital in northern India.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Antitubercular Agents; CD4 Lymphocyte Count; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; India; Isoniazid; Male; Mycobacterium tuberculosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary; Viral Load | 2011 |
[Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Electroporation; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Oxidoreductases; Plasmids; Rifampin; Streptomycin | 2011 |
Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
Topics: Antitubercular Agents; Base Sequence; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Markers; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pentosyltransferases; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2011 |
Tuberculous damaged lung in a child.
Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Isoniazid; Lung; Lung Neoplasms; Mycobacterium tuberculosis; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Pulmonary | 2011 |
Pyrazinamide-induced sideroblastic anemia.
Topics: 5-Aminolevulinate Synthetase; alpha-Thalassemia; Anemia, Sideroblastic; Antitubercular Agents; Aza Compounds; Bone Marrow; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Hemolysis; Humans; Isoniazid; Middle Aged; Moxifloxacin; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Quinolines; Rifampin | 2012 |
[Anti-tuberculosis chemotherapy and management of adverse reactions].
Topics: Aged, 80 and over; Antitubercular Agents; Child; Drug Administration Schedule; Drug Hypersensitivity; Ethambutol; Female; Humans; Isoniazid; Liver; Pregnancy; Pyrazinamide; Rifampin; Tuberculosis | 2011 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
Clinical presentations and therapeutic effect of presumed choroidal tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Ocular; Young Adult | 2012 |
Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
Topics: Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Ethambutol; Isoniazid; Pyrazinamide; Rifampin; Solubility; Spectroscopy, Near-Infrared | 2012 |
Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Flow Cytometry; Humans; Isoniazid; Neutrophils; Phagocytosis; Pyrazinamide; Respiratory Burst; Rifampin; Staphylococcus aureus; Tuberculosis | 2011 |
Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships.
Topics: Antitubercular Agents; Cell Wall; Coumarins; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Rifampin; Streptomycin; Structure-Activity Relationship | 2011 |
How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Biopsy; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Predictive Value of Tests; Pyrazinamide; Rifampin; ROC Curve; Tuberculin Test; Tuberculosis, Cutaneous; Young Adult | 2011 |
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Burkina Faso; Chromatography, High Pressure Liquid; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Plasma; Pyrazinamide; Rifampin; Tuberculosis | 2012 |
Cutaneous polyarteritis nodosa induced by Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Phenylpropionates; Polyarteritis Nodosa; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Cutaneous | 2012 |
[Sudden decrease in visual acuity and pulmonary infiltrates].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Laser Coagulation; Male; Neovascularization, Pathologic; Pyrazinamide; Radiography; Recurrence; Retinal Hemorrhage; Retinal Vasculitis; Rifampin; Tuberculosis, Pulmonary; Visual Acuity; Young Adult | 2012 |
[Comparison of proportion method in Löwenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 2011 |
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Topics: Adult; Aged; Alcoholism; Antibiotics, Antitubercular; Antitubercular Agents; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Recurrence; Rifampin; Schizophrenia; Sputum; Treatment Failure; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
Topics: Aged; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
A case of isolated pancreatic tuberculosis mimicking pancreatic carcinoma.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pancreatic Diseases; Pancreatic Neoplasms; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2011 |
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
Topics: Animals; Antitubercular Agents; Aza Compounds; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Markov Chains; Mice; Models, Theoretical; Moxifloxacin; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Quinolines; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Proteins; Catalase; Child; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Mutation, Missense; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Sensitivity and Specificity; Tuberculosis; Young Adult | 2012 |
Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin | 2012 |
Minimally invasive posterior stabilization for treating spinal tuberculosis.
Topics: Adult; Antitubercular Agents; Bed Rest; Casts, Surgical; Combined Modality Therapy; Ethambutol; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Minimally Invasive Surgical Procedures; Orthopedic Procedures; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2013 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Virus Replication; Young Adult | 2012 |
[Sternal tumour in a 46-year-old woman].
Topics: Antitubercular Agents; Biopsy; Carcinoma; Combined Modality Therapy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Lymphatic Diseases; Middle Aged; Mycobacterium tuberculosis; Osteolysis; Osteomyelitis; Pleural Effusion; Pleural Neoplasms; Pyrazinamide; Rifampin; Sputum; Sternum; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2012 |
Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Cross Infection; Discitis; Disease Outbreaks; Diskectomy, Percutaneous; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Sacroiliitis; Surgical Wound Infection; Treatment Outcome | 2012 |
Tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Male; Pyrazinamide; Rifampin; Tuberculosis, Ocular; Uveitis; Young Adult | 2012 |
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2012 |
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Georgia (Republic); Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Predictive Value of Tests; Pyrazinamide; Retrospective Studies; Rifampin; Risk Assessment; Risk Factors; Sputum; Time Factors; Treatment Outcome; Tuberculosis | 2012 |
[Swelling of right knee in an immunologically compromised patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Arthritis, Infectious; Bacteremia; Candidiasis, Oral; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Knee Joint; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Radiography; Rifampin; Tuberculosis, Osteoarticular | 2012 |
Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Mangalore.
Topics: Antitubercular Agents; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2010 |
Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
Topics: Antitubercular Agents; Biomarkers; Cell Line, Tumor; Drug Discovery; Ethambutol; High-Throughput Screening Assays; Humans; Isoniazid; Leukemia, Monocytic, Acute; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Pentachlorophenol; Pyrazinamide; Rifampin; Streptomycin | 2012 |
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Risk Assessment; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2012 |
The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Coinfection; Epidemics; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
[Paradoxical radiologic progression despite appropriate anti-tuberculous therapy].
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Random Allocation; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].
Topics: Adult; Antitubercular Agents; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Female; Granulomatous Mastitis; Humans; Isoniazid; Mastitis; Methotrexate; Mycobacterium tuberculosis; Polymerase Chain Reaction; Prednisone; Pyrazinamide; Recurrence; Rifampin; Tuberculosis | 2012 |
A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient.
Topics: Clarithromycin; Ethambutol; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Optic Neuritis; Rifampin; Tenosynovitis; Wrist | 2012 |
Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
Topics: Anorexia Nervosa; Antibodies, Bacterial; Antitubercular Agents; Ethambutol; Female; Humans; Interferon-gamma; Isoniazid; Lung Diseases; Lymphocytes; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Young Adult | 2012 |
Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Rifampin; Sulfamethoxazole; Trimethoprim | 2012 |
Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Republic of Korea; Retrospective Studies; Rifabutin; Rifampin | 2012 |
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Lupus vulgaris in an immunocompromised patient.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Kidney Transplantation; Lupus Vulgaris; Pyrazinamide; Rifampin | 2014 |
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis.
Topics: Adamantane; Antitubercular Agents; Aza Compounds; Diarylquinolines; Drug Combinations; Drug Synergism; Ethambutol; Ethylenediamines; Fluoroquinolones; Isoniazid; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Quinolines; Rifampin; Spiro Compounds; Thiazines; Thienamycins | 2012 |
Extensive chronic Tuberculosis luposa treated incorrectly with long-term course of isoniazid monotherapy.
Topics: Aged; Antitubercular Agents; Bacteriological Techniques; Chronic Disease; Diagnostic Errors; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lupus Vulgaris; Male; Mycobacterium tuberculosis; Polymerase Chain Reaction; Predictive Value of Tests; Rifampin; Skin; Time Factors; Treatment Outcome; Tuberculin Test | 2013 |
Rapid identification and drug susceptibility screening of ESAT-6 secreting Mycobacteria by a NanoELIwell assay.
Topics: Antigens, Bacterial; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Limit of Detection; Microbial Sensitivity Tests; Mycobacterium kansasii; Mycobacterium smegmatis; Nanostructures; Reagent Kits, Diagnostic; Rifampin | 2012 |
[Treatment of intractable tuberculous meningitis using intrathecal isoniazid administration and steroid pulse therapy; a report of two cases].
Topics: Adult; Antitubercular Agents; Dexamethasone; Drug Therapy, Combination; Ethambutol; Female; Humans; Injections, Spinal; Isoniazid; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2012 |
Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets.
Topics: Antitubercular Agents; Chromatography, Reverse-Phase; Chromatography, Thin Layer; Ethambutol; Ethanol; Isoniazid; Pyrazinamide; Reproducibility of Results; Rifampin; Tablets | 2012 |
[A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 2012 |
Intraretinal tuberculosis.
Topics: Administration, Oral; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Granuloma; Humans; Isoniazid; Male; Prednisolone; Pyrazinamide; Retinal Vasculitis; Rifampin; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2012 |
Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Therapy, Combination; Ethambutol; Female; Glucocorticoids; Humans; Interferon-gamma Release Tests; Isoniazid; Male; Middle Aged; Prednisone; Prospective Studies; Pyrazinamide; Racial Groups; Radiography, Thoracic; Rifampin; Risk Factors; Sensitivity and Specificity; Spain; Surveys and Questionnaires; Tuberculin Test; Tuberculosis, Ocular; Urban Population; Uveitis; Young Adult | 2013 |
Paucibacillary tubercular vulval ulcer in a sexually inactive pubertal girl: role of therapeutic trial.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculin Test; Tuberculosis, Female Genital; Vulvar Diseases | 2012 |
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Genetic Markers; Genotype; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Sensitivity and Specificity; South Africa; Sputum; Time Factors | 2012 |
[Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
Topics: Adult; Antitubercular Agents; Argentina; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Topics: Acetyltransferases; Adolescent; Age Factors; Antitubercular Agents; Area Under Curve; Biological Availability; Child; Child, Preschool; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Infant; Isoniazid; Least-Squares Analysis; Male; Malnutrition; Polymorphism, Genetic; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; Venezuela; World Health Organization | 2012 |
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.
Topics: Adult; Antitubercular Agents; Cluster Analysis; Cross Infection; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; HIV Infections; Hospitals, Rural; Humans; Isoniazid; Male; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prevalence; Pyrazinamide; Retrospective Studies; Rifampin; Sequence Analysis, DNA; South Africa | 2013 |
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.
Topics: Antitubercular Agents; Epidemiological Monitoring; Ethambutol; Greece; Humans; Isoniazid; Latent Tuberculosis; Prescription Drugs; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
[Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
Topics: Antitubercular Agents; Cervical Vertebrae; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Epidural Abscess; Ethambutol; Humans; Isoniazid; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thoracic Vertebrae; Tuberculosis, Central Nervous System | 2012 |
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Biological Transport; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Ethambutol; Genotype; Isoniazid; Kanamycin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Protein Structure, Secondary; Protein Structure, Tertiary; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2013 |
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Interactions; Ethambutol; Female; Genotype; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Organophosphonates; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Single Nucleotide; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Tenofovir; Tuberculosis; Young Adult | 2013 |
[Anti-mycobacteria drugs therapy for periductal mastitis with fistula].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Female; Fistula; Humans; Isoniazid; Mastitis; Nontuberculous Mycobacteria; Pyrazinamide; Retrospective Studies; Rifampin; Young Adult | 2012 |
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
Topics: Adult; Clarithromycin; Cysts; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Tuberculosis, Pulmonary | 2012 |
A pregnant woman with dyspnoea, fever & decreased vision.
Topics: Adult; Antitubercular Agents; Choroid Diseases; Ethambutol; Female; Humans; Isoniazid; Pregnancy; Pregnancy Outcome; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Miliary | 2012 |
Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.
Topics: Agar; Antitubercular Agents; Culture Media; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Reproducibility of Results; Rifampin; Streptomycin | 2013 |
[Thyroid tuberculosis; a rare cause of compressive goiter].
Topics: Antitubercular Agents; Biopsy; Combined Modality Therapy; Deglutition Disorders; Drainage; Ethambutol; Goiter; Hormone Replacement Therapy; Humans; Hypothyroidism; Isoniazid; Lymphatic Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pyrazinamide; Rifampin; Thyroiditis; Thyroxine; Tuberculosis, Endocrine | 2013 |
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Bacterial; Epidemiological Monitoring; Ethambutol; Female; Health Surveys; Humans; Incidence; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Risk Factors; Saudi Arabia; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
[A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache].
Topics: Abdominal Pain; Antitubercular Agents; Biomarkers; CA-125 Antigen; Diagnosis, Differential; Diarrhea; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Peritonitis, Tuberculous; Pyrazinamide; Receptors, Interleukin-2; Renal Dialysis; Rifampin; Treatment Outcome | 2013 |
Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Topics: Antitubercular Agents; Drug Substitution; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Infant; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Radiography, Thoracic; Rifampin; Streptomycin; Treatment Outcome; Tuberculoma, Intracranial; Tuberculosis, Miliary; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Rifampin; Sputum | 2013 |
[Primary sinonasal tuberculosis: apropos of a case].
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Maxillary Sinusitis; Mycobacterium tuberculosis; Nasal Obstruction; Nasal Polyps; Pyrazinamide; Rifampin; Tuberculosis | 2013 |
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Chaperonin 60; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Skin; Skin Diseases, Bacterial | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in Brazil: an ecological study.
Topics: Antitubercular Agents; Brazil; Drug Combinations; Ethambutol; Health Plan Implementation; Humans; Incidence; Isoniazid; Population Density; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Time Factors; Tuberculosis | 2013 |
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tanzania; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2013 |
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; Catalase; Codon; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Follow-Up Studies; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Promoter Regions, Genetic; Recurrence; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2013 |
Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tandem Mass Spectrometry; Tuberculosis; Young Adult | 2013 |
Severe hyponatremia and MRI point to diagnosis of tuberculous meningitis in the Southwest USA.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Hyponatremia; Isoniazid; Magnetic Resonance Imaging; Pyrazinamide; Rifampin; Southwestern United States; Tuberculosis, Meningeal; Young Adult | 2013 |
A breathtaking response to tuberculosis therapy.
Topics: Adult; Antitubercular Agents; Disease Progression; Dyspnea; Ethambutol; Female; Humans; Isoniazid; Mediastinum; Pericarditis, Tuberculous; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Lymph Node | 2013 |
Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Hand Strength; Humans; Immunocompetence; Isoniazid; Levofloxacin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium marinum; Osteomyelitis; Range of Motion, Articular; Retrospective Studies; Rifampin; Scaphoid Bone; Synovectomy; Tenosynovitis | 2013 |
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis | 2013 |
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed | 2013 |
Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Benzoquinones; Blood Chemical Analysis; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Isoniazid; Kidney; Lipid Peroxidation; Lipids; Liver; Liver Function Tests; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rifampin; Superoxide Dismutase | 2013 |
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Topics: Adult; Antitubercular Agents; Biological Availability; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Dosage Calculations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
A case of skin and lung tuberculosis: diagnostic difficulties.
Topics: Antitubercular Agents; Bronchitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; CD4-CD8 Ratio; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Facial Dermatoses; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sarcoidosis; Sputum; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2013 |
[Primary penile tuberculosis].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Male; Middle Aged; Penile Diseases; Pyrazinamide; Rifampin; Skin Ulcer; Tuberculosis, Male Genital; Vitiligo | 2013 |
Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs.
Topics: Antitubercular Agents; Ethambutol; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin | 2014 |
Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Directly Observed Therapy; Drug Monitoring; Ethambutol; Female; Half-Life; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Turkey; Young Adult | 2013 |
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Automation, Laboratory; Colony Count, Microbial; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Feasibility Studies; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Predictive Value of Tests; Prospective Studies; Pyrazinamide; Rifampin; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Uganda; Young Adult | 2013 |
Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
Topics: Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patch Tests; Pyrazines; Rifampin | 2013 |
Anti‑tuberculosis drugs decrease viability and stimulate the expression of chondrocyte marker genes in human nucleus pulposus cells.
Topics: Adolescent; Aggrecans; Antitubercular Agents; Cell Survival; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type II; Ethambutol; Glycosaminoglycans; Humans; Intervertebral Disc; Isoniazid; Pyrazinamide; Rifampin; RNA, Messenger; SOX9 Transcription Factor; Transforming Growth Factor beta1; Young Adult | 2014 |
[Evaluation of multidrug-resistant tuberculosis treatment in Ivory Coast from 2008 to 2010].
Topics: Adult; Antitubercular Agents; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, University; Humans; Isoniazid; Male; Medication Adherence; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Withholding Treatment; Young Adult | 2013 |
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clone Cells; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Operon; Phylogeny; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam | 2013 |
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].
Topics: Adult; Antibiotics, Antitubercular; Ethambutol; Female; Humans; Immunization; Isoniazid; Purpura, Thrombocytopenic, Idiopathic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2013 |
In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Synergism; Ethambutol; Furocoumarins; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Vero Cells | 2014 |
TB determined: tuberculous osteomyelitis.
Topics: Antitubercular Agents; Aza Compounds; Bone Neoplasms; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fluorodeoxyglucose F18; Fluoroquinolones; Humans; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Moxifloxacin; Osteomyelitis; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Rifampin; Spine; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2014 |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |
Tenosynovitis of the right hand. Mycobacterium kansasii.
Topics: Anti-Bacterial Agents; C-Reactive Protein; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Fingers; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Physical Examination; Rifampin; Tenosynovitis | 2013 |
[Antimicrobial resistance in tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spain; Streptomycin; Tuberculosis, Pulmonary | 2013 |
The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
Topics: Adult; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; China; Cross-Sectional Studies; Cytochrome P-450 CYP2E1; Drug Therapy, Combination; Ethambutol; Female; Gene Frequency; Genetic Association Studies; Glutathione Transferase; Humans; Incidence; Isoniazid; Male; Middle Aged; Polymorphism, Single Nucleotide; Prevalence; Pyrazinamide; Rifampin; Sex Distribution; Tuberculosis, Pulmonary; Young Adult | 2014 |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.
Topics: Adalimumab; Administration, Oral; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Male; Mycobacterium; Mycobacterium Infections; Polychondritis, Relapsing; Rifampin; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Esophageal anthracosis with tuberculous lymphadenitis confirmed on transesophageal endoscopic ultrasound-guided fine-needle aspiration.
Topics: Aged; Anthracosis; Antitubercular Agents; Chest Pain; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Esophagus; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node; Weight Loss | 2014 |
Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2014 |
An unusual cause of breast lump: isolated tuberculosis of the breast.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Breast Diseases; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2014 |
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.
Topics: Alkynes; Antitubercular Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Enzyme Activation; Ethambutol; Humans; Hydroxylation; Isoniazid; Microsomes, Liver; Pyrazinamide; Rifampin | 2014 |
Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.
Topics: Adolescent; Adult; Antitubercular Agents; Biopsy; Diagnostic Errors; Ethambutol; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; India; Isoniazid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Cohort Studies; Cost of Illness; Drug Combinations; Ethambutol; Female; Health Care Costs; Humans; Isoniazid; Male; Middle Aged; Prevalence; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Biomarkers; C-Reactive Protein; Copper; Ethambutol; Hemoglobins; Host-Pathogen Interactions; Humans; Inflammation; Iron; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Serum Albumin; Serum Globulins; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Zinc | 2014 |
Novel bronchoscopic balloon dilation for patients with bronchostenosis caused by bronchial tuberculosis: a case report.
Topics: Antitubercular Agents; Bronchial Diseases; Bronchoscopy; Constriction, Pathologic; Dilatation; Ethambutol; Female; Humans; Isoniazid; Lung; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
Pros and cons of the tuberculosis drugome approach--an empirical analysis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tamoxifen; Tuberculosis | 2014 |
Genotoxic effects of some antituberculosis drugs and mixtures in rats.
Topics: Animals; Antitubercular Agents; DNA Damage; Drug Combinations; Ethambutol; Isoniazid; Kidney; Liver; Male; Pyrazinamide; Rats; Rifampin | 2015 |
An unusual lung mass post stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Stem Cell Transplantation | 2014 |
[Mycobacterium tuberculosis strains isolated from Van region four different sensitivity detection method antimycobacterial agents].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity | 2014 |
A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India.
Topics: DNA, Intergenic; Drug Resistance, Bacterial; Ethambutol; Genetic Variation; Genotype; Humans; India; Isoniazid; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Streptomycin; Tuberculosis | 2014 |
False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene.
Topics: Aged; Amikacin; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Molecular Sequence Data; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary | 2014 |
Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.
Topics: Antitubercular Agents; Biopsy, Fine-Needle; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Lymph Node | 2014 |
Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.
Topics: Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Streptomycin | 2014 |
Successful renal transplant in patient with controlled pulmonary non-tuberculous mycobacterium infection.
Topics: Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Middle Aged; Mycobacterium Infections, Nontuberculous; Recurrence; Rifampin; Treatment Outcome | 2014 |
Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
Topics: Aminoglycosides; Antitubercular Agents; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Polymerase Chain Reaction; Rifampin; Slovakia; Tuberculosis, Pulmonary | 2015 |
The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Environmental Exposure; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence; Retrospective Studies; Rifampin; Soil Microbiology; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Disparities; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Sex Factors; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Urban Population; Young Adult | 2015 |
Molecular epidemiology of tuberculosis in Sicily, Italy: what has changed after a decade?
Topics: Adult; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Molecular Typing; Mycobacterium tuberculosis; Rifampin; Sicily; Tuberculosis | 2014 |
Re-emphasizing Thygeson's warning: conjunctival phlyctenulosis as presenting sign of impending clinical tuberculosis.
Topics: Antitubercular Agents; Blood Sedimentation; Child; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Keratoconjunctivitis; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Ocular | 2014 |
Severe meningoencephalitis co-infection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus.
Topics: Amphotericin B; Antitubercular Agents; Child; Coinfection; Cryptococcosis; Cryptococcus neoformans; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Lupus Erythematosus, Systemic; Meningoencephalitis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin | 2015 |
In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs.
Topics: Antitubercular Agents; Benzofurans; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Genotype; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Phytotherapy; Piper; Plant Extracts; Plant Leaves; Plants, Medicinal; Rifampin | 2014 |
Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Hospital Mortality; Hospitalization; Humans; Infant; Infant, Newborn; Isoniazid; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Tuberculosis of the cervix mimicking cervical cancer.
Topics: Antitubercular Agents; Cervix Uteri; Diagnosis, Differential; Ethambutol; Female; Gynecological Examination; Humans; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Female Genital; Ultrasonography; Uterine Cervical Neoplasms | 2014 |
[The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Retreatment; Retrospective Studies; Rifampin; Sputum; Thorax; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2014 |
[Fixed drug eruption after taking ethambutol].
Topics: Adult; Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Humans; Hypopigmentation; Isoniazid; Lip Diseases; Male; Rifampin; Tuberculosis, Pulmonary | 2015 |
Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Humans; Isoniazid; Liver; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2015 |
Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Dexamethasone; Ethambutol; Female; Humans; Infliximab; Isoniazid; Middle Aged; Prednisolone; Pyrazinamide; Rifampin; Tuberculoma, Intracranial; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha | 2015 |
Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Effective anti-tuberculosis therapy correlates with plasma small RNA.
Topics: Adult; Antitubercular Agents; Biomarkers; Coinfection; Ethambutol; Female; Gene Expression Profiling; HIV Infections; Humans; Isoniazid; Male; MicroRNAs; Prospective Studies; Pyrazinamide; Rifampin; RNA; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
[A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents].
Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunologic Tests; Isoniazid; Levofloxacin; Lymphocyte Activation; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal | 2015 |
Tuberculosis cutis orificialis in an immunocompetent patient.
Topics: Antibiotics, Antitubercular; Diagnosis, Differential; Drug Combinations; Ethambutol; Female; Humans; Middle Aged; Mycobacterium tuberculosis; Oral Ulcer; Pyrazinamide; Rifampin; Tuberculosis, Oral | 2015 |
Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Infant; Isoniazid; Malawi; Male; Plasma; Pyrazinamide; Rifampin | 2015 |
Safe and effective treatment for patients with isoniazid drug resistance.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
In reply.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis | 2015 |
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Brazil; Cohort Studies; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Topics: Adolescent; Antitubercular Agents; Area Under Curve; Child; Child, Preschool; Ethambutol; Ethnicity; Female; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Regression Analysis; Rifampin; Tandem Mass Spectrometry; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.
Topics: Adult; Antitubercular Agents; Coinfection; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis; Uganda | 2015 |
Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.
Topics: Adult; Child, Preschool; Communicable Disease Control; Contact Tracing; Disease Outbreaks; Ethambutol; Europe; Female; Humans; Incidence; Interferon-gamma Release Tests; Isoniazid; Italy; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis | 2015 |
Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cardiovascular Diseases; Child; Drug Therapy, Combination; Ethambutol; Female; Glomerular Filtration Rate; Humans; Isoniazid; Japan; Male; Middle Aged; Pyrazinamide; Renal Insufficiency, Chronic; Retrospective Studies; Rifampin; Risk Factors; Serum Albumin; Sputum; Steroids; Streptomycin; Survival Rate; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013.
Topics: Adolescent; Adult; Drug Resistance; Ethambutol; Female; Humans; Iran; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
Possible association of rare polymorphism in the ABCB1 gene with rifampin and ethambutol drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Frequency; Genetic Association Studies; Haplotypes; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Genetic; Rifampin; Risk Factors; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
Topics: Antitubercular Agents; Arginase; B7-2 Antigen; Cell Differentiation; Cells, Cultured; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12 Subunit p35; Isoniazid; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Middle Aged; Mycobacterium tuberculosis; Nitric Oxide; Phagocytosis; Phenotype; Pyrazinamide; Receptors, Cell Surface; Rifampin; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcriptional Activation; Transforming Growth Factor beta; Tuberculosis, Pulmonary; Up-Regulation | 2015 |
Pulmonary Infection Caused by Mycobacterium shinjukuense.
Topics: Aged; Antitubercular Agents; Bronchoalveolar Lavage Fluid; DNA, Bacterial; Ethambutol; Female; Genotyping Techniques; Humans; Isoniazid; Japan; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2015 |
Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; Hospitals, Public; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prevalence; Retreatment; Rifampin; Risk Assessment; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Ethambutol; Finger Injuries; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mycobacterium Infections, Nontuberculous; Renal Dialysis; Rhabdomyolysis; Rifampin; Simvastatin | 2015 |
In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.
Topics: Animals; Antitubercular Agents; Ethambutol; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 2015 |
Isolated hepatosplenic tuberculosis: a rare presentation.
Topics: Abdominal Pain; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Hepatic; Tuberculosis, Splenic; Weight Loss | 2015 |
Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report.
Topics: Adult; Anti-Bacterial Agents; Brain Abscess; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2015 |
Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchial Fistula; Cysts; Ethambutol; Humans; Hydropneumothorax; Immunocompromised Host; Liver Diseases; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pleura; Rifampin; Tomography, X-Ray Computed | 2015 |
A Clinical Study of Miliary Brain Tuberculomas in China.
Topics: Adult; Aged; Antitubercular Agents; Brain; Contrast Media; Drug Therapy, Combination; Ethambutol; Female; Gadolinium; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculoma, Intracranial | 2016 |
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Female; Genetic Variation; Genotype; Humans; Indonesia; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Isolated tuberculosis of tunica albuginea and tunica vaginalis presenting as acute hydrocoele: a diagnostic dilemma.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Scrotum; Testicular Hydrocele; Testis; Treatment Outcome; Tuberculosis, Male Genital | 2015 |
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay.
Topics: Agar; Antitubercular Agents; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2015 |
The relationship between chitotriosidase activity and tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Biomarkers; Case-Control Studies; China; Ethambutol; Female; Hexosaminidases; Humans; Isoniazid; Lung; Male; Middle Aged; Pyrazinamide; Radiography; Rifampin; Streptomycin; Thioacetazone; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Topics: Amoxicillin; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Xanthenes | 2016 |
Pleural tuberculosis in a patient with untreated type 1 Gaucher disease.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gaucher Disease; Humans; Isoniazid; Male; Pulmonary Fibrosis; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Turkey | 2016 |
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Mass Spectrometry; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Immunocompromised Host; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Rifampin; Tomography, X-Ray Computed | 2015 |
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia; Retrospective Studies; Rifampin | 2016 |
Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment.
Topics: Adult; Antitubercular Agents; Ethambutol; Extracorporeal Membrane Oxygenation; Humans; Male; Renal Dialysis; Respiratory Distress Syndrome; Rifampin; Tuberculosis | 2016 |
Primary Gingival Tuberculosis Diagnosed Based on Genetic Identification.
Topics: Aged; Antitubercular Agents; Biopsy; Diagnosis, Differential; DNA, Bacterial; Ethambutol; Female; Gingival Diseases; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Oral | 2015 |
Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genotype; HIV Infections; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Phylogeography; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2015 |
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransformation; Body Weight; Clinical Trials as Topic; Cohort Studies; Coinfection; Computer Simulation; Ethambutol; Female; Half-Life; HIV Infections; Humans; Isoniazid; Liver; Male; Middle Aged; Models, Statistical; Rifampin; Tuberculosis, Pulmonary | 2016 |
The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
Topics: Antitubercular Agents; Body Weight; Child; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2015 |
Thanks to Trauma: A Delayed Diagnosis of Pott Disease.
Topics: Accidental Falls; Antitubercular Agents; Child, Preschool; Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fractures, Comminuted; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Spinal Injuries; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis, Spinal | 2015 |
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice, Inbred BALB C; Mice, Inbred C3H; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
A rare cause of pulmonary tuberculosis.
Topics: Animals; Antitubercular Agents; Cattle; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunocompetence; Isoniazid; Lung; Meat-Packing Industry; Middle Aged; Mycobacterium bovis; Radiography; Rifampin; Tuberculosis, Bovine; Tuberculosis, Pulmonary | 2015 |
[THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Drug Combinations; Early Diagnosis; Ethambutol; Genetic Testing; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin | 2015 |
Painful Red Eye in a Woman in Her 70s.
Topics: Aged; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Eye Infections, Bacterial; Eye Pain; Female; Humans; Interferon-gamma Release Tests; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Radiography, Thoracic; Rifampin; Scleritis; Skin Tests; Tuberculoma; Tuberculosis, Ocular | 2016 |
Repeat exposure to active tuberculosis and risk of re-infection.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Emergency Service, Hospital; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Parents; Pyrazinamide; Recurrence; Rifampin; Risk Assessment; Risk Factors; Siblings; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
[CLINICAL EFFECTS OF TREATMENT FOR MYCOBACTERIUM TUBERCULOSIS INFECTION IN PATIENTS AT A SPECIALIZED HOSPITAL IN 2011].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Hospitals, Special; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; China; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2016 |
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Withholding Treatment | 2016 |
Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Coordination Complexes; Copper; Drug Resistance, Bacterial; Drug Synergism; Ethambutol; Humans; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; China; Cross-Sectional Studies; Ethambutol; Female; Humans; Infant; Isoniazid; Logistic Models; Male; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
Topics: Antitubercular Agents; Combined Modality Therapy; Drug Combinations; Drug Hypersensitivity Syndrome; Ethambutol; Glucocorticoids; Herpesvirus 6, Human; Humans; Isoniazid; Leukapheresis; Male; Multiple Organ Failure; Plasmapheresis; Pyrazinamide; Rifampin; Roseolovirus Infections; Tuberculosis, Pleural; Young Adult | 2017 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
Ameliorative Effects of Kolaviron, a Biflavonoid Fraction from Garcinia Kola Seed, on Hepato-renal Toxicity of Anti-tuberculosis Drugs in Wistar Rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Antitubercular Agents; Aspartate Aminotransferases; Ethambutol; Flavonoids; Garcinia kola; Glutathione; Glutathione Peroxidase; Isoniazid; Kidney; Liver; Male; Malondialdehyde; Oxidative Stress; Pyrazinamide; Rats, Wistar; Rifampin; Seeds | 2016 |
Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; China; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Regression Analysis; Residence Characteristics; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, Liquid; Coinfection; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Spectrometry, Mass, Electrospray Ionization; Treatment Outcome; Tuberculosis | 2016 |
Anterior debridement may not be necessary in the treatment of tuberculous spondylitis of the thoracic and lumbar spine in adults: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Decompression, Surgical; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Kyphosis; Laminectomy; Lumbar Vertebrae; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Spinal Fusion; Spondylitis; Thoracic Vertebrae; Tuberculosis, Spinal | 2016 |
[A CASE OF MILIARY TUBERCULOSIS ORIGINATED FROM CUTANEOUS INFECTION].
Topics: Aged, 80 and over; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Cutaneous; Tuberculosis, Miliary | 2016 |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report.
Topics: Adult; Bronchoalveolar Lavage Fluid; Clarithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Sputum; Tomography, X-Ray Computed | 2016 |
Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Gentian Violet; Humans; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2016 |
Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
Topics: Animals; Antitubercular Agents; CHO Cells; Cricetulus; Drug Synergism; Ethambutol; Furans; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2016 |
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
[Analysis on drug resistance of Mycobacterium tuberculosis and influencing factors in six provinces of China].
Topics: Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; Streptomycin; Surveys and Questionnaires; Tuberculosis, Multidrug-Resistant | 2016 |
Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Ethambutol; Isoniazid; Mice, Inbred C57BL; Models, Biological; Pyrazinamide; Rifampin; Sample Size | 2016 |
Tuberculous cellulitis: diseases behind cellulitislike erythema.
Topics: Aged, 80 and over; Antitubercular Agents; Cellulitis; Diagnosis, Differential; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Rifampin; Skin; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2016 |
[EVALUATION OF THE EFFICIENCY OF TREATMENT AND THE CHOICE OF CONTROL COMPUTED TOMOGRAPHY TIME IN CHILDREN WITH MINOR FORMS OF INTRATHORACIC TUBERCULOSIS].
Topics: Antitubercular Agents; Child; Child, Preschool; Comparative Effectiveness Research; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Male; Outcome Assessment, Health Care; Pyrazinamide; Rifampin; Thorax; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2010 |
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Topics: Adult; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry | 2016 |
Cutaneous Tuberculosis Occurring After a Skin Cut in a Child.
Topics: Abattoirs; Adolescent; Animals; Antitubercular Agents; Axilla; Ethambutol; Finger Injuries; Humans; Isoniazid; Lupus Vulgaris; Lymphadenopathy; Male; Mycobacterium tuberculosis; Occupational Diseases; Pyrazinamide; Rifampin; Sheep; Treatment Outcome; Turkey; Wound Healing | 2016 |
Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
Topics: Aged; Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Bacterial; Ethambutol; Female; Gene Expression; Genes, Bacterial; Humans; Lung; Macrolides; Male; Middle Aged; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; RNA, Ribosomal, 23S; Survival Analysis; Treatment Outcome | 2016 |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
Topics: Clarithromycin; Diagnosis, Differential; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Rifampin; Tuberculosis, Pulmonary | 2017 |
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
Topics: Adult; Age Factors; Alleles; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Gene Expression; Gene Frequency; Haplotypes; Humans; Isoniazid; Liver; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Prospective Studies; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Thioredoxin Reductase 1; Tuberculosis, Pulmonary | 2016 |
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Topics: Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Polymorphism, Restriction Fragment Length; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant | 2016 |
Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study.
Topics: Adult; Alkaloids; Antitubercular Agents; Benzodioxoles; Cytochrome P-450 Enzyme Inhibitors; Drug Combinations; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pilot Projects; Piperidines; Polyunsaturated Alkamides; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2016 |
Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Seropositivity; Hospitals; Humans; Isoniazid; Logistic Models; Male; Rifampin; Socioeconomic Factors; Treatment Outcome; Tuberculosis | 2016 |
Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Catalase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Genome, Bacterial; Humans; Isoniazid; Male; Middle Aged; Mutation; Myanmar; Mycobacterium tuberculosis; Recurrence; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2016 |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung.
Topics: Aged; Animals; Antibiotics, Antitubercular; Clarithromycin; Cough; Ethambutol; Fishes; Humans; Lethargy; Male; Mycobacterium Infections, Nontuberculous; Pulmonary Disease, Chronic Obstructive; Rifampin; Treatment Outcome; Wastewater; Weight Loss | 2016 |
Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis.
Topics: Acyclic Monoterpenes; Alkenes; Antitubercular Agents; Bicyclic Monoterpenes; Cyclohexenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Limonene; Microbial Sensitivity Tests; Monoterpenes; Mycobacterium tuberculosis; Rifampin; Sesquiterpenes; Terpenes | 2017 |
Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Ethambutol; Female; Follow-Up Studies; Hepatitis; Humans; Incidence; Infant; Infant, Newborn; Isoniazid; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2016 |
Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection.
Topics: Anti-Bacterial Agents; Bronchiectasis; Chest Pain; Clarithromycin; Cough; Drug Therapy, Combination; Dyspnea; Ethambutol; Humans; Leukocytosis; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tracheobronchomegaly; Veterans | 2017 |
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Latent Tuberculosis; Logistic Models; Male; Mexico; Middle Aged; Multivariate Analysis; Philippines; Pyrazinamide; Rifampin; Risk Factors; Vietnam; Washington; Young Adult | 2017 |
Tuberculous pericarditis: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Pericarditis, Tuberculous; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculin Test | 2016 |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Lung Diseases; Male; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Respiratory Insufficiency; Rifampin; Risk Factors; Spinal Diseases; Sputum | 2016 |
Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Design; Ethambutol; HEK293 Cells; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Rifampin; Structure-Activity Relationship; Triazoles | 2017 |
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
Topics: Adolescent; Adult; Antitubercular Agents; Cohort Studies; Early Diagnosis; Ethambutol; Female; Humans; Isoniazid; Male; Mali; Microbial Sensitivity Tests; Microscopy; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Synthesis of Adamantane Aminoethers with Antitubercular Potential.
Topics: Adamantane; Amines; Antitubercular Agents; Ethambutol; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Rifampin | 2017 |
Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.
Topics: Adult; Antitubercular Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Hospitals, General; Humans; Isoniazid; Male; Pyrazinamide; Qatar; Retrospective Studies; Rifampin; Sputum; Tablets; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
Topics: Antitubercular Agents; Bacterial Proteins; Bacterial Typing Techniques; Catalase; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Gene Expression; Genetic Fitness; Genetic Variation; Humans; Isoniazid; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pentosyltransferases; Ribosomal Proteins; Rifampin; Streptomycin; Vietnam | 2017 |
TB Alliance regimen development for multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Clinical Protocols; Diarylquinolines; Dose-Response Relationship, Drug; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Linezolid; Moxifloxacin; Nitroimidazoles; Pyrazinamide; Randomized Controlled Trials as Topic; Research Design; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Marketing; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Treatment Outcome | 2017 |
Concomitant metastatic cutaneous tuberculous abscesses and Pott disease in an immunocompetent patient.
Topics: Abscess; Adult; Antitubercular Agents; Arthrodesis; Debridement; Ethambutol; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tuberculosis, Cutaneous; Tuberculosis, Spinal | 2016 |
SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.
Topics: Acquired Hyperostosis Syndrome; Anti-Bacterial Agents; Autoantibodies; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Interferon-gamma; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome | 2017 |
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
Topics: Adult; Alleles; Antitubercular Agents; Asian People; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2B6; Ethambutol; Female; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2017 |
Mycobacterium gordonae Skin Infection in an Immunocompetent Child.
Topics: Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Dermatologic Surgical Procedures; Ethambutol; Face; Humans; Immunocompetence; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin | 2017 |
The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007.
Topics: Adolescent; Antitubercular Agents; Asian People; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Incidence; Infant; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Republic of Korea; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Poncet's disease in human immunodeficiency virus: a case report.
Topics: Adult; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Arthritis, Reactive; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2017 |
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2017 |
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
Topics: Animals; Antitubercular Agents; Bacterial Load; Colony Count, Microbial; Disease Models, Animal; DNA, Bacterial; Ethambutol; Female; Isoniazid; Lung; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nonlinear Dynamics; Predictive Value of Tests; Pyrazinamide; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2017 |
Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
Topics: Adolescent; Adult; Aged; Bacterial Proteins; Child; DNA-Directed RNA Polymerases; DNA, Bacterial; Ethambutol; Genes, Bacterial; Histones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Pakistan; Pathology, Molecular; Pentosyltransferases; Rifampin; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Massive choroidal granuloma as the presenting feature of disseminated tuberculosis in immunocompetent patients.
Topics: Adolescent; Adult; Antitubercular Agents; Choroid Diseases; Drug Combinations; Ethambutol; Female; Granuloma; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Ocular; Tuberculosis, Pulmonary; Ultrasonography | 2018 |
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
Topics: Adult; Aged; Antitubercular Agents; Biomarkers; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Receptors, Urokinase Plasminogen Activator; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2017 |
Band pattern analysis of mutations in rifampicin resistance strain of Mycobacterium tuberculosis by Line Probe assay in patients from Delhi, India.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 2017 |
Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.
Topics: Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Skin; Skin Diseases, Bacterial | 2017 |
Disseminated Mycobacterium scrofulaceum Infection in an Immunocompetent Host.
Topics: Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium scrofulaceum; Osteomyelitis; Rifampin | 2017 |
Simultaneous Determination of First-Line 4-FDC Antituberculosis Drugs by UHPLC-UV and HPLC-UV: A Comparative Study.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Isoniazid; Pyrazinamide; Rifampin | 2017 |
A 25-Year-Old Woman With a Deceptive Pancreas Cyst: All Is Not as It Appears!
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pancreatic Cyst; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis | 2018 |
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Isoniazid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
An unusual pain in the gut.
Topics: Abdominal Pain; Africa; Anti-Bacterial Agents; Colon, Transverse; Colonoscopy; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Mycobacterium bovis; Pyrazinamide; Rifampin; Thailand; Travel; Treatment Outcome; Tuberculosis, Gastrointestinal | 2017 |
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Variation; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mitoxantrone; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Rifampin; Sequence Analysis; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
A novel presentation of Mycobacterium avium complex in a recipient of a lung transplant: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Graft Rejection; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisone; Pulmonary Fibrosis; Rifampin; Tacrolimus; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2017 |
An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs).
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genes, Reporter; Humans; Isoniazid; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Rifampin; Tuberculosis | 2017 |
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Topics: Adult; Antitubercular Agents; C-Reactive Protein; Case-Control Studies; Dehydroepiandrosterone; Ethambutol; Female; Gene Expression Regulation; Humans; Hydrocortisone; Interferon-gamma; Interleukin-6; Isoniazid; Leukocytes, Mononuclear; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Receptors, Glucocorticoid; Rifampin; Transforming Growth Factor beta; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Bacterial Proteins; Cell Wall; Drug Resistance, Multiple, Bacterial; Ethambutol; Galactans; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Ion Pumps; Isoniazid; Ligases; Mannosyltransferases; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Peptidoglycan; Rifampin; Serine Proteases; Thienamycins; Vancomycin | 2017 |
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Biomedical Research; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Combinations; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Research Design; Rifampin; Tuberculosis, Pulmonary; Uganda | 2017 |
Cutaneous Mycobacterium gordonae infection in an elderly diabetic returned traveller.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diagnosis, Differential; Ethambutol; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin Diseases, Infectious; Travel | 2017 |
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; China; Ethambutol; Female; Follow-Up Studies; Humans; Infant; Isoniazid; Logistic Models; Male; Middle Aged; Prevalence; Retrospective Studies; Rifampin; Rural Population; Streptomycin; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
A rapid and simple resazurin assay to detect minimum inhibitory concentrations of first-line drugs for Mycobacterium tuberculosis isolated from cerebrospinal fluid.
Topics: Antitubercular Agents; Cerebrospinal Fluid; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Streptomycin; Tuberculosis, Meningeal; Xanthenes | 2018 |
Achieving High
Topics: Antitubercular Agents; Deuterium; Ethambutol; Isoniazid; Magnetic Resonance Spectroscopy; Pyrazinamide; Rifampin | 2017 |
The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Tolerance; Ethambutol; Gene Expression Regulation, Bacterial; Gentamicins; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sigma Factor; Streptomycin; Vancomycin | 2017 |
'A most malignant malady': a rare case of laryngeal tuberculosis in epidermal growth factor receptor mutant lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Antibiotics, Antitubercular; Drug Therapy, Combination; Dysphonia; ErbB Receptors; Ethambutol; Female; Gene Expression Regulation, Neoplastic; Humans; Isoniazid; Lung Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Laryngeal | 2017 |
Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
Topics: Adult; Aged; Antitubercular Agents; Asian People; China; Clinical Audit; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Outcome Assessment, Health Care; Prescriptions; Pyrazinamide; Retreatment; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Myelodysplastic Syndromes; Rifampin; Treatment Outcome | 2018 |
A 75-year-old woman presenting with nasal vestibulitis.
Topics: Aged; Antitubercular Agents; Biopsy; Dermatitis; Ethambutol; Female; Humans; Isoniazid; Lupus Vulgaris; Mycobacterium tuberculosis; Nose; Rifampin; Treatment Outcome | 2018 |
Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Gene Expression Profiling; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Proteomics; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethambutol; Female; HIV; HIV Infections; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Topics: Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Nucleic Acid Synthesis Inhibitors; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Tuberculosis of the tonsil simulating a cancer.
Topics: Adenoids; Adult; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Pharyngeal Neoplasms; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2017 |
A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; Ethiopia; Female; HIV Infections; Hospitals, General; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
A Painful Red Eye.
Topics: Alcoholism; Antitubercular Agents; Conjunctival Diseases; Ethambutol; Eye Pain; Glucocorticoids; Humans; Hyperemia; Interferon-gamma; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Scleritis; Tobacco Use Disorder; Tuberculosis, Pulmonary | 2018 |
Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Topics: Antitubercular Agents; DNA, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Kanamycin; Laboratories; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Referral and Consultation; Rifampin; South Africa | 2017 |
Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
Topics: Adult; Age Factors; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Regression Analysis; Retrospective Studies; Rifampin; Saudi Arabia; Sex Factors; Streptomycin; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2018 |
Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs.
Topics: Adult; Antitubercular Agents; Desensitization, Immunologic; Ethambutol; Female; Humans; Hypersensitivity; Isoniazid; Male; Middle Aged; Retrospective Studies; Rifampin | 2018 |
Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation.
Topics: Antitubercular Agents; Automation, Laboratory; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2018 |
Antituberculosis Treatment in a Patient with Celiac Disease.
Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Substitution; Drug Therapy, Combination; Ethambutol; Glutens; Hemoptysis; Humans; Isoniazid; Male; Metronidazole; Moxifloxacin; Pyrazinamide; Rifampin; Smoking; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2018 |
Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
Topics: Adolescent; Adult; Cross-Sectional Studies; Ethambutol; Ethiopia; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Rifampin; RNA, Viral; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Ethambutol; Female; Humans; Isoniazid; Liver; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Purines; Pyrazinamide; Rifampin; Tuberculosis; Young Adult | 2018 |
Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
Topics: Antitubercular Agents; Caffeic Acids; Crystallization; Drug Combinations; Drug Stability; Drug Storage; Ethambutol; Humans; Isoniazid; Models, Molecular; Pyrazinamide; Rifampin; Tuberculosis; Vanillic Acid | 2018 |
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Lost to Follow-Up; Male; Multivariate Analysis; Patient Discharge; Patient Transfer; Prisoners; Prisons; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Risk Factors; Sputum; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2018 |
Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy.
Topics: Antitubercular Agents; Clinical Trials as Topic; Electrocardiography; Ethambutol; Female; Gatifloxacin; Heart Rate; Humans; Isoniazid; Male; Models, Theoretical; Multivariate Analysis; Pyrazinamide; Rifampin; Sex Factors; Tuberculosis | 2018 |
Exposure of Nursed Infants to Maternal Treatment with Ethambutol and Rifampicin.
Topics: Adult; Algorithms; Antitubercular Agents; Breast Feeding; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Infant; Milk, Human; Models, Biological; Rifampin; Tissue Distribution; Tuberculosis | 2018 |
Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Predictive Value of Tests; Pyrazinamide; Reproducibility of Results; Rifampin; Spectrometry, Mass, Electrospray Ionization; Streptomycin; Tandem Mass Spectrometry; Tuberculosis | 2018 |
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Ocular; Uveitis; Visual Acuity | 2018 |
Improving treatment outcome assessment in a mouse tuberculosis model.
Topics: Administration, Oral; Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Female; Genotype; Humans; Mice; Mice, Inbred BALB C; Models, Theoretical; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2018 |
[Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
Topics: Adult; Antitubercular Agents; Brain Infarction; Diagnostic Errors; Disease Progression; Drug Resistance, Microbial; Drug Substitution; Ethambutol; Female; Host-Pathogen Interactions; Humans; Isoniazid; Magnetic Resonance Imaging; Meningitis, Viral; Moxifloxacin; Mycobacterium tuberculosis; Neuroimaging; Optic Chiasm; Paresis; Prednisone; Pyrazinamide; Rifampin; Thalamus; Tuberculoma; Tuberculosis, Meningeal; Vision Disorders | 2018 |
Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome.
Topics: Adult; Clarithromycin; Diagnosis, Differential; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Retrospective Studies; Rifampin; Skin Diseases, Bacterial; Treatment Outcome | 2018 |
A case of tuberculosis pericarditis with an interesting echocardiographic image.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Diagnosis, Differential; Echocardiography; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pericardial Effusion; Pericarditis, Tuberculous; Rifampin; Streptomycin | 2018 |
Protein Binding of First-Line Antituberculosis Drugs.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2018 |
Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Dried Blood Spot Testing; Drug Monitoring; Ethambutol; Female; Humans; Infant; Male; Pyrazinamide; Rifampin; Tuberculosis | 2018 |
A Breast Lump in an Elderly Lady - Carcinoma or else ?.
Topics: Aged; Antitubercular Agents; Biopsy, Fine-Needle; Breast; Breast Neoplasms; Ethambutol; Female; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2016 |
Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Topics: Antitubercular Agents; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2018 |
Left lung hypoplasia with a right tuberculous pleural effusion after childbirth: A case report.
Topics: Abnormalities, Multiple; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium tuberculosis; Parturition; Pleural Effusion; Pregnancy; Pulmonary Heart Disease; Respiratory Insufficiency; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2018 |
Perianal ulcerative skin tuberculosis: A case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Fissure in Ano; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 2018 |
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Topics: Antitubercular Agents; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pakistan; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Antitubercular Agents; Cell Line; Drug Therapy, Combination; Ethambutol; Glutathione; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; THP-1 Cells; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Genome, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Tuberculosis; Whole Genome Sequencing | 2018 |
Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Infant; Isoniazid; Longitudinal Studies; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Rural Population; Tanzania; Tuberculosis | 2020 |
Splenic granulomas: a rare manifestation of
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Diagnosis, Differential; Ethambutol; Granuloma; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Polymerase Chain Reaction; Rifampin; Spleen; Splenic Diseases | 2018 |
A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
Topics: Algorithms; Antitubercular Agents; Ethambutol; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Whole Genome Sequencing | 2019 |
Scrofuloderma with disseminated tuberculosis in an Ethiopian child: a case report.
Topics: Anti-Inflammatory Agents; Antitubercular Agents; Child; Ethambutol; Female; Humans; Isoniazid; Mycobacterium tuberculosis; Neck; Prednisolone; Pyrazinamide; Rifampin; Skin; Treatment Outcome; Tuberculosis, Cutaneous | 2018 |
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Incidence; Isoniazid; Kuwait; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Adverse reactions associated with long-term drug administration in
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Humans; Japan; Logistic Models; Lung Diseases; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Time Factors; Young Adult | 2018 |
Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study.
Topics: Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iran; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2019 |
Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
Topics: Antitubercular Agents; Child; Child, Preschool; Contact Tracing; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Spain; Tuberculosis, Multidrug-Resistant | 2019 |
Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Desensitization, Immunologic; Drug Hypersensitivity; Ethambutol; Female; Humans; Incidence; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
Topics: Animals; Antitubercular Agents; Cattle; Drug Resistance, Bacterial; Ethambutol; Genes, Bacterial; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Bovine | 2019 |
Acute tubulointerstitial nephritis caused by rifampicin: An increasing and often overlooked side effect in elderly patients
.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Nephritis, Interstitial; Rifampin; Tuberculosis, Pleural | 2019 |
Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.
Topics: Adult; Antitubercular Agents; Autophagy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ethambutol; Humans; Hypoglycemic Agents; Insulin; Interferon-gamma; Interleukin-10; Isoniazid; Leukocytes, Mononuclear; Metformin; Microtubule-Associated Proteins; Middle Aged; Pyrazinamide; Rifampin; Sputum; Superoxide Dismutase; Tuberculosis | 2019 |
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Lung Diseases; Macrolides; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nontuberculous Mycobacteria; Republic of Korea; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Clarithromycin; Ethambutol; Female; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium Complex; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Young Adult | 2019 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |
Prevailing practices in the treatment of tuberculous meningitis (TBM): a cross-sectional study.
Topics: Anticonvulsants; Antitubercular Agents; Cross-Sectional Studies; Disease Management; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Humans; India; Isoniazid; Levetiracetam; Neurologists; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Meningeal | 2019 |
Compatibility Between Four Anti-TB Drugs and Tablet Excipients Determined By Microcalorimetry.
Topics: Antitubercular Agents; Calorimetry; Ethambutol; Excipients; Isoniazid; Pyrazinamide; Rifampin | 2019 |
Image Gallery: Fish tank granuloma on the face with sporotrichoid cervicofacial lymphadenitis and abscesses due to Mycobacterium marinum infection.
Topics: Abscess; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Rifampin; Skin Diseases, Bacterial | 2019 |
Tuberculosis Meningitis in a 10-Month-Old Living in an Immigrant Township.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Brain; Diagnosis, Differential; Electroencephalography; Emigrants and Immigrants; Ethambutol; Female; Glucocorticoids; Humans; Infant; Isoniazid; Magnetic Resonance Imaging; Prednisone; Pyrazinamide; Rifampin; Romania; Texas; Tuberculosis, Meningeal | 2019 |
First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Ethambutol; Female; Germany; Humans; Infant; Isoniazid; Logistic Models; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prevalence; Public Health Surveillance; Pyrazinamide; Rifampin; Risk Factors; Streptomycin; Tuberculosis, Multidrug-Resistant | 2019 |
A Rare Case of a Tuberculosis Patient with Sarcoidosis.
Topics: Adult; Antitubercular Agents; Deprescriptions; Ethambutol; Female; Glucocorticoids; Humans; Isoniazid; Prednisolone; Pyrazinamide; Radiography, Thoracic; Rifampin; Romania; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed; Tuberculosis, Pulmonary; Vitamin B 6; Vitamin B Complex | 2019 |
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Humans; Incidence; Isoniazid; Logistic Models; Middle Aged; Netherlands; Pyrazinamide; Registries; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.
Topics: Antitubercular Agents; Bacterial Load; Biological Assay; Biomarkers, Pharmacological; Computer Simulation; DNA, Bacterial; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Malawi; Male; Models, Statistical; Mozambique; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Tanzania; Time Factors; Tuberculosis, Pulmonary | 2019 |
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Logistic Models; London; Male; Middle Aged; Practice Guidelines as Topic; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult | 2019 |
First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Public Health; Rifampin; Sputum; Streptomycin; Tertiary Care Centers; Tuberculosis, Multidrug-Resistant; Turkey; Young Adult | 2019 |
Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a suspected soft-tissue tumor.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Clarithromycin; Diagnosis, Differential; Elbow Joint; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Soft Tissue Neoplasms; Treatment Outcome | 2020 |
Individualising therapy for drug-sensitive tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Precision Medicine; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2019 |
Multiplex PCR for Rapid Diagnosis of Drug Resistant Mycobacterium Tuberculosis.
Topics: Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant | 2019 |
Determinants of serum concentration of first-line anti-tuberculosis drugs from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Case-Control Studies; China; Chromatography, Liquid; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Smoking; Tuberculosis; Young Adult | 2019 |
[Tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
Topics: Adult; Alanine Transaminase; Antitubercular Agents; Asian People; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; China; Drug Therapy, Combination; Ethambutol; Female; Genetic Predisposition to Disease; Genotype; Humans; Isoniazid; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Polymorphism, Single Nucleotide; Pyrazinamide; Rifampin; Risk Factors; Sex Factors; Tuberculosis; Young Adult | 2020 |
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacterial Load; Diagnostic Tests, Routine; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Pakistan; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Young Adult | 2019 |
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
Topics: Adult; Antitubercular Agents; Brazil; Ethambutol; Female; HIV Seropositivity; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary; Weight Gain | 2020 |
Exposure to first line anti-tuberculosis drugs in prepubertal age reduces the quality and functional competence of spermatozoa and oocytes in Swiss albino mice.
Topics: Animals; Antitubercular Agents; Cell Nucleus; Ethambutol; Female; Isoniazid; Male; Metaphase; Mice; Oocytes; Pharmaceutical Preparations; Pregnancy; Pyrazinamide; Rifampin; Spermatozoa; Streptomycin | 2020 |
Miliary tuberculosis and choroidal tuberculoma in a three-month old baby girl: Diagnosis and follow-up of a case.
Topics: Adrenal Cortex Hormones; Amikacin; Antitubercular Agents; Choroid Diseases; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Ophthalmoscopy; Pyrazinamide; Rifampin; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular; Uveitis, Posterior | 2020 |
Acute paraplegia in a healthy child.
Topics: Acute Disease; Antibiotics, Antitubercular; Biopsy, Fine-Needle; Child; Ethambutol; Female; Humans; Isoniazid; Magnetic Resonance Imaging; Recovery of Function; Rifampin; Spinal Cord; Treatment Outcome; Tuberculosis, Spinal; Urinary Retention | 2019 |
Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Pyrazinamide; Reference Standards; Reproducibility of Results; Rifabutin; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tuberculosis | 2020 |
Presumed Intraocular Tuberculosis Manifesting as Unilateral Iris Granuloma.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Granuloma; Humans; Iris Diseases; Isoniazid; Male; Microscopy, Acoustic; Pyrazinamide; Rifampin; Tuberculin Test; Tuberculosis, Ocular | 2020 |
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.
Topics: Adult; Aminoglycosides; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; France; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pentosyltransferases; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Whole Genome Sequencing | 2020 |
LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Ethambutol; Humans; Isoniazid; Mass Spectrometry; Plasma; Pyrazinamide; Rifampin | 2020 |
Fisherman's Dilemma: Disseminated Mycobacterium marinum in an Immunosuppressed Patient.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Debridement; Deprescriptions; Drug Therapy, Combination; Ethambutol; Finger Joint; Fisheries; Fresh Water; Humans; Immunocompromised Host; Infliximab; Male; Metacarpophalangeal Joint; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Osteomyelitis; Rifampin; Spondylitis, Ankylosing; Synovectomy; Tenosynovitis; Tumor Necrosis Factor Inhibitors; Wrist Joint | 2020 |
Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.
Topics: Acid Phosphatase; Administration, Oral; Animals; Animals, Outbred Strains; Antitubercular Agents; Drug Combinations; Esterases; Ethambutol; Fluoroquinolones; Gene Expression; Glycerolphosphate Dehydrogenase; Isoniazid; L-Lactate Dehydrogenase; Lymphocytes; Male; Primary Cell Culture; Prothionamide; Pyrazinamide; Rats; Rifampin; Succinate Dehydrogenase | 2020 |
[Experience of using TB test kit for the rapid drug susceptibility testing of M. tuberculosis.]
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Rifampin; Streptomycin | 2020 |
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Tuberculous meningitis manifesting with neuroregression in a eleven month child.
Topics: Acetazolamide; Antitubercular Agents; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid; Early Medical Intervention; Ethambutol; Female; Glucocorticoids; Humans; Hydrocephalus; Infant; Isoniazid; Magnetic Resonance Imaging; Neurodevelopmental Disorders; Nucleic Acid Amplification Techniques; Prednisolone; Pyrazinamide; Rifampin; Stomach; Treatment Outcome; Tuberculosis, Meningeal | 2020 |
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Antitubercular Agents; Cohort Studies; Cough; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fever; Humans; Isoniazid; Male; Middle Aged; Mortality; Prognosis; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Sex Distribution; Sputum; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Weight Loss; Young Adult | 2020 |
Primary tuberculosis of the glans penis in an immunocompetent male.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Male; Penile Diseases; Pyrazinamide; Rifampin; Tuberculosis, Male Genital | 2020 |
Gene expression responses to anti-tuberculous drugs in a whole blood model.
Topics: Antitubercular Agents; Bacterial Proteins; Blood; Drug Combinations; Drug Repositioning; Ethambutol; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Isoniazid; Models, Biological; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Pyrazinamide; Rifampin; Sputum | 2020 |
Esophageal Tuberculosis - A Mass of Confusion.
Topics: Aged; Antitubercular Agents; Deglutition Disorders; Delayed Diagnosis; Diagnosis, Differential; Directly Observed Therapy; Endoscopy, Digestive System; Esophageal Neoplasms; Esophagitis; Ethambutol; Fever; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Male; Mexican Americans; Pyrazinamide; Rifampin; Substance-Related Disorders; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal; Ultrasonography | 2020 |
Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.
Topics: Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Immunoblotting; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis | 2020 |
A Complete Triad: Horner's Syndrome in Tuberculous Meningitis.
Topics: Antitubercular Agents; Brain; Ethambutol; Horner Syndrome; Humans; Immunocompetence; Isoniazid; Male; Nucleic Acid Amplification Techniques; Pyrazinamide; Pyridoxine; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Uganda; Young Adult | 2020 |
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Topics: Adult; Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis; Whole Genome Sequencing | 2020 |
Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Japan; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Negative Results; Pneumonia, Bacterial; Rifampin | 2020 |
Inclusion of Mechanical Ventilation in Severity Staging of Tuberculous Meningitis Improves Outcome Prediction.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antitubercular Agents; Child; Child, Preschool; Consciousness Disorders; Ethambutol; Female; Humans; Hydrocephalus; India; Isoniazid; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Pyrazinamide; Registries; Respiration, Artificial; Rifampin; Seizures; Severity of Illness Index; Tomography, X-Ray Computed; Tuberculosis, Meningeal; Ventriculoperitoneal Shunt; Young Adult | 2020 |
Tuberculosis sepsis after tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Multiple Organ Failure; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sepsis; Treatment Outcome; Tuberculosis | 2020 |
Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India.
Topics: Adult; Aged; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; Eye Diseases; Female; Humans; India; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis; Vision Disorders | 2020 |
BCGitis of the wrist after intravesical BCG therapy: A case report.
Topics: Antibiotics, Antitubercular; Arthritis, Infectious; BCG Vaccine; Carpal Bones; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Rifampin; Surgical Flaps; Synovectomy; Tuberculosis, Osteoarticular; Urinary Bladder Neoplasms; Wrist Joint | 2020 |
First Etiologically Confirmed Cases of Mycobacterium Marinum Infection in Bulgaria.
Topics: Adult; Antitubercular Agents; Bulgaria; Carpal Tunnel Syndrome; Culture Techniques; Delayed Diagnosis; DNA, Bacterial; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Occupational Diseases; Rifampin; Soft Tissue Infections | 2020 |
An Unexpected Cause of Conjunctivitis in an Adolescent.
Topics: Adolescent; Antitubercular Agents; Conjunctivitis; Diagnosis, Differential; Ethambutol; Glucocorticoids; Humans; Isoniazid; Male; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 2020 |
Primary breast tuberculosis in an HIV-infected patient.
Topics: Adult; Antitubercular Agents; Biopsy; Breast; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis | 2020 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
[Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
Topics: Antitubercular Agents; Ethambutol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2020 |
Intestinal tuberculosis in a patient with end-stage renal disease on hemodialysis: A case report.
Topics: Anorexia; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Kidney Failure, Chronic; Male; Middle Aged; Muscle Weakness; Pyrazinamide; Renal Dialysis; Republic of Korea; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Gastrointestinal | 2020 |
Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bangladesh; Child; Child, Preschool; Clinical Protocols; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Mycobacterium marinum infection in an immunocompromised patient with infliximab.
Topics: Anti-Inflammatory Agents; Clarithromycin; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Infliximab; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2020 |
Tuberculosis drug resistance in Canakkale, Turkey.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Turkey | 2020 |
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nucleic Acid Amplification Techniques; Polymyalgia Rheumatica; Polyps; Prednisolone; Pulmonary Atelectasis; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Intravesical BCG instillation as a possible cause of acute and chronic kidney injury.
Topics: Acute Kidney Injury; Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Kidney; Male; Nephritis; Renal Insufficiency, Chronic; Rifampin; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
About three cases of Mycobacterium bovis bone and joint infections after BCG therapy.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Arthritis, Infectious; BCG Vaccine; Ethambutol; Fatal Outcome; Humans; Isoniazid; Male; Mycobacterium bovis; Mycobacterium Infections; Rifampin; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
Miliary tuberculosis secondary to intravesical instillation of Bacillus Calmette-Guérin. Report of two cases.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Mycobacterium bovis; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Miliary; Urinary Bladder Neoplasms | 2021 |
Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population.
Topics: Administration, Oral; Adult; Antitubercular Agents; China; Drug Administration Schedule; Eating; Ethambutol; Fasting; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality.
Topics: Adult; Amikacin; Antibiotics, Antitubercular; APACHE; Brazil; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Intensive Care Units; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis | 2021 |
Point-of-Care Ultrasound Image of Intra-Abdominal Lymphadenopathy in Tuberculosis.
Topics: Abdomen; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lymph Nodes; Lymphadenopathy; Mycobacterium tuberculosis; Point-of-Care Systems; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis; Ultrasonography; Young Adult | 2020 |
Recurrent disseminated
Topics: Adult; Anti-Bacterial Agents; Asian People; Autoantibodies; Azithromycin; Bacteremia; Disease Progression; Ethambutol; Female; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon-gamma; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pericarditis; Pleurisy; Pneumonia, Bacterial; Recurrence; Rifampin; Rituximab; Thailand | 2021 |
A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Ethambutol; Female; Humans; Isoniazid; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2021 |
Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Azithromycin; Cross-Over Studies; Cystic Fibrosis; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 2021 |
Distribution and antibiotic sensitivity pattern of Mycobacterium tuberculosis isolates from children, enrolled in a tertiary care hospital.
Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pakistan; Rifampin; Streptomycin; Tertiary Care Centers; Tuberculosis, Pulmonary | 2021 |
A novel agar base medium for drug susceptibility testing of
Topics: Agar; Antitubercular Agents; Culture Media; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 2021 |
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
Topics: Aged; Amikacin; Antitubercular Agents; Azithromycin; Biomarkers; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Stem Cells | 2022 |
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.
Topics: Adult; Antitubercular Agents; Child; Child, Preschool; Ethambutol; Female; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis; World Health Organization | 2022 |
Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Transcriptome; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2021 |
Images in Clinical Tropical Medicine.
Topics: Adolescent; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Knee; Lupus Vulgaris; Male; Pyrazinamide; Rifampin | 2021 |
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Topics: Adult; Antitubercular Agents; Child; Drug Combinations; Ethambutol; Female; Humans; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tablets; Tuberculosis | 2022 |
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients.
Topics: Adult; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Ethambutol; Humans; Isoniazid; Plasma; Pyrazinamide; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2021 |
Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2022 |
Life-threatening Mycobacterium intracellulare pleuritis in an immunocompetent host: Case reports.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pleurisy; Rifampin; Tomography, X-Ray Computed | 2021 |
Importance of asking a social history: atypical pulmonary infections and occupational hazards.
Topics: Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis | 2022 |
Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Retrospective Studies; Rifampin; Treatment Outcome | 2022 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis.
Topics: Adult; Antitubercular Agents; Bacillus; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Sputum; Tuberculosis, Pulmonary | 2022 |
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
Topics: Animals; Antitubercular Agents; Clofazimine; Ethambutol; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
Topics: Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoniazid; Pyrazinamide; Republic of Korea; Rifampin | 2022 |
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node | 2022 |
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2022 |
Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study.
Topics: Antitubercular Agents; Child; Cohort Studies; Ethambutol; Female; Humans; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Tanzania; Tuberculosis; United States | 2022 |
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
Topics: Antitubercular Agents; Ethambutol; HIV Infections; Humans; Interferon-gamma; Isoniazid; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome | 2022 |
Prevalence and Drug Resistance Pattern of
Topics: Adolescent; Adult; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iraq; Isoniazid; Mycobacterium tuberculosis; Prevalence; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2022 |
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Topics: Clarithromycin; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Japan; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury.
Topics: Animals; Antitubercular Agents; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Ethambutol; Isoniazid; Liver; Pyrazinamide; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rifampin | 2022 |
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Community Health Services; Ethambutol; Humans; Internet; Isoniazid; Prevalence; Pyrazinamide; Rifampin; South Africa | 2022 |
Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.
Topics: Antitubercular Agents; Cohort Studies; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Evaluation of whole-genome sequence to predict drug resistance of nine anti-
Topics: Antitubercular Agents; Drug Resistance; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tanzania; Tuberculosis, Multidrug-Resistant | 2022 |
Tuberculosis: Common Questions and Answers.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Latent Tuberculosis; Pyrazinamide; Rifampin; Tuberculin; Tuberculosis; United States | 2022 |
Chronic purulent pericarditis: case report.
Topics: Adult; COVID-19; Ethambutol; Humans; Isoniazid; Male; Mediastinitis; Pericarditis; Pericardium; Pyrazinamide; Rifampin; Sclerosis; Suppuration | 2022 |
Distribution and Pattern of Anti-Tubercular Drug Resistance in Patients with Pulmonary Tuberculosis in Mymensingh Region of Bangladesh.
Topics: Antitubercular Agents; Bangladesh; Cross-Sectional Studies; Drug Resistance; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment.
Topics: Anti-Bacterial Agents; Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium kansasii; Retrospective Studies; Rifampin; Tuberculosis | 2023 |
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis | 2022 |
Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Female; Humans; Isoniazid; Milk, Human; Pyrazinamide; Rifabutin; Rifampin; Tandem Mass Spectrometry | 2022 |
Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2022 |
Topics: Ethambutol; Genotype; Humans; Isoniazid; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Rifampin; Timor-Leste | 2022 |
Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis.
Topics: Antitubercular Agents; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Substandard Drugs; Tablets; Tuberculosis | 2022 |
[An atypical presentation of tuberculosis].
Topics: Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Naringenin protects hepato-renal tissues against antituberculosis drugs induced toxic manifestations by modulating interleukin-6, insulin like growth factor-1, biochemical and ultra-structural integrity.
Topics: Animals; Antioxidants; Antitubercular Agents; Cytochrome P-450 CYP2E1; Ethambutol; Insulin-Like Growth Factor I; Interleukin-6; Isoniazid; Liver; Oxidative Stress; Pyrazinamide; Rats; Rats, Wistar; Rifampin | 2023 |
[A clinical case of occupational cutaneous tuberculosis in the healthcare field].
Topics: Biopsy; Delivery of Health Care; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Rifampin | 2022 |
Evaluation Study of xMAP TIER Assay on a Microsphere-Based Platform for Detecting First-Line Anti-Tuberculosis Drug Resistance.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
An efficient CRISPR interference-based prediction method for synergistic/additive effects of novel combinations of anti-tuberculosis drugs.
Topics: Antitubercular Agents; Clustered Regularly Interspaced Short Palindromic Repeats; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2022 |
Epidemiology-based wastewater monitoring for ecological risks of anti-tuberculosis drugs mixture effects.
Topics: Antitubercular Agents; Ethambutol; Isoniazid; Rifampin; Wastewater | 2023 |
A physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis | 2023 |
Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis.
Topics: Ethambutol; Fluoroquinolones; Humans; Isoniazid; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 2023 |
Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Topics: Antitubercular Agents; Bayes Theorem; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ethambutol; Humans; Isoniazid; Reference Standards; Rifampin; Tandem Mass Spectrometry; Tuberculosis | 2023 |
Clinical performance of nucleotide MALDI-TOF-MS in the rapid diagnosis of pulmonary tuberculosis and drug resistance.
Topics: Drug Resistance; Ethambutol; Humans; Isoniazid; Mycobacterium tuberculosis; Nucleotides; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Pulmonary | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |
Protein binding investigation of first-line and second-line antituberculosis drugs.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Moxifloxacin; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis | 2023 |